thyroxine has been researched along with Basedow Disease in 1362 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In spite of previous conflicting results, an adjuvant role of selenium in the treatment of Graves' disease (GD) hyperthyroidism has been proposed." | 9.24 | Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial. ( Bartalena, L; Di Cera, M; Ionni, I; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Masiello, E; Piantanida, E; Premoli, P; Rotondo Dottore, G; Sassi, L; Tanda, ML; Vitti, P, 2017) |
| "We conducted a retrospective review of Thai patients with Graves' disease (GD) who developed hypothyroidism following radioactive iodine treatment from 2016 to 2020 at Theptarin hospital." | 9.22 | Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens. ( Butadej, S; Chatchomchuan, W; Himathongkam, T; Mathiphanit, S; Nakasatien, S; Rajatanavin, R; Thewjitcharoen, Y; Wanothayaroj, E; Yenseung, N, 2022) |
| "Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 9.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
| "Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses." | 9.12 | Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. ( Fukata, S; Hamada, N; Itoh, K; Miyauchi, A; Nakamura, H; Noh, JY, 2007) |
| " This study evaluated the effect of methimazole pretreatment on the efficacy of 131I therapy in Graves' hyperthyroidism." | 9.09 | The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. ( Andrade, VA; Gross, JL; Maia, AL, 2001) |
| "To investigate the effect of thyroxine upon the prevention of recurrence of Graves disease after treatment by antithyroid drugs." | 9.09 | [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs]. ( Jie, Y; Situ, Y; Wu, G, 2001) |
| " We studied the effect of adjunctive antithyroid drugs (ATD) and L-thyroxine (L-T4) on the result of radioiodine (RAI) 131I therapy and determined the incidence of hypothyroidism and relapse of hyperthyroidism." | 9.08 | The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism. ( Cheng, AC; Kung, AW; Yau, CC, 1995) |
| " To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 9.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 9.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| " We, therefore, evaluated the effect of colestipol-hydrochloride administration on clinical and biochemical indices of patients with hyperthyroidism." | 9.08 | Role of colestipol in the treatment of hyperthyroidism. ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| "The levels of antibodies to TSH receptors were measured during treatment with methimazole, either alone or in combination with thyroxine, in 109 patients with hyperthyroidism due to Graves' disease." | 9.07 | Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. ( Arai, M; Hashizume, K; Ichikawa, K; Kobayashi, M; Miyamoto, T; Nagasawa, T; Sakurai, A; Suzuki, S; Takeda, T, 1991) |
| "In 28 patients with Graves' disease showing a wide range of thyroid function between the extremes of hypothyroidism and hyperthyroidism, the following parameters of peripheral thyroid function were measured: serum thyroxine concentration, serum-free thyroxine concentration, serum triiodothyronine concentration, and serum-free triiodothyronine concentration." | 9.04 | The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. ( Burke, G; Clifton-Bligh, P, 1975) |
| "Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterised by an abnormally increased affinity of albumin for serum thyroxine." | 8.31 | Familial dysalbuminemic hyperthyroxinemia combined with Graves' disease: a rare case report. ( Chai, X; Chi, Y; Li, N; Li, Y; Lian, X; Liu, H, 2023) |
| "Supraphysiological doses of biotin are being tested in patients with multiple sclerosis." | 7.88 | [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use]. ( de Heide, LJM; Lutgers, HL; Slim, CL; van den Berg, R; Wolthuis, A, 2018) |
| " Intra-amniotic levothyroxine (L-T4) administration was performed, and the fetal goiter decreased in size." | 7.85 | Fetal goitrous hypothyroidism treated by intra-amniotic levothyroxine administration: case report and review of the literature. ( Kobayashi, M; Naito, A; Nemoto, A; Saito, T; Sugita, K; Yagasaki, H, 2017) |
| "There is insufficient information about the appetite-related hormones orexin-A, nesfatin-1, agouti-related peptide (AgRP), and neuropeptide Y (NPY) in hyperthyroidism." | 7.81 | Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism. ( Akturk, M; Altinova, A; Arslan, M; Cerit, ET; Gulbahar, O; Sanlier, N; Tohma, Y; Toruner, F; Yassibas, E, 2015) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 7.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| " Therefore, chorea in this patient is associated with hyperthyroxinemia and not with autoantibodies." | 7.79 | Rising serum thyroxine levels and chorea in graves' disease. ( Alos, N; Carmant, L; Duval, M; Leblicq, C; Van Vliet, G, 2013) |
| " The Endocrine Society guidelines recommend the use of propylthiouracil as a first-line drug for thyrotoxicosis in pregnancy because of associations between carbimazole or methimazole and congenital anomalies." | 7.78 | Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. ( Bowman, P; Osborne, NJ; Sturley, R; Vaidya, B, 2012) |
| "RAI combined with lithium is safe and more effective than RAI alone in the cure of hyperthyroidism due to Graves' disease." | 7.76 | Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. ( Bartalena, L; Bogazzi, F; Campomori, A; Ceccarelli, C; Compri, E; Fessehatsion, R; Giovannetti, C; Martino, E; Pinchera, A; Rossi, G; Tanda, ML; Vitti, P, 2010) |
| " The H-TSH and N-TSH groups were similar in gross thyroid size, percentage of patients with exophthalmos, serum free thyroxine, duration of MMI treatment, TSAb status, duration that their TSAb tests remained negative, and thyroid peroxidase antibody titers." | 7.76 | Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease. ( Choo, YK; Chung, HK; Kim, DW; Yoo, WS, 2010) |
| "We report on a 32-year-old women who presented with persistent clinical and biochemical signs of hypothyroidism after thyroid surgery for Graves' disease despite high doses of levothyroxine replacement therapy." | 7.75 | [Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009]. ( Georges, G; Häring, HU; Klein, R; Mörike, K; Müssig, K; Schnauder, G; Sträter, J, 2009) |
| " Administration of the mAbs KSAb1 (IgG2b) or KSAb2 (IgG2a), which have similar stimulating properties but different TSH-binding blocking activity, resulted in significantly elevated serum thyroxine (T(4)) levels and thyroid hyperplasia." | 7.74 | Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. ( Banga, JP; David, CS; Flynn, JC; Gilbert, JA; Kong, YC; Meroueh, C; Snower, DP, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 7.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 7.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 7.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
| "With the aim of establishing optimal dosage schedules, 171 women with either overt (OH, n = 80) or subclinical (SCH, n = 91) hypothyroidism were assessed before and 6 months after starting L-thyroxine (LT4) replacement therapy." | 7.70 | Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage. ( Bossa, N; Pusiol, E; Rezzónico, JN; Rezzónico, M; Saravi, FD, 1999) |
| "Patients with primary thyroid failure on levothyroxine (LT4) replacement who develop nephrotic syndrome (NS) may rarely present with an increase in LT4 requirements." | 7.70 | Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome. ( Balow, JE; Collins, MT; Csako, G; Pucino, F; Remaley, AT; Sarlis, NJ; Skarulis, MC, 2000) |
| "In eight female patients with diagnosed Graves disease and 8 healthy control subjects (7 females and one male) several parameters of oxidative stress (the level of conjugated dienes [CD], malondialdehyde [MDA] and Schiff bases [SB]) were estimated before and during the treatment with methimazole (Metizol -POLFA) as well as by hormonal and immunological tests." | 7.70 | Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. ( Lewinski, A; Nowak, D; Sewerynek, J; Wiktorska, J, 2000) |
| "In order to differentiate silent thyroiditis (SLT) from Graves' disease, the usefulness of the measurement of the urinary concentration of iodine was evaluated in this study." | 7.69 | [Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease]. ( Iino, S; Ito, K; Momotani, N; Sugimoto, T, 1994) |
| " In this report we describe a patient with Graves' disease diagnosed in early pregnancy and treated with propylthiouracil, which resulted in a large fetal goitre and fetal hypothyroidism." | 7.69 | In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. ( Bos, AF; Derksen, JT; Rouwé, CW; Van Loon, AJ, 1995) |
| "We report a case of isolated levothyroxine malabsorption in the course of chronic intestinal giardiasis, leading to severe hypothyroidism." | 7.69 | Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism--implications for localization of thyroid hormone absorption in the gut. ( Rose, F; Schlaghecke, R; Seppel, T, 1996) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 7.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "Hypothyroxinemia and hypertriiodothyroninemia may occur in the course of antithyroid drug or 131I treatment for hyperthyroid Graves' disease and toxic multinodular goiter." | 7.68 | Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter. ( Akalin, S; Gedik, O; Ozdemir, T, 1991) |
| "Thyroxine replacement dose in 70 patients with post-radioiodine (for Graves' thyrotoxicosis) hypothyroidism was compared with that in 34 patients with autoimmune hypothyroidism matched for age and sex and diagnosed during the same period." | 7.68 | Thyroxine replacement in post-radioiodine hypothyroidism. ( Bearcroft, CP; Monson, JP; Noonan, K; Toms, GC; Williams, SJ, 1991) |
| "Serum fructosamine was measured in patients with Graves' disease and primary hypothyroidism." | 7.68 | [The significance of serum fructosamine measurement in patients with thyroid diseases]. ( Ban, Y; Hara, H; Ito, K; Kaihara, M; Kushima, K; Nagakura, H; Sato, R; Taniyama, M, 1990) |
| "Serum concentrations of total thyroxine (T4) and total triiodothyronine (T3) were measured in a group of patients (n = 113) presenting with untreated hyperthyroidism due to Graves' disease and in subjects receiving oral T4 replacement (n = 93) in whom the total T4 concentration was supraphysiological (greater than 150 nmol/l)." | 7.67 | Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement. ( Himsworth, RL; Pearce, CJ, 1984) |
| "Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma." | 7.67 | Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986) |
| "We assessed the post-natal thyroid function in eight infants of mothers with Graves' disease whose thyroid function at birth was suppressed by maternal ingestion of propylthiouracil during pregnancy." | 7.67 | Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. ( Ishikawa, N; Ito, K; Momotani, N; Noh, J; Yamashita, R; Yoshimoto, M, 1989) |
| "Nine patients with hyperthyroidism due to Graves' disease did not respond to therapy with very large doses (800 to 2000 mg/d) of propylthiouracil." | 7.67 | Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance. ( Cooper, DS, 1985) |
| "We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 7.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
| "This study describes a family with intrinsic thyroid disease in addition to familial dysalbuminemic hyperthyroxinemia, a syndrome associated with euthyroidism and increased binding of thyroxine to serum albumin." | 7.67 | Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease. ( Braverman, LE; Stoffer, SS; Young, RA, 1987) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 7.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 7.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
| "The serum triiodothyronine concentration is superior to the serum thyroxine concentration, the resin uptake test and the free thyroxine index in the diagnosis of hyperthyroidism." | 7.65 | Serum triiodothyronine concentration in the diagnosis of hyperthyroidism. ( Marsden, P; McKerron, CG, 1975) |
| "Compartmental analysis of the peripheral distribution of labeled thyroxine was applied to various groups of subjects with thyrotoxicosis and hypothyroidism." | 7.64 | Studies of peripheral thyroxine distribution in thyrotoxicosis and hypothyroidism. ( Dowling, JT; Nicoloff, JT, 1968) |
| "MP group than the TG group experienced adverse events." | 7.01 | Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial. ( Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H, 2021) |
| " No adverse cardiovascular event was reported." | 6.82 | Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study. ( Abdullah, AE; Archange, C; Baumstarck, K; Benisvy, D; Bournaud, C; Caron, P; Catargi, B; Cavarec, MB; Eberle, MC; Faugeron, I; Mundler, O; Schvartz, C; Taïeb, D; Toubert, ME, 2016) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 6.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "145 patients with Graves' disease were randomly divided into 3 groups and all patients initially received 30 mg of methimazole daily for at least 1 month and then followed the titration -regimen with or without L-thyroxine: group 1 (30 mg→20 mg→15 mg→10 mg→5 mg); group 2 (30 mg→20 mg→15 mg→10 mg+L-thyroxine→5 mg+L-thyroxine); group 3 (30 mg→20 mg→15 mg→10 mg+L-thyroxine→5 mg+L-thyroxine→2." | 6.79 | A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease. ( Gao, A; Gao, S; Liu, L; Liu, S; Liu, X; Qiang, W; Shi, B, 2014) |
| "We have presented a rare case of Graves' disease that was resistant to high-dose MMI." | 6.72 | Very rare case of Graves' disease with resistance to methimazole: a case report and literature review. ( Fukui, T; Hiromura, M; Kushima, H; Mori, Y; Ohara, M; Takahashi, Y; Terasaki, M; Yamagishi, SI, 2021) |
| "Of 346 patients with Graves' disease enrolled 225 were euthyroid 4 weeks after antithyroid drug withdrawal and were randomly assigned to receive levothyroxine (114 patients) or no treatment (controls, 111 patients)." | 6.70 | Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. ( Dettmann, J; Hackenberg, K; Hirche, H; Hoermann, R; Mann, K; Meng, W; Pfeilschifter, J; Prehn, B; Quadbeck, B; Reschke, K; Roggenbuck, U; Szabolcs, I, 2002) |
| "Medical treatment of Graves' disease involves antithyroid drugs with or without the addition of exogenous T4." | 6.69 | Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. ( Abbott, EC; Douglas, R; Givner, ML; Lehmann, L; Reddy, S; Rittmaster, RS; Salisbury, SR; Shlossberg, AH; Tan, MH; York, SE, 1998) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 6.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "Methimazole dose, pretreatment serum T3 levels, and goitre size are the main determinants of the therapeutic response to methimazole in Graves' disease, at least in areas comprising low, subnormal and normal iodine supply." | 6.68 | Response to methimazole in Graves' disease. The European Multicenter Study Group. ( Benker, G; Hirche, H; Kahaly, G; Raue, F; Reinwein, D; Tegler, L; Vitti, P, 1995) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 6.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "Medical treatment of Graves' disease involves use of antithyroid drugs with or without the addition of exogenous L-T4." | 6.68 | Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. ( Abbott, EC; Douglas, R; Givner, ML; Gupta, MK; Lehmann, L; Reddy, S; Rittmaster, RS; Salisbury, SR; Shlossberg, AH; Tan, MH; York, SE; Zwicker, H, 1996) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 6.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| "In both groups, recurrence of hyperthyroidism occurred, most commonly during the first 6 months (35% of HD and 44% of TD)." | 6.67 | Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose. ( Edmonds, CJ; Tellez, M, 1994) |
| "Graves' disease is the most common cause of hyperthyroidism." | 6.66 | Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review. ( Bai, L; Li, J; Wei, F; Wei, J; Wei, M; Xiao, Y; Yan, W, 2020) |
| "Thirty-four patients with Graves' disease, first rendered euthyroid with antithyroid drugs (ATD) then given supplementary thyroxine (T4), were randomly allocated to three treatment groups." | 6.66 | Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine. ( Hennebry, TM; Jarvis, KJ; Kaur, S; Lester, E; Parr, JH; Ramsay, ID, 1988) |
| "38 patients with Graves' disease were treated at random with the glucocorticosteroid betamethasone or with placebo." | 6.66 | Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease. ( Gamstedt, A; Kågedal, B; Tegler, L, 1988) |
| "Group II (18 patients) received no treatment." | 6.65 | Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease. ( Beck, JS; Crooks, J; Gunn, A; Isles, TE; Wilkin, TJ, 1979) |
| "Current therapy of Graves' disease is symptomatically effective in eliminating hyperthyroidism but is not directed towards the immunological cause of the disease." | 6.40 | [Administration of levothyroxine in the treatment of Basedow disease]. ( Hörmann, R, 1999) |
| "Biotin is a water-soluble vitamin that acts as a cofactor for carboxylase, and is often used as a component in several immunoassays." | 5.91 | Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report. ( Emoto, M; Fujiwara, N; Hamaoka, A; Inami, M; Kamei, N; Morioka, T; Shimmaru, K, 2023) |
| " We aimed to (a) develop a mathematical model capturing the dynamics of free thyroxine (FT4) during MMI treatment (b), validate this model by use of numerical simulation in comparison with real-life patient data (c), develop the software application Digital Thyroid (DigiThy) serving either as a practice tool for treating virtual patients or as a decision support system with dosing recommendations for MMI, and (d) validate this software framework by comparing the efficacy of its MMI dosing recommendations with that from clinical endocrinologists." | 5.72 | Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves' Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method. ( Benninger, T; Pilz, S; Reichhartinger, M; Theiler-Schwetz, V; Trummer, C, 2022) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 5.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "Initial treatment options for Graves' disease include antithyroid drugs, radioactive iodine (RAI), and surgery." | 5.56 | The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study. ( Choi, JY; Chung, JH; Kim, HI; Kim, SW; Kim, TH; Park, H; Park, J; Park, SY, 2020) |
| "A 31-year-old woman had unstable thyroid function during the third trimester of pregnancy, making it impossible to reduce her dosage of antithyroid medication." | 5.56 | Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report. ( Adachi, H; Ariake, C; Fujishima, A; Fukuoka, Y; Kameyama, S; Miura, H; Sato, A; Shimoda, Y; Terada, Y, 2020) |
| "Fetal goitrous hypothyroidism is a rare entity and is caused mainly by maternal treatment of Graves' disease (GD)." | 5.51 | Graves' disease complicated by fetal goitrous hypothyroidism treated with intra-amniotic administration of levothyroxine. ( Campos, RA; Castro, JM; Machado, CM; Oliveira, MJ, 2019) |
| "Severe hyperthyroidism, with particularly high TRAb concentrations at diagnosis, may facilitate the identification of patients requiring regular serum fT3 determinations and potentially needing higher doses of ATD dosage during follow-up." | 5.42 | Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications. ( Alberti, C; Boizeau, P; Carel, JC; Chevenne, D; Guilmin Crepon, S; Harvengt, J; Léger, J; Paulsen, A; Simon, D; Zenaty, D, 2015) |
| "Overt hyperthyroidism, defined as suppressed thyrotropin (previously thyroid-stimulating hormone) and high concentration of triiodothyronine (T3) and/or free thyroxine (FT4), affects approximately 0." | 5.41 | Hyperthyroidism: A Review. ( Lee, SY; Pearce, EN, 2023) |
| "After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges." | 5.40 | A case of fetal hyperthyroidism treated with maternal administration of methimazole. ( Hayashi, S; Ishii, K; Mitsuda, N; Murata, M; Sasahara, J; Sato, Y, 2014) |
| "Thyrotoxicosis is a rare clinical syndrome resulting from an exacerbation of hyperthyroidism, with various etiology and triggering factors." | 5.39 | [Plasmapheresis before thyroidectomy in a patient with thyrotoxicosis and hepatotoxicity by propylthiouracil: case report]. ( Almeida, RF; Comarella, AP; Ferri Casini, A; Silva, AR; Silveira, MB, 2013) |
| "The duration of time required for normalization of serum free T4 on initial treatment and the incidence of adverse effects for 1 year after the start of MMI were compared." | 5.38 | Higher dose of methimazole causes frequent adverse effects in the management of Graves' disease in children and adolescents. ( Inomata, H; Kazukawa, I; Kohno, Y; Konda, S; Minagawa, M; Minamitani, K; Sanayama, K; Sasaki, N; Sato, H; Sugihara, S; Wataki, K, 2012) |
| "3,5,3'-triiodothyronine-predominant Graves' disease (T(3)-P-GD) is characterized by a persistently high serum T(3) level and normal or even lower serum thyroxine (T(4)) level during antithyroid drug therapy." | 5.37 | Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease. ( Amino, N; Ito, M; Iwasaka, T; Miyauchi, A; Nishikawa, M; Nomura, E; Takamatsu, J; Takamura, Y; Toyoda, N, 2011) |
| "Treatment of Graves' disease during pregnancy with antithyroid drugs (ATDs) poses a risk of inducing hypothyroidism and, thus, development of a goiter to the fetus." | 5.37 | Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine. ( Bliddal, S; Brocks, V; Feldt-Rasmussen, U; Rasmussen, ÅK; Skovbo, P; Sundberg, K, 2011) |
| " The optimal management strategy for thyroid hormone dosing in hypothyroid women during pregnancy is controversial." | 5.35 | The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. ( Burman, KD; Jonklaas, J; Loh, JA; Wartofsky, L, 2009) |
| "Propylthiouracil 300 mg/day was started for each patient at the time of diagnosis and doses were titrated according to repeat thyroid studies." | 5.35 | Predictors of time to remission and treatment failure in patients with Graves' disease treated with propylthiouracil. ( Akdemir, N; Bilir, C; Buyukkaya, R; Cinemre, H; Erdogmus, B; Gokosmanoglu, F, 2009) |
| "Methimazole treatment resulted in all markers being normalized in the patients without infiltrative ophthalmopathy, yet oxidative stress was still present in the ophthalmopathy group." | 5.33 | Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. ( Bednarek, J; Sowiński, J; Wysocki, H, 2005) |
| "The diagnosis of thyrotoxicosis due to Graves' disease was made." | 5.32 | Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report. ( Agarwal, A; Dhiraaj, S; Pandey, CK; Raza, M; Singh, PK, 2004) |
| "Leptin is a protein product of the ob gene, mainly produced by adipocytes." | 5.31 | Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors. ( Abe, Y; Ashizawa, K; Eguchi, K; Ejima, E; Ide, A; Imaizumi, M; Ohmoto, Y; Sera, N; Tominaga, T; Usa, T; Yokoyama, N, 2000) |
| "Likelihood ratio of Graves' disease in case of prediction by the index is 4." | 5.31 | [An index based on the age and free thyroxine rate predicts the likelihood of Graves' disease in hyperthyroidism]. ( Fain, O; Guilpain, P; Kettaneh, A; Pariès, J; Sitbon, M; Thomas, M, 2001) |
| "One hundred seven patients with Graves' disease were treated with methimazole (MMI)." | 5.31 | Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. ( Komiya, I; Kouki, T; Nishimori, T; Sato, A; Takasu, N; Yamada, T, 2001) |
| "Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI." | 5.29 | Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 5.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "Thirty patients with Graves' disease without previous treatment for hyperthyroidism were included." | 5.29 | Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose. ( Cavaliere, H; Knobel, M; Lima, N; Medeiros-Neto, G; Perozim, LM, 1993) |
| "A 46-year-old woman with hypothyroid Graves' disease (EMO syndrome) is reported." | 5.29 | Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit. ( Fujiwara, K; Hayakawa, K; Koh, T; Koshiyama, H; Mori, S, 1993) |
| "No ipodate was discontinued in the eight patients who did not respond, and they were then treated with MMI." | 5.29 | Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| "Some patients with Graves' disease respond well to anti-thyroid drug treatment but others do not." | 5.29 | The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease. ( Andoh, S; Gemma, R; Mori, T; Nakamura, H; Suzuki, Y; Yoshimi, T, 1996) |
| "Seventy-eight patients with Graves' disease had been treated with MMI for 1-3 yr before pregnancy, and MMI was discontinued 5-6 months after the onset of pregnancy because the levels of antibodies to TSH receptors decreased during early pregnancy." | 5.28 | Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. ( Hashizume, K; Ichikawa, K; Kobayashi, M; Miyamoto, T; Nishii, Y; Sakurai, A; Suzuki, S; Takeda, T, 1992) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 5.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "Two patients with Graves' disease treated with methimazole (MMI) showed a discrepancy between serum free T4 (FT4) values and other hormone values (especially total T4) which was due to the presence of potent binding activity to labelled T4 analogue (125I-aT4) in their serum." | 5.28 | [Studies on thyroid hormone autoantibody (THAA) in 2 cases of Graves' disease with spuriously high free thyroxine values]. ( Fukasawa, N; Hara, Y; Hase, K; Iitaka, M; Ishii, J; Miura, S; Sakatume, Y; Yanagisawa, M, 1991) |
| "NK activity in the Graves' disease patients, however, did not increase when either the NT or HT medium was used at E : T ratios of 25 : 1 and 50 : 1." | 5.28 | Defective response of natural killer activity to thyroxine in Graves' disease. ( Hong, SW; Hong, WS; Kang, TW; Lee, JO; Lee, MS, 1990) |
| "The performed studies covered 48 subjects, inhabiting the Western Pomerania, therein 40 patients with hyperthyroidism in the course of Graves-Basedow's disease (32 females and 8 males, aged 21-64 years) as well as 8 healthy individuals (5 females and 3 males, aged 23-36 years, with negative anamnesis towards thyroid diseases), who made up the control group at determining the pharmacokinetic parameters after a single oral dose containing 60 mg of thiamazole." | 5.28 | [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics]. ( Syrenicz, A, 1990) |
| "The sera from two patients with Graves' disease gave abnormally high serum free T4 values as compared with the total T4 and other hormone values, suggesting the presence of autoantibodies to labelled T4 analogue used in the Amersham free T4 assay kit." | 5.28 | The mechanism for the discrepancy between serum total and free thyroxine values induced by autoantibodies: report on two patients with Graves' disease. ( Fukasawa, N; Hara, Y; Hase, K; Iitaka, MI; Ishii, J; Miura, S; Sakatsume, Y; Yanagisawa, M, 1990) |
| " For several years following treatment, the patient displayed clinical hypothyroidism and persistently low serum thyroxine (T4) and triiodothyronine (T3) levels despite large T4 replacement dosage (0." | 5.28 | Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy. ( Bregant, R; Burman, KD; Burns, TW; Premachandra, BN; Williams, IK, 1989) |
| "In 50 consecutive patients with Graves' disease treated with PTU, 7 (group 1) developed increasing goitre in spite of unmeasurable TSH." | 5.27 | Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment. ( Andersen, E; Bech, K; Bliddal, H; Hansen, JM; Hansen, P; Hegedüs, L; Jensen, K; Kampmann, JP; Karstrup, S, 1984) |
| "Propranolol was also given for the first 3 weeks." | 5.27 | Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. ( Beardwell, CG; Davies, D; Longson, D; MacFarlane, IA; Shalet, SM, 1983) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 5.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "In 49 patients with Graves' disease, the 20-min thyroidal uptake of 99mTc and serum levels of thyroid stimulating hormone (TSH) receptor antibody were estimated at presentation and at intervals during a 1-yr course of carbimazole and triiodothyronine." | 5.27 | Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. ( Cuthbert, GF; McKillop, JH; Pearson, DW; Thomson, JA; Wilson, R, 1985) |
| "Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs." | 5.27 | Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. ( Hosoya, T; Kohno, Y; Kuma, K; Mozai, T; Naito, N; Sakane, S; Takamatsu, J; Takeda, K; Tarutani, O; Yoshimura, H, 1988) |
| "The iodine content of Tg was 28 +/- 3." | 5.27 | Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. ( Laurberg, P, 1987) |
| "Of 47 patients with hyperthyroid Graves' disease, 37 patients had a serum T3 to T4 ratio greater than 20 ng/micrograms before therapy (normal range, 12-20; mean, 16." | 5.27 | Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. ( Kuma, K; Mozai, T; Takamatsu, J, 1986) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 5.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "In 272 patients with Graves' disease, 209 of 240 (87%) untreated patients without complications had high T3 to T4 ratios (nanograms per micrograms) of more than 20." | 5.26 | Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. ( Amino, N; Iwatani, Y; Kumahara, Y; Miki, T; Miyai, K; Mori, H; Morimoto, S; Nakatani, K; Nishi, K; Yabu, Y, 1981) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 5.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| " High pretreatment T3 values were comparatively common among patients in whom a fixed CMI dosage had a insufficient effect." | 5.26 | Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen. ( Dahlberg, PA; Karlsson, FA; Lindström, B; Wide, L, 1981) |
| "In Tg from patients with treated Graves' disease, iodine, T(3), and T(4) were reduced, but the reduction in the latter was more substantial, resulting in a T(4)/T(3) molar ratio of 3." | 5.26 | Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. ( Izumi, M; Larsen, PR, 1977) |
| " Lithium carbonate was administered for 4-7 weeks in a dosage (900 mg/day) which maintained serum lithium levels between 0." | 5.26 | Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. ( Burman, KD; Dimond, RC; Earll, JM; Wartofsky, L; Wright, FD, 1976) |
| "The 13 patients with Graves' disease were divided into three groups." | 5.25 | Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. ( Larsen, PR, 1975) |
| "In spite of previous conflicting results, an adjuvant role of selenium in the treatment of Graves' disease (GD) hyperthyroidism has been proposed." | 5.24 | Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial. ( Bartalena, L; Di Cera, M; Ionni, I; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Masiello, E; Piantanida, E; Premoli, P; Rotondo Dottore, G; Sassi, L; Tanda, ML; Vitti, P, 2017) |
| "We conducted a retrospective review of Thai patients with Graves' disease (GD) who developed hypothyroidism following radioactive iodine treatment from 2016 to 2020 at Theptarin hospital." | 5.22 | Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens. ( Butadej, S; Chatchomchuan, W; Himathongkam, T; Mathiphanit, S; Nakasatien, S; Rajatanavin, R; Thewjitcharoen, Y; Wanothayaroj, E; Yenseung, N, 2022) |
| "Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 5.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
| "Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses." | 5.12 | Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. ( Fukata, S; Hamada, N; Itoh, K; Miyauchi, A; Nakamura, H; Noh, JY, 2007) |
| " In view of the increased enterohepatic circulation of thyroxine (T4) and triiodothyronine (T3) in thyrotoxicosis, and metabolic effects of konjac glucomannan in gastrointestinal system, we aimed to determine the activity of glucomannan in treatment of hyperthyroidism." | 5.12 | The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. ( Azezli, AD; Bayraktaroglu, T; Orhan, Y, 2007) |
| "To test whether thyroid hormone regulates MBL levels, we studied eight patients with Graves' hyperthyroidism before and after methimazole therapy, eight healthy subjects before and after short-term experimental hyperthyroidism, and eight hypothyroid patients with chronic auto-immune thyroiditis before and after L-thyroxine substitution." | 5.11 | Thyroid hormone increases mannan-binding lectin levels. ( Gjedde, S; Gormsen, LC; Gravholt, CH; Hansen, TK; Jørgensen, JO; Møller, N; Riis, AL; Thiel, S; Weeke, J, 2005) |
| " This study evaluated the effect of methimazole pretreatment on the efficacy of 131I therapy in Graves' hyperthyroidism." | 5.09 | The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. ( Andrade, VA; Gross, JL; Maia, AL, 2001) |
| "To investigate the effect of thyroxine upon the prevention of recurrence of Graves disease after treatment by antithyroid drugs." | 5.09 | [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs]. ( Jie, Y; Situ, Y; Wu, G, 2001) |
| " We studied the effect of adjunctive antithyroid drugs (ATD) and L-thyroxine (L-T4) on the result of radioiodine (RAI) 131I therapy and determined the incidence of hypothyroidism and relapse of hyperthyroidism." | 5.08 | The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism. ( Cheng, AC; Kung, AW; Yau, CC, 1995) |
| " To investigate this discrepancy we determined TNF-alpha and interleukin 6 (IL-6) levels in 25 hyperthyroid patients who responded to propylthiouracil treatment (16 with Graves' disease and nine with toxic multinodular goiter) and compared them with the levels found in euthyroid patients with simple diffuse goiter (n = 15) and normal healthy controls (n = 15)." | 5.08 | Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. ( Akalin, S; Celik, I; Erbaş, T, 1995) |
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 5.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| " We, therefore, evaluated the effect of colestipol-hydrochloride administration on clinical and biochemical indices of patients with hyperthyroidism." | 5.08 | Role of colestipol in the treatment of hyperthyroidism. ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| " All the patients received thyroxine to avert hypothyroidism, except those treated with iodine-131, who received thyroxine only if hypothyroidism developed." | 5.07 | Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. ( Blomgren, H; Ljunggren, JG; Lundell, G; Tallstedt, L; Taube, A; Tørring, O; Wallin, G, 1992) |
| "The levels of antibodies to TSH receptors were measured during treatment with methimazole, either alone or in combination with thyroxine, in 109 patients with hyperthyroidism due to Graves' disease." | 5.07 | Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. ( Arai, M; Hashizume, K; Ichikawa, K; Kobayashi, M; Miyamoto, T; Nagasawa, T; Sakurai, A; Suzuki, S; Takeda, T, 1991) |
| " The patient complained about fatigue and myalgia 7 weeks after receiving methimazole (MMI) treatment." | 5.05 | Myopathy after rapid correction of hyperthyroidism: A case report and review of literature. ( Gao, H; Hong, T; Lu, R; Wang, H, 2020) |
| "In 28 patients with Graves' disease showing a wide range of thyroid function between the extremes of hypothyroidism and hyperthyroidism, the following parameters of peripheral thyroid function were measured: serum thyroxine concentration, serum-free thyroxine concentration, serum triiodothyronine concentration, and serum-free triiodothyronine concentration." | 5.04 | The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. ( Burke, G; Clifton-Bligh, P, 1975) |
| "" If eradication of thyroid hormone excess suffices for the label "cure," then all patients can be cured because total thyroidectomy or high doses of ¹³¹I will abolish hyperthyroidism albeit at the expense of creating another disease (hypothyroidism) requiring lifelong medication with levothyroxine." | 5.01 | Graves' Disease: Can It Be Cured? ( Wiersinga, WM, 2019) |
| " For goitrous fetal hypothyroidism leading to hydramnios, repeated intra-amniotic injections of thyroxine have been reported to decrease the size of the fetal thyroid." | 4.90 | Fetal thyroïdology. ( Luton, D; Polak, M, 2014) |
| " The male infant who was born by spontaneous delivery at 35 weeks of gestational age presented with fever, tachycardia and tachypnea at rest on day 11 after birth, and developed severe apnea on day 14." | 4.89 | [Neonatal hyperthyroidism: a case report and literature review]. ( Li, N; Li, XH; Yao, YM, 2013) |
| " More solid evidence, based on still lacking well-conducted controlled studies, is desirable to determine if there is a therapeutic role for L-thyroxine treatment in ameliorating the skin manifestations of urticaria." | 4.87 | Urticaria and thyroid autoimmunity. ( Bagnasco, M; Benvenga, S; Gangemi, S; Minciullo, PL; Saraceno, GS, 2011) |
| " For goitrous fetal hypothyroidism leading to hydramnios, repeated intra-amniotic injections of thyroxine have been reported to decrease the size of the fetal thyroid." | 4.87 | Thyroid disorders during pregnancy: impact on the fetus. ( Polak, M, 2011) |
| " Continued thyroxine treatment following initial antithyroid therapy does not appear to provide any benefit in terms of recurrence of hyperthyroidism." | 4.86 | Antithyroid drug regimen for treating Graves' hyperthyroidism. ( Abraham, P; Avenell, A; Bevan, JS; Clark, LF; McGeoch, SC, 2010) |
| " The aim of treating hyperthyroidism in pregnancy with antithyroid drugs is to maintain serum thyroxine (T(4)) in the upper normal range of the assay used with the lowest possible dose of drug, whereas in hypothyroidism, the goal is to return serum thyroid-stimulating hormone (TSH) to the range between 0." | 4.85 | Autoimmune thyroid disease in pregnancy: a review. ( Davies, TF; Galofre, JC, 2009) |
| " Continued thyroxine treatment following initial antithyroid therapy does not appear to provide any benefit in terms of recurrence of hyperthyroidism." | 4.82 | Antithyroid drug regimen for treating Graves' hyperthyroidism. ( Abraham, P; Avenell, A; Bevan, JS; Park, CM; Watson, WA, 2005) |
| " With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values." | 4.79 | Detection and treatment of hypothyroidism and Graves' disease. ( Gharib, H; Hurley, DL, 1995) |
| "Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterised by an abnormally increased affinity of albumin for serum thyroxine." | 4.31 | Familial dysalbuminemic hyperthyroxinemia combined with Graves' disease: a rare case report. ( Chai, X; Chi, Y; Li, N; Li, Y; Lian, X; Liu, H, 2023) |
| "Euthyroidism was defined as both serum thyrotropin (thyroid-stimulating hormone [TSH]) and free thyroxine (FT4) within their reference ranges or, when only one was available, it was within its reference range; hypothyroidism as TSH ≥ 10 mU/L, or subnormal FT4 regardless of TSH; hyperthyroidism as TSH below and FT4 above their reference ranges; dysthyroidism as the sum of hypo- and hyperthyroidism; subclinical hypothyroidism as normal FT4 and TSH between the upper limit of normal and <10 mU/L; and subclinical hyperthyroidism as low TSH and normal FT4." | 4.12 | Postradioiodine Graves' management: The PRAGMA study. ( Abraham, P; Atkin, SL; Basu, A; Bennett, S; Boelaert, K; Crown, A; Dayan, C; Drake, WM; Falinska, A; Gibb, FW; Gilbert, J; Gleeson, H; Grossman, A; Hickey, J; Jarvis, S; Johnson, A; Johnston, C; Jones, TH; Karavitaki, N; Lazarus, JH; Leese, GP; Levy, MJ; Madathil, A; Malik, I; Mishra, B; Moran, C; Nag, S; Orme, SM; Pariani, N; Perros, P; Plummer, Z; Ray, DW; Razvi, S; Rees, A; Sanderson, V; Sathyapalan, T; Sturrock, N; Syed, AA; Vaidya, B; Velusamy, A; Williams, GR; Žarković, MP, 2022) |
| "The hyperthyroid mother underwent subtotal thyroidectomy before pregnancy and regularly took levothyroxine to avoid hypothyroidism, but still had a high-level thyroid-stimulating hormone receptor antibody (TRAb)." | 4.12 | A hypothyroid mother after subtotal thyroidectomy delivered a newborn with hyperthyroidism from fetal stage: a case report. ( Fan, L; Gao, Y; Hou, X; Li, L; Peng, C; Sun, W; Zhang, X, 2022) |
| "5%) required further levothyroxine (L-T4) supplementation due to CeH or, in one case, due to primary hypothyroidism." | 4.12 | Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism. ( Kucharska, A; Pyrżak, B; Rumińska, M; Witkowska-Sędek, E, 2022) |
| " The patient complained of myalgia two weeks after methimazole treatment." | 4.02 | Myopathy Associated with Treatment of Graves' Disease. ( Ji, YK; Kim, SH, 2021) |
| "Mendelian randomization analyses for stroke and CAD using genetic instruments associated with normal range thyrotropin (TSH) and free thyroxine levels or Hashimoto's thyroiditis and Graves' disease." | 3.96 | Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study. ( Chaker, L; Del Greco M, F; Deloukas, P; Kus, A; Marouli, E; Medici, M; Peeters, R; Teumer, A, 2020) |
| "GD = Graves disease; hCG = human chorionic gonadotropin; MMI = methimazole; PPT = postpartum thyroiditis; PTU = propylthiouracil; T3 = triiodothyronine; T4 = thyroxine; TBG = thyroxine-binding globulin; TRAb = TSH receptor antibody; TSH = thyroid-stimulating hormone." | 3.91 | MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD. ( Pearce, EN, 2019) |
| " They had been euthyroid on stable doses of levothyroxine for many years, and they presented to our clinic with clinically and biochemically overt hyperthyroidism that persisted even after stopping levothyroxine." | 3.91 | Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles - a case series. ( Clark, SN; Kafrouni Gerges, AR; Shawa, H, 2019) |
| "Supraphysiological doses of biotin are being tested in patients with multiple sclerosis." | 3.88 | [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use]. ( de Heide, LJM; Lutgers, HL; Slim, CL; van den Berg, R; Wolthuis, A, 2018) |
| "In a 36-year-old patient with post-surgery hypothyroidism, thyrotropin values ranged between 100 and 400 mUI/L, although daily replacement therapy included 300 μg of L-thyroxine and 75 μg of L-triiodothyronine." | 3.85 | [Once weekly L-thyroxine treatment in non-compliance: A case report]. ( Grino, M; Moatti Vacher-Coponat, P; Morange, I; Oliver, C; Retornaz, F, 2017) |
| " Intra-amniotic levothyroxine (L-T4) administration was performed, and the fetal goiter decreased in size." | 3.85 | Fetal goitrous hypothyroidism treated by intra-amniotic levothyroxine administration: case report and review of the literature. ( Kobayashi, M; Naito, A; Nemoto, A; Saito, T; Sugita, K; Yagasaki, H, 2017) |
| "ATD = antithyroid drug CBZ = carbimazole FT3 = free T3 FT4 = free T4 GD = Graves disease GO = Graves orbitopathy MENA = Middle East and North Africa MMI = methimazole RAI = radioactive iodine RAIU = RAI uptake T3 = tri-iodothyronine T4 = thyroxine TG Ab = antithyroglobulin antibodies TRAb = TSH-receptor autoantibody TSH = thyroid-stimulating hormone PTU = propylthiouracil TID = thrice daily UAE = United Arab Emirates US = ultrasound." | 3.85 | A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA. ( Alzahrani, AS; Benbarka, MM; Beshyah, SA; Chadli, A; Hussein, W; Khalil, AB; Raza, SA; Sherif, IH, 2017) |
| " The preferred ATD in pregnancy is propylthiouracil in the first trimester and methimazole in the second and third trimesters, similar to North America." | 3.83 | A 2013 European survey of clinical practice patterns in the management of Graves' disease. ( Bartalena, L; Burch, HB; Burman, KD; Kahaly, GJ, 2016) |
| " With current dosing schemes, the vast majority of patients develop permanent post-RAI hypothyroidism and are placed on life-long levothyroxine therapy." | 3.83 | Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests. ( Doi, SA; Sheehan, MT, 2016) |
| "There is insufficient information about the appetite-related hormones orexin-A, nesfatin-1, agouti-related peptide (AgRP), and neuropeptide Y (NPY) in hyperthyroidism." | 3.81 | Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism. ( Akturk, M; Altinova, A; Arslan, M; Cerit, ET; Gulbahar, O; Sanlier, N; Tohma, Y; Toruner, F; Yassibas, E, 2015) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 3.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| " Serum levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4), TSH-receptor antibody (TRAb), the duration of hyperthyroidism in pregnancy, doses of antithyroid medication, and the duration of maternal antithyroid medication throughout pregnancy were compared." | 3.80 | Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease. ( Ebina, Y; Morioka, I; Tairaku, S; Tanimura, K; Uenaka, M; Yamada, H, 2014) |
| " All patients received the measurements of Zung Self-Rating Depression Scale (SDS) and serum thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and TSH receptor antibodies (TRAb)." | 3.80 | [Relationship between depression and thyroid hormone levels in patients with Graves disease]. ( Huang, H; Yan, YR; Yan, Z; Zeng, J, 2014) |
| " All women were treated with levothyroxine (L-T₄) during pregnancy." | 3.79 | Pregnancy outcomes in women with severe hypothyroidism. ( Hirsch, D; Kopel, V; Levy, S; Nadler, V; Shainberg, B; Toledano, Y, 2013) |
| "To characterize thyroid hormone levels at the time of diagnosis in the nosological types of thyrotoxicosis diagnosed in the population and to analyze determinants for serum thyroxine (T4) and tri-iodothyronine (T3)." | 3.79 | Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. ( Carlé, A; Knudsen, N; Laurberg, P; Ovesen, L; Pedersen, IB; Perrild, H; Rasmussen, LB, 2013) |
| " We assessed the subjects according to the Simplified Menopause Index, menstrual status, thyroid hormone measurements (thyroid stimulating hormone, free thyroxine, free triiodothyronine), the presence of Hashimoto's disease antibodies (anti-thyroid peroxidase antibody or anti-thyroglobulin antibody), the presence of Grave's disease (anti-TSH receptor antibody), markers of thyroid tumor (high thyroglobulin), and thyroid ultrasonography studies." | 3.79 | Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years. ( Ohi, K; Oi, N, 2013) |
| " Therefore, chorea in this patient is associated with hyperthyroxinemia and not with autoantibodies." | 3.79 | Rising serum thyroxine levels and chorea in graves' disease. ( Alos, N; Carmant, L; Duval, M; Leblicq, C; Van Vliet, G, 2013) |
| " The Endocrine Society guidelines recommend the use of propylthiouracil as a first-line drug for thyrotoxicosis in pregnancy because of associations between carbimazole or methimazole and congenital anomalies." | 3.78 | Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. ( Bowman, P; Osborne, NJ; Sturley, R; Vaidya, B, 2012) |
| "RAI combined with lithium is safe and more effective than RAI alone in the cure of hyperthyroidism due to Graves' disease." | 3.76 | Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. ( Bartalena, L; Bogazzi, F; Campomori, A; Ceccarelli, C; Compri, E; Fessehatsion, R; Giovannetti, C; Martino, E; Pinchera, A; Rossi, G; Tanda, ML; Vitti, P, 2010) |
| "Urinary calcium (dUCa) and serum level of TSH, FT4 and of bone turnover markers (BTMs) such as alkaline phosphatase (ALP), osteocalcin (OC), cross linked N-telopeptide of type 1 collagen (NTx) as well as lumbar spine L 1-4 (BMD-L) and femoral hip (BMD-F) mineral density were determined in 113 postmenopausal women consisting of 42 patients with Graves disease treated by carbimazole, 32 patients with thyroid cancer treated with L-thyroxine and 39 age matched women without any thyroid and osteological disorders." | 3.76 | The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women. ( Baqi, L; Cierny, D; Jackuliak, P; Killinger, Z; Langer, P; Payer, J; Susienkova, K, 2010) |
| " The patient subsequently developed hypothyroidism and required a much higher dose of levothyroxine than his weight-based estimate of a full replacement dose to maintain euthyroidism." | 3.76 | Resistance to thyroid hormone in a patient with coexisting Graves' disease. ( Chaidarun, S; Sivakumar, T, 2010) |
| " The H-TSH and N-TSH groups were similar in gross thyroid size, percentage of patients with exophthalmos, serum free thyroxine, duration of MMI treatment, TSAb status, duration that their TSAb tests remained negative, and thyroid peroxidase antibody titers." | 3.76 | Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease. ( Choo, YK; Chung, HK; Kim, DW; Yoo, WS, 2010) |
| "In Sapporo city of Japan, neonatal screening for congenital hypothyroidism has used the measurement of free thyroxine (T4) and thyroid-stimulating hormone (TSH) in the filter-paper blood spot." | 3.75 | Elevated free thyroxine levels detected by a neonatal screening system. ( Fujieda, K; Fujikura, K; Fukushi, M; Jo, W; Tajima, T, 2009) |
| "We report on a 32-year-old women who presented with persistent clinical and biochemical signs of hypothyroidism after thyroid surgery for Graves' disease despite high doses of levothyroxine replacement therapy." | 3.75 | [Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009]. ( Georges, G; Häring, HU; Klein, R; Mörike, K; Müssig, K; Schnauder, G; Sträter, J, 2009) |
| " Despite severe thyrotoxicosis, combined IFN-alpha and ribavirin therapy was continued and radioiodine treatment was considered for Graves' disease." | 3.74 | IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report. ( Duncea, I; Pepene, CE, 2008) |
| " Here we report an unusual case with radiation-induced hypothyroidism who had undergone hemithyroidectomy for adenomatous goiter 8 years before the radiotherapy for nasopharyngeal cancer and subclinical hyperthyroidism due to Graves' disease developed during thyroxine replacement therapy." | 3.74 | Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Ozaki, H; Yoshida, K, 2007) |
| " Administration of the mAbs KSAb1 (IgG2b) or KSAb2 (IgG2a), which have similar stimulating properties but different TSH-binding blocking activity, resulted in significantly elevated serum thyroxine (T(4)) levels and thyroid hyperplasia." | 3.74 | Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. ( Banga, JP; David, CS; Flynn, JC; Gilbert, JA; Kong, YC; Meroueh, C; Snower, DP, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 3.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "We experienced a case of fetal goitrous hypothyroidism in an infant delivered by a 33-year-old woman receiving 300 mg/day of propylthiouracil (PTU) for hyperthyroidism due to Graves' disease." | 3.74 | Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation. ( Abe-Gotyo, N; Eto, Y; Kanno, K; Miyata, I; Seo, M; Sugiura, K; Tajima, A; Tanaka, T; Teramoto, S; Yoshikawa, H, 2007) |
| "A unique case of fetal goiter accompanied by bilateral ovarian cysts in a mother treated with methimazole for Graves'disease is reported." | 3.74 | Fetal goiter and bilateral ovarian cysts. ( Juul, A; Lassen, PD; Skibsted, L; Sundberg, K, 2008) |
| "3% of diagnosable samples showed unambiguous hyperthyroidism or triiodothyronine (T3) toxicosis, 16." | 3.73 | Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. ( Boudreau, C; Slyper, AH; Wyatt, D, 2005) |
| "To examine the natural history of a subnormal serum thyroid-stimulating hormone (TSH) concentration with normal concentrations of both serum free thyroxine (FT4) and free triiodothyronine (FT3) (subclinical hyperthyroidism)." | 3.73 | Observations concerning the natural history of subclinical hyperthyroidism. ( Woeber, KA, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| " For fetal hyperthyroidism, the mother received antithyroid drugs; for fetal hypothyroidism, maternal antithyroid treatment was reduced, and thyroxine was injected into the amniotic sac." | 3.72 | Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. ( Nachum, Z; Rakover, Y; Shalev, E; Weiner, E, 2003) |
| " For the diagnosis of autoimmune thyroiditis, blood levels of thyrotropin (TSH), free thyroxine (FT4), and the titration of thyroid autoantibodies (TgAb and TmAb) were measured, and the thyroid gland was ultrasonographycally evaluated." | 3.72 | The presence of the antigliadin antibodies in autoimmune thyroid diseases. ( Akçay, G; Akçay, MN, 2003) |
| " Three months later hypothyroidism was observed requiring treatment with levothyroxine." | 3.71 | [Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report]. ( Bogner, S; Maschek, W; Pichler, R; Shamiyeh, A; Sulzbacher, H; Wölfl, S, 2002) |
| "Two cases of hypothyroidism with cardiac attack (acute myocardial infarction, AMI) following thyroxine replacement were reported." | 3.71 | Severe myocardial ischemia following hormone replacement in two cases of hypothyroidism with normal coronary arteriogram. ( Hara, Y; Kohno, A, 2001) |
| " The patient was subsequently treated with levothyroxine because of the occurrence of a iatrogenic hypothyroidism." | 3.70 | [Hematological changes in hyperthyroidism. A case report]. ( Bertola, G; Bocchia, M; Orlandini, B; Ribotto, P; Torchio, G, 1998) |
| "We evaluated the concentration of epidermal growth factor (EGF) in platelets, serum and plasma obtained from 47 patients with Graves' disease, 7 with hypothyroidism and 20 healthy subjects." | 3.70 | Platelet epidermal growth factor in thyroid disorders. ( Fujinami, T; Ito, J; Kamiya, Y; Kawaguchi, M; Okada, M; Shibata, H; Yoshimata, T, 1998) |
| " Levels of sCD27 were normal after the establishment of euthyroidism with propylthiouracil (PTU) or radio iodine in primary hypothyroidism, chronic thyroiditis, and the hyperthyroid and euthyroid phases of subacute thyroiditis." | 3.70 | Soluble CD27 in thyroid disorders. ( Kallio, P; Murphy, ED, 1998) |
| "Patient aged 49 who developed hypothyroidism after receiving 1131 for relapsing Graves' disease after treatment with propylthiouracil followed by homeopathy." | 3.70 | [Attempted suicide with 400 thyroxine pills: what happened to the physician-patient relationship?]. ( Martin-du Pan, RC, 1999) |
| "In women with hypothyroidism, levothyroxine (LT) requirements after delivery are assumed to return to prepregnancy values." | 3.70 | Postpartum thyroiditis in women with hypothyroidism antedating pregnancy? ( Albareda, M; Caixàs, A; Corcoy, R; de Leiva, A; García-Patterson, A; Rodríguez-Espinosa, J, 1999) |
| "In a part of patients with thyrotoxicosis the serum triiodothyronine concentration increases only while free thyroxin level remains in the normal range (T3-thyrotoxicosis)." | 3.70 | [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake]. ( Konrády, A, 2000) |
| "With the aim of establishing optimal dosage schedules, 171 women with either overt (OH, n = 80) or subclinical (SCH, n = 91) hypothyroidism were assessed before and 6 months after starting L-thyroxine (LT4) replacement therapy." | 3.70 | Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage. ( Bossa, N; Pusiol, E; Rezzónico, JN; Rezzónico, M; Saravi, FD, 1999) |
| "Patients with primary thyroid failure on levothyroxine (LT4) replacement who develop nephrotic syndrome (NS) may rarely present with an increase in LT4 requirements." | 3.70 | Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome. ( Balow, JE; Collins, MT; Csako, G; Pucino, F; Remaley, AT; Sarlis, NJ; Skarulis, MC, 2000) |
| "In eight female patients with diagnosed Graves disease and 8 healthy control subjects (7 females and one male) several parameters of oxidative stress (the level of conjugated dienes [CD], malondialdehyde [MDA] and Schiff bases [SB]) were estimated before and during the treatment with methimazole (Metizol -POLFA) as well as by hormonal and immunological tests." | 3.70 | Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. ( Lewinski, A; Nowak, D; Sewerynek, J; Wiktorska, J, 2000) |
| "Thyroid cells obtained from 21 normal human thyroid tissue samples and 17 tissue samples from diseased thyroid, including one of Graves disease, 4 with follicular adenoma, 11 with papillary carcinoma, and 1 with follicular carcinoma, were cultured in collagen gel, and ability to produce thyroglobulin (Tg), triiodothyronine (T3) and thyroxine (T4) was determined." | 3.69 | Productivity of thyroglobulin and thyroid hormone on human thyroid cell in collagen gel culture. ( Koezuka, M; Kusunoki, T; Murata, K; Nishida, S; Tomura, T, 1995) |
| "In order to differentiate silent thyroiditis (SLT) from Graves' disease, the usefulness of the measurement of the urinary concentration of iodine was evaluated in this study." | 3.69 | [Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease]. ( Iino, S; Ito, K; Momotani, N; Sugimoto, T, 1994) |
| "The effects of hyperthyroidism on uric acid metabolism were investigated." | 3.69 | Hyperuricemia in patients with hyperthyroidism due to Graves' disease. ( Aizawa, T; Komiya, I; Sato, A; Shinoda, T; Shirota, T; Takemura, Y; Yamada, T, 1995) |
| " To evaluate this hypothesis, the density of TSH receptors and the activity of adenylate cyclase were determined in the thyroid membranes from hyperthyroid and hypothyroid adult male rats; they were rendered hyperthyroid either with bovine TSH, TRH, or T3 for 7 days and hypothyroid by propylthiouracil treatment or by hypophysectomy." | 3.69 | Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland. ( Denereaz, N; Lemarchand-Beraud, T, 1995) |
| " In September 1988 we introduced early thyroxine (T4) administration after 131I therapy for hyperthyroidism caused by Graves' disease." | 3.69 | Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? ( Blomgren, H; Bring, J; Lundell, G; Tallstedt, L, 1994) |
| " In this report we describe a patient with Graves' disease diagnosed in early pregnancy and treated with propylthiouracil, which resulted in a large fetal goitre and fetal hypothyroidism." | 3.69 | In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. ( Bos, AF; Derksen, JT; Rouwé, CW; Van Loon, AJ, 1995) |
| "We report a case of isolated levothyroxine malabsorption in the course of chronic intestinal giardiasis, leading to severe hypothyroidism." | 3.69 | Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism--implications for localization of thyroid hormone absorption in the gut. ( Rose, F; Schlaghecke, R; Seppel, T, 1996) |
| " Treatment of these three patients was best done with the continuation of PTU therapy at a lower dose and the addition of thyroxine as soon as mild hypothyroidism developed." | 3.69 | Management of multiple-antibody-mediated hyperthyroidism in children with Down's syndrome. ( Bhowmick, SK; Grubb, PH, 1997) |
| " Compared with two second-generation assays, TSH-30 better discriminated between patients with subnormal TSH due to hyperthyroidism, thyroxine overreplacement, and nonthyroidal illness but there was still significant overlap between results for these groups." | 3.68 | Chemiluminescent third-generation assay (Amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed. ( Beckett, GJ; Rae, PW; Spencer, CA; Thomson, KJ; Toft, AD; Wilkinson, E, 1993) |
| "We report the case of a 70-year-old man who developed hypothyroidism associated with TSH receptor antibodies and severe ophthalmopathy during lithium therapy." | 3.68 | Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report. ( Hiromatsu, Y; Hoshino, T; Kojima, K; Kurose, S; Nakashima, A; Nonaka, K; Sato, K; Sato, M; Tanaka, K, 1992) |
| "Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 3.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
| "Twenty-nine patients (22 female) aged 2 to 17 years were followed with serial measurements of serum triiodothyronine, thyroxine, and thyrotropin during medical therapy for Graves disease." | 3.68 | Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood. ( Horlick, MN; Rapaport, R; Sills, IN, 1992) |
| "Hypothyroxinemia and hypertriiodothyroninemia may occur in the course of antithyroid drug or 131I treatment for hyperthyroid Graves' disease and toxic multinodular goiter." | 3.68 | Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter. ( Akalin, S; Gedik, O; Ozdemir, T, 1991) |
| " During a first pregnancy that ended by miscarriage in the 3rd month, the titer of anti-thyroxine autoantibodies decreased by about 30%." | 3.68 | Changes in serum thyroid hormone autoantibody concentrations during pregnancy: a case report. ( Abs, R; Blockx, P; Martin, M, 1991) |
| "Thyroxine replacement dose in 70 patients with post-radioiodine (for Graves' thyrotoxicosis) hypothyroidism was compared with that in 34 patients with autoimmune hypothyroidism matched for age and sex and diagnosed during the same period." | 3.68 | Thyroxine replacement in post-radioiodine hypothyroidism. ( Bearcroft, CP; Monson, JP; Noonan, K; Toms, GC; Williams, SJ, 1991) |
| "Serum fructosamine was measured in patients with Graves' disease and primary hypothyroidism." | 3.68 | [The significance of serum fructosamine measurement in patients with thyroid diseases]. ( Ban, Y; Hara, H; Ito, K; Kaihara, M; Kushima, K; Nagakura, H; Sato, R; Taniyama, M, 1990) |
| " These symptoms progressed for a year; at age 16, she was found to have a firm goiter, thyroid autoantibodies, very low serum thyroxine and high thyrotropin values, indicating autoimmune thyroiditis with hypothyroidism." | 3.67 | Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. ( Ehrlich, R; Row, VV; Steiner, G; Volpé, R, 1984) |
| "Serum concentrations of total thyroxine (T4) and total triiodothyronine (T3) were measured in a group of patients (n = 113) presenting with untreated hyperthyroidism due to Graves' disease and in subjects receiving oral T4 replacement (n = 93) in whom the total T4 concentration was supraphysiological (greater than 150 nmol/l)." | 3.67 | Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement. ( Himsworth, RL; Pearce, CJ, 1984) |
| "Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma." | 3.67 | Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986) |
| "We compared fetal and maternal serum indexes of thyroid status at delivery in 70 patients with Graves' disease who required therapy with thionamides (such as propylthiouracil) during pregnancy." | 3.67 | Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. ( Ishikawa, N; Ito, K; Momotani, N; Noh, J; Oyanagi, H, 1986) |
| "We assessed the post-natal thyroid function in eight infants of mothers with Graves' disease whose thyroid function at birth was suppressed by maternal ingestion of propylthiouracil during pregnancy." | 3.67 | Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. ( Ishikawa, N; Ito, K; Momotani, N; Noh, J; Yamashita, R; Yoshimoto, M, 1989) |
| "We examined 25 patients with untreated, newly diagnosed Graves' disease using the Hyperthyroid Symptom Scale (HSS) and serum levels of thyroxine (T4), triiodothyronine (T3) relative insulin area (RIA), and estimates of free thyroxine index (FTI)." | 3.67 | Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. ( Greenhouse, J; Klein, I; Levey, GS; Roberts, M; Trzepacz, PT, 1989) |
| "Recognition of transient forms of neonatal hypothyroidism is difficult because of the urgency of thyroxine treatment." | 3.67 | Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins. ( Connors, MH; Styne, DM, 1986) |
| "T-lymphocyte subpopulations, anti-thyroid microsomal antibody titres, and free triiodothyronine and free thyroxine levels were investigated in 10 patients with Graves' disease before, during and after pregnancy." | 3.67 | T-lymphocyte subsets in pregnant women with Graves' disease. ( Bizzarro, A; Daponte, A; De Bellis, A; Fontana, A; Iacono, G; Peluso, G, 1987) |
| "Nine patients with hyperthyroidism due to Graves' disease did not respond to therapy with very large doses (800 to 2000 mg/d) of propylthiouracil." | 3.67 | Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance. ( Cooper, DS, 1985) |
| "Natural killer (NK) cells were assessed in patients with hyperthyroxinemia due to Graves' disease or treatment with thyroxine (T4)." | 3.67 | Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. ( Fletcher, MA; Guffee, J; McKenzie, JM; Papic, M; Stein-Streilein, J; Zakarija, M, 1987) |
| "We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 3.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
| "This study describes a family with intrinsic thyroid disease in addition to familial dysalbuminemic hyperthyroxinemia, a syndrome associated with euthyroidism and increased binding of thyroxine to serum albumin." | 3.67 | Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease. ( Braverman, LE; Stoffer, SS; Young, RA, 1987) |
| "Appropriate dosage of levothyroxine for the treatment of hypothyroidism is assessed by determining the serum thyroxine (T4) concentration in secondary and tertiary types." | 3.66 | Laboratory tests for evaluating thyroid therapy. ( Kabadi, UM, 1982) |
| " Homogenates of human thyroid follicular adenoma and carcinomas were incubated with [125I]T4 and dithiothreitol (DTT) at 37 C for 60 min under N2 gas." | 3.66 | Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. ( Imura, H; Inada, M; Ishii, H; Mashio, Y; Naito, K; Nishikawa, M; Tanaka, K, 1981) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 3.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 3.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
| "The therapeutic success of fractionated radioiodine treatment of hyperthyroid patients with and without endocrine ophthalmopathy is examined." | 3.65 | [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)]. ( Koch, B; Mertz, DP, 1977) |
| "Serum concentrations of thyroxine (T4) and triiodothyronine (T3) were measured in 74 untreated hyperthyroid patients." | 3.65 | Thyroxine toxicosis in patients with iodine induced thyrotoxicosis. ( Limbert, ES; Santos, MA; Sobrinho, LG, 1977) |
| "The serum triiodothyronine concentration is superior to the serum thyroxine concentration, the resin uptake test and the free thyroxine index in the diagnosis of hyperthyroidism." | 3.65 | Serum triiodothyronine concentration in the diagnosis of hyperthyroidism. ( Marsden, P; McKerron, CG, 1975) |
| "Compartmental analysis of the peripheral distribution of labeled thyroxine was applied to various groups of subjects with thyrotoxicosis and hypothyroidism." | 3.64 | Studies of peripheral thyroxine distribution in thyrotoxicosis and hypothyroidism. ( Dowling, JT; Nicoloff, JT, 1968) |
| "StatPearls [Internet]." | 3.30 | A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. ( Bhakat, B; Charaborty, SK; Das, S; Pal, J; SircarMedical, NR, 2023) |
| "MP group than the TG group experienced adverse events." | 3.01 | Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial. ( Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H, 2021) |
| " No adverse cardiovascular event was reported." | 2.82 | Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study. ( Abdullah, AE; Archange, C; Baumstarck, K; Benisvy, D; Bournaud, C; Caron, P; Catargi, B; Cavarec, MB; Eberle, MC; Faugeron, I; Mundler, O; Schvartz, C; Taïeb, D; Toubert, ME, 2016) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 2.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "145 patients with Graves' disease were randomly divided into 3 groups and all patients initially received 30 mg of methimazole daily for at least 1 month and then followed the titration -regimen with or without L-thyroxine: group 1 (30 mg→20 mg→15 mg→10 mg→5 mg); group 2 (30 mg→20 mg→15 mg→10 mg+L-thyroxine→5 mg+L-thyroxine); group 3 (30 mg→20 mg→15 mg→10 mg+L-thyroxine→5 mg+L-thyroxine→2." | 2.79 | A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease. ( Gao, A; Gao, S; Liu, L; Liu, S; Liu, X; Qiang, W; Shi, B, 2014) |
| "Patients with Graves' disease (GD, n = 51) or toxic nodular goitre (TNG, n = 49) were randomized to (131) I either 8 days following discontinuation of methimazole (-BRT, n = 52, median dose: 5 mg) or while on a continuous block-replacement regimen (+BRT, n = 48, median dose 15 mg methimazole and 100 μg levothyroxine)." | 2.76 | A randomized trial evaluating a block-replacement regimen during radioiodine therapy. ( Boel-Jørgensen, H; Bonnema, SJ; Brix, TH; Grupe, P; Hegedüs, L, 2011) |
| " Our aim was to find an optimum dosing strategy for (131)I treatment of hyperthyroidism due to Graves' disease (GD)." | 2.76 | Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study. ( Chen, DY; Chen, TH; He, ZM; Jing, J; Schneider, PF; Zhang, XS, 2011) |
| "Conventional therapies for Graves' disease, consisting of medical therapy or radioiodine are unsatisfactory, because of limited efficacy and adverse events." | 2.73 | Rituximab in relapsing Graves' disease, a phase II study. ( Corssmit, EP; Heemstra, KA; Huizinga, TW; Pereira, AM; Romijn, JA; Sepers, J; Smit, JW; Toes, RE, 2008) |
| "The majority of patients with Graves' disease gradually enter remission of TSH-receptor autoimmunity during medical or after surgical therapy, with no difference between the types of therapy." | 2.73 | TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. ( Abraham-Nordling, M; Laurberg, P; Lundell, G; Tallstedt, L; Tørring, O; Wallin, G, 2008) |
| "Subacute thyroiditis, autoimmune thyroiditis and an atypical form of thyroiditis are complications of COVID-19." | 2.72 | Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). ( Somogyi, P; Speer, G, 2021) |
| "We have presented a rare case of Graves' disease that was resistant to high-dose MMI." | 2.72 | Very rare case of Graves' disease with resistance to methimazole: a case report and literature review. ( Fukui, T; Hiromura, M; Kushima, H; Mori, Y; Ohara, M; Takahashi, Y; Terasaki, M; Yamagishi, SI, 2021) |
| "Unlike Graves' disease, familial non-autoimmune hyperthyroidism cases present with antithyroid drug-dependence." | 2.72 | Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study. ( Bezdicka, M; Borecka, M; El-Lababidi, E; Kleiblova, P; Malikova, J; Rataj, M; Smrz, D; Soucek, J; Soucek, O; Sumnik, Z, 2021) |
| "TSH has been incriminated in Graves' disease for increasing the production of antibodies against TSH receptor (TRAb)." | 2.71 | T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy. ( Doufas, AG; Koutras, DA; Mantzos, E; Mantzos, J; Mastorakos, G, 2003) |
| "Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves' ophthalmopathy (GO)." | 2.71 | A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy. ( Dickinson, J; Frewin, S; Kendall-Taylor, P; Neoh, C; Perros, P, 2005) |
| "Relapse rates of Graves' disease were independent of ATD regimen whether followed by l-T(4) therapy or not." | 2.70 | Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. ( Aanderud, S; Eide, GE; Holm, PI; Husebye, ES; Lien, EA; Nedrebo, BG; Skeie, S; Sorheim, JI; Uhlving, S, 2002) |
| "Of 346 patients with Graves' disease enrolled 225 were euthyroid 4 weeks after antithyroid drug withdrawal and were randomly assigned to receive levothyroxine (114 patients) or no treatment (controls, 111 patients)." | 2.70 | Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. ( Dettmann, J; Hackenberg, K; Hirche, H; Hoermann, R; Mann, K; Meng, W; Pfeilschifter, J; Prehn, B; Quadbeck, B; Reschke, K; Roggenbuck, U; Szabolcs, I, 2002) |
| "Thus, compared with the overall 30% recurrence risk, non-smoking patients with a negative TSHR-Ab (at the end of ATD) had a lower (18%) recurrence risk; smoking patients with negative TSHR-Ab (at the end of ATD) had a 57% recurrence risk; non-smoking patients with positive TSHR-Ab (at the end of ATD) had a high (86%) recurrence risk; the recurrence risk was 100% in those few patients who both smoked and maintained a positive TSHR-Ab at the end of ATD treatment." | 2.70 | Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. ( Bex, M; de Nayer, P; Glinoer, D, 2001) |
| "The degree of amelioration of diplopia did not significantly differ between the two groups (P = 0." | 2.70 | Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. ( Barbesino, G; Bartalena, L; Bartolomei, MP; Cartei, F; Dell'Unto, E; Lepri, P; Manetti, L; Marcocci, C; Mazzi, B; Nardi, M; Pinchera, A; Rocchi, R; Tanda, ML, 2001) |
| "Medical treatment of Graves' disease involves antithyroid drugs with or without the addition of exogenous T4." | 2.69 | Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. ( Abbott, EC; Douglas, R; Givner, ML; Lehmann, L; Reddy, S; Rittmaster, RS; Salisbury, SR; Shlossberg, AH; Tan, MH; York, SE, 1998) |
| "Another method of assessing Graves' disease by measuring adenylate cyclase activity in thyroid cells, known as thyroid-stimulating antibodies (TSAb), differs from TBIAb not only in terms of assay but also in immunoglobulin type according to recent studies." | 2.69 | Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease. ( Hirai, K; Kuma, K; Ohsawa, N; Sakane, S; Takamatsu, J; Yamano, Y, 1999) |
| "Methimazole was interrupted 4 days before 131I therapy." | 2.69 | Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. ( Andrade, VA; Gross, JL; Maia, AL, 1999) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 2.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "Methimazole dose, pretreatment serum T3 levels, and goitre size are the main determinants of the therapeutic response to methimazole in Graves' disease, at least in areas comprising low, subnormal and normal iodine supply." | 2.68 | Response to methimazole in Graves' disease. The European Multicenter Study Group. ( Benker, G; Hirche, H; Kahaly, G; Raue, F; Reinwein, D; Tegler, L; Vitti, P, 1995) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 2.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "The percentage of recurrence in group A patients during the first 12 months of follow-up was significantly greater (65% vs 23%, p < 0." | 2.68 | [Recurrence of Graves-Basedow disease: the influence of treatment schedule]. ( Apiñániz, EA; Forga Llenas, L; Goñi Iriarte, MJ; Iriarte Beroiz, A; Menéndez Torre, E; Rodríguez Erdozain, R, 1995) |
| "There was no difference between the recurrence rates in the two groups, despite the fact that serum thyrotropin concentrations were undetectable in 73 percent of patients in the carbimazole-T4 group on at least 75 percent of their visits." | 2.68 | Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. ( Beckett, G; Gold, A; McIver, B; Rae, P; Toft, A; Wilkinson, E, 1996) |
| "Ninety-four patients with Graves' disease who were suitable for treatment with antithyroid drugs." | 2.68 | Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. ( Kallner, G; Ljunggren, JG; Vitols, S, 1996) |
| "Medical treatment of Graves' disease involves use of antithyroid drugs with or without the addition of exogenous L-T4." | 2.68 | Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. ( Abbott, EC; Douglas, R; Givner, ML; Gupta, MK; Lehmann, L; Reddy, S; Rittmaster, RS; Salisbury, SR; Shlossberg, AH; Tan, MH; York, SE; Zwicker, H, 1996) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 2.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| " These treatment regimens were continued for 24 weeks, and physicians were allowed to adjust MMI dosage during follow-up visits." | 2.68 | Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. ( Abe, Y; Fukawa, E; Kawakami-Tani, T; Makino, I; Tanaka, H, 1997) |
| "To explore the therapeutic effect and its mechanism mainly using traditional Chinese medicine (TCM) of replenishing Qi and nourishing Yin (RQNY) with a small dosage of Tapazol for treatment of Graves disease (GD)." | 2.68 | [Therapeutic effect and its mechanism exploration on mainly using traditional Chinese medicine of replenishing qi and nourishing yin in treating Graves disease]. ( Zha, LL, 1997) |
| "In both groups, recurrence of hyperthyroidism occurred, most commonly during the first 6 months (35% of HD and 44% of TD)." | 2.67 | Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose. ( Edmonds, CJ; Tellez, M, 1994) |
| "We have carried out a prospective study to investigate whether orbital radiotherapy combined with high dose systemic glucocorticoids is more effective than orbital radiotherapy alone for Graves' ophthalmopathy." | 2.67 | Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. ( Bartalena, L; Bogazzi, F; Bruno-Bossio, G; Lepri, A; Marcocci, C; Pinchera, A, 1991) |
| "Graves' disease is the most common cause of hyperthyroidism." | 2.66 | Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review. ( Bai, L; Li, J; Wei, F; Wei, J; Wei, M; Xiao, Y; Yan, W, 2020) |
| "Thirty-four patients with Graves' disease, first rendered euthyroid with antithyroid drugs (ATD) then given supplementary thyroxine (T4), were randomly allocated to three treatment groups." | 2.66 | Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine. ( Hennebry, TM; Jarvis, KJ; Kaur, S; Lester, E; Parr, JH; Ramsay, ID, 1988) |
| "Graves' disease is an autoimmune disease characterized by a course of remission and relapse." | 2.66 | Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. ( Badenhoop, K; Bogner, U; Finke, R; Fischer, C; Hensen, J; Holl, G; Holle, R; Mayr, WR; Schleusener, H; Schwander, J, 1989) |
| " There is a lack of controlled prospective trials studying the results of antithyroid drug therapy while considering the many variables such as disease heterogeneity, regional differences, drug dosage and duration of treatment." | 2.66 | Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosis. ( Alexander, WD; Benker, G; Beyer, J; Creutzig, H; Galvan, G; Hirche, H; Kahály, G; Lazarus, JH; McCruden, D; Reinwein, D, 1987) |
| "38 patients with Graves' disease were treated at random with the glucocorticosteroid betamethasone or with placebo." | 2.66 | Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease. ( Gamstedt, A; Kågedal, B; Tegler, L, 1988) |
| " These results support the hypothesis that large antithyroid drug doses may have greater immunosuppressive effects than low dosage regimens." | 2.65 | Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. ( Bromberg, N; Farah, CS; Reis, LC; Rodrigues, HF; Romaldini, JH; Tanaka, LM; Werner, MC; Werner, RS, 1983) |
| "Group II (18 patients) received no treatment." | 2.65 | Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease. ( Beck, JS; Crooks, J; Gunn, A; Isles, TE; Wilkin, TJ, 1979) |
| " In patients with a high TSH despite being clinically euthyroid, the use of thyroid extract in low dosage (50 mg/day) would appear to be desirable in avoiding the subsequent development of hypothyroidism." | 2.64 | [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine]. ( Brunelle, P; Courtois, H; Nouel, JP; Poirier, A; Schrub, JC; Segond, G, 1976) |
| "Graves' disease is characterized by the appearance of stimulating TSH receptor antibodies leading to hyperthyroidism." | 2.55 | [Autoimmune diseases of the thyroid gland]. ( Allelein, S; Feldkamp, J; Schott, M, 2017) |
| "Graves disease is the most common etiology in developed countries." | 2.53 | Endocrinology Update: Thyroid Disorders. ( Kelley, S, 2016) |
| "All forms of thyroid diseases are much more frequently observed in women than men, although the reasons are still not completely elucidated." | 2.48 | Thyroid disorders. ( Gessl, A; Kautzky-Willer, A; Lemmens-Gruber, R, 2012) |
| "Treatment of Graves-Basedow disease in childhood is a debated question." | 2.47 | [Current questions of thyroid diseases in childhood]. ( Ilyés, I, 2011) |
| "Hypothyroidism is very often subclinical in nature and not easily recognized without specific screening programs." | 2.44 | Obstetric management of thyroid disease. ( Rashid, M; Rashid, MH, 2007) |
| "Since no causative treatment of Graves' disease is available, symptomatic therapy has been derived from clinical studies (evidence class I and II)." | 2.42 | [Problems and new developments in the management of Graves' disease: medical therapy]. ( Janssen, OE; Mann, K; Quadbeck, B, 2004) |
| "Graves' disease is most often managed with radioiodine in the United States today." | 2.41 | Surgical management in Graves' disease. ( Thompson, GB, 2002) |
| "Current therapy of Graves' disease is symptomatically effective in eliminating hyperthyroidism but is not directed towards the immunological cause of the disease." | 2.40 | [Administration of levothyroxine in the treatment of Basedow disease]. ( Hörmann, R, 1999) |
| "However, we considered Graves' disease upon persisting thyrotoxicosis despite thyroxine withdrawal, positive serum TSH receptor antibody titers, and other imaging findings." | 1.91 | A Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination. ( Altay, FP; Bozkuş, Y; İyidir, ÖT; Nar, A; Taşkaldıran, I; Tütüncü, NB, 2023) |
| "Biotin is a water-soluble vitamin that acts as a cofactor for carboxylase, and is often used as a component in several immunoassays." | 1.91 | Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report. ( Emoto, M; Fujiwara, N; Hamaoka, A; Inami, M; Kamei, N; Morioka, T; Shimmaru, K, 2023) |
| " Finally, in 78 patients who failed the 2nd RAI therapy, the mean ATD dosage significantly reduced 5." | 1.72 | Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease. ( Cho, BY; Cho, SW; Choi, HS; Kim, MJ; Kim, YA; Park, DJ; Park, YJ, 2022) |
| " We aimed to (a) develop a mathematical model capturing the dynamics of free thyroxine (FT4) during MMI treatment (b), validate this model by use of numerical simulation in comparison with real-life patient data (c), develop the software application Digital Thyroid (DigiThy) serving either as a practice tool for treating virtual patients or as a decision support system with dosing recommendations for MMI, and (d) validate this software framework by comparing the efficacy of its MMI dosing recommendations with that from clinical endocrinologists." | 1.72 | Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves' Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method. ( Benninger, T; Pilz, S; Reichhartinger, M; Theiler-Schwetz, V; Trummer, C, 2022) |
| "Hyperthyroidism was initially treated with high-dose methimazole monotherapy and later the patient developed overt hypothyroidism (clinical and biochemical), but without remission of the underlying autoimmune disease." | 1.72 | ["Block and replace" of sodium levothyroxine therapy]. ( Cozzolino, A, 2022) |
| "Graves disease (GD) and type 2 diabetes mellitus (T2DM) both impair liver function; we therefore explored the possibility of a relationship among diabetic control, thyroid function, and liver function." | 1.72 | Clinical significance of hepatic function in Graves disease with type 2 diabetic mellitus: A single-center retrospective cross-sectional study in Taiwan. ( Hsieh, YS; Hsu, CH; Huang, CL; Lee, YW; Lin, YP; Lin, YY; Weng, SF, 2022) |
| "He had Graves' disease and underwent total thyroidectomy about 4 years before." | 1.72 | Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia. ( Dan, K; Iwamoto, Y; Kaku, K; Kaneto, H; Katakura, Y; Kimura, T; Mune, T; Nakanishi, S; Shimoda, M; Tatsumi, F; Wamata, R, 2022) |
| "Neutropenia was defined as ANC <1500 cells/μL." | 1.62 | Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism ( Alvarez, AG; Litao, MKS; Shah, B, 2021) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 1.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "Its use in the management of Graves' disease (GD) is still debated mainly because the frequency of side effects of ATD is dose dependent." | 1.56 | "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients. ( Barera, G; Di Frenna, M; Mora, S; Peroni, E; Vigone, MC; Weber, G, 2020) |
| "Initial treatment options for Graves' disease include antithyroid drugs, radioactive iodine (RAI), and surgery." | 1.56 | The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study. ( Choi, JY; Chung, JH; Kim, HI; Kim, SW; Kim, TH; Park, H; Park, J; Park, SY, 2020) |
| "Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
| "We enrolled 40 patients with Graves' disease (GD), 20 patients with Hashimoto's thyroiditis (HT), and 14 healthy controls." | 1.56 | Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases. ( Cheng, CW; Fang, WF; Lin, JD; Tang, KT; Wu, CZ, 2020) |
| "Radioiodine (RAI) treatment for hyperthyroidism is a very common modality, chosen by physicians worldwide." | 1.56 | Predictors of euthyreosis in hyperthyroid patients treated with radioiodine ( Budlewski, T; Franek, E; Gryn, T; Kałuża, B; Stachura, A, 2020) |
| "A 31-year-old woman had unstable thyroid function during the third trimester of pregnancy, making it impossible to reduce her dosage of antithyroid medication." | 1.56 | Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report. ( Adachi, H; Ariake, C; Fujishima, A; Fukuoka, Y; Kameyama, S; Miura, H; Sato, A; Shimoda, Y; Terada, Y, 2020) |
| "Activity of Graves' disease (GD) is known to improve during gestation, as values of thyrotropin (TSH) receptor antibody (TRAb) also improve." | 1.56 | TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease. ( Ito, K; Kinoshita, K; Ohnishi, J; Saito, M; Sugino, K; Suzuki, N; Yoshihara, A; Yoshimura Noh, J, 2020) |
| "Patients with Graves' disease had a higher VCAM-1 level (1309 ± 292 vs." | 1.56 | Hyperthyroidism and vascular cell adhesion molecule-1 are associated with a low ankle-brachial index. ( Lee, IT; Li, YH, 2020) |
| " There was no statistical correlation between drug dosage and increased serum CK level." | 1.56 | Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs. ( Cheng, Y; Ren, L; Sun, Z; Yang, H; Zhong, D, 2020) |
| "Fetal goitrous hypothyroidism is a rare entity and is caused mainly by maternal treatment of Graves' disease (GD)." | 1.51 | Graves' disease complicated by fetal goitrous hypothyroidism treated with intra-amniotic administration of levothyroxine. ( Campos, RA; Castro, JM; Machado, CM; Oliveira, MJ, 2019) |
| "Graves' Disease is a representative autoimmune thyroid disease that presents with hyperthyroidism." | 1.51 | Serum autotaxin levels are associated with Graves' disease. ( Aoki, J; Araki, O; Igarashi, K; Kano, K; Kihara, S; Kurano, M; Murakami, M; Nakawatari, K; Nishikawa, M; Nojiri, T; Shimamoto, S; Yatomi, Y, 2019) |
| "Unlike other inflammatory diseases, in Graves' disease; hematological parameters may not give information about inflammatory state of the disease." | 1.51 | Evaluation of neutrophil-to-lymphocyte ratio and hematologic parameters in patients with Graves' disease. ( Turan, E, 2019) |
| "Thyrotoxicosis is both rarer and more severe in children than in adults, rendering management difficult and often unsatisfactory." | 1.48 | Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling. ( Ahmed, SF; Al Towati, M; Donaldson, MDC; Hunter, I; Kourime, M; McGowan, S; Stewart, G; Williamson, S, 2018) |
| "After the initiation of MMI treatment, the hyperthyroid state moves towards subclinical hyperthyroidism and then euthyroidism." | 1.48 | A patient-specific treatment model for Graves' hyperthyroidism. ( Antonelli, A; Benvenga, S; Di Bari, F; Merrill, SJ; Pandiyan, B, 2018) |
| "At diagnosis and before treatment, the relapse group had higher serum TSH-receptor antibody and free thyroxine levels and larger goiters than the remission group, with no differences in Graves' orbitopathy prevalence and severity." | 1.48 | Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management. ( Bartalena, L; Bianconi, E; Chiovato, L; Cusini, C; Gallo, D; Ippolito, S; Masiello, E; Piantanida, E; Premoli, P; Rosetti, S; Sabatino, J; Tanda, ML; Veronesi, G; Wiersinga, WM, 2018) |
| "Graves' disease is the most common form of autoimmune thyroid disorder, characterized by hyperthyroidism due to circulating autoantibodies." | 1.46 | Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice. ( Hu, X; Niu, M; Song, S; Wang, H; Wang, J; Xia, N; Xu, H; Ye, X, 2017) |
| "Goiter was associated with female sex (p = 0." | 1.46 | [Hyperthyroidism in children at the University Hospital in Dakar (Senegal)]. ( Ba, A; Ba, ID; Boiro, D; Diallo, IM; Diédhiou, D; Dieng, YJ; Diop, SN; Guèye, M; Mbodj, M; Ndiaye, O; Ndongo, AA; Niang, B; Sarr, A; Seck, N; Sow, D; Thiam, L; Thiongane, A, 2017) |
| "Our data suggest that Graves' disease patients with elevated immunoglobulin G4 levels at diagnosis have a phenotype characterized by higher anti-thyroglobulin antibody and antithyroid peroxidase antibody titers, less severe T3 hyperthyroidism, younger age at ophthalmopathy onset and require a shorter duration of the first methimazole treatment cycle." | 1.46 | Serum immunoglobulin G4 levels and Graves' disease phenotype. ( Barbu, CG; Betivoiu, MA; Fica, SV; Florea, S; Martin, CS; Sirbu, AE, 2017) |
| "Although Graves' disease and systemic sclerosis are both autoimmune disorders, their relationship is rarely reported." | 1.46 | Limited cutaneous systemic sclerosis arising in a patient with Graves' disease. ( Quisumbing, JP; Yu, MG, 2017) |
| "Graves' disease is an autoimmune thyroid disorder characterized by hyperthyroidism, and patients exhibit thyroid-stimulating hormone receptor antibody." | 1.46 | Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. ( Kamoi, K; Kaneko, K; Kaneko, M; Kitazawa, M; Minagawa, S; Miyakoshi, M; Ohara, N; Uemura, Y, 2017) |
| "Ten patients with thyrotoxicosis due to Graves' disease were treated with a rapid thyroid hormone blocking protocol of Lugol's solution, dexamethasone and a beta-blocker." | 1.43 | Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease. ( Fischli, S; Henzen, C; Lucchini, B; Müller, W; Slahor, L, 2016) |
| "Methimazole 10 mg/day was started." | 1.43 | Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report. ( Carvalho, D; Cunha, FM; Oliveira, J; Rodrigues, E; Saavedra, A; Vinhas, LS, 2016) |
| "Whether radioactive iodine treatment of Graves' disease (GD) during pregnancy will increase pregnancy loss and affect fetal development is still a matter of concern." | 1.43 | The preliminary clinical observation and analysis of childbearingage women with a history of iodine-131 treatment for Graves' disease. ( Chen, G; Guan, L; Wang, L; Zhang, J, 2016) |
| "Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades." | 1.43 | The management of Graves' disease in New Zealand 2014. ( Conaglen, JV; Cox, SC; Elston, MS; Tamatea, JA, 2016) |
| "Altogether, 226 Graves' disease (GD), 57 autoimmune thyroiditis, 74 non-autoimmune nodular goiter and 49 thyroid cancer patients, as well as 41 healthy controls were retrospectively evaluated." | 1.43 | Clinical Evaluation of the First Automated Assay for the Detection of Stimulating TSH Receptor Autoantibodies. ( Allelein, S; Dringenberg, T; Ehlers, M; Feldkamp, J; Goretzki, S; Haase, M; Hautzel, H; Hermsen, D; Schmid, C; Schott, M, 2016) |
| "A transient model for human Graves' disease was successfully established in mice using up to 3 immunizations with recombinant adenovirus expressing the extracellular A-subunit of the human TSH receptor (TSHR) (Ad-TSHR)." | 1.42 | Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy. ( Faßbender, J; Goebel, S; Holthoff, HP; Li, Z; Lohse, MJ; Münch, G; Reimann, A; Ungerer, M; Zeibig, S, 2015) |
| "Severe hyperthyroidism, with particularly high TRAb concentrations at diagnosis, may facilitate the identification of patients requiring regular serum fT3 determinations and potentially needing higher doses of ATD dosage during follow-up." | 1.42 | Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications. ( Alberti, C; Boizeau, P; Carel, JC; Chevenne, D; Guilmin Crepon, S; Harvengt, J; Léger, J; Paulsen, A; Simon, D; Zenaty, D, 2015) |
| "Sensitivity and specificity are 99." | 1.42 | Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation. ( Braeth, S; Dietrich, JW; Frank, CU; Loos, U; Wanjura, D, 2015) |
| "Relapse was most common during the first year, and prognosis was excellent after 4 years without relapse." | 1.40 | Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010. ( Eliasson, M; Filipsson Nyström, H; Mohlin, E, 2014) |
| "Onset of thyrotoxicosis was distributed from 2 to 12 months postpartum." | 1.40 | Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. ( Amino, N; Ide, A; Ito, M; Kang, S; Kudo, T; Miyauchi, A; Nakamura, H; Nishihara, E; Yoshioka, W, 2014) |
| "Overt neonatal Graves' disease is rare, but may be severe, even life threatening, with deleterious effects on neural development." | 1.40 | Follow-up of newborns of mothers with Graves' disease. ( Boyko, V; Lerner-Geva, L; Levy-Shraga, Y; Pinhas-Hamiel, O; Tamir-Hostovsky, L, 2014) |
| "After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges." | 1.40 | A case of fetal hyperthyroidism treated with maternal administration of methimazole. ( Hayashi, S; Ishii, K; Mitsuda, N; Murata, M; Sasahara, J; Sato, Y, 2014) |
| "Subjects were 25 Graves' disease patients visiting Metabolic Endocrinology Clinic at Dr." | 1.40 | Immunologic and hormonal effects of prophylthiouracil treatment using maintenance dose in Graves' disease patients. ( Decroli, E; Manaf, A; Syahbuddin, S, 2014) |
| "Median weight gain was 5." | 1.39 | Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis. ( Beckett, GJ; Gibb, FW; Strachan, MW; Zammitt, NN, 2013) |
| "Twenty patients with Graves' disease, 21 patients with Hashimoto hypothyroidism, 21 euthyroid Hashimoto patients, and 27 control subjects were recruited to this study." | 1.39 | Increased serum interleukin-33 levels in patients with Graves' disease. ( Abusoglu, S; Avcikucuk, M; Burnik, SF; Celik, HT; Ceylan, B; Ercan, M; Serdar, MA; Sezer, S; Uguz, N; Yildirimkaya, M, 2013) |
| "A 44-year-old male with Graves' disease ongoing for seven years presented bilateral ophthalmopathy and myxoedema of the big toes." | 1.39 | [Graves' dermopathy on the big toe]. ( Cante, V; Couderc, E; Guillet, G; Renaud, O, 2013) |
| "Thyrotoxicosis is a rare clinical syndrome resulting from an exacerbation of hyperthyroidism, with various etiology and triggering factors." | 1.39 | [Plasmapheresis before thyroidectomy in a patient with thyrotoxicosis and hepatotoxicity by propylthiouracil: case report]. ( Almeida, RF; Comarella, AP; Ferri Casini, A; Silva, AR; Silveira, MB, 2013) |
| "The recognition and treatment of fetal hyperthyroidism are believed to be important to optimize growth and intellectual development in affected fetuses." | 1.39 | Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy. ( Ikenoue, S; Ishii, T; Kadohira, I; Kasuga, Y; Matsumoto, T; Minegishi, K; Miyakoshi, K; Momotani, N; Saisho, Y; Sato, S; Yoshimura, Y, 2013) |
| "In the setting of maternal Graves' disease (GD), fetal and neonatal goiters are most commonly caused by maternal treatment with antithyroid medication, and the goiter resolves within days of initiation of thyroxine replacement in the neonate." | 1.39 | Thyroid "vise" in an infant with neonatal Graves' disease. ( Rapaport, R; Regelmann, MO; Sullivan, CK, 2013) |
| "In untreated patients with Graves' disease and HT we observed a significant decrease in CD4+FoxP3 (p < 0." | 1.39 | Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases. ( Bodzenta-Lukaszyk, A; Bossowska, A; Bossowski, A; Dąbrowska, M; Jeznach, M; Moniuszko, M; Rusak, M; Sawicka, B; Wójtowicz, J, 2013) |
| "The duration of time required for normalization of serum free T4 on initial treatment and the incidence of adverse effects for 1 year after the start of MMI were compared." | 1.38 | Higher dose of methimazole causes frequent adverse effects in the management of Graves' disease in children and adolescents. ( Inomata, H; Kazukawa, I; Kohno, Y; Konda, S; Minagawa, M; Minamitani, K; Sanayama, K; Sasaki, N; Sato, H; Sugihara, S; Wataki, K, 2012) |
| "A 16-year-old girl with a history of Graves' disease presented with two episodes of generalised tonic-clonic seizures, necessitating intensive care admission." | 1.38 | Seizures and postictal stupor in a patient with uncontrolled Graves' hyperthyroidism. ( De Leu, N; Poppe, K; Unuane, D; Velkeniers, B, 2012) |
| "3,5,3'-triiodothyronine-predominant Graves' disease (T(3)-P-GD) is characterized by a persistently high serum T(3) level and normal or even lower serum thyroxine (T(4)) level during antithyroid drug therapy." | 1.37 | Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease. ( Amino, N; Ito, M; Iwasaka, T; Miyauchi, A; Nishikawa, M; Nomura, E; Takamatsu, J; Takamura, Y; Toyoda, N, 2011) |
| "Treatment of Graves' disease during pregnancy with antithyroid drugs (ATDs) poses a risk of inducing hypothyroidism and, thus, development of a goiter to the fetus." | 1.37 | Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine. ( Bliddal, S; Brocks, V; Feldt-Rasmussen, U; Rasmussen, ÅK; Skovbo, P; Sundberg, K, 2011) |
| "Graves' disease is a B cell-mediated and T cell-dependent autoimmune disease of the thyroid which is characterized by overproduction of thyroid hormones and thyroid enlargement by agonistic anti-thyrotrophin receptor (TSHR) autoantibody." | 1.37 | B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism. ( Abiru, N; Eguchi, K; Ichikawa, T; Kobayashi, M; Nagayama, Y; Nakahara, M; Ueki, I, 2011) |
| "Graves' disease is a common organ-specific autoimmune disease." | 1.37 | Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit. ( Gao, S; Hou, P; Shi, B; Tian, Z; Wu, L; Xu, L; Xun, L; Yang, J; Zhang, Y, 2011) |
| "Stimulatory autoantibodies in Graves' disease activate the thyroid-stimulating hormone receptor leading to thyroid hyperplasia and unregulated thyroid hormone production and secretion." | 1.37 | Graves' disease: diagnostic and therapeutic challenges (multimedia activity). ( Grebe, SK; Kahaly, GJ; Lupo, MA; McDonald, N; Sipos, JA, 2011) |
| "Subacute thyroiditis is a painful, inflammatory disease frequently accompanied with fever." | 1.37 | Graves' disease following subacute thyroiditis. ( Kurihara, H; Nakano, Y; Sasaki, J, 2011) |
| "This type of hyperthyroidism is usually de novo and is accompanied by more clinical signs, symptoms, and analytical derangements, as well as higher titres of TRAb at diagnosis than milder forms of hyperthyroidism." | 1.36 | Severe hyperthyroidism: aetiology, clinical features and treatment outcome. ( Dévora, O; Díez, JJ; García, J; García-Arévalo, C; Iglesias, P; Tajada, P, 2010) |
| "Prednisone was started 1 d after RAI and withdrawn after 6 wk." | 1.36 | Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. ( Bartalena, L; Compri, E; Lai, A; Marino, F; Piantanida, E; Sassi, L; Sivelli, P; Tanda, ML, 2010) |
| "The diagnosis of Hashimoto's disease (chronic thyroiditis) was based on clinical manifestation, high TSHs level, positive thyroid peroxidase antibody and thyroglobulin antibody, and supported by positive results of fine needle aspiration biopsy." | 1.36 | Hashimoto's thyroiditis following Graves' disease. ( Adam, JM; Muallima, N; Sanusi, H; Umar, H, 2010) |
| "The development of Graves' disease (GD) from Hashimoto's thyroiditis (HT) has sporadically been reported, but no data are available concerning the prevalence of this sequence of events in GD patients." | 1.36 | Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. ( Arrigo, T; Corrias, A; De Luca, F; Lombardo, F; Mussa, A; Salerno, M; Vigone, MC; Wasniewska, M, 2010) |
| "We report a case of Graves' disease in a patient on regular hemodialysis." | 1.36 | [A rare case of Graves' disease in a patient on regular haemodialysis]. ( Abbes, M; Ben Abdellah, T; Ben Maïz, H; Boubaker, K; El Younsi, F; Harzallah, A; Kaaroud, H; Kheder, A; Khiari, K; Ounissi, M, 2010) |
| "We applied this procedure to Graves' disease and evaluated its feasibility and outcomes." | 1.36 | Endoscopic thyroidectomy via breast approach for patients with Graves' disease. ( Cao, LP; Li, ZY; Que, RS; Wang, P; Wang, Y; Xu, SM, 2010) |
| "These results indicated that Graves' disease (GD) caused primary hyperthyroidism." | 1.36 | Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). ( Sato, H, 2010) |
| "Thymic hyperplasia is associated with Graves' disease, particularly in young patients." | 1.36 | Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. ( Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA, 2010) |
| "He was diagnosed with Graves' disease (GD) and central diabetes insipidus (CDI)." | 1.36 | Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease. ( Komatsu, M; Nishio, S; Sato, A; Uehara, T; Yamazaki, M, 2010) |
| "The pleural effusions were transudates." | 1.36 | Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis. ( Fujita, H; Furumoto, Y; Inoshita, S; Kaneko, S; Kinoshita, H; Maruyama, Y; Suenaga, M; Susa, K; Tomiyama, J; Usui, R; Yakushiji, F; Yasuda, M, 2010) |
| "To determine the association between Graves' disease (GD) susceptibility and CT60 polymorphism of the CTLA4 gene." | 1.35 | Association of CT60 polymorphism of the CTLA4 gene with Graves' disease in Taiwanese children. ( Chang, YT; Chen, CK; Chu, CC; Huang, CY; Lee, YJ; Li, HJ; Lin, CH; Lin, M; Liu, HF; Lo, FS; Tanizawa, T; Tsai, ST; Wang, ZC, 2008) |
| "In the remaining 20 subjects, 1 had Graves' disease, 6 had adenoma (of which 2 were toxic adenomas), 7 had multinodular goiter, and 6 were considered normal." | 1.35 | Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Tromsø study. ( Bjørndal, MM; Jorde, R; Lu, T; Sandmo Wilhelmsen, K, 2008) |
| " The optimal management strategy for thyroid hormone dosing in hypothyroid women during pregnancy is controversial." | 1.35 | The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. ( Burman, KD; Jonklaas, J; Loh, JA; Wartofsky, L, 2009) |
| "Graves'-like hyperthyroidism is induced by immunizing BALB/c mice with adenovirus expressing the thyrotropin receptor (TSHR) or its A-subunit." | 1.35 | Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies. ( Aliesky, HA; McLachlan, SM; Misharin, AV; Mizutori, Y; Nagayama, Y; Rapoport, B, 2009) |
| "In subjects with Graves' disease, we propose using a pre-determined 131I activity, which is higher than that derived from the guidelines." | 1.35 | Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up. ( Condorelli, A; Latina, A; Marturano, I; Pezzino, V; Regalbuto, C, 2009) |
| "Propylthiouracil 300 mg/day was started for each patient at the time of diagnosis and doses were titrated according to repeat thyroid studies." | 1.35 | Predictors of time to remission and treatment failure in patients with Graves' disease treated with propylthiouracil. ( Akdemir, N; Bilir, C; Buyukkaya, R; Cinemre, H; Erdogmus, B; Gokosmanoglu, F, 2009) |
| "We present 4 patients with Graves' disease who developed spontaneous hypothyroidism during follow-up." | 1.35 | [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease]. ( Aznar Ondoño, I; Del Monte Jarabo Bueno, M; González-González, A; Recio Cordova, JM, 2009) |
| "We report a patient with Graves' disease who developed myalgias with elevated creatine kinase levels after total thyroidectomy." | 1.35 | Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome? ( Kim, CS; Shaheen, D, 2009) |
| "Clinicians should be aware that the recurrence of Graves' disease after the withdrawal of ATD may be transient." | 1.35 | The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease. ( Amino, N; Arishima, T; Fukata, S; Ito, M; Kubota, S; Kudo, T; Miyauchi, A; Nishihara, E; Ohye, H; Takata, K, 2008) |
| "Rhabdomyolysis was diagnosed by elevated CK and serum myoglobin, and the difference between urinary blood occult reaction and red blood cell count." | 1.35 | [Rhabdomyolysis in a patient with postoperative hypothyroidism and hypoparathyroidism]. ( Kurihara, I, 2008) |
| "In adult women primary hypothyroidism and thyrotoxicosis have a prevalence of 3." | 1.35 | Thyroid function disorders--Guidelines of the Netherlands Association of Internal Medicine. ( Berghout, A; Hermus, AR; Kooy, A; Muller, AF; Smits, JW; Wiersinga, WM, 2008) |
| "In a clinical study of Graves' disease patients who had side effects from antithyroid drugs, we found that treatment by AJBHT resulted in a reduction of serum triiodothyronine (T3) and free thyroxine (FT4) levels and an increase in thyroid stimulating hormone (TSH) levels (T3: p<0." | 1.35 | An alternative therapy for graves' disease: clinical effects and mechanisms of an herbal remedy. ( Ahn, SY; Ahn, YM; Doo, HK; Kang, SI; Lee, BC, 2008) |
| "In a mouse model of autoimmune Graves' disease, stimulatory anti-TSH receptor (TSHR) antibodies (TSAbs) slowly evolve upon repeated immunization with TSHR and lead to hyperthyroidism." | 1.34 | Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses. ( Dorevitch, S; Gangi, E; Gupta, S; Lefranc, MP; Martinez, O; Mordi, D; Prabhakar, BS, 2007) |
| "The association of idiopathic thrombocytopenic purpura and Graves' disease is rare." | 1.34 | [Graves' disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases]. ( Bruckert, E; Cohen Aubart, F; Jublanc, C, 2007) |
| "Inadequately treated maternal Graves' disease not only may lead to CH-C but also carries an, until now, unrecognized risk of thyroid disintegration in the offspring as well." | 1.34 | Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. ( de Vijlder, JJ; Kempers, MJ; Smets, AM; Smit, BJ; van Rijn, RR; van Trotsenburg, AS; Vulsma, T, 2007) |
| "Among the pretreatment hyperthyroid cohort a lower stiffness was found when the muscle was relaxed (2." | 1.34 | Thigh muscle stiffness assessed with magnetic resonance elastography in hyperthyroid patients before and after medical treatment. ( An, KN; Bensamoun, SF; Brennan, M; Chen, Q; Ehman, RL; Ringleb, SI, 2007) |
| "In an individual patient with Graves' disease, the serum TSH level may be more reflective of the circulating TSI concentration than is thyroid gland function as expressed by free T4 and T3 concentrations and therefore may be as reliable a predictor of remission as TSI." | 1.34 | Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function? ( Kabadi, UM; Premachandra, BN, 2007) |
| "Methimazole treatment resulted in all markers being normalized in the patients without infiltrative ophthalmopathy, yet oxidative stress was still present in the ophthalmopathy group." | 1.33 | Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. ( Bednarek, J; Sowiński, J; Wysocki, H, 2005) |
| "Therefore, the diagnostic accuracy for Graves' disease might be increased by using the three parameters in combination." | 1.33 | Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. ( Kato, Y; Sato, K; Shimizu, S; Takano, K; Yanagisawa, T, 2005) |
| "An association between Graves' disease (GD) and chronic hepatitis C (C-HC) has been observed both in the presence and the absence of recombinant interferon-alpha (rIFN-alpha) treatment." | 1.33 | Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. ( Barilli, AL; Bertoni, R; Coiro, V; Delsignore, R; Di Seclì, C; Ferrari, C; Finardi, L; Jotti, GS; La Gioia, D; Minelli, R; Valli, MA, 2005) |
| " Thyroid function and ATD dosage were monitored in the mothers." | 1.33 | Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. ( Boissinot, C; Castanet, M; Czernichow, P; Garel, C; Guibourdenche, J; Le Gac, I; Léger, J; Luton, D; Noel, M; Oury, JF; Polak, M; Schlageter, MH; Tébeka, B; Toubert, ME; Vuillard, E, 2005) |
| "Women with a past history of Graves' disease and no current treatment display a normal thyroid function and adaptation during pregnancy." | 1.33 | Thyroid function during pregnancy in women with past Graves' disease. ( Guibourdenche, J; Le Gac, I; Luton, D; Noel, M; Polak, M, 2005) |
| "Forty-five patients were treated for active hyperthyroidism, 161 were euthyroid (85 immediately before withdrawal of antithyroid drug at maintenance doses, 76 in stable remission after withdrawal of antithyroid treatment)." | 1.33 | Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease. ( Baldini, M; Bonfanti, MT; Cantalamessa, L; Castagnone, D; Orsatti, A, 2005) |
| "Previous studies suggested that Graves' disease (GD) patients had elevated anti-Gal titers compared to normal controls, but titers returned to normal after treatment." | 1.33 | The possible contribution of anti-Gal to Graves' disease. ( Bahn, R; Fullmer, J; Lindall, A; Mariash, CN, 2005) |
| "The patient was initially treated for Graves' disease, on the basis of ultrasonographic, laboratoristic and scintigraphic evidence." | 1.33 | Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels. ( Di Carlo, C; Di Spiezio Sardo, A; Giordano, E; Guida, M; Mandato, VD; Nappi, C, 2005) |
| "We believe that RTX treatment in Graves' disease may cause amelioration of ophthalmopathy by depleting total lymphocytes population in the orbit." | 1.33 | Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. ( Avignone, S; Beck-Peccoz, P; Bonara, P; Campi, I; Guastella, C; Pirola, G; Ratiglia, R; Rossi, S; Salvi, M; Sbrozzi, F; Vannucchi, G, 2006) |
| "Post-partum thyrotoxicosis due to Graves' disease may be treated with radioiodine but it requires radiation safety measurements for infant and is contraindicated if the mother is breast-feeding." | 1.33 | Treatment of post-partum thyrotoxicosis. ( Azizi, F, 2006) |
| "Hyperthyroidism is in a sympathovagal imbalanced state, characterized by both increased sympathetic and decreased vagal modulation of the heart rate." | 1.33 | Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. ( Chen, JL; Chiu, HW; Chu, WC; Tseng, YJ, 2006) |
| "Eighty-five patients with Graves' disease (males : females ratio 1:5." | 1.33 | Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status. ( Dimitrakov, DY; Dimov, RS; Mateva, NG; Nonchev, BI; Terzieva, DD; Tsvetkova, TZ, 2005) |
| "Investigations excluded a TSH-secreting pituitary adenoma and a thyroid hormone resistance state and confirmed false elevation in serum TSH concentration due to assay interference from heterophile antibodies." | 1.33 | A hyperthyroid patient with measurable thyroid-stimulating hormone concentration - a trap for the unwary. ( Cheah, WK; Hawkins, R; Mukherjee, JJ; Tan, F; Tan, M, 2006) |
| "Maternal Graves' disease can, due to the presence of anti-thyroid stimulating hormone (TSH) receptor antibodies and the maternal use of anti-thyroid drugs, result in thyroid dysfunction in the neonate." | 1.33 | [Central congenital hypothyroidism due to Graves' disease in the mother]. ( de Mol, AC; Kempers, MJ; Liebrand, CA; Noordam, C, 2006) |
| "Incidence of the hyperthyroidism is continuously increasing, whereas our knowledge concerning the facilitating or etiologic factors of this increase are still partial." | 1.33 | HLA class II distribution in Congolese with hyperthyroidism: preliminary results. ( Bidingija, M; Buzzetti, R; Ditu, M; Galgani, A, 2006) |
| " Patients with chronic thyroiditis treated with a high replacement dosage of levothyroxin (125-200 microg daily) had higher serum levels of IgA antigliadin antibodies in comparison with patients treated with a lower dosage (50-100 microg daily) (medians: 13." | 1.32 | IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. ( Jiskra, J; Kocna, P; Límanová, Z; Vanícková, Z, 2003) |
| "Twenty-eight untreated patients with Graves' disease were treated with thiamazole and followed for up to 13 years." | 1.32 | Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease. ( Amino, N; Hidaka, Y; Izumi, Y; Mizuta, I; Tada, H; Takano, T; Tatsumi, KI, 2003) |
| "Sixty-nine patients with hyperthyroid Graves' disease in the euthyroid state after 2-5 years of antithyroid drug therapy and 32 healthy subjects as the control group." | 1.32 | The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease. ( Fukao, A; Hanafusa, T; Hayashi, S; Kuma, K; Miyauchi, A; Murakami, Y; Sakane, S; Takamatsu, J, 2003) |
| "The etiology of Graves' disease is multifactorial." | 1.32 | A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism. ( McLachlan, SM; Nagayama, Y; Niwa, M; Rapoport, B, 2003) |
| "Since theraphy of Graves' disease is not directed towards the cause of the disease, medical theraphy is still the first choice and symptomatically effective in treating hyperthyroidism." | 1.32 | [Drug treatment of immune hyperthyroidism (Basedow disease). Patient selection, long-term follow-up and prevention of recurrence]. ( Hörmann, R; Janssen, OE; Mann, K; Quadbeck, B, 2003) |
| "Although Graves' disease does not arise spontaneously in animals, thyrotropin receptor (TSHR) antibodies can be induced in mice by vaccination with TSHR-DNA in a plasmid." | 1.32 | Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. ( Chen, CR; David, C; McLachlan, SM; Pichurin, P; Pichurina, O; Rapoport, B, 2003) |
| "Because all mothers were insufficiently treated during pregnancy, it is hypothesized that a hyperthyroid fetal environment impaired maturation of the fetal hypothalamic-pituitary-thyroid system." | 1.32 | Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. ( de Vijlder, JJ; Kempers, MJ; van Tijn, DA; van Trotsenburg, AS; Vulsma, T; Wiedijk, BM, 2003) |
| "The diagnosis of thyrotoxicosis due to Graves' disease was made." | 1.32 | Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report. ( Agarwal, A; Dhiraaj, S; Pandey, CK; Raza, M; Singh, PK, 2004) |
| "The study included 80 females: 16 with Graves' disease, 15 with Hashimoto's thyroiditis and subclinical hypothyroidism, 14 with Hashimoto's thyroiditis with fibrosis and clinical hypothyroidism, 20 after subtotal thyroidectomy following nodular non-toxic goitre and 15 healthy controls." | 1.32 | Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders. ( Berdowska, A; Birkner, E; Jedrzejowska-Szypułka, H; Jochem, J; Korzonek-Szlacheta, I; Polaniak, R; Sitkiewicz, A; Zwirska-Korczala, K, 2004) |
| "An 18-year-old woman being treated for Graves disease underwent elective thyroidectomy." | 1.32 | Intraoperative thyroid storm: a case report. ( Goh, YS; Grimes, CM; Montgomery, WH; Muniz, H, 2004) |
| "An experimental murine model of Graves' disease was used to produce monoclonal antibodies (mAbs) with thyroid stimulating activity." | 1.32 | Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. ( Bonomi, M; Costagliola, S; Morgenthaler, NG; Panneels, V; Refetoff, S; Van Durme, J; Vassart, G, 2004) |
| "However, the development of Graves' disease (GD) in this clinical setting has not been reported to date." | 1.32 | Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. ( Davey, RT; Falloon, J; Jimenez, C; Moran, SA; Sarlis, NJ; Sereti, I; Wynne, S; Yen, PM, 2004) |
| "The prevalence of postpartum recurrence or exacerbation of GH within 1 year after delivery was examined." | 1.31 | Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Yamamoto, M; Yoshida, K, 2002) |
| "Patients with Graves' disease are more susceptible to calcium and vitamin D deficiency during the winter than during the summer, resulting in the tendency toward a higher incidence of postoperative tetany in winter." | 1.31 | Seasonal changes in calcium homeostasis affect the incidence of postoperative tetany in patients with Graves' disease. ( Kawamoto, H; Murakami, T; Noguchi, S; Ohshima, A; Toda, M; Uchino, S; Watanabe, S; Yamashita, H, 2000) |
| "Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology most commonly affecting young females." | 1.31 | A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland. ( Blichert-Toft, M; Christensen, L; Feldt-Rasmussen, U; Hansen, HS; Kirkegaard, J; Zimmermann-Belsing, T, 2000) |
| "Nevertheless, very few cases of Graves' disease, occurred in such condition, have been reported in literature." | 1.31 | Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. ( Amato, G; Biondi, B; Carella, C; Del Buono, AD; di Cristofaro, M; Di Iorio, G; Manganella, G; Mazziotti, G; Montella, P; Rotondi, M, 2000) |
| "1." | 1.31 | Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. ( Ishikawa, N; Ito, K; Makino, F; Momotani, N; Noh, JY; Yamashita, R, 2000) |
| "In hyperthyroid Graves' disease, short-term methimazole is sufficient to induce lasting remission in some patients, but even long-term treatment fails to do so in others." | 1.31 | An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. ( Eto, S; Ito, Y; Komiya, I; Nishimori, T; Sato, A; Tanaka, Y; Terao, A; Yamada, T, 2000) |
| "Seven patients with Graves' disease, eight with toxic nodular goiter and seven with non-toxic nodular goiter, were followed after 131I-treatment." | 1.31 | Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter. ( Faber, J; Jarløv, AE; Kristensen, LO; Nygaard, B, 2000) |
| "Leptin is a protein product of the ob gene, mainly produced by adipocytes." | 1.31 | Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors. ( Abe, Y; Ashizawa, K; Eguchi, K; Ejima, E; Ide, A; Imaizumi, M; Ohmoto, Y; Sera, N; Tominaga, T; Usa, T; Yokoyama, N, 2000) |
| "The primary manifestation of Graves' disease with hypothyroidism was caused by blocking TSH receptor antibodies." | 1.31 | [Hypothyroidism and endocrine orbitopathy]. ( Knierim, C; Knierim, M; Schmid, C; Wiesli, P, 2000) |
| "However, of patients with Graves' disease (GD) maintained on antithyroid drug (ATD) treatment, some exhibit persistent suppression of TSH long after normalization of their serum free T3 (FT3) and free T4 (FT4) levels." | 1.31 | Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. ( Inaba, M; Ishikawa, T; Kumeda, Y; Kurioka, Y; Morii, H; Nishizawa, Y; Tahara, H, 2000) |
| " The beginning of therapy, dosage of drugs, length of application and results of treatment are critically evaluated, with special emphasis on the rate and time of remission, on the frequency of recurrences and on the success of additional treatments such as surgery and/or radioiodine application." | 1.31 | [Graves' disease. Clinical features and treatment results]. ( Amor, H; Crivellaro, C; Leimgruber, K; Oberhofer, R, 2001) |
| "Likelihood ratio of Graves' disease in case of prediction by the index is 4." | 1.31 | [An index based on the age and free thyroxine rate predicts the likelihood of Graves' disease in hyperthyroidism]. ( Fain, O; Guilpain, P; Kettaneh, A; Pariès, J; Sitbon, M; Thomas, M, 2001) |
| "In patients with Graves' disease, APA were not associated with thyroid status." | 1.31 | Detection of antipituitary antibodies in patients with autoimmune thyroid disease. ( Kanda, T; Kobayashi, I; Murakami, M; Nishino, M; Yabe, S, 2001) |
| "Sevoflurane was discontinued and dantrolene was given by intravenous bolus." | 1.31 | Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. ( Genma, R; Kitahara, A; Matsushita, A; Nakamura, H; Nakano, K; Natsume, H; Nishiyama, K; Sasaki, S; Yamamoto, Y, 2001) |
| "Furthermore, in thyrotoxic Graves' disease patients, we detected a positive correlation between free T4 and sIL-2R levels (r2 = 0." | 1.31 | Serum cytokines levels in Graves' disease. ( Al-Humaidi, MA, 2000) |
| "One hundred seven patients with Graves' disease were treated with methimazole (MMI)." | 1.31 | Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. ( Komiya, I; Kouki, T; Nishimori, T; Sato, A; Takasu, N; Yamada, T, 2001) |
| "Spontaneous remission of Graves' disease during pregnancy is thought to be due to a reduction of thyroid-stimulating antibody activity." | 1.31 | Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. ( Kohn, LD; Kung, AW; Lau, KS, 2001) |
| "Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism." | 1.31 | Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. ( Faber, J; Mehlsen, J; Schifter, S; Wiinberg, N, 2001) |
| "400 consecutive patients (300 with Graves' disease and 100 with silent thyroiditis) who underwent radioiodine scanning of the thyroid." | 1.31 | Association between lithium use and thyrotoxicosis caused by silent thyroiditis. ( Daniels, GH; Miller, KK, 2001) |
| "Some patients with Graves' disease who select surgical therapy so they can discontinue antithyroid medication require lifelong levo-thyroxin (l-T4) replacement therapy because of irreversible postoperative hypothyroidism." | 1.31 | Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease. ( Akasu, H; Kitagawa, W; Kitamura, Y; Kumasaki, T; Kumita, S; Nagahama, M; Oshina, T; Shimizu, K; Tanaka, S, 2002) |
| "However, in predicting the recurrence of thyrotoxicosis after discontinuing ATD it has been of little value." | 1.31 | Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. ( Feldt-Rasmussen, U; Nygaard, B; Rasmussen, AK; Zimmermann-Belsing, T, 2002) |
| "In patients with untreated Graves' disease, 8-OHdG and cytochrome c levels in culture supernatant of mononuclear cells were significantly higher than those of healthy control subjects, while the cytochrome c levels were significantly higher in patients with untreated Graves' disease and Hashimoto's thyroiditis than those of control subjects." | 1.31 | Production of 8-OHdG and cytochrome c by cultured human mononuclear cells in patients with autoimmune thyroid disease. ( Ban, Y; Hara, H; Sato, R, 2001) |
| "We describe a patient with Graves' disease who developed a lateral cystic neck mass that was later confirmed to be a metastatic lymph node from papillary thyroid microcarcinoma." | 1.31 | Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass. ( Batista, J; Braga, M; Graf, H; Hakim, NC; Ogata, A, 2002) |
| "In patients with Graves' disease, the anti-thyroid treatment resulted in significant reductions of plasma thyroxine and triiodothyronine levels." | 1.31 | Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. ( Hoffstedt, J; Wahrenberg, H; Wennlund, A, 2002) |
| "Four patients with Graves' disease presented elevated plasma concentrations of calcitonin, but none of these patients also had an elevated serum gastrin." | 1.31 | Prevalence of hypergastrinemia in patients with hyper- and hypothyroidism: impact for calcitonin? ( Bieglmayer, Ch; Gessl, A; Nowotny, P; Vierhapper, H, 2002) |
| "A Graves' disease was diagnosed and the patient was initially controlled with antithyroid drugs." | 1.31 | [Acute posterior multifocal placoid pigment epitheliopathy associated with Graves-Basedow's disease]. ( Buil Calvo, JA; Castilla Céspedes, M; Martínez Giralto, O; Ruiz Viñals, AT, 2002) |
| "With the diagnosis of neonatal Graves' disease established, both twins were treated with propranolol (2 mg/kg." | 1.30 | [Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism]. ( Grüters, A; Hüfner, M; Lakomek, M; Roth, C; Siggelkow, H, 1997) |
| "Total thyroidectomy for Graves' disease is an effective and safe therapy." | 1.30 | Total thyroidectomy for Graves' disease. ( Lippes, HA; Lore, JM; Rassael, H; Razack, MS; Schaefer, DP, 1997) |
| "To determine whether Graves' disease or primary hypothyroidism influence platelet function, we evaluated platelet aggregation in the platelet-rich plasma (PRP) from such patients." | 1.30 | Alteration of platelet aggregation in patients with thyroid disorders. ( Hagiwara, M; Hayakawa, N; Hidaka, H; Hirano, E; Kato, R; Kotake, M; Masunaga, R; Mokuno, T; Nagasaka, A; Nakai, A; Oda, N; Sawai, Y; Shimazaki, K, 1997) |
| "However, as pregnancy is associated with type 2 rather than type 1 cytokine production, a decrease in thyroid-stimulating antibody (TSAb) activity alone is unlikely to account for the remission during pregnancy." | 1.30 | A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. ( Jones, BM; Kung, AW, 1998) |
| "In patients showing hyperthyreosis or a TRAK value > 11 U/l at the beginning of RIT, a significantly lower therapeutic dosage and effective iodine half-life were found than in non-hyperthyreotic patients or patients with TRAK < or = 11 U/l." | 1.30 | [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]. ( Bares, R; Büll, U; Dohmen, BM; Kaiser, HJ; Sabri, O; Schreckenberger, M; Schulz, G; Wagenknecht, G; Zimny, D; Zimny, M, 1998) |
| "The outcome of Graves' disease depends on the individual changes of the TRAb levels rather than on their absolute values." | 1.30 | [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease]. ( Garth, H; Holle, LH; Rink, T; Schroth, HJ, 1998) |
| "Eighteen patients with Graves' disease, 24 patients with Hashimoto's thyroiditis and 32 sex- and age-matched healthy control subjects were studied." | 1.30 | Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease. ( Aguilar, M; Escobar, L; Gavilán, I; Girón, JA; Rojano, J; Sasián, S, 1998) |
| "Euthyroid Graves' disease is defined as Graves' ophthalmopathy without hyperthyroidism, and the thyroid-stimulating antibody (TSAb) has been known to be a good marker for diagnosis." | 1.30 | Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease. ( Amino, N; Fujikado, T; Hidaka, Y; Kashiwai, T; Shimaoka, Y; Tada, H; Watanabe, Y; Yagoro, A, 1998) |
| "Spontaneous remission of Graves' disease with a decrease of thyroid stimulating antibody (TSAb) activity is commonly observed in pregnancy." | 1.30 | Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. ( Fukui, H; Mitani, Y; Murakami, H; Murao, A; Santou, Y; Shigemasa, C; Taniguchi, S; Ueta, Y; Yamamoto, R; Yamanouchi, Y, 1999) |
| "Although spontaneous development of Graves' disease cannot be excluded, the time sequence and the negative familial and personal history for autoimmune diseases suggest a possible connection between the two phenomena." | 1.30 | Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma. ( Pezzino, V; Regalbuto, C; Salamone, S; Scollo, C; Vigneri, R, 1999) |
| "Hyperthyroidism of Graves' disease (Morbus Basedow) is known to involve the thyroid gland in toto, unlike Graves' ophthalmopathy which clinically may either be unilateral or bilateral." | 1.30 | Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient. ( Dimai, HP; Lax, S; Leb, G; Lipp, RW; Ramschak-Schwarzer, S, 1999) |
| "These data indicated that she also had autoimmune hepatitis (AIH) and mixed connective tissue disease (MCTD)." | 1.30 | A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease. ( Ando, B; Inoue, K; Masuda, A; Okajima, T; Sakai, K; Takeshita, M; Tanaka, E; Yamamoto, M, 1999) |
| "Severe hypothyroidism was discovered in a young woman in her 29th week of pregnancy." | 1.30 | Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. ( Bellastella, A; Caccavale, C; Carella, C; Del Buono, A; Di Serio, C; Glinoer, D; Rotondi, M; Sorvillo, F, 1999) |
| "Iopanoic acid is a compound that induces a rapid decrease in serum T3 levels, mainly by inhibition of peripheral conversion of T4 to T3." | 1.30 | Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients. ( Lengyel, AM; Ramos-Dias, JC, 1999) |
| "A 34-year-old woman developed Graves' disease with mild ophthalmopathy." | 1.30 | Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease. ( Abbadi, V; Bucalo, ML; Colletti, I; Compagno, V; Donatelli, M; Macchia, E; Pisa, R; Russo, V; Valenti, TM, 1999) |
| "Patients with hypothyroid Graves' disease induced by the excess administration of MMI showed significantly lower IGFBP-3 levels as compared to those in healthy controls (P<0." | 1.30 | Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases. ( Fujiwara, Y; Inukai, T; Takanashi, K; Takebayashi, K; Takemura, Y; Tayama, K, 1999) |
| "295 patients of Graves' disease were studied for early development of transient hypothyroidism (TH) and its prognostic value following I131 therapy." | 1.30 | Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis. ( Gera, A; Khanna, CM; Magdum, M; Sankar, R, 1998) |
| "Twenty-five patients with Graves' disease were untreated before pregnancy (Group A) and twenty treated with carbimazole throughout pregnancy (Group B)." | 1.29 | Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy. ( Escobar-Jiménez, F; Fernández-Soto, ML; Glinoer, D; González-Jiménez, A; Navarrete, L, 1993) |
| "Five of them were affected by Graves' disease and one by De Quervain's thyroiditis." | 1.29 | Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases. ( Di Prima, MA; Faralli, AR; Leri, O; Paggi, A; Paparo, BS; Pellegrino, C; Sinopoli, MT, 1995) |
| "We examined 13 patients with euthyroid Graves' disease suspected ophthalmologically, by comparing them with 20 patients with untreated Graves' disease and by following them up for 5 to 10 years." | 1.29 | Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease. ( Amino, N; Asahi, K; Hidaka, Y; Iwatani, Y; Kashiwai, T; Tada, H; Tamaki, H, 1995) |
| "Fifteen patients affected by new-onset Graves' disease with ophthalmopathy have been examined for lymphocyte subset phenotypes by two-colour cytometric analysis." | 1.29 | CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease. ( Afeltra, A; Amoroso, A; Bonomo, L; Di Prima, MA; Faralli, AR; Ferri, GM; Paggi, A; Startari, S, 1993) |
| "We conclude that in untreated Graves' disease there is a decrease in NK cell activity in PBMC, probably dependent on the autoimmune process." | 1.29 | Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. ( Albarrán, F; Alvarez-Mon, M; Durántez, A; Lucas, T; Marazuela, M; Vargas, JA, 1995) |
| "Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI." | 1.29 | Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994) |
| "Visualization of thyroidal and orbital Graves' disease is feasible, but further investigation is necessary to establish the role of [111In-DTPA-D-Phe1]octreotide scintigraphy in representing disease activity and expression and in predicting therapeutical outcome." | 1.29 | [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? ( Hooijkaas, H; Kooy, PP; Krenning, EP; Oei, HY; Postema, PT; Reubi, JC; van den Bosch, WA; van der Loos, T; Wiersinga, WM; Wijngaarde, R, 1994) |
| "HLA alleles of 106 patients with Graves' disease were determined, and the frequency of HLA-B46 was found to be significantly increased." | 1.29 | Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. ( Inoko, H; Onuma, H; Ota, M; Sugenoya, A, 1994) |
| "The sCD4 level in the Graves' disease group was not different from control values and did not change significantly with treatment." | 1.29 | Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. ( Balázs, C; Bokk, A; Farid, NR, 1994) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 1.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "We present two cases of Graves' disease whose initial thyroidal scintiscan with 99mTcO4- (Case 1) and 123I (Case 2) showed unilateral diffuse uptake of radioisotopes." | 1.29 | Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes. ( Fukui, M; Fuwa, Y; Goto, S; Matsui, I; Ogawa, T; Sakata, S; Sarui, H; Sasano, N; Takuno, H; Yuasa, H, 1993) |
| "Fourteen patients were affected by Graves' disease, eight by silent thyroiditis, five by Hashimoto's thyroiditis." | 1.29 | Anti-cardiolipin antibodies in autoimmune thyroid diseases. ( Afeltra, A; Amoroso, A; Bonomo, L; Caccavo, D; Di Prima, MA; Ferri, GM; Paggi, A; Vaccaro, F, 1994) |
| "We report two patients with primary hypothyroidism due to Hashimoto's disease that unexpectedly, developed a hyperthyroidism due to Basedow-Graves disease." | 1.29 | [Basedow-Graves disease development in 2 patients with primary hypothyroidism: exceptional development of the autoimmune thyroid disease]. ( Arteaga, E; Campusano, C; Michaud, P, 1993) |
| "The serum sIL2R in 17 patients with Graves' disease was determined after treatment with antithyroid drugs (propylthiouracil) for a short period (1." | 1.29 | [The association of Graves' disease with serum soluble interleukin 2 receptor]. ( Ren, YZ; Song, ZG, 1993) |
| "Hyperthyroid Graves' disease was diagnosed in four of the six patients, subacute thyroiditis in one, and transient post-partum thyrotoxicosis in one." | 1.29 | A long-term follow-up study of patients with non-toxic diffuse goitre in Japan. ( Fukata, S; Hara, T; Kuma, K; Mukuta, T; Nakagawa, T; Tamai, H, 1993) |
| "Thyrotoxicosis in Graves' disease is often aggravated in early pregnancy and is closely associated with postpartum recurrence of stimulative thyrotoxicosis." | 1.29 | Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease. ( Amino, N; Asahi, K; Itoh, E; Kaneda, T; Mitsuda, N; Tamaki, H; Tanizawa, O, 1993) |
| "Thirty patients with Graves' disease without previous treatment for hyperthyroidism were included." | 1.29 | Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose. ( Cavaliere, H; Knobel, M; Lima, N; Medeiros-Neto, G; Perozim, LM, 1993) |
| "We studied 83 patients with Graves' disease who were euthyroid for at least 6 months under antithyroid maintenance therapy, and we examined the relationship between thyrotoxicosis relapse, attack of allergic rhinitis, and peripheral eosinophil increase." | 1.29 | Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. ( Amino, N; Hidaka, Y; Itoh, E; Iwatani, Y; Matsunaga, M; Tamaki, H, 1993) |
| "Our results show that patients with Graves' disease tend to have more signs and symptoms than patients with Plummer's disease." | 1.29 | Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level. ( Haak, A; Hermans, J; Tak, PP, 1993) |
| "A 46-year-old woman with hypothyroid Graves' disease (EMO syndrome) is reported." | 1.29 | Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit. ( Fujiwara, K; Hayakawa, K; Koh, T; Koshiyama, H; Mori, S, 1993) |
| "No ipodate was discontinued in the eight patients who did not respond, and they were then treated with MMI." | 1.29 | Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| "37% of the mothers had postpartal recurrence of hyperthyroidism." | 1.29 | [Treatment of Basedow-Graves disease in pregnancy]. ( Konrády, A, 1995) |
| "We present two cases of maternal Graves' disease complicated by fetal goitrous hypothyroidism." | 1.29 | In utero treatment of fetal goitrous hypothyroidism caused by maternal Graves' disease. ( Hadi, HA; Strickland, D, 1995) |
| "Some patients with Graves' disease respond well to anti-thyroid drug treatment but others do not." | 1.29 | The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease. ( Andoh, S; Gemma, R; Mori, T; Nakamura, H; Suzuki, Y; Yoshimi, T, 1996) |
| "A 56-year-old female with Graves' disease who presented with decreased secretion of gonadotropins is described." | 1.29 | Decreased secretion of gonadotropins in a patient with Graves' disease. ( Hakamata, M; Itoh, M; Katada, E; Miyata, N; Sudo, Y, 1996) |
| "A patient with longstanding Hashimoto's thyroiditis who was treated with L-thyroxine at a dosage of 0." | 1.29 | Graves' disease and autoimmune factor VIII deficiency. ( Goldstein, ML; Sievert, R; Surks, MI, 1996) |
| "Graves disease is an autoimmune thyroid disease characterized by the presence of antibodies against the thyrotropin receptor (TSHR), which stimulate the thyroid to cause hyperthyroidism and/or goiter." | 1.29 | Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. ( Hirai, A; Hoshioka, A; Kikuoka, S; Kohn, LD; Kohno, Y; Niimi, H; Saito, Y; Shimojo, N; Tahara, K; Tamura, Y; Yamaguchi, K, 1996) |
| "When she developed Graves' disease, serum concentration of antibodies to the 55-kDa protein had decreased from +2 to +/-, those reactive with other eye muscle antigens had not changed significantly, and TSH receptor antibodies had increased 3-fold." | 1.29 | Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism. ( Barsouk, A; Kennerdell, J; Kiljanski, J; Nebes, V; Peele, K; Stachura, I; Stolarski, C; Volpe, R; Wall, J, 1996) |
| "Although exophthalmos has often been included in clinical descriptions, no previous study has reported actual measurements in patients with active and treated Cushing's syndrome, and in control patients." | 1.29 | Exophthalmos in Cushing's syndrome. ( Kelly, W, 1996) |
| "The development of Graves' disease as evidenced by diagnostic imaging and appearance of TSH receptor antibodies is described in a 49-year-old woman 6 months after onset of subacute thyroiditis." | 1.29 | The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging. ( Bennedbaek, FN; Gram, J; Hegedüs, L, 1996) |
| "The serum P1CP levels of the untreated Graves' disease were significantly higher than in the controls (176." | 1.29 | Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease. ( Demura, H; Miyakawa, M; Tsushima, T, 1996) |
| "We report herein a case of hyperthyroid Graves' disease developed from asymptomatic autoimmune thyroiditis (AAT)." | 1.29 | Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report. ( Amano, J; Fujimori, M; Hama, Y; Kasuga, Y; Kobayashi, S; Maruyama, M; Shingu, K, 1996) |
| "The diagnosis of toxic Graves' disease with thyroid hemiagenesis was, therefore, made." | 1.28 | Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements. ( Dickstein, G; Kraiem, Z; Shechner, C; Zuckerman, E, 1992) |
| "Graves' disease in a girl with Turner's syndrome (karyotype 46,Xdel(Xp)) is described." | 1.28 | Hyperthyroidism accelerates growth in Turner's syndrome. ( de Zegher, F; Dooms, L; Massa, G; Vanderschueren-Lodeweyckx, M, 1992) |
| "Graves' disease was initially diagnosed in an 11-year-old Chinese boy in March 1989." | 1.28 | Class IV lupus nephritis associated with Graves' disease. ( Chao, T; Chen, WP; Fu, LS; Lin, CY; Ooi, SK; Yang, LY, 1992) |
| "The patients had Graves' disease, but no other immune-mediated diseases, had not yet received specific treatment for their ophthalmopathy and were euthyroid during the entire study period." | 1.28 | Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. ( Koornneef, L; Mourits, MP; Prummel, MF; Van der Gaag, R; Wiersinga, WM, 1992) |
| "Seventy-eight patients with Graves' disease had been treated with MMI for 1-3 yr before pregnancy, and MMI was discontinued 5-6 months after the onset of pregnancy because the levels of antibodies to TSH receptors decreased during early pregnancy." | 1.28 | Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. ( Hashizume, K; Ichikawa, K; Kobayashi, M; Miyamoto, T; Nishii, Y; Sakurai, A; Suzuki, S; Takeda, T, 1992) |
| "Neonatal hyperthyroidism is only seen in children whose mothers had an autoimmune thyroid disease." | 1.28 | [Neonatal hyperthyroidism secondary to Basedow's disease in the mother]. ( Bovero, G; Martin Laval, A; Mouroux, D; Nicolino, J, 1991) |
| "Nineteen patients with Graves' disease were regarded as euthyroid at the end of therapy." | 1.28 | Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug. ( Akiyama, H; Inukai, T; Kobayashi, I; Kobayashi, S; Kondo, Y; Shoda, Y; Yamaguchi, T, 1991) |
| "In 26 patients with untreated Graves' disease and 7 hyperthyroid patients with Hashimoto's thyroiditis, the mean levels of soluble IL-2 receptor were both significantly higher than in normal controls (1497 +/- 649 (mean +/- SD), 641 +/- 137 vs 221 +/- 63 10(3) U/l, p less than 0." | 1.28 | Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. ( Nakanishi, K; Ohta, Y; Taniguchi, Y, 1991) |
| "Thus, it is possible that Graves' disease, subacute aggravation of chronic thyroiditis and hypothyroidism coexist in the same individual." | 1.28 | Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism. ( Kouchi, T; Mashiba, H; Mitani, Y; Shigemasa, C; Shirota, K; Ueta, Y; Urabe, K; Yoshida, A, 1991) |
| " The dosage of 0." | 1.28 | The effect of xenotransplantation of human thyroid tissue following radioactive iodine-induced thyroid ablation on thyroid function in the nude mouse. ( Akasu, F; Jamieson, C; Kasuga, Y; Matsubayashi, S; Sakatsume, Y; Volpé, R, 1991) |
| "Eighty-five patients with Graves' disease in clinical remission after treatment for over 1 year by methimazole therapy (36 patients, group A) or subtotal thyroidectomy (49 patients, group B) who became undetectable for serum thyrotropin levels (TSH less than 0." | 1.28 | A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays. ( Kuma, K; Matsubayashi, S; Morita, T; Mukuta, T; Nagai, K; Nakagawa, T; Tamai, H, 1991) |
| "When patients with previously treated Graves' disease (n = 4 in each group) were eliminated, the differences in bone density at the hip were no longer seen." | 1.28 | Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. ( Block, JE; Friedlander, AL; Genant, HK; Greenspan, FS; Greenspan, SL; Resnick, NM, 1991) |
| "The mean RBC CAI in Graves' disease was decreased (180 +/- 53 nmol/g Hb), and 22 patients (88%) had subnormal values." | 1.28 | Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. ( Abe, K; Fukazawa, H; Kaise, K; Kaise, N; Kiso, Y; Mori, K; Yoshida, K; Yoshinaga, K, 1991) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 1.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "In pregnant women with active Graves' disease TBII levels reflect stimulatory TSH receptor antibody activity." | 1.28 | Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. ( Galligan, JP; Mortimer, RH; Perry-Keene, DA; Tan, YM; Tyack, SA, 1990) |
| "Four of the six had Graves' disease previously treated with antithyroidal drugs, one had Graves' disease treated with 131I and one had subacute thyroiditis and subsequently became hypothyroid." | 1.28 | Follow-up study of thyroid stimulating-blocking antibodies in hypothyroid patients. ( Hara, T; Hidaka, A; Kasagi, K; Konishi, J; Kuma, K; Kumagai, LF; Morita, T; Nagataki, S; Tamai, H, 1990) |
| "Among 24 ICA+ patients, 20 (83%) had IDDM." | 1.28 | Islet cell antibodies in patients with autoimmune thyroid disease. ( Akazawa, S; Chikuba, N; Nagataki, S; Nakanishi, T; Ueda, Y; Yamaguchi, Y; Yamamoto, H; Yamasaki, H, 1991) |
| "Two patients with Graves' disease treated with methimazole (MMI) showed a discrepancy between serum free T4 (FT4) values and other hormone values (especially total T4) which was due to the presence of potent binding activity to labelled T4 analogue (125I-aT4) in their serum." | 1.28 | [Studies on thyroid hormone autoantibody (THAA) in 2 cases of Graves' disease with spuriously high free thyroxine values]. ( Fukasawa, N; Hara, Y; Hase, K; Iitaka, M; Ishii, J; Miura, S; Sakatume, Y; Yanagisawa, M, 1991) |
| "We have experienced two cases of Graves' disease with antithyroid hormone autoantibodies (Case 1: anti-T4; Case 2: anti-T3) who finally underwent subtotal thyroidectomy after antithyroid drug treatment." | 1.28 | Two cases of Graves' disease with antithyroid hormone antibodies: implication on the role of thyroglobulin as an antigen. ( Kohno, Y; Komaki, T; Matsuda, M; Nagai, K; Ogawa, T; Saito, K; Sakata, S; Takuno, H; Tarutani, O; Tokimitsu, N, 1990) |
| "NK activity in the Graves' disease patients, however, did not increase when either the NT or HT medium was used at E : T ratios of 25 : 1 and 50 : 1." | 1.28 | Defective response of natural killer activity to thyroxine in Graves' disease. ( Hong, SW; Hong, WS; Kang, TW; Lee, JO; Lee, MS, 1990) |
| "The performed studies covered 48 subjects, inhabiting the Western Pomerania, therein 40 patients with hyperthyroidism in the course of Graves-Basedow's disease (32 females and 8 males, aged 21-64 years) as well as 8 healthy individuals (5 females and 3 males, aged 23-36 years, with negative anamnesis towards thyroid diseases), who made up the control group at determining the pharmacokinetic parameters after a single oral dose containing 60 mg of thiamazole." | 1.28 | [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics]. ( Syrenicz, A, 1990) |
| " A dosage of 4000 U/mouse of human IFN gamma (hIFN gamma) was injected intraperitoneally daily for six consecutive weeks into the xenotransplanted mice." | 1.28 | Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice. ( Jamieson, C; Kasuga, Y; Matsubayashi, S; Miller, N; Sakatsume, Y; Volpé, R, 1990) |
| "Seven days after surgery when Graves' disease patients became euthyroid their ANP markedly decreased to 4." | 1.28 | Plasma atrial natriuretic peptide in patients with Graves' disease. ( Kato, R; Morita, M; Murakami, N; Murakami, T; Naomi, S; Noguchi, S; Sato, T; Tajiri, J; Umeda, T, 1990) |
| "The sera from two patients with Graves' disease gave abnormally high serum free T4 values as compared with the total T4 and other hormone values, suggesting the presence of autoantibodies to labelled T4 analogue used in the Amersham free T4 assay kit." | 1.28 | The mechanism for the discrepancy between serum total and free thyroxine values induced by autoantibodies: report on two patients with Graves' disease. ( Fukasawa, N; Hara, Y; Hase, K; Iitaka, MI; Ishii, J; Miura, S; Sakatsume, Y; Yanagisawa, M, 1990) |
| " One hundred and eighty-six were given a dose adjusted for thyroid size and radioactive iodine uptake (Protocol 1), and a second group received the same dosage followed by antithyroid drug therapy plus potassium iodide for 15 days (Protocol 2)." | 1.28 | Comparison of RA 131I treatment protocols for Graves' disease. ( DeGroot, LJ; Mangklabruks, A; McCormick, M, 1990) |
| "In patients with Graves' disease, thyrostatic drug treatment may induce definitive remission without the need of more aggressive measures such as surgery or radioiodine." | 1.28 | Factors influencing the outcome of thyrostatic drug therapy in Graves' disease. ( Agren, H; Dahlberg, A; Jansson, R; Karlsson, FA; Winsa, B, 1990) |
| "Chronic lymphocytic thyroiditis (Hashimoto's disease) is usually regarded as a stable and irreversible condition." | 1.28 | Hypothyroidism with spontaneous progression to hyperthyroidism. ( Barkan, AL, 1989) |
| "Secretion of thyroid hormones in Graves' disease may be regulated not only by circulating thyroid-stimulating antibodies but also by intrathyroidal stimulatory factors or by inhibitory or destructive factors." | 1.28 | Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease. ( Amino, N; Ichihara, K; Iwatani, Y; Kimura, M; Mitsuda, N; Miyai, K; Tachi, J; Tamaki, H; Tanizawa, O, 1989) |
| "Treatment with carbimazole produced a significant rise in LSH and SOD." | 1.28 | Free radicals and Graves' disease: the effects of therapy. ( Bradley, H; Chopra, M; McKillop, JH; Smith, WE; Thomson, JA; Wilson, R, 1989) |
| " For several years following treatment, the patient displayed clinical hypothyroidism and persistently low serum thyroxine (T4) and triiodothyronine (T3) levels despite large T4 replacement dosage (0." | 1.28 | Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy. ( Bregant, R; Burman, KD; Burns, TW; Premachandra, BN; Williams, IK, 1989) |
| "A patient with Graves' disease associated with severe muscle weakness who was finally diagnosed as polymyositis by pathological examination of the muscle is reported." | 1.28 | A case of Graves' disease associated with polymyositis. ( Fuwa, Y; Goshima, E; Maeda, M; Miura, K; Nakamura, S; Sakata, S; Yamakita, N, 1989) |
| "Treatment-induced improvement of Graves' disease was associated with an increase in LFA-1-positive cell number." | 1.28 | Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease. ( Amiel, C; Bene, MC; Faure, G; Guerin, V; Hartemann, P; Leclere, J, 1989) |
| "Subjects with Graves' disease had significant elevated serum levels of thyroxine (24." | 1.28 | Insulin secretion and sensitivity in hyperthyroidism. ( Ho, LT; Jap, TS; Won, JG, 1989) |
| "We suggest that hyperthyroidism due to Graves' disease is mild in aged patients because responsiveness of the thyrocyte to the abnormal stimulator, thyrotropin-receptor antibody, may be reduced." | 1.28 | Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease. ( Aizawa, T; Hashizume, K; Ishihara, M; Takasu, N; Yamada, T, 1989) |
| "A patient with Graves' disease had a symptomatic thrombocytopathy during periods of remission." | 1.28 | Modulation of mild bleeding disorder during remissions and exacerbations of Graves' disease. ( Iannuzzi, D; Zeigler, ZR, 1989) |
| "In this study of untreated toxic Graves' disease we have taken two assays (LATS protector and thyrotrophin binding inhibiting immunoglobulin, TBII) which depend upon the measurement of binding to thyroid cell membranes, and correlated them with a bioassay which measures as the index of activity the biologically relevant end point of T3 secretion from thyroid tissue." | 1.27 | The assay of Graves' immunoglobulins: a comparison of different methods. ( Atkinson, S; Hardisty, CA; Humphries, H; Kendall-Taylor, P; Munro, DS, 1983) |
| "In 50 consecutive patients with Graves' disease treated with PTU, 7 (group 1) developed increasing goitre in spite of unmeasurable TSH." | 1.27 | Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment. ( Andersen, E; Bech, K; Bliddal, H; Hansen, JM; Hansen, P; Hegedüs, L; Jensen, K; Kampmann, JP; Karstrup, S, 1984) |
| "In 29 patients with thyrotoxic Graves' disease treated with conventional long term antithyroid drug therapy, serum thyroglobulin (Tg) was serially determined by RIA and compared with clinical course, goiter shrinkage, and 131I uptake suppression." | 1.27 | Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy. ( Kawamura, S; Kishino, B; Mashita, K; Tajima, K; Tarui, S, 1983) |
| "A man with previous Graves' disease spontaneously developed hypothyroidism." | 1.27 | Thyroid disease with monoclonal (immunoglobulin G lambda) antibody to triiodothyronine and thyroxine. ( Bastomsky, CH; Meltzer, SJ; Moroz, LA, 1983) |
| "Propranolol was also given for the first 3 weeks." | 1.27 | Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. ( Beardwell, CG; Davies, D; Longson, D; MacFarlane, IA; Shalet, SM, 1983) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 1.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "Glycerol clearance was increased in hyperthyroidism and followed a double exponential decay with a shortened second component half-time." | 1.27 | Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. ( Alberti, KG; Baylis, PH; Clark, F; Johnston, DG; Kendall-Taylor, P; McCulloch, AJ; Young, ET, 1983) |
| "Twenty-seven patients with untreated Graves' disease were studied in order to determine alterations of concentration/attention and their possible association with levels of T4, T3RU, free thyroxin index (FTI), and anxiety." | 1.27 | Attention disturbance in Graves' disease. ( Alavez, E; Alvarez, MA; Gómez, A; Navarro, D, 1983) |
| "In 74 patients with hyperthyroid Graves' disease, TRH tests were undertaken every third month during the course of a standardized antithyroid drug and T4 treatment program." | 1.27 | Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission. ( Dahlberg, PA; Jansson, R; Karlsson, FA; Wide, L, 1985) |
| "These results suggest that Graves' disease may evolve into chronic thyroiditis in some patients who are in permanent remission, and some patients in apparent permanent remission have hyperthyroidism and concomitant chronic thyroiditis." | 1.27 | Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment. ( Hayashi, Y; Hirota, Y; Kuma, K; Kumagai, LF; Matsubayashi, S; Matsuzuka, F; Nagataki, S; Tamai, H, 1986) |
| "Thyroid follicles obtained from Graves' disease glands gave modified results with an earlier and intensified T3 response and no increase in Tg." | 1.27 | Functional properties of human thyroid follicles cultured within collagen gel. ( Condé, D; Edan, G; Hody, B; Leclech, G; Massart, C; Nicol, M, 1988) |
| "In 49 patients with Graves' disease, the 20-min thyroidal uptake of 99mTc and serum levels of thyroid stimulating hormone (TSH) receptor antibody were estimated at presentation and at intervals during a 1-yr course of carbimazole and triiodothyronine." | 1.27 | Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. ( Cuthbert, GF; McKillop, JH; Pearson, DW; Thomson, JA; Wilson, R, 1985) |
| " In 6 of 25 patients, however, a discordant behaviour was clearly documented including dose-response curves." | 1.27 | Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease. ( Hörmann, R; Mann, K; Müller, R; Saller, B, 1985) |
| "Graves' disease was confirmed by persistent thyrotoxicosis, high 99mTc thyroidal uptake, negative T3 suppressibility and detection of TSH-receptor antibodies." | 1.27 | Changes in thyroid-stimulating and TSH-binding inhibitory activities in a patient who developed hyperthyroidism due to Graves' disease following primary hypothyroidism. ( Iida, Y; Kasagi, K; Konishi, J; Mori, T; Torizuka, K, 1986) |
| "Twenty-three (12." | 1.27 | Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. ( Aizawa, T; Kamoi, K; Koizumi, Y; Murakami, M; Takahashi, Y; Watanabe, T; Yamada, T, 1988) |
| "Between 1973 and 1980, 93 patients with Graves' disease underwent subtotal thyroidectomy by the same surgeon (the size of thyroid remnant was 4 g per side)." | 1.27 | Long term thyroid function after subtotal thyroidectomy for Graves' disease. ( Betterle, C; Busnardo, B; Eccher, C; Girelli, ME; Rubello, D, 1988) |
| "Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs." | 1.27 | Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. ( Hosoya, T; Kohno, Y; Kuma, K; Mozai, T; Naito, N; Sakane, S; Takamatsu, J; Takeda, K; Tarutani, O; Yoshimura, H, 1988) |
| "In methimazole-treated patients with T3-suppressible thyroid uptake, anti-DNA antibody was found in 9% (3 of 35)." | 1.27 | Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. ( Aizawa, T; Hiramatsu, K; Ishihara, M; Kameko, M; Kanai, M; Katakura, M; Maruyama, K; Takasu, N; Yamada, T; Yukimura, Y, 1987) |
| "The thyroid volume in patients with Graves' disease who had been in remission (33." | 1.27 | [Determination of thyroid volume using computerized ultrasonography and its clinical application]. ( Miki, K, 1986) |
| "The iodine content of Tg was 28 +/- 3." | 1.27 | Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism. ( Laurberg, P, 1987) |
| "In 4 patients with Graves' disease, the placental T4 concentration was elevated." | 1.27 | Measurement of thyroid hormone concentrations in human placenta. ( Furuhashi, N; Saito, S; Sakurada, T; Suzuki, M; Takahashi, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1987) |
| " In other cases, dosing of the free hormones T3 and T4 remains a vital supplementary test." | 1.27 | [Thyroid biological evaluation: critical study]. ( Heshmati, HM; Izembart, M; Nasser, H; Vallée, G, 1987) |
| "Hence patients with Graves' disease having a small thyroid gland should be treated medically while surgery or radioiodine may be a more reasonable choice in Graves' patients with medium size or large goitres." | 1.27 | Goitre size and outcome of medical treatment of Graves' disease. ( Buchholtz Hansen, PE; Eskjaer Jensen, S; Iversen, E; Laurberg, P; Weeke, J, 1986) |
| "Of 47 patients with hyperthyroid Graves' disease, 37 patients had a serum T3 to T4 ratio greater than 20 ng/micrograms before therapy (normal range, 12-20; mean, 16." | 1.27 | Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. ( Kuma, K; Mozai, T; Takamatsu, J, 1986) |
| "A rare complication of Graves' disease is thyrotoxic crisis." | 1.27 | Fatal thyrotoxic crisis. ( Herman, GE; Husain, M; Kanluen, S; Monforte, J; Spitz, WU, 1986) |
| "Pretibial myxedema is typically associated with clinical hyperthyroidism, diffuse goiter, and ophthalmopathy in patients with Graves' disease." | 1.27 | Euthyroid pretibial myxedema. ( Chen, JJ; Ladenson, PW, 1987) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 1.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| " Furthermore, they support the hypothesis that the dosage of thionamide compounds and the duration of therapy with the initial doses necessary to induce euthyroidism may vary in various parts of the world." | 1.27 | Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter. ( Azizi, F, 1985) |
| "Medical treatments for Graves' disease and for hypothyroidism are simulated with a view to enhancing clinical significance." | 1.27 | Computer simulation for hormones related to primary thyropathy. ( Hatakeyama, T; Yagi, H, 1985) |
| "Relapse of Graves' disease months after inadequate treatment with 131I is well-recognized." | 1.27 | Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I). ( Hegele, RA; Volpé, R, 1985) |
| " We conclude that 1) ipodate (500 mg daily) reduces serum T4 and T3 levels as fast and as much as does the 1-g daily dose studied previously; 2) long term use (for 23-31 weeks) of ipodate for the treatment of Graves' hyperthyroidism is clinically feasible; no adverse effects occurred during or after ipodate treatment; and 3) RAI uptake returns to pretreatment levels as early as 7 days after the discontinuation of ipodate." | 1.27 | Long term treatment of Graves' hyperthyroidism with sodium ipodate. ( Bian, TY; Chopra, IJ; Huang, HW; Jeng, CY; Shen, DC; Shian, LR; Solomon, DH; Wu, SY, 1985) |
| "Five women with Graves' disease, 26-52 years of age, with serum concentrations of triiodothyronine (T3) 4." | 1.26 | Lack of effect of somatostatin on thyroid gland function in Graves' disease. ( Frey, HM; Skare, S, 1980) |
| "In 272 patients with Graves' disease, 209 of 240 (87%) untreated patients without complications had high T3 to T4 ratios (nanograms per micrograms) of more than 20." | 1.26 | Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. ( Amino, N; Iwatani, Y; Kumahara, Y; Miki, T; Miyai, K; Mori, H; Morimoto, S; Nakatani, K; Nishi, K; Yabu, Y, 1981) |
| "In untreated patients with Graves' disease, the percentage of T gamma lymphocytes (mean +/- SD, 8." | 1.26 | Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. ( Amino, N; Asari, S; Iwatani, Y; Izumiguchi, Y; Kumahara, Y; Miyai, K; Mori, H, 1982) |
| "Furthermore in Graves' disease progression of exophthalmos has sometimes been seen following thyroidectomy." | 1.26 | Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease. ( Blichert-Toft, M; Christiansen, C; Date, J; Feldt-Rasmussen, U, 1982) |
| "This suggests that hyperthyroidism affects the responsiveness of the hypothalamic-pituitary axis to sexual steroid hormones." | 1.26 | Functional relationships of the hypothalamic-pituitary-testicular system in Graves' disease. ( Bános, C; Bodrogi, L; Borvendég, J; Csillag, J; Fehér, T; Földes, J; Szalay, F; Takó, J, 1982) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 1.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "In order to study the prognosis of Graves' disease, 236 patients, who had been diagnosed as having had Graves' disease more than 10 years before, were examined." | 1.26 | [Primary hypothyroidism as a possible cause of hypertension from long-term follow-up studies of patients with Graves' disease (author's transl)]. ( Inoue, K; Nakashima, T; Nishitani, H; Okamura, K; Omae, T; Shiroozu, A; Yoshinari, M; Yoshizumi, T, 1980) |
| "The findings might indicate that Graves' disease is closely related to Hashimoto's thyroiditis, especially in sibling patients with Graves' disease." | 1.26 | Clinical and pathological significance of sibling Graves' disease. ( Hidaka, H; Katayama, S; Kuma, K; Matsuzuka, F; Tamai, H; Tanaka, T, 1980) |
| " High pretreatment T3 values were comparatively common among patients in whom a fixed CMI dosage had a insufficient effect." | 1.26 | Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen. ( Dahlberg, PA; Karlsson, FA; Lindström, B; Wide, L, 1981) |
| "Patients with both exophthalmos and hyperthyroidism were treated with different modes of therapy for their hyperthyroidism." | 1.26 | Effect on exophthalmos of various methods of treatment of Graves' disease. ( Ascher, MS; Elias, AN; Gwinup, G, 1982) |
| "These data indicate that Graves' disease is aggravated in early pregnancy and after delivery and ameliorates in the latter half of pregnancy." | 1.26 | Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. ( Amino, N; Iwatani, Y; Kumahara, Y; Kurachi, K; Miyai, K; Mori, H; Tanizawa, O; Yamada, T, 1982) |
| "Twenty-eight patients with Graves' disease were treated with short-term antithyroid drug therapy." | 1.26 | Early remission in thyrotoxicosis produced by short courses of treatment. ( Bing, RF; Rosenthal, FD, 1982) |
| "Ninety five patients with Graves' disease were studied before and at three months intervals after antithyroid drugs (ATD) (31 cases) or radioiodine (64 cases) therapy until recovery." | 1.26 | Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. ( Baldet, L; Jaffiol, C; Lapinski, H; Mirouze, J; Papachristou, C; Robin, M, 1977) |
| " It is suggested therefore that the long term administration of antithryoid drugs can be a useful treatment for intractable cases." | 1.26 | Long term antithyroid drug therapy for intractable cases of Graves' disease. ( Shizume, K, 1978) |
| "LATS containing sera and a number of Graves' disease sera stimulated T4 release from mouse thyroids in vitro as determined by RIA, thus confirming the presence of a thyroid hormone releasing factor in sera of thyrotoxic patients." | 1.26 | An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients. ( Dawry, FP; Maayan, ML; Volpert, EM, 1978) |
| "The relationship of Graves' disease and heredity was studied in 97 clinically and biochemically euthyroid relatives (resin T3 uptake and serum T3, T4, and TSH within normal ranges) who had more than two thyrotoxic relatives within the second degree relationship." | 1.26 | Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease. ( Ikemi, Y; Kuma, K; Kumagai, LF; Matsuzuka, F; Nagataki, S; Shizume, K; Suematsu, H; Tamai, H, 1978) |
| "In 6 TRH non-responsive patients with Graves' disease, serum TSH levels were suppressed from 2." | 1.26 | The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease. ( Frey, HM; Haug, E; Sand, T, 1977) |
| "32 patients with Graves' Disease were investigated before treatment, during ATD therapy and after recovery with a normal T3 suppression test." | 1.26 | [Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease]. ( Aberlenc, M; Baldet, L; Castelnau, P; Jaffiol, C; Mirouze, J, 1978) |
| "Four patients with Graves' disease whose hyperthyroidism was in remission following antithyroid therapy were studied without any treatment during and after pregnancy." | 1.26 | Transient recurrence of hyperthyroidism after delivery in Graves' disease. ( Amino, N; Kuro, R; Miyai, K; Tanaka, F; Yamamoto, T, 1977) |
| "In Tg from patients with treated Graves' disease, iodine, T(3), and T(4) were reduced, but the reduction in the latter was more substantial, resulting in a T(4)/T(3) molar ratio of 3." | 1.26 | Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. ( Izumi, M; Larsen, PR, 1977) |
| "Triiodothyronine (T3) toxicity has been well documented in adults, but only isolated cases have been reported in children." | 1.26 | T3 toxicosis in children. ( Fawcett, DM; Harland, PC; McArthur, RG, 1977) |
| "The study also indicates that treatment of hypothyroidism may occasionally not be lifelong." | 1.26 | Graves' hyperthyroidism. Spontaneous occurrence after autoimmune hypothyroidism with persistent infiltrative ophthalmopathy. ( McDougall, IR; Sung, LC, 1978) |
| " The physiopathogenetic bases for this are examined in relation to dosage and early diagnosis." | 1.26 | [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism]. ( Biagioli, R; Dradi, C; Riceputi, G; Riva, P, 1979) |
| "Propranolol alone was used to prepare 20 thyrotoxic patients, 19 women and 1 man, for subtotal thyroidectomy." | 1.26 | Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy. ( Boyd, D; Tevaarwerk, GJ, 1979) |
| "In patients with Graves' disease there was no correlation between the level of TSAb and hormonal status except serum triiodothyronine (rs = 0." | 1.26 | Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases. ( Bech, K; Nistrup Madsen, S, 1979) |
| " Lithium carbonate was administered for 4-7 weeks in a dosage (900 mg/day) which maintained serum lithium levels between 0." | 1.26 | Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. ( Burman, KD; Dimond, RC; Earll, JM; Wartofsky, L; Wright, FD, 1976) |
| "Circulating immune complexes in Graves' disease sera were detected by the 125I Clq deviation test." | 1.26 | Circulating immune complexes in Graves' disease. ( Cano, PO; Chertman, MM; Jerry, LM; McKenzie, JM, 1976) |
| "Hyperthyroidism is a clinically dramatic but usually benign syndrome that is most commonly associated with the clinical triad known as Graves' disease." | 1.26 | Hyperthyroidism. ( Larsen, PR, 1976) |
| "Hyperthyroidism was diagnosed clinically after elevated serum T3 concentrations in 11 patients and at the same time in 2 patients." | 1.25 | Hormonal pattern of relapse in hyperthyroidism. ( Acosta, M; Chalkley, S; Howorth, PJ; Leatherdale, B; Marsden, P; McKerron, CG, 1975) |
| "Hypothyroidism was treated by thyroxine or tri-iodothyronine replacement therapy." | 1.25 | Intentional radioiodine ablation in Graves' disease. ( Ahmad, A; Burnet, RB; Harding, PE; Wise, PH, 1975) |
| "The 13 patients with Graves' disease were divided into three groups." | 1.25 | Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. ( Larsen, PR, 1975) |
| "2) In 30 cases with 131I treated Graves' disease, TSH concentration was 22." | 1.25 | [Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treate ( Takeda, Y, 1975) |
| "This ratio was increased in all Graves' disease patients with the highest value being 0." | 1.25 | Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. ( Dussault, JH; Fisher, DA; Low, JC; Nicoloff, JT, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 532 (39.06) | 18.7374 |
| 1990's | 303 (22.25) | 18.2507 |
| 2000's | 269 (19.75) | 29.6817 |
| 2010's | 195 (14.32) | 24.3611 |
| 2020's | 63 (4.63) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, YK | 1 |
| Kim, SH | 2 |
| Fang, Y | 1 |
| Du, WH | 2 |
| Zhang, CX | 1 |
| Zhao, SX | 1 |
| Song, HD | 1 |
| Gao, GQ | 2 |
| Dong, M | 1 |
| Fujita, N | 1 |
| Ono, Y | 1 |
| Sano, A | 1 |
| Kimata, M | 1 |
| Oyama, S | 1 |
| Hashimoto, K | 3 |
| Sato, I | 1 |
| Kudo, M | 1 |
| Miyashiro, Y | 1 |
| Fujikata, A | 1 |
| Tanaka, Y | 4 |
| Zheng, D | 1 |
| Liao, H | 1 |
| Chen, S | 1 |
| Liu, X | 5 |
| Mao, C | 2 |
| Zhang, C | 1 |
| Meng, M | 1 |
| Wang, Z | 1 |
| Wang, Y | 4 |
| Jiang, Q | 2 |
| Xue, Y | 2 |
| Zhou, L | 1 |
| Chen, Y | 1 |
| Araruna, LVM | 1 |
| de Oliveira, DC | 1 |
| Pereira, MC | 1 |
| Moura Neto, A | 1 |
| Tambascia, MA | 2 |
| Zantut-Wittmann, DE | 2 |
| Meling Stokland, AE | 1 |
| Ueland, G | 1 |
| Lima, K | 1 |
| Grønning, K | 1 |
| Finnes, TE | 1 |
| Svendsen, M | 1 |
| Ewa Tomkowicz, A | 1 |
| Emblem Holte, S | 1 |
| Therese Sollid, S | 1 |
| Debowska, A | 1 |
| Singsås, H | 1 |
| Landsverk Rensvik, M | 1 |
| Lejon, H | 1 |
| Sørmo, DE | 1 |
| Svare, A | 1 |
| Blika, S | 1 |
| Milova, P | 1 |
| Korsgaard, E | 1 |
| Husby, Ø | 1 |
| Breivik, L | 1 |
| Jørgensen, AP | 1 |
| Sverre Husebye, E | 1 |
| Perros, P | 2 |
| Basu, A | 1 |
| Boelaert, K | 2 |
| Dayan, C | 1 |
| Vaidya, B | 2 |
| Williams, GR | 1 |
| Lazarus, JH | 8 |
| Hickey, J | 1 |
| Drake, WM | 1 |
| Crown, A | 1 |
| Orme, SM | 1 |
| Johnson, A | 1 |
| Ray, DW | 1 |
| Leese, GP | 1 |
| Jones, TH | 1 |
| Abraham, P | 6 |
| Grossman, A | 1 |
| Rees, A | 1 |
| Razvi, S | 1 |
| Gibb, FW | 3 |
| Moran, C | 1 |
| Madathil, A | 1 |
| Žarković, MP | 1 |
| Plummer, Z | 1 |
| Jarvis, S | 1 |
| Falinska, A | 1 |
| Velusamy, A | 1 |
| Sanderson, V | 1 |
| Pariani, N | 1 |
| Atkin, SL | 1 |
| Syed, AA | 1 |
| Sathyapalan, T | 1 |
| Nag, S | 1 |
| Gilbert, J | 1 |
| Gleeson, H | 1 |
| Levy, MJ | 1 |
| Johnston, C | 1 |
| Sturrock, N | 1 |
| Bennett, S | 1 |
| Mishra, B | 1 |
| Malik, I | 1 |
| Karavitaki, N | 1 |
| Peng, C | 1 |
| Sun, W | 1 |
| Fan, L | 1 |
| Li, L | 1 |
| Zhang, X | 2 |
| Gao, Y | 1 |
| Hou, X | 1 |
| Dahiya, V | 1 |
| Vasudeva, N | 1 |
| Sharma, S | 1 |
| Kumar, A | 1 |
| Derkach, KV | 2 |
| Fokina, EA | 1 |
| Bakhtyukov, AA | 2 |
| Sorokoumov, VN | 2 |
| Stepochkina, AM | 1 |
| Zakharova, IO | 1 |
| Shpakov, AO | 2 |
| Pyrżak, B | 1 |
| Rumińska, M | 1 |
| Witkowska-Sędek, E | 1 |
| Kucharska, A | 1 |
| Kim, MJ | 1 |
| Cho, SW | 2 |
| Kim, YA | 2 |
| Choi, HS | 2 |
| Park, YJ | 2 |
| Park, DJ | 2 |
| Cho, BY | 5 |
| Taşkaldıran, I | 1 |
| Altay, FP | 1 |
| Bozkuş, Y | 1 |
| İyidir, ÖT | 1 |
| Nar, A | 1 |
| Tütüncü, NB | 1 |
| Theiler-Schwetz, V | 1 |
| Benninger, T | 1 |
| Trummer, C | 1 |
| Pilz, S | 1 |
| Reichhartinger, M | 1 |
| Rotondi, M | 5 |
| Bendotti, G | 1 |
| Croce, L | 1 |
| Molteni, M | 1 |
| Carbone, A | 1 |
| Magri, F | 1 |
| Pearce, EN | 3 |
| Chiovato, L | 5 |
| Cozzolino, A | 1 |
| Mathiphanit, S | 1 |
| Yenseung, N | 1 |
| Chatchomchuan, W | 1 |
| Butadej, S | 1 |
| Nakasatien, S | 1 |
| Wanothayaroj, E | 1 |
| Rajatanavin, R | 3 |
| Himathongkam, T | 3 |
| Thewjitcharoen, Y | 1 |
| Nakano, M | 1 |
| Konishi, H | 1 |
| Koshiba, M | 1 |
| Merakchi, K | 1 |
| Djerbib, S | 1 |
| Soleimani, M | 1 |
| Dumont, JE | 1 |
| Miot, F | 1 |
| De Deken, X | 1 |
| Azizi, F | 3 |
| Saadat, N | 1 |
| Abdi, H | 1 |
| Mehran, L | 1 |
| Masoumi, S | 1 |
| Takyar, MA | 1 |
| Amouzegar, A | 1 |
| Gong, L | 2 |
| Huang, G | 1 |
| Weng, L | 1 |
| Xu, J | 2 |
| Li, Y | 2 |
| Cui, W | 1 |
| Li, M | 2 |
| Lee, YW | 1 |
| Lin, YY | 1 |
| Weng, SF | 1 |
| Hsu, CH | 1 |
| Huang, CL | 1 |
| Lin, YP | 1 |
| Hsieh, YS | 1 |
| Liu, S | 2 |
| Miao, JJ | 1 |
| Zhou, X | 1 |
| Sun, Q | 1 |
| Mao, XM | 1 |
| Iwamoto, Y | 1 |
| Tatsumi, F | 1 |
| Katakura, Y | 1 |
| Dan, K | 1 |
| Wamata, R | 1 |
| Kimura, T | 4 |
| Shimoda, M | 1 |
| Nakanishi, S | 1 |
| Kaku, K | 2 |
| Mune, T | 2 |
| Kaneto, H | 3 |
| Perez, DB | 1 |
| Jani, P | 1 |
| Maheshwari, R | 1 |
| Shah, D | 1 |
| Katahira, M | 1 |
| Tsunekawa, T | 1 |
| Mizoguchi, A | 1 |
| Yamaguchi, M | 1 |
| Tsuru, K | 1 |
| Takashima, H | 1 |
| Terada, R | 1 |
| Bhakat, B | 1 |
| Pal, J | 1 |
| Das, S | 1 |
| Charaborty, SK | 1 |
| SircarMedical, NR | 1 |
| Shimmaru, K | 1 |
| Inami, M | 1 |
| Hamaoka, A | 1 |
| Fujiwara, N | 1 |
| Morioka, T | 1 |
| Emoto, M | 1 |
| Kamei, N | 1 |
| Suonsyrjä, N | 1 |
| Laihia, I | 1 |
| Huhtala, H | 1 |
| Jaatinen, P | 1 |
| Metso, S | 1 |
| Lee, SY | 1 |
| Chi, Y | 1 |
| Chai, X | 1 |
| Liu, H | 1 |
| Li, N | 3 |
| Lian, X | 1 |
| Li, P | 1 |
| Wang, W | 2 |
| Yan, M | 1 |
| Pan, J | 1 |
| Ito, M | 9 |
| Kawasaki, M | 1 |
| Danno, H | 1 |
| Kohsaka, K | 1 |
| Nakamura, T | 1 |
| Hisakado, M | 1 |
| Yoshioka, W | 2 |
| Kasahara, T | 1 |
| Kudo, T | 5 |
| Nishihara, E | 6 |
| Fukata, S | 8 |
| Nishikawa, M | 10 |
| Nakamura, H | 5 |
| Miyauchi, A | 15 |
| Machado, CM | 1 |
| Castro, JM | 1 |
| Campos, RA | 1 |
| Oliveira, MJ | 1 |
| Bowen, R | 1 |
| Benavides, R | 1 |
| Colón-Franco, JM | 1 |
| Katzman, BM | 1 |
| Muthukumar, A | 1 |
| Sadrzadeh, H | 1 |
| Straseski, J | 1 |
| Klause, U | 1 |
| Tran, N | 1 |
| Kaplowitz, PB | 1 |
| Jiang, J | 1 |
| Vaidyanathan, P | 1 |
| Marín Urueña, SI | 1 |
| Infante López, ME | 1 |
| Samaniego Fernández, CM | 1 |
| Montejo Vicente, MM | 1 |
| Escribano García, C | 1 |
| Izquierdo Caballero, R | 1 |
| Mulero Collantes, I | 1 |
| Caserío Carbonero, S | 1 |
| Vigone, MC | 2 |
| Peroni, E | 1 |
| Di Frenna, M | 1 |
| Mora, S | 1 |
| Barera, G | 1 |
| Weber, G | 1 |
| Powell, A | 1 |
| Wilson, P | 1 |
| Powell, T | 1 |
| Park, H | 1 |
| Kim, HI | 1 |
| Park, J | 1 |
| Park, SY | 1 |
| Kim, TH | 1 |
| Chung, JH | 2 |
| Choi, JY | 1 |
| Kim, SW | 1 |
| Plazinska, MT | 1 |
| Sawicka-Gutaj, N | 2 |
| Czarnywojtek, A | 2 |
| Wolinski, K | 1 |
| Kobylecka, M | 1 |
| Karlińska, M | 1 |
| Prasek, K | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Borowska, M | 1 |
| Gut, P | 1 |
| Ruchala, M | 2 |
| Krolicki, L | 1 |
| Lu, R | 1 |
| Wang, H | 2 |
| Hong, T | 1 |
| Gao, H | 1 |
| Kew, JL | 1 |
| Bain, SC | 1 |
| Suzuki, N | 4 |
| Yoshimura Noh, J | 3 |
| Sugisawa, C | 1 |
| Hoshiyama, A | 1 |
| Hiruma, M | 1 |
| Kawaguchi, A | 1 |
| Morisaki, M | 1 |
| Ohye, H | 6 |
| Suzuki, M | 5 |
| Matsumoto, M | 5 |
| Kunii, Y | 4 |
| Yoshihara, A | 4 |
| Watanabe, N | 3 |
| Sugino, K | 6 |
| Ito, K | 26 |
| Cheng, CW | 2 |
| Wu, CZ | 1 |
| Tang, KT | 2 |
| Fang, WF | 2 |
| Lin, JD | 2 |
| Marouli, E | 1 |
| Kus, A | 1 |
| Del Greco M, F | 1 |
| Chaker, L | 1 |
| Peeters, R | 1 |
| Teumer, A | 1 |
| Deloukas, P | 1 |
| Medici, M | 1 |
| Hu, RT | 1 |
| Liu, DS | 1 |
| Li, B | 1 |
| Stachura, A | 1 |
| Gryn, T | 1 |
| Kałuża, B | 1 |
| Budlewski, T | 1 |
| Franek, E | 1 |
| Fujishima, A | 1 |
| Sato, A | 8 |
| Miura, H | 1 |
| Shimoda, Y | 1 |
| Kameyama, S | 1 |
| Ariake, C | 1 |
| Adachi, H | 1 |
| Fukuoka, Y | 1 |
| Terada, Y | 1 |
| Kinoshita, K | 1 |
| Ohnishi, J | 1 |
| Saito, M | 1 |
| Ishikawa, T | 2 |
| Uchiyama, H | 1 |
| Iwashima, S | 1 |
| Baba, T | 1 |
| Ohishi, A | 1 |
| Iijima, S | 1 |
| Itoh, H | 1 |
| Renne, SL | 1 |
| Valeri, M | 1 |
| Radaelli, S | 1 |
| Collini, P | 1 |
| Barisella, M | 1 |
| Li, YH | 1 |
| Lee, IT | 1 |
| Cheng, Y | 1 |
| Sun, Z | 1 |
| Zhong, D | 1 |
| Ren, L | 1 |
| Yang, H | 1 |
| Litao, MKS | 1 |
| Alvarez, AG | 1 |
| Shah, B | 1 |
| Speer, G | 1 |
| Somogyi, P | 1 |
| Khamisi, S | 1 |
| Lundqvist, M | 1 |
| Emadi, P | 1 |
| Almby, K | 1 |
| Ljunggren, Ö | 1 |
| Karlsson, FA | 5 |
| Ye, X | 2 |
| Zhao, H | 1 |
| Liu, J | 1 |
| Lu, B | 1 |
| Shao, J | 1 |
| Wang, J | 2 |
| Li, J | 1 |
| Bai, L | 1 |
| Wei, F | 1 |
| Wei, M | 1 |
| Xiao, Y | 2 |
| Yan, W | 1 |
| Wei, J | 1 |
| Azova, S | 1 |
| Rajabi, F | 1 |
| Modi, BP | 1 |
| Mansfield, L | 1 |
| Jonas, MM | 1 |
| Drobysheva, A | 1 |
| Boyd, TK | 1 |
| Wassner, AJ | 1 |
| Smith, JR | 1 |
| Mori, Y | 2 |
| Hiromura, M | 1 |
| Terasaki, M | 1 |
| Kushima, H | 1 |
| Ohara, M | 1 |
| Fukui, T | 2 |
| Takahashi, Y | 2 |
| Yamagishi, SI | 1 |
| Washio, K | 1 |
| Uenaka, M | 2 |
| Tanimura, K | 2 |
| Deguchi, M | 1 |
| Nishida, K | 1 |
| Fujioka, K | 1 |
| Yamada, H | 3 |
| Bezdicka, M | 1 |
| Kleiblova, P | 1 |
| Soucek, J | 1 |
| Borecka, M | 1 |
| El-Lababidi, E | 1 |
| Smrz, D | 1 |
| Rataj, M | 1 |
| Sumnik, Z | 1 |
| Malikova, J | 1 |
| Soucek, O | 1 |
| Chen, X | 2 |
| Cai, HY | 1 |
| Ong, SS | 1 |
| Kiew, JJ | 1 |
| Teo, DB | 1 |
| Okazaki-Hada, M | 1 |
| Maruoka, A | 1 |
| Yamamoto, M | 10 |
| Hirokawa, M | 1 |
| Akamizu, T | 2 |
| Toyoda, N | 3 |
| Xia, N | 2 |
| Hu, X | 1 |
| Song, S | 1 |
| Xu, H | 1 |
| Niu, M | 1 |
| Segal, KL | 1 |
| Nelson, CC | 1 |
| Wang, F | 2 |
| Zhang, SJ | 1 |
| Yao, X | 1 |
| Tian, DM | 1 |
| Zhang, KQ | 1 |
| She, DM | 1 |
| Guo, FF | 1 |
| Zhai, QW | 1 |
| Ying, H | 1 |
| Creo, AL | 1 |
| Candela, N | 1 |
| Lee, MM | 1 |
| Feldman, PM | 1 |
| Oliver, C | 1 |
| Grino, M | 1 |
| Moatti Vacher-Coponat, P | 1 |
| Morange, I | 1 |
| Retornaz, F | 1 |
| Al-Majdoub, M | 1 |
| Lantz, M | 1 |
| Spégel, P | 1 |
| Kobayashi, M | 5 |
| Yagasaki, H | 1 |
| Saito, T | 1 |
| Nemoto, A | 1 |
| Naito, A | 1 |
| Sugita, K | 1 |
| Matsumoto, S | 2 |
| Nakajima, Y | 2 |
| Tsujimoto, K | 1 |
| Yamakage, H | 1 |
| Satoh-Asahara, N | 1 |
| Noh, JY | 8 |
| Mori, M | 4 |
| Yamada, M | 4 |
| Ogawa, Y | 1 |
| Adachi, M | 1 |
| Soneda, A | 1 |
| Boiro, D | 1 |
| Diédhiou, D | 1 |
| Niang, B | 1 |
| Sow, D | 1 |
| Mbodj, M | 1 |
| Sarr, A | 1 |
| Ndongo, AA | 1 |
| Thiongane, A | 1 |
| Guèye, M | 1 |
| Thiam, L | 1 |
| Seck, N | 1 |
| Dieng, YJ | 1 |
| Ba, A | 1 |
| Ba, ID | 1 |
| Diallo, IM | 1 |
| Ndiaye, O | 1 |
| Diop, SN | 1 |
| Honda, A | 2 |
| Uchida, T | 1 |
| Komiya, K | 1 |
| Goto, H | 1 |
| Takeno, K | 2 |
| Sato, J | 1 |
| Suzuki, R | 1 |
| Himuro, M | 1 |
| Watada, H | 1 |
| Kourime, M | 1 |
| McGowan, S | 1 |
| Al Towati, M | 1 |
| Ahmed, SF | 1 |
| Stewart, G | 1 |
| Williamson, S | 1 |
| Hunter, I | 1 |
| Donaldson, MDC | 1 |
| Pandiyan, B | 1 |
| Merrill, SJ | 1 |
| Di Bari, F | 1 |
| Antonelli, A | 3 |
| Benvenga, S | 7 |
| Guo, Q | 1 |
| Wu, D | 1 |
| Yu, H | 2 |
| Bao, J | 1 |
| Peng, S | 1 |
| Shan, Z | 1 |
| Guan, H | 1 |
| Teng, W | 1 |
| Garla, VV | 1 |
| Abdul Salim, S | 1 |
| Yanes-Cardozo, LL | 1 |
| Al Jassim, A | 1 |
| Wallace, T | 1 |
| Bouhabel, S | 1 |
| Majdan, A | 1 |
| Hier, M | 1 |
| Forest, VI | 1 |
| Payne, R | 1 |
| Nisihara, R | 1 |
| Pigosso, YG | 1 |
| Prado, N | 1 |
| Utiyama, SRR | 1 |
| De Carvalho, GA | 1 |
| Skare, TL | 1 |
| Masiello, E | 2 |
| Veronesi, G | 1 |
| Gallo, D | 1 |
| Premoli, P | 2 |
| Bianconi, E | 1 |
| Rosetti, S | 1 |
| Cusini, C | 1 |
| Sabatino, J | 1 |
| Ippolito, S | 1 |
| Piantanida, E | 3 |
| Tanda, ML | 6 |
| Wiersinga, WM | 13 |
| Bartalena, L | 11 |
| Meringolo, D | 1 |
| Campi, I | 2 |
| Costante, G | 2 |
| Neumann, S | 3 |
| Krieger, CC | 1 |
| Gershengorn, MC | 3 |
| Smith, TJ | 2 |
| Scanlan, TS | 2 |
| Fernando, R | 2 |
| Gonzalez-Aguilera, B | 1 |
| Betea, D | 1 |
| Lutteri, L | 1 |
| Cavalier, E | 1 |
| Geenen, V | 1 |
| Beckers, A | 1 |
| Valdes-Socin, H | 1 |
| Cole, M | 1 |
| Hynes, AM | 1 |
| Howel, D | 1 |
| Hall, L | 1 |
| Abinun, M | 1 |
| Allahabadia, A | 3 |
| Barrett, T | 1 |
| Drake, AJ | 1 |
| Dimitri, P | 1 |
| Kirk, J | 1 |
| Zammitt, N | 1 |
| Pearce, S | 1 |
| Cheetham, T | 1 |
| van den Berg, R | 1 |
| Slim, CL | 1 |
| Lutgers, HL | 1 |
| de Heide, LJM | 1 |
| Wolthuis, A | 1 |
| Zhang, J | 4 |
| Meng, Z | 3 |
| Gao, Z | 1 |
| Li, H | 3 |
| Liu, N | 1 |
| Nojiri, T | 1 |
| Kurano, M | 1 |
| Araki, O | 1 |
| Nakawatari, K | 1 |
| Shimamoto, S | 1 |
| Igarashi, K | 1 |
| Kano, K | 1 |
| Aoki, J | 1 |
| Kihara, S | 1 |
| Murakami, M | 4 |
| Yatomi, Y | 1 |
| Tseng, FY | 1 |
| Chen, YT | 1 |
| Chi, YC | 1 |
| Chen, PL | 1 |
| Yang, WS | 1 |
| Vorasart, P | 1 |
| Sriphrapradang, C | 1 |
| Kafrouni Gerges, AR | 1 |
| Clark, SN | 1 |
| Shawa, H | 1 |
| Ochi, Y | 3 |
| Bertola, G | 2 |
| Bianchi, R | 1 |
| Giambona, S | 1 |
| Berra, SA | 1 |
| Turan, E | 1 |
| Sato, H | 3 |
| Sasaki, N | 2 |
| Minamitani, K | 2 |
| Minagawa, M | 2 |
| Kazukawa, I | 2 |
| Sugihara, S | 2 |
| Wataki, K | 2 |
| Konda, S | 2 |
| Inomata, H | 2 |
| Sanayama, K | 2 |
| Kohno, Y | 5 |
| Reza, S | 1 |
| Shaukat, A | 1 |
| Arain, TM | 1 |
| Riaz, QS | 1 |
| Mahmud, M | 1 |
| Siemińska, L | 1 |
| Foltyn, W | 1 |
| Głogowska-Szeląg, J | 1 |
| Kajdaniuk, D | 1 |
| Marek, B | 1 |
| Nowak, M | 1 |
| Walczak, K | 1 |
| Kos-Kudła, B | 1 |
| Baldini, M | 3 |
| Gambini, D | 1 |
| Airaghi, L | 1 |
| Tomirotti, M | 1 |
| Cappellini, MD | 1 |
| Kuznik, BI | 1 |
| Vitkovsky, YA | 1 |
| Gvozdeva, OV | 1 |
| Solpov, AV | 1 |
| Magen, E | 1 |
| Zammitt, NN | 2 |
| Beckett, GJ | 4 |
| Strachan, MW | 2 |
| Celik, HT | 1 |
| Abusoglu, S | 1 |
| Burnik, SF | 1 |
| Sezer, S | 1 |
| Serdar, MA | 1 |
| Ercan, M | 1 |
| Uguz, N | 1 |
| Avcikucuk, M | 1 |
| Ceylan, B | 1 |
| Yildirimkaya, M | 1 |
| Couderc, E | 1 |
| Cante, V | 1 |
| Renaud, O | 1 |
| Guillet, G | 1 |
| Hirsch, D | 1 |
| Levy, S | 1 |
| Nadler, V | 1 |
| Kopel, V | 1 |
| Shainberg, B | 1 |
| Toledano, Y | 1 |
| Almeida, RF | 1 |
| Comarella, AP | 1 |
| Silveira, MB | 1 |
| Silva, AR | 1 |
| Ferri Casini, A | 1 |
| Peng, D | 1 |
| Xu, B | 1 |
| Guo, H | 2 |
| Jiang, Y | 1 |
| Carlé, A | 2 |
| Knudsen, N | 2 |
| Pedersen, IB | 1 |
| Perrild, H | 2 |
| Ovesen, L | 2 |
| Rasmussen, LB | 2 |
| Laurberg, P | 9 |
| Matsumoto, T | 1 |
| Miyakoshi, K | 1 |
| Saisho, Y | 1 |
| Ishii, T | 1 |
| Ikenoue, S | 1 |
| Kasuga, Y | 6 |
| Kadohira, I | 1 |
| Sato, S | 5 |
| Momotani, N | 13 |
| Minegishi, K | 1 |
| Yoshimura, Y | 1 |
| Wu, LP | 1 |
| Fu, J | 1 |
| Lv, HJ | 1 |
| Guan, XY | 1 |
| Xu, L | 4 |
| Chen, P | 1 |
| Gao, CQ | 1 |
| Hou, P | 4 |
| Ji, MJ | 1 |
| Shi, BY | 1 |
| Regelmann, MO | 1 |
| Sullivan, CK | 1 |
| Rapaport, R | 3 |
| Li, XH | 1 |
| Yao, YM | 1 |
| Takeshima, K | 1 |
| Inaba, H | 1 |
| Furukawa, Y | 1 |
| Nishi, M | 1 |
| Yamaoka, H | 1 |
| Miyamoto, W | 1 |
| Ota, T | 1 |
| Doi, A | 1 |
| Kawashima, H | 1 |
| Ariyasu, H | 1 |
| Wakasaki, H | 1 |
| Furuta, H | 1 |
| Nakao, T | 1 |
| Sasaki, H | 1 |
| Szczepanek-Parulska, E | 1 |
| Hernik, A | 1 |
| Zeng, H | 1 |
| Ren, M | 1 |
| Yan, H | 1 |
| Xu, M | 1 |
| Feng, Z | 1 |
| Liang, W | 1 |
| Yang, C | 1 |
| Cheng, H | 1 |
| Ding, H | 1 |
| Yan, L | 1 |
| Mohlin, E | 1 |
| Filipsson Nyström, H | 1 |
| Eliasson, M | 1 |
| Ide, A | 2 |
| Amino, N | 32 |
| Kang, S | 1 |
| Batra, R | 1 |
| Krishnasamy, SK | 1 |
| Buch, H | 1 |
| Sandramouli, S | 1 |
| Levy-Shraga, Y | 1 |
| Tamir-Hostovsky, L | 1 |
| Boyko, V | 1 |
| Lerner-Geva, L | 1 |
| Pinhas-Hamiel, O | 1 |
| Gutaj, P | 1 |
| Sowiński, J | 3 |
| Wender-Ożegowska, E | 1 |
| Brązert, J | 1 |
| Ruchała, M | 1 |
| Polak, M | 4 |
| Luton, D | 4 |
| Bisschop, PH | 1 |
| van Trotsenburg, AS | 3 |
| Matta, A | 1 |
| Koppala, J | 1 |
| Gossman, W | 1 |
| Tairaku, S | 1 |
| Morioka, I | 1 |
| Ebina, Y | 1 |
| Hernán Martínez, J | 1 |
| Sánchez, A | 1 |
| Torres, O | 1 |
| Palermo, C | 1 |
| Santiago, M | 1 |
| Figueroa, C | 1 |
| Trinidad, R | 1 |
| Mangual, M | 1 |
| Gutierrez, M | 1 |
| González, E | 1 |
| Miranda, Mde L | 1 |
| Kruljac, I | 1 |
| Solter, D | 1 |
| Vrkljan, AM | 1 |
| Solter, M | 1 |
| Zeng, J | 1 |
| Yan, YR | 1 |
| Yan, Z | 1 |
| Huang, H | 1 |
| Guo, N | 1 |
| Yang, K | 1 |
| Lin, YS | 1 |
| Wang, T | 1 |
| Qiang, W | 1 |
| Liu, L | 1 |
| Gao, A | 1 |
| Gao, S | 2 |
| Shi, B | 5 |
| Fricke-Otto, S | 1 |
| Yasuda, S | 1 |
| Mukasa, K | 3 |
| Nagataki, S | 21 |
| Taniyama, M | 3 |
| Joshi, AS | 1 |
| Varthakavi, PK | 1 |
| Bhagwat, NM | 1 |
| Thiruvengadam, NR | 1 |
| Zhang, H | 1 |
| Liang, L | 1 |
| Xie, Z | 1 |
| Yang, J | 3 |
| Li, LF | 1 |
| Xu, Q | 1 |
| Weng, WW | 1 |
| Zhu, YJ | 1 |
| Dong, MJ | 1 |
| Sato, Y | 2 |
| Murata, M | 1 |
| Sasahara, J | 1 |
| Hayashi, S | 2 |
| Ishii, K | 1 |
| Mitsuda, N | 5 |
| Catalina, PF | 1 |
| Carpio, D | 1 |
| Holthoff, HP | 1 |
| Goebel, S | 1 |
| Li, Z | 1 |
| Faßbender, J | 1 |
| Reimann, A | 1 |
| Zeibig, S | 1 |
| Lohse, MJ | 1 |
| Münch, G | 1 |
| Ungerer, M | 1 |
| Burch, HB | 3 |
| Burman, KD | 6 |
| Kahaly, GJ | 2 |
| Khater, C | 1 |
| Ceccaldi, PF | 1 |
| Poujade, O | 1 |
| Banigé, M | 1 |
| Ottenwalter, A | 1 |
| Decroli, E | 1 |
| Manaf, A | 1 |
| Syahbuddin, S | 1 |
| Harvengt, J | 1 |
| Boizeau, P | 1 |
| Chevenne, D | 1 |
| Zenaty, D | 1 |
| Paulsen, A | 1 |
| Simon, D | 1 |
| Guilmin Crepon, S | 1 |
| Alberti, C | 1 |
| Carel, JC | 1 |
| Léger, J | 2 |
| Kameda, T | 2 |
| Chen, L | 2 |
| Shen, Q | 1 |
| Liu, T | 1 |
| Jiang, L | 1 |
| Gu, X | 1 |
| Sun, J | 1 |
| Liu, C | 1 |
| Tohma, Y | 2 |
| Akturk, M | 2 |
| Altinova, A | 1 |
| Yassibas, E | 1 |
| Cerit, ET | 2 |
| Gulbahar, O | 1 |
| Arslan, M | 1 |
| Sanlier, N | 1 |
| Toruner, F | 1 |
| Goichot, B | 2 |
| Caron, P | 2 |
| Landron, F | 1 |
| Bouée, S | 1 |
| Frank, CU | 1 |
| Braeth, S | 1 |
| Dietrich, JW | 1 |
| Wanjura, D | 1 |
| Loos, U | 2 |
| Motylewska, E | 1 |
| Nieć, M | 1 |
| Siejka, A | 1 |
| Komorowski, J | 1 |
| Ławnicka, H | 1 |
| Świętosławski, J | 1 |
| Stępień, H | 1 |
| Iwaku, K | 1 |
| Kobayashi, S | 5 |
| Rariy, CM | 1 |
| Schram, A | 1 |
| Ruan, DT | 1 |
| Vaidya, A | 1 |
| Alexander, E | 1 |
| Villagelin, D | 1 |
| Romaldini, JH | 4 |
| Santos, RB | 1 |
| Milkos, AB | 1 |
| Ward, LS | 1 |
| Murphy, T | 1 |
| Zhang, L | 1 |
| Huang, B | 1 |
| Veitla, V | 1 |
| Scherlag, BJ | 1 |
| Kem, DC | 1 |
| Yu, X | 1 |
| Martín-Frías, M | 1 |
| Enes Romero, P | 1 |
| Roldán Martín, MB | 1 |
| Alonso Blanco, M | 1 |
| Barrio Castellanos, R | 1 |
| Li, QM | 1 |
| Wei, JP | 1 |
| Meng, SH | 1 |
| Fischli, S | 1 |
| Lucchini, B | 1 |
| Müller, W | 1 |
| Slahor, L | 1 |
| Henzen, C | 1 |
| Brondfield, S | 1 |
| Feingold, KR | 1 |
| Taïeb, D | 1 |
| Bournaud, C | 1 |
| Eberle, MC | 1 |
| Catargi, B | 1 |
| Schvartz, C | 1 |
| Cavarec, MB | 1 |
| Faugeron, I | 1 |
| Toubert, ME | 2 |
| Benisvy, D | 1 |
| Archange, C | 1 |
| Mundler, O | 1 |
| Abdullah, AE | 1 |
| Baumstarck, K | 1 |
| Vos, XG | 2 |
| Endert, E | 3 |
| Zwinderman, AH | 1 |
| Tijssen, JG | 3 |
| Sheehan, MT | 1 |
| Doi, SA | 1 |
| Vita, R | 1 |
| Lapa, D | 2 |
| Trimarchi, F | 5 |
| Vita, G | 1 |
| Fallahi, P | 2 |
| Cunha, FM | 1 |
| Rodrigues, E | 1 |
| Oliveira, J | 1 |
| Saavedra, A | 1 |
| Vinhas, LS | 1 |
| Carvalho, D | 1 |
| Barbesino, G | 4 |
| Knollman, PD | 1 |
| Giese, A | 1 |
| Bhayani, MK | 1 |
| Guan, L | 1 |
| Chen, G | 2 |
| Wang, L | 1 |
| Tun, NN | 1 |
| Beckett, G | 2 |
| Seckl, JR | 1 |
| Cox, SC | 1 |
| Tamatea, JA | 1 |
| Conaglen, JV | 1 |
| Elston, MS | 1 |
| Xu, F | 1 |
| Gu, A | 1 |
| Pan, Y | 1 |
| Yang, L | 1 |
| Ma, Y | 1 |
| Hawken, C | 1 |
| Sarreau, M | 1 |
| Bernardin, M | 1 |
| Delcourt, AC | 1 |
| Muller, A | 1 |
| Lefort, G | 1 |
| Pernollet, P | 1 |
| Marechaud, R | 1 |
| Kim, D | 1 |
| Matsuki, M | 1 |
| Peng, Y | 1 |
| Qi, Y | 1 |
| Huang, F | 1 |
| Zhou, Y | 1 |
| Ye, L | 1 |
| Ning, G | 4 |
| Wang, S | 3 |
| Leo, M | 1 |
| Rotondo Dottore, G | 1 |
| Ionni, I | 1 |
| Di Cera, M | 1 |
| Sassi, L | 2 |
| Latrofa, F | 1 |
| Vitti, P | 3 |
| Marcocci, C | 5 |
| Marinò, M | 3 |
| Placzek, E | 1 |
| Reese, EA | 1 |
| Placzek, AT | 1 |
| Schwartz, S | 1 |
| Trierweiler, A | 1 |
| Niziol, LM | 1 |
| Raychaudhuri, N | 1 |
| Atkins, S | 1 |
| Martin, CS | 1 |
| Sirbu, AE | 1 |
| Betivoiu, MA | 1 |
| Florea, S | 1 |
| Barbu, CG | 1 |
| Fica, SV | 1 |
| Allelein, S | 2 |
| Ehlers, M | 1 |
| Goretzki, S | 1 |
| Hermsen, D | 1 |
| Feldkamp, J | 2 |
| Haase, M | 1 |
| Dringenberg, T | 1 |
| Schmid, C | 3 |
| Hautzel, H | 1 |
| Schott, M | 2 |
| Kelley, S | 1 |
| Beshyah, SA | 1 |
| Khalil, AB | 1 |
| Sherif, IH | 1 |
| Benbarka, MM | 1 |
| Raza, SA | 1 |
| Hussein, W | 1 |
| Alzahrani, AS | 2 |
| Chadli, A | 1 |
| Yalcin, MM | 1 |
| Altinova, AE | 1 |
| Arslan, E | 1 |
| Yetkin, I | 1 |
| Toruner, FB | 1 |
| Moon, S | 1 |
| Moon, JH | 1 |
| Kim, KW | 2 |
| Yi, KH | 1 |
| Yu, MG | 1 |
| Quisumbing, JP | 1 |
| Ohara, N | 1 |
| Kaneko, M | 1 |
| Kitazawa, M | 1 |
| Uemura, Y | 1 |
| Minagawa, S | 1 |
| Miyakoshi, M | 1 |
| Kaneko, K | 1 |
| Kamoi, K | 3 |
| Zheng, W | 1 |
| Wang, R | 1 |
| Tan, J | 2 |
| Ishikawa, N | 9 |
| Brent, GA | 1 |
| Heemstra, KA | 1 |
| Toes, RE | 1 |
| Sepers, J | 1 |
| Pereira, AM | 1 |
| Corssmit, EP | 1 |
| Huizinga, TW | 1 |
| Romijn, JA | 1 |
| Smit, JW | 1 |
| Bossowski, A | 6 |
| Czarnocka, B | 1 |
| Bardadin, K | 1 |
| Urban, M | 4 |
| Niedziela, M | 1 |
| Dadan, J | 1 |
| Strieder, TG | 1 |
| Wenzel, BE | 1 |
| Tsai, ST | 1 |
| Huang, CY | 1 |
| Lo, FS | 1 |
| Chang, YT | 1 |
| Tanizawa, T | 1 |
| Chen, CK | 1 |
| Wang, ZC | 1 |
| Liu, HF | 1 |
| Chu, CC | 1 |
| Lin, M | 1 |
| Lin, CH | 1 |
| Li, HJ | 1 |
| Lee, YJ | 1 |
| Miao, J | 1 |
| Zhao, YJ | 2 |
| Jiang, XH | 1 |
| Zhao, ZF | 1 |
| Gu, LQ | 2 |
| Gu, XJ | 1 |
| Chu, CH | 2 |
| Lee, JK | 2 |
| Wang, MC | 2 |
| Lu, CC | 2 |
| Sun, CC | 2 |
| Chuang, MJ | 2 |
| Lam, HC | 2 |
| Smit, N | 1 |
| Brosschot, JF | 1 |
| Bischoff, A | 1 |
| Hunzeker, CM | 1 |
| Kamino, H | 1 |
| Walters, RF | 1 |
| Kovich, OI | 1 |
| Bjørndal, MM | 1 |
| Sandmo Wilhelmsen, K | 1 |
| Lu, T | 1 |
| Jorde, R | 2 |
| Duncea, I | 1 |
| Pepene, CE | 1 |
| Koga, M | 1 |
| Murai, J | 1 |
| Saito, H | 2 |
| Kasayama, S | 1 |
| Jiskra, J | 3 |
| Antosová, M | 2 |
| Límanová, Z | 3 |
| Telicka, Z | 2 |
| Lacinová, Z | 1 |
| Lee, SW | 1 |
| Lee, J | 1 |
| Bae, JH | 1 |
| Seo, JH | 1 |
| Kang, SM | 1 |
| Ahn, BC | 1 |
| Lee, I | 1 |
| Loh, JA | 1 |
| Wartofsky, L | 7 |
| Jonklaas, J | 1 |
| Nagele, W | 1 |
| Hörmann, J | 1 |
| Nagele, J | 1 |
| Misharin, AV | 1 |
| Nagayama, Y | 7 |
| Aliesky, HA | 2 |
| Mizutori, Y | 1 |
| Rapoport, B | 8 |
| McLachlan, SM | 7 |
| Regalbuto, C | 3 |
| Marturano, I | 1 |
| Condorelli, A | 1 |
| Latina, A | 1 |
| Pezzino, V | 2 |
| Nanba, T | 1 |
| Watanabe, M | 4 |
| Inoue, N | 1 |
| Iwatani, Y | 14 |
| Cinemre, H | 1 |
| Bilir, C | 1 |
| Gokosmanoglu, F | 1 |
| Akdemir, N | 1 |
| Erdogmus, B | 1 |
| Buyukkaya, R | 1 |
| Endo, T | 1 |
| Kobayashi, T | 1 |
| Zwaveling-Soonawala, N | 1 |
| van Trotsenburg, P | 1 |
| Vulsma, T | 3 |
| Tajima, T | 1 |
| Jo, W | 1 |
| Fujikura, K | 1 |
| Fukushi, M | 2 |
| Fujieda, K | 1 |
| González-González, A | 1 |
| Recio Cordova, JM | 1 |
| Aznar Ondoño, I | 1 |
| Del Monte Jarabo Bueno, M | 1 |
| Gen, R | 1 |
| Akbay, E | 1 |
| Camsari, A | 1 |
| Ozcan, T | 1 |
| Iglesias, P | 1 |
| Dévora, O | 1 |
| García, J | 1 |
| Tajada, P | 1 |
| García-Arévalo, C | 1 |
| Díez, JJ | 1 |
| Papendieck, P | 1 |
| Chiesa, A | 2 |
| Prieto, L | 1 |
| Gruñeiro-Papendieck, L | 2 |
| Bałdys-Waligórska, A | 1 |
| Stefańska, A | 1 |
| Gołkowski, F | 1 |
| Sokołowski, G | 1 |
| Hubalewska-Dydejczyk, A | 1 |
| Sato, W | 1 |
| Hoshi, K | 2 |
| Kawakami, J | 2 |
| Sato, K | 4 |
| Sugawara, A | 2 |
| Saito, Y | 3 |
| Yoshida, K | 11 |
| Johnson, KT | 1 |
| Wittig, A | 1 |
| Loesch, C | 1 |
| Esser, J | 1 |
| Sauerwein, W | 1 |
| Eckstein, AK | 1 |
| Bogazzi, F | 4 |
| Giovannetti, C | 1 |
| Fessehatsion, R | 1 |
| Campomori, A | 2 |
| Compri, E | 2 |
| Rossi, G | 2 |
| Ceccarelli, C | 1 |
| Pinchera, A | 8 |
| Martino, E | 5 |
| Shaheen, D | 1 |
| Kim, CS | 1 |
| Müssig, K | 1 |
| Mörike, K | 1 |
| Klein, R | 1 |
| Sträter, J | 1 |
| Georges, G | 1 |
| Häring, HU | 1 |
| Schnauder, G | 1 |
| Galofre, JC | 1 |
| Davies, TF | 5 |
| Lai, A | 1 |
| Marino, F | 1 |
| Sivelli, P | 1 |
| Avenell, A | 5 |
| McGeoch, SC | 1 |
| Clark, LF | 1 |
| Bevan, JS | 5 |
| Cetinkalp, S | 1 |
| Karadeniz, M | 1 |
| Erdoğan, M | 1 |
| Eroğlu, Z | 1 |
| Zengi, A | 1 |
| Kosova, B | 1 |
| Yilmaz, C | 1 |
| Tezcanli, B | 1 |
| Kabalak, T | 1 |
| Ozgen, AG | 1 |
| Baqi, L | 1 |
| Payer, J | 1 |
| Killinger, Z | 1 |
| Susienkova, K | 1 |
| Jackuliak, P | 1 |
| Cierny, D | 1 |
| Langer, P | 1 |
| Sivakumar, T | 1 |
| Chaidarun, S | 1 |
| Umar, H | 1 |
| Muallima, N | 1 |
| Adam, JM | 1 |
| Sanusi, H | 1 |
| Potlukova, E | 1 |
| Freiberger, T | 1 |
| Zivorova, D | 1 |
| Malickova, K | 1 |
| Springer, D | 1 |
| Grodecka, L | 1 |
| Pesickova, SS | 1 |
| Trendelenburg, M | 1 |
| Wasniewska, M | 1 |
| Corrias, A | 2 |
| Arrigo, T | 1 |
| Lombardo, F | 1 |
| Salerno, M | 1 |
| Mussa, A | 1 |
| De Luca, F | 2 |
| Nunes, Vdos S | 1 |
| Tagliarini, JV | 1 |
| Marques, ME | 1 |
| de Godoi, JA | 1 |
| Mazeto, GM | 1 |
| Boubaker, K | 1 |
| Ounissi, M | 1 |
| Khiari, K | 1 |
| Harzallah, A | 1 |
| Abbes, M | 1 |
| El Younsi, F | 1 |
| Ben Abdellah, T | 1 |
| Ben Maïz, H | 1 |
| Kaaroud, H | 1 |
| Kheder, A | 1 |
| Li, ZY | 1 |
| Wang, P | 1 |
| Xu, SM | 1 |
| Cao, LP | 1 |
| Que, RS | 1 |
| Corral, E | 1 |
| Reascos, M | 1 |
| Preiss, Y | 1 |
| Rompel, SM | 1 |
| Sepulveda, W | 1 |
| Sawicka, B | 2 |
| Szalecki, M | 1 |
| Wysoka, J | 1 |
| Koput, A | 1 |
| Zelazowska-Rutkowska, B | 1 |
| Tobolczyk, J | 1 |
| Rogowski, F | 1 |
| Łuba, M | 1 |
| Choo, YK | 1 |
| Yoo, WS | 1 |
| Kim, DW | 1 |
| Chung, HK | 1 |
| Fitzpatrick, DL | 1 |
| Russell, MA | 1 |
| Popoveniuc, G | 1 |
| Sharma, M | 1 |
| Devdhar, M | 1 |
| Wexler, JA | 1 |
| Carroll, NM | 1 |
| Prakash, KM | 1 |
| Kek, PC | 1 |
| Yamazaki, M | 1 |
| Nishio, S | 1 |
| Uehara, T | 1 |
| Komatsu, M | 1 |
| Kinoshita, H | 1 |
| Yasuda, M | 1 |
| Kaneko, S | 1 |
| Usui, R | 1 |
| Inoshita, S | 1 |
| Furumoto, Y | 1 |
| Maruyama, Y | 1 |
| Susa, K | 1 |
| Suenaga, M | 1 |
| Fujita, H | 1 |
| Tomiyama, J | 1 |
| Yakushiji, F | 1 |
| Nomura, E | 1 |
| Takamura, Y | 1 |
| Iwasaka, T | 1 |
| Takamatsu, J | 12 |
| Eliseeva, E | 1 |
| McCoy, JG | 1 |
| Napolitano, G | 1 |
| Giuliani, C | 1 |
| Monaco, F | 1 |
| Huang, W | 1 |
| Micallef, T | 1 |
| Gruppetta, M | 1 |
| Cassar, A | 1 |
| Fava, S | 1 |
| Ye, F | 2 |
| Wu, X | 2 |
| Gao, L | 2 |
| Ma, X | 2 |
| Wu, L | 3 |
| Aoki, S | 1 |
| Satoh, K | 1 |
| Mori, K | 5 |
| Bliddal, S | 1 |
| Rasmussen, ÅK | 2 |
| Sundberg, K | 2 |
| Brocks, V | 1 |
| Skovbo, P | 1 |
| Feldt-Rasmussen, U | 6 |
| Bonnema, SJ | 1 |
| Grupe, P | 1 |
| Boel-Jørgensen, H | 1 |
| Brix, TH | 1 |
| Hegedüs, L | 5 |
| Konishi, T | 1 |
| Okamoto, Y | 3 |
| Ueda, M | 3 |
| Fukuda, Y | 1 |
| Harusato, I | 1 |
| Tsukamoto, Y | 1 |
| Hamada, N | 8 |
| Ueki, I | 1 |
| Abiru, N | 1 |
| Nakahara, M | 1 |
| Ichikawa, T | 2 |
| Eguchi, K | 2 |
| Bowman, P | 1 |
| Osborne, NJ | 1 |
| Sturley, R | 1 |
| Xun, L | 1 |
| Tian, Z | 1 |
| Zhang, Y | 2 |
| Bagnasco, M | 2 |
| Minciullo, PL | 1 |
| Saraceno, GS | 1 |
| Gangemi, S | 1 |
| Zhao, L | 1 |
| Zhu, W | 1 |
| Li, FY | 1 |
| Zhang, MJ | 1 |
| Liu, Y | 1 |
| Liu, JM | 1 |
| Jin, M | 1 |
| Jiang, X | 1 |
| Higashi, T | 1 |
| Shimizu, C | 1 |
| Nagai, S | 1 |
| Inagaki, S | 1 |
| Min, JZ | 1 |
| Chiba, H | 1 |
| Ikegawa, S | 1 |
| Toyo'oka, T | 1 |
| Ilyés, I | 1 |
| Aslan, M | 1 |
| Cosar, N | 1 |
| Celik, H | 1 |
| Aksoy, N | 1 |
| Dulger, AC | 1 |
| Begenik, H | 1 |
| Soyoral, YU | 1 |
| Kucukoglu, ME | 1 |
| Selek, S | 1 |
| Chen, DY | 1 |
| Schneider, PF | 1 |
| Zhang, XS | 1 |
| He, ZM | 1 |
| Jing, J | 1 |
| Chen, TH | 1 |
| Amato-Stratmann, M | 1 |
| Grebe, SK | 2 |
| Lupo, MA | 1 |
| McDonald, N | 1 |
| Sipos, JA | 1 |
| Stoppa-Vaucher, S | 1 |
| Van Vliet, G | 3 |
| Deladoëy, J | 1 |
| Wintergerst, KA | 1 |
| Rogers, ES | 1 |
| Foster, MB | 1 |
| Berman, DC | 1 |
| Andersen, S | 1 |
| Bülow Pedersen, I | 2 |
| Dong, QY | 1 |
| Li, SJ | 1 |
| Liu, XM | 1 |
| Li, WX | 1 |
| Liang, CG | 1 |
| Wsng, YL | 1 |
| Nakano, Y | 1 |
| Kurihara, H | 1 |
| Sasaki, J | 1 |
| Gerber, PA | 1 |
| Soll, C | 1 |
| González Cabrera, N | 1 |
| Kalic, AK | 1 |
| Antón Miguel, MÁ | 1 |
| Sierra Polo, P | 1 |
| Vicente Vicente, MÁ | 1 |
| Yasuda, T | 1 |
| Miyashita, K | 1 |
| Takahara, M | 1 |
| Sakamoto, F | 1 |
| Miyatsuka, T | 1 |
| Kitamura, T | 1 |
| Katakami, N | 1 |
| Kawamori, D | 1 |
| Otsuki, M | 1 |
| Matsuoka, TA | 1 |
| Shimomura, I | 1 |
| De Leu, N | 1 |
| Unuane, D | 1 |
| Poppe, K | 1 |
| Velkeniers, B | 1 |
| Balázs, C | 3 |
| Türke, B | 1 |
| Vámos, A | 1 |
| Gundara, JS | 1 |
| Lee, JC | 1 |
| Ip, J | 1 |
| Sidhu, SB | 1 |
| Kamath, C | 1 |
| Young, S | 1 |
| Kabelis, K | 1 |
| Sanders, J | 1 |
| Adlan, MA | 1 |
| Furmaniak, J | 1 |
| Rees Smith, B | 1 |
| Premawardhana, LD | 1 |
| Hamidi, S | 1 |
| Williams, RW | 1 |
| Oi, N | 1 |
| Ohi, K | 1 |
| Gessl, A | 3 |
| Lemmens-Gruber, R | 1 |
| Kautzky-Willer, A | 1 |
| Matsumoto, C | 1 |
| Yamakawa, N | 1 |
| Yoshida, H | 1 |
| Date, A | 1 |
| Hidaka, Y | 12 |
| Takano, T | 5 |
| Zhu, M | 1 |
| Jørgensen, T | 1 |
| Moniuszko, M | 1 |
| Dąbrowska, M | 1 |
| Rusak, M | 1 |
| Jeznach, M | 1 |
| Wójtowicz, J | 1 |
| Bodzenta-Lukaszyk, A | 1 |
| Bossowska, A | 1 |
| Leblicq, C | 1 |
| Duval, M | 1 |
| Carmant, L | 1 |
| Alos, N | 1 |
| Gerhardt, A | 1 |
| Hackenberg, K | 4 |
| Morgenthaler, NG | 3 |
| Nagata, A | 2 |
| Katayama, S | 4 |
| Bergmann, A | 1 |
| Iitaka, M | 4 |
| Goswami, R | 3 |
| Guleria, R | 1 |
| Gupta, AK | 1 |
| Gupta, N | 2 |
| Marwaha, RK | 1 |
| Pande, JN | 1 |
| Kochupillai, N | 3 |
| Radetti, G | 1 |
| Bona, G | 1 |
| Cappa, M | 1 |
| DeSanctis, V | 1 |
| Lauriola, S | 1 |
| Paganini, C | 1 |
| Rigon, F | 1 |
| Nakagawa, Y | 2 |
| Hoshikawa, S | 2 |
| Ito, S | 2 |
| Zauli, D | 1 |
| Grassi, A | 1 |
| Ballardini, G | 1 |
| Contestabile, S | 1 |
| Zucchini, S | 1 |
| Bianchi, FB | 1 |
| Brogioni, S | 1 |
| Traino, C | 2 |
| De Martino, F | 1 |
| Lippi, F | 1 |
| Bunevicius, R | 1 |
| Jakuboniene, N | 1 |
| Jakubonien, N | 1 |
| Jurkevicius, R | 1 |
| Cernicat, J | 1 |
| Lasas, L | 1 |
| Prange, AJ | 1 |
| Gorman, CA | 3 |
| Garrity, JA | 1 |
| Fatourechi, V | 1 |
| Bahn, RS | 1 |
| Petersen, IA | 1 |
| Stafford, SL | 1 |
| Earle, JD | 1 |
| Forbes, GS | 1 |
| Kline, RW | 1 |
| Buettner, H | 1 |
| Robertson, DM | 1 |
| Bergstralh, EJ | 1 |
| Offord, KP | 1 |
| Rademacher, DM | 1 |
| Stanley, NM | 1 |
| Bartley, GB | 1 |
| Pichler, R | 2 |
| Wölfl, S | 1 |
| Bogner, S | 1 |
| Sulzbacher, H | 1 |
| Shamiyeh, A | 1 |
| Maschek, W | 2 |
| Thompson, GB | 1 |
| Nedrebo, BG | 1 |
| Holm, PI | 1 |
| Uhlving, S | 1 |
| Sorheim, JI | 1 |
| Skeie, S | 1 |
| Eide, GE | 1 |
| Husebye, ES | 1 |
| Lien, EA | 1 |
| Aanderud, S | 1 |
| Schneider, P | 2 |
| Körber, C | 2 |
| Körber-Hafner, N | 2 |
| Hänscheid, H | 2 |
| Reiners, C | 4 |
| Centanni, M | 1 |
| Viceconti, N | 1 |
| Luisi, S | 1 |
| Reis, FM | 1 |
| Gargano, L | 1 |
| Maiani, F | 1 |
| Franchi, A | 1 |
| Canettieri, G | 1 |
| Petraglia, F | 1 |
| Li, AW | 1 |
| West, KA | 1 |
| Chang, CH | 1 |
| Wall, JR | 5 |
| Stasiak-Barmuta, A | 2 |
| Hoermann, R | 4 |
| Quadbeck, B | 3 |
| Roggenbuck, U | 1 |
| Szabolcs, I | 1 |
| Pfeilschifter, J | 3 |
| Meng, W | 1 |
| Reschke, K | 1 |
| Dettmann, J | 1 |
| Prehn, B | 1 |
| Hirche, H | 3 |
| Mann, K | 7 |
| Vanícková, Z | 1 |
| Kocna, P | 1 |
| Tada, H | 8 |
| Mizuta, I | 1 |
| Tatsumi, KI | 3 |
| Izumi, Y | 5 |
| Zöphel, K | 1 |
| Wunderlich, G | 1 |
| Kopprasch, C | 1 |
| Koch, R | 1 |
| Franke, WG | 1 |
| Kotzerke, J | 1 |
| Fukao, A | 1 |
| Murakami, Y | 2 |
| Sakane, S | 5 |
| Kuma, K | 35 |
| Hanafusa, T | 2 |
| Niwa, M | 1 |
| Braga-Basaria, M | 2 |
| Basaria, S | 2 |
| Rotman-Pikielny, P | 1 |
| Brucker-Davis, F | 1 |
| Turner, ML | 1 |
| Sarlis, NJ | 3 |
| Skarulis, MC | 2 |
| Nachum, Z | 1 |
| Rakover, Y | 2 |
| Weiner, E | 2 |
| Shalev, E | 2 |
| Hörmann, R | 5 |
| Janssen, OE | 2 |
| Brokken, LJ | 1 |
| Prummel, MF | 2 |
| BENUA, RS | 1 |
| ALBERT, A | 1 |
| KEATING, FR | 1 |
| ZINNITZ, F | 1 |
| DELTOUR, G | 1 |
| BRICAIRE, H | 1 |
| FREEDBERG, AS | 2 |
| HAMOLSKY, MW | 2 |
| INGBAR, SH | 6 |
| FREINKEL, N | 1 |
| DE GENNES, JL | 2 |
| TRUFFERT, J | 1 |
| NOGUCHI, A | 1 |
| SALTIEL, H | 1 |
| GREER, MA | 3 |
| SNYDER, NJ | 1 |
| GREEN, DE | 1 |
| SOLOMON, DH | 16 |
| KOUTRAS, DA | 4 |
| ALEXANDER, WD | 3 |
| BUCHANAN, WW | 1 |
| HARDEN, RM | 1 |
| HUNTER, RD | 1 |
| ADAMS, DD | 2 |
| KLOTZ, HP | 2 |
| SAPORTA, L | 1 |
| WERNER, SC | 2 |
| Nakai, M | 1 |
| Okada, Y | 1 |
| Tanikawa, T | 1 |
| Kanda, K | 1 |
| Morita, E | 1 |
| Nakata, Y | 1 |
| Watson, WA | 4 |
| Park, CM | 4 |
| Weetman, AP | 3 |
| Shepherdley, CA | 1 |
| Mansell, P | 1 |
| Ubhi, CS | 1 |
| Visser, TJ | 3 |
| Pichurin, P | 2 |
| Chen, CR | 2 |
| Pichurina, O | 1 |
| David, C | 1 |
| Aliesky, H | 1 |
| Li, XM | 1 |
| Cao, YF | 1 |
| Kruś, J | 1 |
| Szymański, W | 1 |
| Korbal, P | 1 |
| Kempers, MJ | 3 |
| van Tijn, DA | 1 |
| de Vijlder, JJ | 2 |
| Wiedijk, BM | 1 |
| Pandey, CK | 1 |
| Raza, M | 1 |
| Dhiraaj, S | 1 |
| Agarwal, A | 1 |
| Singh, PK | 1 |
| Finkielstain, G | 1 |
| Heinrich, JJ | 1 |
| Mastorakos, G | 1 |
| Doufas, AG | 1 |
| Mantzos, E | 1 |
| Mantzos, J | 1 |
| ROCHE, J | 1 |
| MICHEL, O | 1 |
| DELTOUR, GH | 1 |
| MICHEL, R | 1 |
| Vrca, VB | 1 |
| Skreb, F | 1 |
| Cepelak, I | 1 |
| Romic, Z | 1 |
| Mayer, L | 1 |
| Liu, A | 1 |
| Nicol, TL | 1 |
| Zwirska-Korczala, K | 1 |
| Berdowska, A | 1 |
| Jochem, J | 1 |
| Sitkiewicz, A | 1 |
| Birkner, E | 1 |
| Polaniak, R | 1 |
| Jedrzejowska-Szypułka, H | 1 |
| Korzonek-Szlacheta, I | 1 |
| Grimes, CM | 1 |
| Muniz, H | 1 |
| Montgomery, WH | 1 |
| Goh, YS | 1 |
| Land, KJ | 2 |
| Moll, JS | 1 |
| Kaplan, MH | 1 |
| Seetharamaiah, GS | 3 |
| Cardia, MS | 1 |
| Lima, N | 2 |
| Knobel, M | 2 |
| Medeiros-Neto, G | 3 |
| Bednarek, J | 2 |
| Wysocki, H | 2 |
| He, CT | 1 |
| Hsieh, AT | 1 |
| Pei, D | 2 |
| Hung, YJ | 1 |
| Wu, LY | 1 |
| Yang, TC | 1 |
| Lian, WC | 1 |
| Huang, WS | 3 |
| Kuo, SW | 3 |
| Schumm-Draeger, PM | 3 |
| Müller, OA | 1 |
| Akçay, MN | 1 |
| Akçay, G | 2 |
| Kim, MI | 1 |
| Johnson, KB | 1 |
| Pirnat, E | 1 |
| Zaletel, K | 1 |
| Gaberscek, S | 1 |
| Fidler, V | 1 |
| Hojker, S | 1 |
| Costagliola, S | 2 |
| Bonomi, M | 1 |
| Van Durme, J | 1 |
| Panneels, V | 1 |
| Refetoff, S | 4 |
| Vassart, G | 2 |
| Baker, G | 1 |
| Mazziotti, G | 3 |
| von Ruhland, C | 1 |
| Ludgate, M | 1 |
| Saitoh, O | 1 |
| Kano, H | 1 |
| Kumazawa, Y | 1 |
| Karner, I | 1 |
| Stefanic, M | 1 |
| Topuzović, N | 1 |
| Jimenez, C | 1 |
| Moran, SA | 1 |
| Sereti, I | 1 |
| Wynne, S | 1 |
| Yen, PM | 1 |
| Falloon, J | 1 |
| Davey, RT | 1 |
| Cooper, DS | 8 |
| Yanagisawa, T | 1 |
| Kato, Y | 2 |
| Shimizu, S | 1 |
| Takano, K | 1 |
| Lee, DS | 1 |
| Chung, JK | 1 |
| Koh, CS | 3 |
| Lee, M | 1 |
| Cameron, SJ | 1 |
| Hagedorn, JC | 1 |
| Sokoll, LJ | 1 |
| Caturegli, P | 1 |
| Ladenson, PW | 4 |
| Higuchi, R | 2 |
| Miyawaki, M | 1 |
| Kumagai, T | 2 |
| Okutani, T | 1 |
| Shima, Y | 1 |
| Yoshiyama, M | 1 |
| Ban, H | 1 |
| Yoshikawa, N | 2 |
| Tsai, WC | 1 |
| Wang, TF | 1 |
| Wu, DA | 1 |
| Li, JC | 1 |
| Wei, CL | 1 |
| Lee, CH | 1 |
| Chen, SP | 1 |
| Aldasouqi, S | 1 |
| Salam, SA | 1 |
| Sultan, A | 1 |
| Vinzio, S | 1 |
| Kendall-Taylor, P | 6 |
| Neoh, C | 1 |
| Frewin, S | 1 |
| Dickinson, J | 1 |
| Minelli, R | 3 |
| Coiro, V | 1 |
| Valli, MA | 1 |
| Finardi, L | 1 |
| Di Seclì, C | 1 |
| Bertoni, R | 1 |
| La Gioia, D | 1 |
| Barilli, AL | 1 |
| Ferrari, C | 3 |
| Jotti, GS | 1 |
| Delsignore, R | 1 |
| Slyper, AH | 2 |
| Wyatt, D | 1 |
| Boudreau, C | 1 |
| Woeber, KA | 3 |
| Gillett, MJ | 1 |
| Le Gac, I | 2 |
| Vuillard, E | 1 |
| Castanet, M | 1 |
| Guibourdenche, J | 2 |
| Noel, M | 2 |
| Boissinot, C | 1 |
| Schlageter, MH | 1 |
| Garel, C | 1 |
| Tébeka, B | 1 |
| Oury, JF | 1 |
| Czernichow, P | 1 |
| Takeoka, K | 3 |
| Tang, XL | 1 |
| Liu, XJ | 1 |
| Sun, WM | 1 |
| Zhao, J | 1 |
| Zheng, RL | 1 |
| Orsatti, A | 1 |
| Bonfanti, MT | 1 |
| Castagnone, D | 2 |
| Cantalamessa, L | 2 |
| Riis, AL | 1 |
| Hansen, TK | 1 |
| Thiel, S | 1 |
| Gravholt, CH | 1 |
| Gjedde, S | 1 |
| Gormsen, LC | 1 |
| Jørgensen, JO | 1 |
| Weeke, J | 4 |
| Møller, N | 1 |
| Fukada, S | 1 |
| Maeda, S | 1 |
| Uga, T | 1 |
| Hayashida, N | 1 |
| Ishigaki, K | 1 |
| Furui, J | 1 |
| Kanematsu, T | 1 |
| Fullmer, J | 1 |
| Lindall, A | 1 |
| Bahn, R | 1 |
| Mariash, CN | 2 |
| Guida, M | 1 |
| Mandato, VD | 1 |
| Di Spiezio Sardo, A | 1 |
| Di Carlo, C | 1 |
| Giordano, E | 1 |
| Nappi, C | 1 |
| Anolik, JR | 1 |
| Kubota, S | 4 |
| Sasaki, I | 1 |
| Hardy, OT | 1 |
| Smolinski, KN | 1 |
| Yan, AC | 1 |
| Grimberg, A | 1 |
| Das, PK | 1 |
| Wherrett, D | 1 |
| Dror, Y | 1 |
| Salvi, M | 5 |
| Vannucchi, G | 1 |
| Rossi, S | 1 |
| Bonara, P | 1 |
| Sbrozzi, F | 1 |
| Guastella, C | 1 |
| Avignone, S | 1 |
| Pirola, G | 1 |
| Ratiglia, R | 1 |
| Beck-Peccoz, P | 4 |
| O'Sullivan, AJ | 1 |
| Lewis, M | 2 |
| Diamond, T | 1 |
| Zhou, S | 1 |
| Liang, Y | 1 |
| Xiao, C | 1 |
| Shen, H | 1 |
| Pan, H | 1 |
| Deng, H | 1 |
| Wang, N | 1 |
| Li, QQ | 1 |
| Tan, EK | 1 |
| Chan, LL | 1 |
| Gola, M | 1 |
| Doga, M | 1 |
| Bonadonna, S | 1 |
| Giustina, A | 2 |
| Hiraiwa, T | 1 |
| Imagawa, A | 1 |
| Chen, JL | 1 |
| Chiu, HW | 1 |
| Tseng, YJ | 1 |
| Chu, WC | 1 |
| Keng, HM | 1 |
| Wei, MC | 1 |
| Duntas, LH | 1 |
| Nonchev, BI | 1 |
| Terzieva, DD | 1 |
| Dimov, RS | 1 |
| Mateva, NG | 1 |
| Tsvetkova, TZ | 1 |
| Dimitrakov, DY | 1 |
| Yokota, T | 1 |
| Kuwahara, K | 1 |
| Murabe, H | 1 |
| Murakami, N | 3 |
| Mimura, T | 5 |
| Tanigawa, S | 1 |
| Ishikawa, K | 1 |
| Ito, C | 1 |
| Okuda, N | 1 |
| Watanabe, C | 1 |
| Yano, G | 1 |
| Fink, HJ | 1 |
| Hintze, G | 1 |
| Tan, M | 1 |
| Tan, F | 1 |
| Hawkins, R | 1 |
| Cheah, WK | 1 |
| Mukherjee, JJ | 1 |
| Bilen, H | 1 |
| Atasoy, M | 1 |
| Akcay, M | 1 |
| Capoglu, I | 1 |
| Gursan, N | 1 |
| Akbas, M | 1 |
| Gopinath, B | 1 |
| Musselman, R | 1 |
| Adams, CL | 1 |
| Tani, J | 1 |
| Beard, N | 1 |
| Ozaki, H | 1 |
| Martinez, O | 1 |
| Gangi, E | 1 |
| Mordi, D | 1 |
| Gupta, S | 1 |
| Dorevitch, S | 1 |
| Lefranc, MP | 1 |
| Prabhakar, BS | 2 |
| Liebrand, CA | 1 |
| de Mol, AC | 1 |
| Noordam, C | 1 |
| De Moraes, AV | 1 |
| Pedro, AB | 1 |
| Bidingija, M | 1 |
| Galgani, A | 1 |
| Buzzetti, R | 1 |
| Ditu, M | 1 |
| Chung, YJ | 1 |
| Lee, BW | 2 |
| Kim, JY | 1 |
| Jung, JH | 1 |
| Min, YK | 1 |
| Lee, MS | 2 |
| Lee, MK | 1 |
| Grosso, M | 1 |
| Boni, G | 1 |
| Ferrari, SM | 1 |
| Romagnani, P | 1 |
| Serio, M | 1 |
| Mariani, G | 2 |
| Ferrannini, E | 1 |
| Kaneda, T | 2 |
| Hakozaki, A | 1 |
| Fuse, T | 1 |
| Muto, A | 1 |
| Yoshida, T | 1 |
| Abraham-Nordling, M | 2 |
| Wallin, G | 3 |
| Lundell, G | 4 |
| Törring, O | 1 |
| Berghout, A | 3 |
| Peeters, RP | 1 |
| Cohen Aubart, F | 1 |
| Jublanc, C | 1 |
| Bruckert, E | 1 |
| Vestergaard, H | 1 |
| Nielsen, S | 1 |
| Christensen, SE | 1 |
| Seefeldt, T | 1 |
| Helleberg, K | 1 |
| Pedersen, KM | 1 |
| Itoh, K | 1 |
| Velickiene, D | 1 |
| Kazanavicius, G | 1 |
| Danilevicius, J | 1 |
| Jankauskiene, J | 1 |
| Nagasaki, T | 1 |
| Inaba, M | 2 |
| Kumeda, Y | 2 |
| Fujiwara-Ueda, M | 1 |
| Hiura, Y | 1 |
| Nishizawa, Y | 2 |
| Park, SE | 1 |
| Cho, MA | 1 |
| Rhee, Y | 1 |
| Kang, ES | 1 |
| Ahn, CW | 1 |
| Cha, BS | 1 |
| Lee, EJ | 1 |
| Kim, KR | 1 |
| Lee, HC | 1 |
| Lim, SK | 1 |
| van Rijn, RR | 1 |
| Smets, AM | 1 |
| Smit, BJ | 1 |
| O'Connor, MJ | 1 |
| Paget-Brown, AO | 1 |
| Clarke, WL | 1 |
| Flynn, JC | 1 |
| Gilbert, JA | 1 |
| Meroueh, C | 1 |
| Snower, DP | 1 |
| David, CS | 1 |
| Kong, YC | 1 |
| Banga, JP | 2 |
| Bossowski, AT | 1 |
| Reddy, V | 1 |
| Perry, LA | 1 |
| Johnston, LB | 1 |
| Banerjee, K | 1 |
| Blair, JC | 1 |
| Savage, MO | 1 |
| Loy, M | 1 |
| Perra, E | 1 |
| Melis, A | 1 |
| Cianchetti, ME | 1 |
| Piga, M | 2 |
| Serra, A | 1 |
| Pinna, G | 1 |
| Mariotti, S | 2 |
| Tagami, T | 1 |
| Hagiwara, H | 1 |
| Usui, T | 1 |
| Shimatsu, A | 1 |
| Naruse, M | 1 |
| Dardano, A | 1 |
| Ballardin, M | 1 |
| Ferdeghini, M | 1 |
| Lazzeri, E | 1 |
| Caraccio, N | 1 |
| Barale, R | 1 |
| Monzani, F | 1 |
| Bensamoun, SF | 1 |
| Ringleb, SI | 1 |
| Chen, Q | 1 |
| Ehman, RL | 1 |
| An, KN | 1 |
| Brennan, M | 1 |
| Mollar Puchades, MA | 1 |
| Merino Torres, JF | 1 |
| Pérez Lázaro, MA | 1 |
| Segovia Portolés, R | 1 |
| Abellán Galiana, P | 1 |
| Piñón Sellés, F | 1 |
| Kurtoglu, S | 1 |
| Keskin, M | 1 |
| Koklu, E | 1 |
| Akcakus, M | 1 |
| Atabek, ME | 1 |
| Hatipoglu, N | 1 |
| Bodlaj, G | 1 |
| Brandstätter, W | 1 |
| Hatzl-Griesenhofer, M | 1 |
| Biesenbach, G | 1 |
| Berg, J | 1 |
| Rashid, M | 1 |
| Rashid, MH | 1 |
| Sopena Bert, E | 1 |
| Valentí Moreno, V | 1 |
| Corcoy Pla, R | 1 |
| Miyata, I | 1 |
| Abe-Gotyo, N | 1 |
| Tajima, A | 1 |
| Yoshikawa, H | 1 |
| Teramoto, S | 1 |
| Seo, M | 1 |
| Kanno, K | 1 |
| Sugiura, K | 1 |
| Tanaka, T | 5 |
| Eto, Y | 1 |
| Owen, PJ | 1 |
| Baghomian, A | 1 |
| Godkin, AJ | 1 |
| Kaklamanou, M | 1 |
| Kabadi, UM | 2 |
| Premachandra, BN | 2 |
| Santoh, T | 1 |
| Kuroda, S | 1 |
| Ueda, D | 1 |
| Lassen, PD | 1 |
| Juul, A | 1 |
| Skibsted, L | 1 |
| Tallstedt, L | 3 |
| Tørring, O | 2 |
| Garcin, B | 1 |
| Louissaint, T | 1 |
| Hosseini, H | 1 |
| Blanc, R | 1 |
| Fénelon, G | 1 |
| Azezli, AD | 1 |
| Bayraktaroglu, T | 1 |
| Orhan, Y | 1 |
| De Martino, E | 1 |
| Pirola, I | 1 |
| Gandossi, E | 1 |
| Delbarba, A | 1 |
| Cappelli, C | 1 |
| Takata, K | 1 |
| Arishima, T | 1 |
| Kurihara, I | 1 |
| Muller, AF | 1 |
| Kooy, A | 1 |
| Smits, JW | 1 |
| Hermus, AR | 1 |
| Lee, BC | 1 |
| Kang, SI | 1 |
| Ahn, YM | 1 |
| Doo, HK | 1 |
| Ahn, SY | 1 |
| Soysal, D | 1 |
| Tatar, E | 1 |
| Solmaz, S | 1 |
| Kabayeğit, O | 1 |
| Tunakan, M | 1 |
| Unsal, B | 1 |
| Cevik, C | 1 |
| Hsieh, CJ | 1 |
| Wang, PW | 2 |
| Namo Cury, A | 1 |
| Longui, CA | 1 |
| Kochi, C | 1 |
| Calliari, LE | 1 |
| Scalissi, N | 1 |
| Salles, JE | 1 |
| Neves Rocha, M | 1 |
| Barbosa de Melo, M | 1 |
| Rezende Melo, M | 1 |
| Monte, O | 1 |
| Feind, CR | 1 |
| Aida, M | 1 |
| Kourides, IA | 2 |
| Pekonen, F | 1 |
| Weintraub, BD | 2 |
| Skare, S | 2 |
| Frey, HM | 3 |
| Bay, V | 1 |
| Yabu, Y | 6 |
| Mori, H | 5 |
| Miyai, K | 14 |
| Tanizawa, O | 4 |
| Takai, SI | 1 |
| Kumahara, Y | 7 |
| Matsuzuka, F | 15 |
| Ravel, R | 1 |
| Atkinson, S | 2 |
| Smyth, PP | 1 |
| Neylan, D | 1 |
| O'Donovan, DK | 1 |
| Gheri, RG | 1 |
| Borghi, A | 1 |
| Pratesi, E | 1 |
| Maiello, M | 1 |
| Hardisty, CA | 1 |
| Humphries, H | 1 |
| Munro, DS | 1 |
| Wenzel, KW | 2 |
| Lente, JR | 2 |
| Leng, S | 1 |
| Hansen, JM | 1 |
| Bech, K | 6 |
| Kampmann, JP | 1 |
| Jensen, K | 1 |
| Andersen, E | 1 |
| Hansen, P | 1 |
| Karstrup, S | 1 |
| Bliddal, H | 2 |
| Smeulers, J | 1 |
| Docter, R | 3 |
| Hennemann, G | 5 |
| Waldstein, SS | 1 |
| McClung, MR | 1 |
| Wuttke, H | 2 |
| Schlieter, D | 2 |
| Mahatumarat, P | 1 |
| Poochanugool, L | 1 |
| Kumpolpunth, S | 1 |
| Krivitskiĭ, DI | 3 |
| Miki, T | 1 |
| Morimoto, S | 1 |
| Nishi, K | 2 |
| Nakatani, K | 2 |
| Degrossi, OJ | 1 |
| Pinkas, M | 1 |
| El Tamer, S | 1 |
| Watanabe, T | 2 |
| Claus, H | 1 |
| García del Rio, H | 1 |
| Sakurada, T | 6 |
| Kaise, N | 5 |
| Kaise, K | 5 |
| Kitaoka, H | 3 |
| Fukazawa, H | 4 |
| Saito, S | 6 |
| Yoshinaga, K | 5 |
| Ban, Y | 10 |
| Iino, S | 3 |
| Asari, S | 2 |
| Izumiguchi, Y | 2 |
| Kawamura, S | 1 |
| Kishino, B | 1 |
| Tajima, K | 1 |
| Mashita, K | 1 |
| Tarui, S | 2 |
| Canonica, GW | 1 |
| Ferrini, S | 1 |
| Biassoni, P | 1 |
| Melioli, G | 1 |
| Ferrini, O | 1 |
| Giordano, G | 1 |
| Bromberg, N | 1 |
| Werner, RS | 1 |
| Tanaka, LM | 1 |
| Rodrigues, HF | 1 |
| Werner, MC | 2 |
| Farah, CS | 1 |
| Reis, LC | 1 |
| Bannai, C | 2 |
| Itakura, M | 1 |
| Fujita, T | 1 |
| Koide, Y | 2 |
| Hisakai, N | 1 |
| Sugawara, M | 4 |
| Lau, R | 1 |
| Wasser, HL | 1 |
| Nelson, AM | 1 |
| Hershman, JM | 4 |
| Bonnyns, M | 2 |
| Bentin, J | 1 |
| Devetter, G | 1 |
| Duchateau, J | 1 |
| McGregor, AM | 3 |
| Petersen, MM | 1 |
| Rooke, P | 1 |
| Smith, BR | 1 |
| Hall, R | 1 |
| Trokoudes, KM | 1 |
| Michelsen, H | 1 |
| Kidd, A | 1 |
| Row, VV | 4 |
| Volpé, R | 11 |
| Saxe, VC | 1 |
| Meskell, M | 1 |
| Maloof, F | 9 |
| Ridgway, EC | 6 |
| Moroz, LA | 1 |
| Meltzer, SJ | 1 |
| Bastomsky, CH | 1 |
| Sato, T | 3 |
| Kajiwara, S | 1 |
| Miyamori, C | 1 |
| Kato, T | 1 |
| Cognini, G | 1 |
| Piantanelli, L | 1 |
| Paolinelli, E | 1 |
| Orlandoni, P | 1 |
| Pellegrini, A | 1 |
| Masera, N | 1 |
| Ishii, H | 5 |
| Inada, M | 5 |
| Tanaka, K | 5 |
| Mashio, Y | 4 |
| Naito, K | 4 |
| Imura, H | 4 |
| Funauchi, M | 1 |
| Hurley, JR | 1 |
| Wehmann, RE | 1 |
| Nisula, BC | 1 |
| Górowski, T | 1 |
| MacFarlane, IA | 1 |
| Davies, D | 1 |
| Longson, D | 1 |
| Shalet, SM | 2 |
| Beardwell, CG | 3 |
| McKenzie, JM | 7 |
| De Marchena, E | 1 |
| Konow-Thorsen, R | 1 |
| Yamada, T | 14 |
| Koizumi, Y | 4 |
| Hashizume, K | 4 |
| Aizawa, T | 9 |
| Takasu, N | 11 |
| Nagata, H | 2 |
| Suhonen, AS | 1 |
| Leppäluoto, J | 1 |
| Salmi, J | 2 |
| Kobayashi, A | 4 |
| Mozai, T | 5 |
| Romelli, PB | 1 |
| Cattaneo, MG | 1 |
| Faglia, G | 2 |
| White, EL | 1 |
| Barlow, JW | 1 |
| Stockigt, JR | 1 |
| Peden, NR | 1 |
| Hart, IR | 1 |
| McConnon, JK | 1 |
| Tsanev, A | 1 |
| Khlebarova, M | 1 |
| Dishlianova, B | 1 |
| Zlateva, S | 1 |
| Ehrlich, R | 1 |
| Steiner, G | 1 |
| Schlumberger, M | 1 |
| Fragu, P | 1 |
| Hill, C | 1 |
| Parmentier, C | 1 |
| Tubiana, M | 1 |
| Pearce, CJ | 1 |
| Himsworth, RL | 1 |
| Kobayashi, I | 3 |
| Khardori, R | 1 |
| Weaver, ME | 1 |
| Soler, NG | 1 |
| Channick, BJ | 1 |
| Endo, Y | 1 |
| Tamaki, H | 8 |
| Kaisou, A | 1 |
| Azushima, M | 1 |
| Burgos, FL | 1 |
| Micames, C | 1 |
| Rivera, JV | 1 |
| Fukino, O | 5 |
| Tamai, H | 19 |
| Nakagawa, T | 7 |
| Inaba, S | 1 |
| Kubota, K | 1 |
| Kuzuya, N | 2 |
| Uchimura, H | 5 |
| Shigemasa, C | 6 |
| Onoyama, S | 1 |
| Okamura, Y | 2 |
| Yoshida, A | 4 |
| Mashiba, H | 4 |
| Abe, K | 4 |
| Romussi, M | 1 |
| Rampini, P | 1 |
| Benco, R | 1 |
| Boghen, M | 1 |
| Paracchi, A | 1 |
| Frezzati, S | 1 |
| Ross, DS | 1 |
| Daniels, GH | 3 |
| De Stefano, P | 1 |
| Semenov, VD | 1 |
| McCulloch, AJ | 1 |
| Johnston, DG | 1 |
| Baylis, PH | 1 |
| Clark, F | 1 |
| Young, ET | 2 |
| Alberti, KG | 1 |
| Barbera, C | 1 |
| Melluso, R | 2 |
| Consolo, F | 1 |
| Arteaga, E | 2 |
| López, JM | 1 |
| Rodríguez, JA | 1 |
| Michaud, P | 2 |
| López, G | 1 |
| Nakamura, S | 7 |
| Murayama, M | 1 |
| Kojima, N | 5 |
| Kamikubo, K | 3 |
| Sakata, S | 10 |
| Yasuda, K | 3 |
| Miura, K | 6 |
| Alvarez, MA | 1 |
| Gómez, A | 1 |
| Alavez, E | 1 |
| Navarro, D | 1 |
| Simonin, R | 1 |
| Sambuc, R | 1 |
| San Marco, JL | 1 |
| Gavelle-Desbrosses, C | 1 |
| Ohsako, N | 4 |
| Takahashi, H | 3 |
| Mizukami, Y | 1 |
| Matsubara, F | 2 |
| Ichihara, K | 3 |
| Azukizawa, M | 3 |
| Kumagai, LF | 7 |
| Ahmad, N | 1 |
| Cohen, MP | 1 |
| Banovac, K | 1 |
| Zakarija, M | 4 |
| Witte, A | 1 |
| Sekso, M | 1 |
| Hurwitz, JJ | 1 |
| Blichert-Toft, M | 3 |
| Christiansen, C | 2 |
| Date, J | 3 |
| Pelkonen, R | 1 |
| Lamberg, BA | 4 |
| Otter, R | 1 |
| Peeters, HF | 1 |
| Bleeker, GM | 1 |
| Touber, JL | 2 |
| Charpentier, G | 1 |
| Coutris, G | 1 |
| Aubry, P | 1 |
| Duron, F | 1 |
| Rieu, M | 3 |
| Thomas, M | 2 |
| Földes, J | 4 |
| Bános, C | 3 |
| Fehér, T | 1 |
| Bodrogi, L | 1 |
| Szalay, F | 1 |
| Borvendég, J | 1 |
| Csillag, J | 1 |
| Takó, J | 2 |
| Teng, CS | 2 |
| Yeung, RT | 2 |
| Feek, CM | 3 |
| Sawers, JS | 1 |
| Irvine, WJ | 1 |
| Ratcliffe, WA | 1 |
| Toft, AD | 3 |
| Shinzato, R | 1 |
| Suematsu, H | 6 |
| Carey, C | 1 |
| Skosey, C | 1 |
| Pinnamaneni, KM | 1 |
| Barsano, CP | 1 |
| DeGroot, LJ | 7 |
| Bradley, EL | 1 |
| DiGirolamo, M | 1 |
| Tarcan, Y | 1 |
| Oishi, M | 1 |
| Kurata, S | 1 |
| Baranov, VG | 1 |
| Savushkina, AS | 1 |
| Puchalski, Z | 1 |
| Piotrowski, Z | 1 |
| Chyczewski, L | 1 |
| Orłowski, K | 1 |
| Kimura, H | 3 |
| Inoue, K | 7 |
| Kojima, T | 1 |
| Shafer, RB | 1 |
| Bianco, JA | 1 |
| Okamura, K | 3 |
| Shiroozu, A | 2 |
| Nakashima, T | 2 |
| Yoshinari, M | 1 |
| Omae, T | 2 |
| Yoshizumi, T | 1 |
| Nishitani, H | 2 |
| Clark, OH | 1 |
| Feingold, K | 1 |
| Dahlberg, PA | 5 |
| Venge, P | 1 |
| Roxin, LE | 1 |
| Jakubowska-Pakułowa, D | 2 |
| Hidaka, H | 4 |
| Studer, H | 2 |
| Horster, FA | 3 |
| Zellmann, HE | 2 |
| Temple, TE | 1 |
| Wilhoit, GB | 1 |
| Williams, RB | 1 |
| Mitchell, GS | 1 |
| Satchwell, S | 1 |
| Harrington, WG | 1 |
| Spence, SN | 1 |
| Yamaguchi, T | 2 |
| Kemp, A | 1 |
| Madsen, SN | 1 |
| Sterling, K | 2 |
| Aranow, H | 1 |
| Talansky, AL | 1 |
| Schulman, P | 1 |
| Vinciguerra, VP | 1 |
| Margouleff, D | 1 |
| Budman, DR | 1 |
| Degnan, TJ | 1 |
| Vassilakis, JS | 1 |
| Nicolopoulos, N | 1 |
| Easton, PA | 1 |
| Sharp, B | 1 |
| Reed, AW | 1 |
| Tamagra, EI | 1 |
| Geffner, DL | 1 |
| Scott, DL | 1 |
| Tymms, DJ | 1 |
| Taylor, MA | 1 |
| Chapman, C | 1 |
| Lindström, B | 1 |
| Wide, L | 2 |
| Wu, SY | 8 |
| Shyh, TP | 1 |
| Chopra, IJ | 18 |
| Huang, HW | 2 |
| Chu, PC | 1 |
| Hagen, GA | 2 |
| Gwinup, G | 1 |
| Elias, AN | 1 |
| Ascher, MS | 1 |
| Konishi, J | 6 |
| Iida, Y | 4 |
| Kousaka, T | 2 |
| Ikekubo, K | 4 |
| Torizuka, K | 4 |
| Izumi, M | 5 |
| Kurachi, K | 1 |
| Jones, KL | 1 |
| Carey, DE | 1 |
| Bergman, TA | 1 |
| Oppenheimer, JH | 2 |
| Vasta, M | 1 |
| Donati, L | 1 |
| Aagaard, J | 1 |
| Bing, RF | 1 |
| Rosenthal, FD | 1 |
| Yamamoto, K | 1 |
| Saito, K | 2 |
| Takai, T | 1 |
| Yoshida, S | 2 |
| Hirota, Y | 3 |
| Hayashi, Y | 2 |
| Reiter, EO | 1 |
| Root, AW | 1 |
| Rettig, K | 1 |
| Vargas, A | 1 |
| Oki, T | 1 |
| Hasegawa, M | 1 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 2 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Kusunoki, T | 1 |
| Nishida, S | 1 |
| Koezuka, M | 1 |
| Murata, K | 1 |
| Tomura, T | 1 |
| Bürgi, U | 1 |
| Maurer, P | 1 |
| González-Jiménez, A | 1 |
| Fernández-Soto, ML | 2 |
| Escobar-Jiménez, F | 3 |
| Glinoer, D | 7 |
| Navarrete, L | 1 |
| Campos Pastor, MM | 1 |
| Fernández Soto, ML | 2 |
| Barredo Acedo, F | 1 |
| Ruiz de Almodóvar, M | 1 |
| Matsuda, M | 3 |
| Takuno, H | 6 |
| Ogawa, T | 6 |
| Matsui, I | 4 |
| Sarui, H | 4 |
| Maekawa, H | 1 |
| Kotani, T | 1 |
| Okuda, K | 1 |
| Tarutani, O | 4 |
| Wenisch, C | 2 |
| Myskiw, D | 2 |
| Parschalk, B | 1 |
| Hartmann, T | 1 |
| Dam, K | 1 |
| Graninger, W | 2 |
| Sibbles, BJ | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| van den Anker, JN | 1 |
| Akamine, H | 2 |
| Komiya, I | 6 |
| Benker, G | 5 |
| Kahaly, G | 4 |
| Raue, F | 1 |
| Tegler, L | 5 |
| Reinwein, D | 8 |
| Paggi, A | 3 |
| Di Prima, MA | 3 |
| Paparo, BS | 1 |
| Pellegrino, C | 1 |
| Faralli, AR | 2 |
| Sinopoli, MT | 1 |
| Leri, O | 1 |
| Yamasaki, H | 2 |
| Takeda, K | 3 |
| Nakauchi, Y | 1 |
| Suehiro, T | 1 |
| Ichikawa, K | 3 |
| Takemura, Y | 3 |
| Belfiore, A | 1 |
| Rosa, GL | 1 |
| Giuffrida, D | 1 |
| Lupo, L | 1 |
| Fiumara, A | 1 |
| Ippolito, O | 1 |
| Als, C | 2 |
| Listewnik, M | 1 |
| Rösler, H | 2 |
| Bartkowiak, E | 1 |
| Koroscil, TM | 1 |
| Ohguni, S | 1 |
| Notsu, K | 1 |
| Gómez, N | 1 |
| Gómez, JM | 2 |
| Orti, A | 1 |
| Gavaldà, L | 1 |
| Villabona, C | 1 |
| Leyes, P | 1 |
| Soler, J | 2 |
| Kashiwai, T | 4 |
| Asahi, K | 2 |
| Afeltra, A | 2 |
| Ferri, GM | 2 |
| Amoroso, A | 2 |
| Startari, S | 1 |
| Bonomo, L | 2 |
| Ito, E | 1 |
| Hurley, DL | 1 |
| Gharib, H | 3 |
| Hayaki, I | 1 |
| Kawai, K | 2 |
| Komaki, G | 2 |
| Matsubayashi, S | 7 |
| De Forteza, R | 1 |
| Ghandur-Mnaymneh, L | 1 |
| Tachi, J | 2 |
| Peters, H | 1 |
| Fischer, C | 2 |
| Bogner, U | 2 |
| Schleusener, H | 2 |
| Di Lorenzo, L | 1 |
| Foggia, L | 1 |
| Panza, N | 1 |
| Calabrese, MR | 1 |
| Motta, G | 1 |
| Tranchino, G | 1 |
| Orio, F | 1 |
| Lombardi, G | 1 |
| Kung, AW | 7 |
| Yau, CC | 2 |
| Cheng, AC | 1 |
| Celik, I | 1 |
| Akalin, S | 2 |
| Erbaş, T | 1 |
| Raynaud, A | 1 |
| Richard, A | 1 |
| Laplanche, S | 1 |
| Sambor, B | 1 |
| Berrod, JL | 1 |
| Nishi, I | 1 |
| Magner, J | 1 |
| Gerber, P | 1 |
| Gill, GN | 1 |
| Carayanniotis, G | 1 |
| Huang, GC | 1 |
| Nicholson, LB | 1 |
| Scott, T | 1 |
| Allain, P | 1 |
| Marazuela, M | 1 |
| Vargas, JA | 1 |
| Alvarez-Mon, M | 1 |
| Albarrán, F | 1 |
| Lucas, T | 1 |
| Durántez, A | 1 |
| Sugimoto, T | 1 |
| Shirota, T | 2 |
| Shinoda, T | 2 |
| Khachatrian, EN | 1 |
| Borisova, PK | 1 |
| Ametov, AS | 2 |
| Daurov, BI | 1 |
| Bondarenko, VO | 1 |
| Ostrenskaia, SV | 1 |
| Goñi Iriarte, MJ | 1 |
| Forga Llenas, L | 1 |
| Iriarte Beroiz, A | 1 |
| Apiñániz, EA | 1 |
| Rodríguez Erdozain, R | 1 |
| Menéndez Torre, E | 1 |
| Denereaz, N | 1 |
| Lemarchand-Beraud, T | 3 |
| Chou, FF | 1 |
| Sheen-Chen, SM | 1 |
| Noh, J | 4 |
| Pickerill, AP | 1 |
| Watson, P | 1 |
| Chatterjee, VK | 2 |
| Edwards, OM | 1 |
| Cheng, A | 1 |
| Nagamine, T | 1 |
| Takehara, K | 1 |
| Hattori, J | 1 |
| Krüger, C | 1 |
| Dörr, HG | 1 |
| Becker, W | 1 |
| Wolf, F | 1 |
| Harms, D | 1 |
| Miura, S | 3 |
| Yoshimura, H | 4 |
| Kitahama, S | 1 |
| Fukasawa, N | 3 |
| Kawakami, Y | 1 |
| Sakurai, S | 1 |
| Urabe, M | 1 |
| Sakatsume, Y | 4 |
| Postema, PT | 1 |
| Krenning, EP | 2 |
| Wijngaarde, R | 1 |
| Kooy, PP | 1 |
| Oei, HY | 1 |
| van den Bosch, WA | 1 |
| Reubi, JC | 1 |
| Hooijkaas, H | 1 |
| van der Loos, T | 1 |
| Onuma, H | 1 |
| Ota, M | 1 |
| Sugenoya, A | 2 |
| Inoko, H | 1 |
| Bokk, A | 1 |
| Farid, NR | 3 |
| Edmonds, CJ | 1 |
| Tellez, M | 1 |
| Hu, CA | 1 |
| Liao, WK | 1 |
| Fung, TC | 1 |
| Sharma, SC | 1 |
| Shaker, JL | 1 |
| Morita, T | 4 |
| Akasu, F | 4 |
| Resetkova, E | 1 |
| Arreaza, G | 1 |
| Miller, N | 3 |
| Jamieson, C | 4 |
| Bazzi, MN | 1 |
| Bagchi, N | 1 |
| Roti, E | 5 |
| Gardini, E | 5 |
| Bianconi, L | 2 |
| Gavaruzzi, G | 1 |
| Ugolotti, G | 1 |
| Braverman, LE | 11 |
| Fuwa, Y | 2 |
| Goto, S | 1 |
| Fukui, M | 1 |
| Yuasa, H | 1 |
| Sasano, N | 1 |
| Blomgren, H | 3 |
| Bring, J | 1 |
| Caccavo, D | 1 |
| Vaccaro, F | 1 |
| Campusano, C | 1 |
| Ren, YZ | 1 |
| Song, ZG | 1 |
| Saboori, AM | 1 |
| Rose, NR | 1 |
| Butscher, WG | 1 |
| Burek, CL | 1 |
| Hara, T | 2 |
| Mukuta, T | 2 |
| Itoh, E | 2 |
| Perozim, LM | 1 |
| Cavaliere, H | 1 |
| Matsunaga, M | 1 |
| Komaki, T | 4 |
| Martin, A | 2 |
| Valentine, M | 1 |
| Unger, P | 1 |
| Lichtenstein, C | 1 |
| Schwartz, AE | 1 |
| Friedman, EW | 1 |
| Shultz, LD | 2 |
| Ahmed, ME | 1 |
| ElWasila, AA | 1 |
| Sanhouri, M | 1 |
| Yagi, K | 1 |
| Tak, PP | 1 |
| Hermans, J | 1 |
| Haak, A | 1 |
| Koshiyama, H | 1 |
| Mori, S | 1 |
| Fujiwara, K | 1 |
| Hayakawa, K | 1 |
| Koh, T | 1 |
| Wilkinson, E | 2 |
| Rae, PW | 2 |
| Thomson, KJ | 1 |
| Spencer, CA | 2 |
| Schwarzbein, D | 1 |
| Guttler, RB | 1 |
| LoPresti, JS | 1 |
| Nicoloff, JT | 6 |
| Mallet, B | 1 |
| Lejeune, PJ | 1 |
| Baudry, N | 1 |
| Niccoli, P | 1 |
| Carayon, P | 1 |
| Franc, JL | 1 |
| McIver, B | 1 |
| Rae, P | 1 |
| Gold, A | 1 |
| Toft, A | 3 |
| Konrády, A | 2 |
| Van Loon, AJ | 1 |
| Derksen, JT | 1 |
| Bos, AF | 1 |
| Rouwé, CW | 1 |
| Hadi, HA | 1 |
| Strickland, D | 1 |
| Listevnik, M | 1 |
| Ritter, EP | 1 |
| Rizvi, A | 1 |
| Crapo, LM | 1 |
| Kim, WB | 1 |
| Park, HY | 1 |
| Lee, HK | 2 |
| Kohn, LD | 3 |
| Tahara, K | 2 |
| Skuza, KA | 1 |
| Sills, IN | 2 |
| Stene, M | 1 |
| Costa Rosa, LF | 1 |
| Curi, R | 1 |
| Kallner, G | 1 |
| Vitols, S | 1 |
| Ljunggren, JG | 3 |
| von Werder, K | 1 |
| Bal, CS | 1 |
| Gemma, R | 1 |
| Mori, T | 5 |
| Andoh, S | 1 |
| Suzuki, Y | 2 |
| Yoshimi, T | 1 |
| Szabó, J | 2 |
| Fóris, G | 1 |
| Mezösi, E | 1 |
| Nagy, EV | 2 |
| Paragh, G | 1 |
| Sztojka, I | 1 |
| Leövey, A | 4 |
| Seppel, T | 1 |
| Rose, F | 1 |
| Schlaghecke, R | 1 |
| Hakamata, M | 1 |
| Itoh, M | 2 |
| Sudo, Y | 1 |
| Katada, E | 1 |
| Miyata, N | 1 |
| Revue, E | 1 |
| Bonete, R | 1 |
| Nunez, S | 1 |
| Rittmaster, RS | 2 |
| Zwicker, H | 1 |
| Abbott, EC | 2 |
| Douglas, R | 2 |
| Givner, ML | 2 |
| Gupta, MK | 1 |
| Lehmann, L | 2 |
| Reddy, S | 2 |
| Salisbury, SR | 2 |
| Shlossberg, AH | 2 |
| Tan, MH | 2 |
| York, SE | 2 |
| Kitamura, K | 1 |
| Eto, T | 1 |
| Katagiri, T | 1 |
| Mann, B | 1 |
| Schmale, P | 1 |
| Stremmel, W | 1 |
| Sievert, R | 1 |
| Goldstein, ML | 1 |
| Surks, MI | 1 |
| Wolfson, BB | 1 |
| Shimojo, N | 1 |
| Yamaguchi, K | 2 |
| Kikuoka, S | 1 |
| Hoshioka, A | 1 |
| Niimi, H | 1 |
| Hirai, A | 1 |
| Tamura, Y | 1 |
| Ozata, M | 1 |
| Bolu, E | 1 |
| Sengul, A | 1 |
| Tasar, M | 1 |
| Beyhan, Z | 1 |
| Corakci, A | 1 |
| Gundogan, MA | 1 |
| Wall, J | 1 |
| Barsouk, A | 1 |
| Stolarski, C | 1 |
| Kiljanski, J | 1 |
| Stachura, I | 1 |
| Nebes, V | 1 |
| Peele, K | 1 |
| Kennerdell, J | 1 |
| Kelly, W | 1 |
| Charkes, ND | 1 |
| Bennedbaek, FN | 1 |
| Gram, J | 1 |
| Ohsawa, N | 2 |
| Ziegler, R | 4 |
| Hara, H | 4 |
| Sugita, E | 1 |
| Sato, R | 4 |
| Miyakawa, M | 2 |
| Tsushima, T | 2 |
| Demura, H | 2 |
| Fujimori, M | 2 |
| Shingu, K | 1 |
| Hama, Y | 1 |
| Maruyama, M | 1 |
| Amano, J | 1 |
| Bhowmick, SK | 1 |
| Grubb, PH | 1 |
| Elser, H | 1 |
| Haufe, S | 1 |
| Georgi, P | 1 |
| Sauter, G | 1 |
| Weiss, M | 3 |
| Roth, C | 1 |
| Siggelkow, H | 1 |
| Grüters, A | 1 |
| Hüfner, M | 2 |
| Lakomek, M | 1 |
| Kasagi, K | 6 |
| Takeuchi, R | 1 |
| Misaki, T | 3 |
| Miyamoto, S | 1 |
| Spitzweg, C | 1 |
| Poertl, S | 1 |
| Heufelder, AE | 1 |
| Razack, MS | 1 |
| Lore, JM | 1 |
| Lippes, HA | 1 |
| Schaefer, DP | 1 |
| Rassael, H | 1 |
| Lucas, A | 1 |
| Salinas, I | 1 |
| Rius, F | 1 |
| Pizarro, E | 1 |
| Granada, ML | 1 |
| Foz, M | 1 |
| Sanmartí, A | 1 |
| Tomaski, SM | 1 |
| Mahoney, EM | 1 |
| Burgess, LP | 1 |
| Raines, KB | 1 |
| Bornemann, M | 1 |
| Matsuura, N | 1 |
| Harada, S | 1 |
| Ohyama, Y | 1 |
| Shibayama, K | 1 |
| Yuri, K | 1 |
| Nakanishi, M | 1 |
| Yokota, Y | 1 |
| Kazahari, K | 1 |
| Oguchi, H | 1 |
| Nygaard, B | 4 |
| Knudsen, JH | 1 |
| Scient, AV | 1 |
| Hansen, JE | 1 |
| Goto, Y | 2 |
| Ohta, Y | 2 |
| Ogawa, N | 1 |
| Ohashi, H | 1 |
| Persani, L | 1 |
| Preziati, D | 1 |
| Matthews, CH | 1 |
| Sartorio, A | 1 |
| Masunaga, R | 1 |
| Nagasaka, A | 1 |
| Nakai, A | 1 |
| Kotake, M | 1 |
| Sawai, Y | 1 |
| Oda, N | 1 |
| Mokuno, T | 1 |
| Shimazaki, K | 1 |
| Hayakawa, N | 1 |
| Kato, R | 3 |
| Hirano, E | 1 |
| Hagiwara, M | 1 |
| Kawakami-Tani, T | 1 |
| Fukawa, E | 1 |
| Tanaka, H | 1 |
| Abe, Y | 3 |
| Makino, I | 1 |
| Escobar-Morreale, HF | 1 |
| Serrano, J | 1 |
| Sancho, JM | 1 |
| Varela, C | 1 |
| Oshiro, C | 1 |
| Murray, CA | 1 |
| Miller, RA | 1 |
| Tan, KC | 2 |
| Shiu, SW | 2 |
| Stensvold, AD | 1 |
| Sundsfjord, J | 1 |
| Ueshiba, H | 1 |
| Takeda, S | 1 |
| Matoba, H | 1 |
| Yuasa, R | 1 |
| Tsuboi, K | 1 |
| Miyachi, Y | 1 |
| Sugawa, H | 1 |
| Kosugi, S | 1 |
| Hai, N | 1 |
| Matsuda, A | 1 |
| Rivolta, R | 1 |
| Meroni, L | 1 |
| Pappalettera, M | 1 |
| Jones, BM | 2 |
| Nielsen, LH | 1 |
| Jacobsen, BB | 1 |
| Fiore, E | 1 |
| Scheen, AJ | 1 |
| Kazuo, K | 1 |
| Fujikado, T | 2 |
| Ohmi, G | 1 |
| Hosohata, J | 1 |
| Tano, Y | 1 |
| Akuzawa, M | 1 |
| Satoh, T | 1 |
| Shimizu, H | 1 |
| Lee, S | 1 |
| Scherberg, N | 1 |
| Sabri, O | 1 |
| Schulz, G | 1 |
| Zimny, M | 1 |
| Schreckenberger, M | 1 |
| Zimny, D | 1 |
| Wagenknecht, G | 1 |
| Kaiser, HJ | 1 |
| Dohmen, BM | 1 |
| Bares, R | 1 |
| Büll, U | 1 |
| Rink, T | 1 |
| Holle, LH | 1 |
| Schroth, HJ | 1 |
| Garth, H | 1 |
| Bocchia, M | 1 |
| Ribotto, P | 1 |
| Orlandini, B | 1 |
| Torchio, G | 1 |
| Potter, MA | 1 |
| Gauthier, D | 1 |
| Hill, RE | 1 |
| Okada, M | 1 |
| Kamiya, Y | 1 |
| Ito, J | 1 |
| Yoshimata, T | 1 |
| Kawaguchi, M | 1 |
| Shibata, H | 1 |
| Fujinami, T | 1 |
| Ford, HC | 2 |
| Fagerström, JN | 1 |
| Cordwell, DP | 1 |
| Delahunt, JW | 1 |
| Toomath, RJ | 1 |
| Tandon, RK | 1 |
| Dudha, A | 1 |
| Sasián, S | 1 |
| Rojano, J | 1 |
| Gavilán, I | 1 |
| Aguilar, M | 1 |
| Escobar, L | 1 |
| Girón, JA | 1 |
| Smolarz, K | 1 |
| Dederichs, B | 1 |
| Schicha, H | 2 |
| De Riva, C | 1 |
| Vircici, F | 1 |
| Escobar Jiménez, F | 1 |
| Luna López, V | 1 |
| Quezada Charneco, M | 1 |
| Watanabe, Y | 2 |
| Shimaoka, Y | 2 |
| Yagoro, A | 1 |
| Kallio, P | 1 |
| Murphy, ED | 1 |
| Zha, LL | 1 |
| Vierhapper, H | 4 |
| Bieglmayer, C | 1 |
| Nowotny, P | 3 |
| Waldhäusl, W | 2 |
| Shorey, S | 1 |
| Badenhoop, K | 2 |
| Walfish, PG | 3 |
| Hagag, P | 1 |
| Nissenbaum, H | 1 |
| Siddiqi, A | 1 |
| Monson, JP | 3 |
| Wood, DF | 1 |
| Besser, GM | 2 |
| Burrin, JM | 1 |
| Okumura, M | 1 |
| Ueta, Y | 2 |
| Fukui, H | 1 |
| Murakami, H | 1 |
| Yamanouchi, Y | 1 |
| Yamamoto, R | 1 |
| Murao, A | 1 |
| Santou, Y | 1 |
| Taniguchi, S | 2 |
| Mitani, Y | 3 |
| Bando, Y | 1 |
| Nagai, Y | 1 |
| Ushiogi, Y | 1 |
| Toya, D | 1 |
| Tanaka, N | 1 |
| Fujisawa, M | 1 |
| Komorsky, GS | 1 |
| Salamone, S | 1 |
| Scollo, C | 1 |
| Vigneri, R | 1 |
| Dimai, HP | 1 |
| Ramschak-Schwarzer, S | 1 |
| Lax, S | 1 |
| Lipp, RW | 1 |
| Leb, G | 1 |
| Maugendre, D | 2 |
| Gatel, A | 1 |
| Campion, L | 1 |
| Massart, C | 3 |
| Guilhem, I | 1 |
| Lorcy, Y | 1 |
| Lescouarch, J | 1 |
| Herry, JY | 1 |
| Allannic, H | 2 |
| Ozaki, O | 2 |
| Iwasaki, H | 1 |
| Wada, N | 1 |
| Díez, S | 1 |
| Banias, H | 1 |
| Díez-Martin, JL | 1 |
| Briz, M | 1 |
| Estrado, J | 1 |
| Barceló, B | 1 |
| Heward, JM | 1 |
| Armitage, M | 1 |
| Hattersley, A | 1 |
| Dodson, PM | 1 |
| Macleod, K | 1 |
| Carr-Smith, J | 1 |
| Daykin, J | 2 |
| Daly, A | 1 |
| Sheppard, MC | 3 |
| Holder, RL | 1 |
| Barnett, AH | 1 |
| Franklyn, JA | 2 |
| Gough, SC | 2 |
| Martin-du Pan, RC | 1 |
| Okajima, T | 1 |
| Tanaka, E | 1 |
| Ando, B | 1 |
| Takeshita, M | 1 |
| Masuda, A | 1 |
| Sakai, K | 1 |
| Sonnet, E | 1 |
| Gibassier, J | 1 |
| Metcalfe, RA | 1 |
| Phipps, J | 1 |
| Nicolle, MW | 1 |
| Mosh, N | 1 |
| Arbelle, JE | 1 |
| Porath, A | 1 |
| Patibandla, SA | 1 |
| Fan, JL | 1 |
| Yamano, Y | 1 |
| Hirai, K | 1 |
| Ward, L | 1 |
| Huot, C | 1 |
| Lambert, R | 1 |
| Deal, C | 1 |
| Collu, R | 1 |
| Barnes, SC | 1 |
| Wicking, JM | 1 |
| Johnston, JD | 1 |
| Hanna, FW | 1 |
| Scanlon, MF | 2 |
| Caccavale, C | 1 |
| Di Serio, C | 1 |
| Del Buono, A | 1 |
| Sorvillo, F | 1 |
| Bellastella, A | 2 |
| Carella, C | 3 |
| Caixàs, A | 1 |
| Albareda, M | 1 |
| García-Patterson, A | 1 |
| Rodríguez-Espinosa, J | 1 |
| de Leiva, A | 1 |
| Corcoy, R | 1 |
| Andrade, VA | 2 |
| Gross, JL | 2 |
| Maia, AL | 2 |
| Kwok, CC | 1 |
| Ramos-Dias, JC | 1 |
| Lengyel, AM | 1 |
| Valenti, TM | 1 |
| Macchia, E | 1 |
| Pisa, R | 1 |
| Bucalo, ML | 1 |
| Russo, V | 1 |
| Colletti, I | 1 |
| Compagno, V | 1 |
| Abbadi, V | 1 |
| Donatelli, M | 1 |
| Inukai, T | 2 |
| Takanashi, K | 1 |
| Takebayashi, K | 1 |
| Fujiwara, Y | 1 |
| Tayama, K | 1 |
| Hiromatsu, Y | 2 |
| Ishibashi, M | 2 |
| Miyake, I | 1 |
| Soyejima, E | 1 |
| Yamashita, K | 2 |
| Koike, N | 1 |
| Nonaka, K | 2 |
| Raber, W | 2 |
| Kmen, E | 1 |
| Kajita, Y | 2 |
| Amato, G | 2 |
| Salzano, I | 1 |
| De Bellis, A | 2 |
| De Felice, G | 1 |
| Costagliola, C | 1 |
| Many, MC | 1 |
| Denef, JF | 1 |
| Pohlenz, J | 1 |
| Rezzónico, JN | 1 |
| Pusiol, E | 1 |
| Saravi, FD | 1 |
| Rezzónico, M | 1 |
| Bossa, N | 1 |
| Ramos, CD | 1 |
| Assumpção, L | 1 |
| Etchebehere, EC | 1 |
| Camargo, EE | 1 |
| Yamashita, H | 2 |
| Noguchi, S | 4 |
| Murakami, T | 2 |
| Watanabe, S | 2 |
| Uchino, S | 1 |
| Ohshima, A | 1 |
| Kawamoto, H | 1 |
| Toda, M | 1 |
| Zimmermann-Belsing, T | 2 |
| Christensen, L | 1 |
| Hansen, HS | 1 |
| Kirkegaard, J | 1 |
| Manetti, L | 3 |
| Dell'Unto, E | 2 |
| Mazzi, B | 3 |
| Rocchi, R | 2 |
| Smith, CM | 1 |
| Gavranich, J | 1 |
| Cotterill, A | 1 |
| Rodda, CP | 1 |
| Luna-López, V | 1 |
| Quesada-Charneco, M | 1 |
| Panz, VR | 2 |
| Raal, FJ | 1 |
| Joffe, BI | 2 |
| Biondi, B | 1 |
| Manganella, G | 1 |
| Del Buono, AD | 1 |
| Montella, P | 1 |
| di Cristofaro, M | 1 |
| Di Iorio, G | 1 |
| Collins, MT | 1 |
| Remaley, AT | 1 |
| Csako, G | 1 |
| Pucino, F | 1 |
| Balow, JE | 1 |
| Sewerynek, J | 1 |
| Wiktorska, J | 1 |
| Nowak, D | 1 |
| Lewinski, A | 1 |
| Yamashita, R | 2 |
| Makino, F | 1 |
| Kubo, T | 1 |
| Toki, J | 1 |
| Kado, Y | 1 |
| Kurihara, M | 1 |
| Moriwake, T | 1 |
| Kanzaki, S | 1 |
| Seino, Y | 1 |
| Nishimori, T | 2 |
| Ito, Y | 3 |
| Terao, A | 1 |
| Eto, S | 1 |
| Jarløv, AE | 1 |
| Kristensen, LO | 1 |
| Faber, J | 2 |
| Vetshev, PS | 1 |
| Balabolkin, MI | 1 |
| Petunina, NA | 1 |
| Trukhina, LV | 1 |
| Khanna, CM | 2 |
| Shankar, LR | 1 |
| Jaggi, CB | 1 |
| Bansal, JK | 1 |
| Chugh, P | 1 |
| Sera, N | 1 |
| Yokoyama, N | 2 |
| Imaizumi, M | 1 |
| Usa, T | 1 |
| Tominaga, T | 1 |
| Ejima, E | 1 |
| Ashizawa, K | 1 |
| Ohmoto, Y | 1 |
| Ricciardi, R | 1 |
| Rossi, B | 1 |
| Muratorio, A | 1 |
| Inoue, Y | 1 |
| Yu, YH | 1 |
| Bilezikian, JP | 1 |
| Wiesli, P | 1 |
| Knierim, M | 1 |
| Knierim, C | 1 |
| Tahara, H | 1 |
| Kurioka, Y | 1 |
| Morii, H | 3 |
| Jubault, V | 1 |
| Penfornis, A | 1 |
| Schillo, F | 1 |
| Hoen, B | 1 |
| Izembart, M | 3 |
| Timsit, J | 1 |
| Kazatchkine, MD | 1 |
| Gilquin, J | 1 |
| Viard, JP | 1 |
| Gessi, A | 1 |
| Saïd, R | 1 |
| Khoo, DH | 2 |
| Eng, PH | 2 |
| Ho, SC | 2 |
| Tai, ES | 2 |
| Seah, LL | 1 |
| Fong, KS | 1 |
| Chee, SP | 1 |
| Choo, CT | 1 |
| Aw, SE | 1 |
| Arisaka, O | 1 |
| Kanazawa, S | 1 |
| Hoshi, M | 1 |
| Kuribayashi, T | 1 |
| Soule, J | 1 |
| Mayfield, R | 1 |
| Sankar, R | 1 |
| Magdum, M | 1 |
| Gera, A | 1 |
| Seven, R | 1 |
| Gelişgen, R | 1 |
| Seven, A | 1 |
| Erbil, Y | 1 |
| Bozbora, A | 1 |
| Burçak, G | 1 |
| Smith, C | 1 |
| Thomsett, M | 1 |
| Choong, C | 1 |
| Rodda, C | 1 |
| McIntyre, HD | 1 |
| Cotterill, AM | 1 |
| Homsanit, M | 1 |
| Sriussadaporn, S | 1 |
| Vannasaeng, S | 1 |
| Peerapatdit, T | 1 |
| Nitiyanant, W | 1 |
| Vichayanrat, A | 1 |
| Davies, JS | 1 |
| Morrish, PK | 1 |
| Yong, AM | 1 |
| Wong, ZW | 1 |
| de Nayer, P | 1 |
| Bex, M | 1 |
| Minami, T | 1 |
| Koyama, H | 1 |
| Ishii, Y | 1 |
| Crivellaro, C | 1 |
| Oberhofer, R | 1 |
| Leimgruber, K | 1 |
| Amor, H | 1 |
| Kettaneh, A | 1 |
| Guilpain, P | 1 |
| Fain, O | 1 |
| Pariès, J | 1 |
| Sitbon, M | 1 |
| Solomon, BL | 2 |
| Ferguson, P | 1 |
| Walpert, N | 2 |
| Howard, R | 1 |
| Colzani, RM | 1 |
| Emdin, M | 1 |
| Conforti, F | 1 |
| Passino, C | 1 |
| Scarlattini, M | 1 |
| Iervasi, G | 1 |
| Suzuki, K | 1 |
| Nakagawa, O | 1 |
| Aizawa, Y | 1 |
| Nishino, M | 1 |
| Yabe, S | 1 |
| Kanda, T | 1 |
| Nishiyama, K | 1 |
| Kitahara, A | 1 |
| Natsume, H | 1 |
| Matsushita, A | 1 |
| Nakano, K | 1 |
| Sasaki, S | 1 |
| Genma, R | 1 |
| Yamamoto, Y | 1 |
| Välimäki, MJ | 1 |
| Al-Humaidi, MA | 1 |
| Kouki, T | 1 |
| Bartolomei, MP | 1 |
| Lepri, P | 1 |
| Cartei, F | 1 |
| Nardi, M | 1 |
| Lau, KS | 1 |
| Wiinberg, N | 1 |
| Schifter, S | 1 |
| Mehlsen, J | 1 |
| Miller, KK | 1 |
| Jódar, E | 1 |
| Martínez-Díaz-Guerra, G | 1 |
| Azriel, S | 1 |
| Hawkins, F | 1 |
| Morimoto, M | 1 |
| Ohara, E | 1 |
| Nishimori, Y | 1 |
| Hisahara, T | 1 |
| Nishida, M | 1 |
| Sugiura, T | 1 |
| Kohno, A | 1 |
| Hara, Y | 3 |
| Wu, G | 1 |
| Jie, Y | 1 |
| Situ, Y | 1 |
| Shimizu, K | 1 |
| Kumita, S | 1 |
| Kitamura, Y | 1 |
| Nagahama, M | 1 |
| Kitagawa, W | 1 |
| Akasu, H | 1 |
| Oshina, T | 1 |
| Kumasaki, T | 1 |
| Tanaka, S | 1 |
| Braga, M | 2 |
| Graf, H | 1 |
| Ogata, A | 1 |
| Batista, J | 1 |
| Hakim, NC | 1 |
| Wahrenberg, H | 1 |
| Wennlund, A | 1 |
| Hoffstedt, J | 1 |
| Fowler, MJ | 1 |
| Pannone, AF | 1 |
| Blevins, LS | 1 |
| Bieglmayer, Ch | 1 |
| Lisi, S | 1 |
| Di Cosmo, C | 1 |
| Sellari-Franceschini, S | 1 |
| Ruiz Viñals, AT | 1 |
| Buil Calvo, JA | 1 |
| Martínez Giralto, O | 1 |
| Castilla Céspedes, M | 1 |
| Endo, K | 2 |
| Okuno, T | 1 |
| Takeda, Y | 4 |
| Lauridsen, UB | 1 |
| Kirkegaard, C | 1 |
| Friis, T | 1 |
| Siersbaek-Nielsen, K | 1 |
| Marsden, P | 2 |
| Chalkley, S | 1 |
| Leatherdale, B | 1 |
| Howorth, PJ | 1 |
| Acosta, M | 1 |
| McKerron, CG | 2 |
| Herrmann, J | 1 |
| Schaps, D | 1 |
| Rusche, HJ | 1 |
| Berger, M | 1 |
| Krüskemper, HL | 1 |
| von zur Hühlen, A | 1 |
| Clifton-Bligh, P | 2 |
| Burke, G | 3 |
| Lamb, AM | 1 |
| Gowland, E | 1 |
| Wise, PH | 1 |
| Burnet, RB | 1 |
| Ahmad, A | 1 |
| Harding, PE | 1 |
| Larsen, PR | 5 |
| Evered, DC | 2 |
| Buerklin, EM | 1 |
| Schimmel, M | 1 |
| Utiger, RD | 1 |
| Lutz, P | 1 |
| Jaffiol, C | 2 |
| Baldet, L | 2 |
| Robin, M | 1 |
| Papachristou, C | 1 |
| Lapinski, H | 1 |
| Mirouze, J | 2 |
| Barnes, HV | 1 |
| Blizzard, RM | 1 |
| Birkhäuser, M | 1 |
| Burer, T | 1 |
| Busset, R | 1 |
| Burger, A | 1 |
| Kammer, H | 1 |
| Bouma, DJ | 1 |
| Esaki, M | 3 |
| Kurakawa, N | 1 |
| Aoki, H | 3 |
| Linquette, M | 1 |
| Fossati, P | 1 |
| Decoulx, M | 1 |
| Racadot, A | 1 |
| Benoit, G | 1 |
| Asfour, M | 1 |
| Nishikawa, Y | 3 |
| Miura, T | 1 |
| Ohno, M | 1 |
| Kitabatake, S | 1 |
| Fujie, T | 1 |
| Onishi, T | 1 |
| Shizume, K | 4 |
| Krück, F | 1 |
| Kuro, R | 2 |
| Weiske, R | 1 |
| Gelinsky, P | 1 |
| Müller, E | 1 |
| Meyer, R | 1 |
| Wilkin, TJ | 1 |
| Gunn, A | 1 |
| Isles, TE | 1 |
| Crooks, J | 1 |
| Beck, JS | 1 |
| Wood, LC | 1 |
| Maayan, ML | 1 |
| Volpert, EM | 1 |
| Dawry, FP | 1 |
| Takata, I | 1 |
| Saida, K | 1 |
| Bigos, ST | 1 |
| Ikemi, Y | 1 |
| Bürgi, H | 2 |
| Johnson, DE | 2 |
| Grau, T | 1 |
| Aspaas, PK | 1 |
| Lovrien, F | 1 |
| Barlow, JF | 1 |
| Mortimer, CH | 1 |
| Anderson, DC | 1 |
| Liendo-Ch, P | 1 |
| Fisher, R | 1 |
| Chan, V | 1 |
| Self, M | 1 |
| Horwitz, DL | 1 |
| Haug, E | 1 |
| Sand, T | 1 |
| Chopra, U | 4 |
| Yoshihara, E | 1 |
| Terasaki, PI | 1 |
| Smith, F | 1 |
| Mertz, DP | 2 |
| Koch, B | 1 |
| Kalinin, AP | 2 |
| Izmaĭlov, GI | 2 |
| Kurokawa, N | 2 |
| Fournier, M | 1 |
| Orgiazzi, J | 4 |
| Magnon-Pujo, B | 1 |
| Quintana, J | 1 |
| Mornex, R | 1 |
| Castelnau, P | 1 |
| Aberlenc, M | 1 |
| Yamamoto, T | 1 |
| Tanaka, F | 1 |
| Yeo, PP | 2 |
| Croxson, MS | 3 |
| Hall, TD | 2 |
| Jaramillo, JE | 1 |
| Verhoeven, RP | 1 |
| Doctor, R | 2 |
| Schalekamp, MA | 1 |
| Golden, MP | 1 |
| Kaplan, SA | 1 |
| Lippe, BM | 1 |
| Lee, WN | 1 |
| Sobrinho, LG | 1 |
| Limbert, ES | 1 |
| Santos, MA | 1 |
| Lotti, G | 1 |
| Delitala, G | 1 |
| Devilla, L | 1 |
| Alagna, S | 1 |
| Masala, A | 1 |
| Harland, PC | 1 |
| McArthur, RG | 1 |
| Fawcett, DM | 1 |
| Roudebush, CP | 1 |
| Hoye, KE | 1 |
| Gatzke, HD | 1 |
| Wildmeister, W | 2 |
| Schwartz, KD | 1 |
| Scazziga, BR | 1 |
| Eraker, SA | 1 |
| Wickamasekaran, R | 1 |
| Goldman, S | 1 |
| Sung, LC | 2 |
| McDougall, IR | 2 |
| Dorfman, SG | 1 |
| Young, RL | 1 |
| Labhart, A | 1 |
| Schellekens, AP | 1 |
| Stuart, DD | 1 |
| Schultz, AL | 1 |
| Wogsurawat, N | 1 |
| Brun, R | 1 |
| Jenny, M | 1 |
| Junod, JP | 1 |
| Dobyns, BM | 1 |
| Dandona, P | 1 |
| El Kabir, DJ | 1 |
| Takayama, H | 1 |
| Chiu, SC | 1 |
| Ikeda, H | 2 |
| Dradi, C | 1 |
| Riceputi, G | 1 |
| Biagioli, R | 1 |
| Riva, P | 1 |
| Tevaarwerk, GJ | 1 |
| Boyd, D | 1 |
| Kaplan, MM | 2 |
| Miyaji, K | 1 |
| Maciel, RM | 1 |
| Ozawa, Y | 2 |
| Geola, F | 1 |
| Bennett, LR | 1 |
| Zaninovich, AA | 2 |
| Boado, R | 1 |
| Degrossi, O | 1 |
| Bromage, N | 1 |
| Matty, AJ | 1 |
| Kliman, B | 1 |
| Kjellberg, RN | 1 |
| Weightman, DR | 1 |
| Marshall, J | 1 |
| Ratcliffe, JG | 1 |
| Nistrup Madsen, S | 1 |
| Schrub, JC | 1 |
| Nouel, JP | 1 |
| Brunelle, P | 1 |
| Segond, G | 1 |
| Courtois, H | 1 |
| Poirier, A | 1 |
| Sandler, R | 1 |
| Emrich, D | 2 |
| Bähre, M | 1 |
| zur Mühlen, A | 1 |
| Hesch, RD | 1 |
| Köbberling, J | 1 |
| Bremner, WJ | 1 |
| Griep, RJ | 1 |
| Dimond, RC | 1 |
| Earll, JM | 1 |
| Wright, FD | 1 |
| Umise, N | 1 |
| Umise, K | 1 |
| Griffiths, BL | 1 |
| Collins, JR | 1 |
| Marshall, WH | 1 |
| Ingram, DW | 1 |
| Cano, PO | 1 |
| Chertman, MM | 1 |
| Jerry, LM | 1 |
| Adler, RA | 1 |
| Dolman, A | 1 |
| De Reus, A | 1 |
| Van Zijl, J | 2 |
| Jånos, F | 1 |
| Erzsebet, G | 1 |
| Jozsefne, J | 1 |
| Williams, DE | 2 |
| Sawhney, RC | 1 |
| Kannan, V | 1 |
| Rastogi, GK | 1 |
| Barnes, ND | 1 |
| O'Connell, EJ | 1 |
| Cloutier, MD | 1 |
| van Soestbergen, MJ | 1 |
| van der Vijver, JC | 1 |
| Graafland, AD | 1 |
| Shirotani, T | 1 |
| Kishikawa, H | 1 |
| Wake, N | 1 |
| Miyamura, N | 1 |
| Hashimoto, Y | 1 |
| Motoyoshi, S | 1 |
| Shichiri, M | 1 |
| Shechner, C | 1 |
| Kraiem, Z | 1 |
| Zuckerman, E | 1 |
| Dickstein, G | 1 |
| Reglinski, J | 1 |
| Smith, WE | 2 |
| Wilson, R | 6 |
| Buchanan, LM | 1 |
| McKillop, JH | 6 |
| Thomson, JA | 6 |
| Sato, M | 1 |
| Kojima, K | 1 |
| Kurose, S | 1 |
| Hoshino, T | 1 |
| Nakashima, A | 1 |
| Itagaki, Y | 1 |
| Ohzeki, T | 1 |
| Hanaki, K | 1 |
| Motozumi, H | 1 |
| Matsuda-Ohtahara, H | 1 |
| Ishitani, N | 1 |
| Shiraki, K | 1 |
| Taube, A | 1 |
| Onoda, N | 1 |
| Etoh, M | 1 |
| Isozaki, O | 1 |
| Arai, M | 2 |
| Hisaoka, T | 1 |
| Harsch, I | 1 |
| Paschke, R | 1 |
| Usadel, KH | 1 |
| Mohari, K | 1 |
| Janoki, G | 1 |
| Tarjan, G | 2 |
| Varga, F | 1 |
| Polk, D | 1 |
| Florsheim, WH | 2 |
| Green, WL | 1 |
| Fisher, DA | 7 |
| Nagy, E | 1 |
| Balazs, G | 1 |
| Bako, G | 2 |
| Boddenberg, B | 1 |
| Cooke, RR | 1 |
| Keightley, EA | 1 |
| Inui, T | 1 |
| Chen, W | 1 |
| Wermann, M | 1 |
| Grussendorf, M | 1 |
| Heilig, B | 1 |
| Massa, G | 1 |
| de Zegher, F | 1 |
| Dooms, L | 1 |
| Vanderschueren-Lodeweyckx, M | 1 |
| Fu, LS | 1 |
| Yang, LY | 1 |
| Chen, WP | 1 |
| Chao, T | 1 |
| Ooi, SK | 1 |
| Lin, CY | 1 |
| Van der Gaag, R | 1 |
| Mourits, MP | 1 |
| Koornneef, L | 1 |
| Horlick, MN | 1 |
| Nishii, Y | 1 |
| Sakurai, A | 2 |
| Miyamoto, T | 2 |
| Suzuki, S | 2 |
| Takeda, T | 2 |
| Mouroux, D | 1 |
| Martin Laval, A | 1 |
| Bovero, G | 1 |
| Nicolino, J | 1 |
| Shoda, Y | 1 |
| Akiyama, H | 1 |
| Kondo, Y | 1 |
| Nakanishi, K | 1 |
| Taniguchi, Y | 1 |
| Shirota, K | 1 |
| Urabe, K | 2 |
| Kouchi, T | 1 |
| Balzano, S | 1 |
| Loviselli, A | 1 |
| Sica, V | 1 |
| Petrini, L | 1 |
| Grasso, L | 2 |
| Solomon, B | 1 |
| Lagasse, R | 1 |
| Ishii, J | 3 |
| Saitou, H | 1 |
| Wolf, MW | 1 |
| Tvede, M | 1 |
| Silva, JE | 1 |
| Gedik, O | 1 |
| Ozdemir, T | 1 |
| Tajiri, J | 2 |
| Morita, M | 2 |
| Tamaru, M | 1 |
| Navarro, MA | 1 |
| Yoshimura, M | 1 |
| Masaki, H | 1 |
| Gondou, A | 1 |
| Yonemoto, T | 1 |
| Piraino, P | 1 |
| Zura, ML | 1 |
| Loureiro, O | 1 |
| Andrade, A | 1 |
| Hashimoto, T | 1 |
| Nishibu, M | 1 |
| Nagai, K | 3 |
| Abs, R | 1 |
| Martin, M | 1 |
| Blockx, P | 1 |
| Bruno-Bossio, G | 1 |
| Lepri, A | 1 |
| Fong, PC | 1 |
| Pun, KK | 1 |
| Tai, YT | 1 |
| Wang, C | 1 |
| Molnár, I | 1 |
| Peterson, FE | 1 |
| Choudhury, K | 1 |
| Nicol, F | 1 |
| Wu, PS | 1 |
| Smith, AF | 1 |
| Arthur, JR | 1 |
| Shen, DC | 2 |
| Shian, LR | 2 |
| Florsheim, W | 2 |
| Wasserman, J | 1 |
| Petrini, B | 1 |
| von Stedingk, LV | 1 |
| Devoto, E | 1 |
| Aravena, L | 1 |
| Hidalgo, MS | 1 |
| Gajardo, H | 1 |
| Lioi, X | 1 |
| Soto, N | 1 |
| Barrera, R | 1 |
| Munizaga, F | 1 |
| Greenspan, SL | 1 |
| Greenspan, FS | 1 |
| Resnick, NM | 1 |
| Block, JE | 1 |
| Friedlander, AL | 1 |
| Genant, HK | 1 |
| Heshmati, HM | 2 |
| Turpin, G | 2 |
| Vallée, G | 2 |
| Federman, DD | 1 |
| Kiso, Y | 1 |
| Nagasawa, T | 1 |
| Koukkou, E | 1 |
| Panayiotidis, P | 1 |
| Alevizou-Terzaki, V | 1 |
| Thalassinos, N | 1 |
| Nolte, C | 1 |
| Olbricht, T | 2 |
| Galvan, G | 2 |
| Gräf, KJ | 1 |
| Schneider, HG | 1 |
| Philippou, G | 1 |
| Piperingos, G | 1 |
| Souvatzoglou, A | 1 |
| Moulopoulos, SD | 1 |
| Kalman, K | 2 |
| Gergely, L | 1 |
| Mortimer, RH | 1 |
| Tyack, SA | 1 |
| Galligan, JP | 1 |
| Perry-Keene, DA | 1 |
| Tan, YM | 1 |
| Kaneko, G | 1 |
| Masuda, H | 1 |
| Takahashi, S | 1 |
| Iida, F | 1 |
| Imai, Y | 2 |
| Odajima, R | 1 |
| Shimizu, T | 3 |
| Shishiba, Y | 3 |
| Hidaka, A | 2 |
| Oh, SK | 1 |
| Shong, YK | 1 |
| Kim, SE | 1 |
| Yoo, HY | 1 |
| Min, HK | 1 |
| Davidson, KM | 1 |
| Richards, DS | 1 |
| Schatz, DA | 1 |
| Yamaguchi, Y | 1 |
| Chikuba, N | 1 |
| Ueda, Y | 2 |
| Yamamoto, H | 1 |
| Nakanishi, T | 1 |
| Akazawa, S | 1 |
| Wickus, GG | 1 |
| Caplan, RH | 1 |
| Mathews, EA | 1 |
| Pehling, GB | 1 |
| Bearcroft, CP | 1 |
| Toms, GC | 1 |
| Williams, SJ | 1 |
| Noonan, K | 2 |
| Yanagisawa, M | 2 |
| Hase, K | 2 |
| Sakatume, Y | 1 |
| Gamstedt, A | 4 |
| Karlsson, A | 2 |
| Fakhri, O | 1 |
| Baxter, MA | 1 |
| Fong, P | 1 |
| Kendler, D | 1 |
| Thung, S | 1 |
| Barth, A | 1 |
| Probst, P | 1 |
| Tokimitsu, N | 1 |
| Hong, WS | 1 |
| Hong, SW | 1 |
| Lee, JO | 1 |
| Kang, TW | 1 |
| Syrenicz, A | 1 |
| Navarro Despaigne, D | 1 |
| Ripoll Ripoll, F | 1 |
| Uehata, S | 1 |
| Kiyohara, K | 1 |
| Naomi, S | 1 |
| Umeda, T | 1 |
| Toh, SH | 2 |
| Brown, PH | 2 |
| Iitaka, MI | 1 |
| Chailurkit, LO | 1 |
| Kongsuksai, A | 1 |
| Teeravaninthorn, U | 1 |
| Messer, PM | 1 |
| Hauffa, BP | 1 |
| Kotulla, P | 1 |
| Morotomi, Y | 1 |
| Fujishima, M | 1 |
| Vana, S | 1 |
| Lakatos, P | 1 |
| Thomas, JE | 1 |
| Bwakura, TR | 1 |
| Dzichauya, TJ | 1 |
| Griffiths, S | 1 |
| Kushima, K | 1 |
| Nagakura, H | 1 |
| Kaihara, M | 1 |
| Bodini, C | 1 |
| Buffoli, MG | 1 |
| Legati, F | 1 |
| Schettino, M | 1 |
| Zuccato, F | 1 |
| Wehrenberg, WB | 1 |
| Rom-Bugoslavskaia, ES | 1 |
| Sakhatov, BIa | 1 |
| Pesotskaia, PM | 1 |
| Mangklabruks, A | 1 |
| McCormick, M | 1 |
| Chang, DC | 1 |
| Woodcock, JP | 1 |
| Shedden, EJ | 1 |
| Wheeler, MH | 1 |
| Winsa, B | 1 |
| Dahlberg, A | 1 |
| Jansson, R | 2 |
| Agren, H | 1 |
| Okamoto, T | 1 |
| Fujimoto, Y | 2 |
| Obara, T | 2 |
| Kodama, T | 1 |
| Kusakabe, K | 1 |
| Stefăneanu, L | 1 |
| Taşcă, C | 1 |
| Chen, JJ | 2 |
| Oyanagi, H | 1 |
| Fang, WY | 1 |
| Ye, WX | 1 |
| Ericsson, UB | 1 |
| Dymling, JF | 2 |
| Thorell, JI | 1 |
| Kaur, S | 1 |
| Parr, JH | 1 |
| Ramsay, ID | 1 |
| Hennebry, TM | 1 |
| Jarvis, KJ | 1 |
| Lester, E | 1 |
| Lin, LX | 1 |
| Barkan, AL | 1 |
| Anania, C | 1 |
| Rubenfeld, S | 1 |
| Lin, JY | 1 |
| Hwu-Liaw, SE | 1 |
| Chang, TC | 1 |
| Zhang, KZ | 1 |
| Liao, ZH | 1 |
| Wang, SH | 1 |
| Ma, SJ | 1 |
| Long, ZZ | 1 |
| Tian, WT | 1 |
| Zhu, JY | 1 |
| Hatabu, H | 1 |
| Ishihara, T | 1 |
| Schwander, J | 1 |
| Holle, R | 1 |
| Holl, G | 1 |
| Hensen, J | 1 |
| Finke, R | 1 |
| Mayr, WR | 1 |
| Grübl, M | 1 |
| Moncayo, R | 1 |
| Schilling, S | 1 |
| Weber, P | 1 |
| Beyer, J | 2 |
| Krause, U | 1 |
| Kimura, M | 1 |
| Takazawa, K | 1 |
| Akasu, R | 1 |
| Onaya, T | 1 |
| Cobin, R | 1 |
| Chopra, M | 1 |
| Bradley, H | 1 |
| Brummelkamp, WH | 1 |
| Gauna, A | 1 |
| Segura, G | 1 |
| Sartorio, G | 1 |
| Soto, R | 1 |
| Segal-Eiras, A | 1 |
| Burns, TW | 1 |
| Bregant, R | 1 |
| Williams, IK | 1 |
| Goshima, E | 1 |
| Yamakita, N | 2 |
| Maeda, M | 1 |
| Yoshimoto, M | 1 |
| Mulder, H | 1 |
| Fischer, HR | 1 |
| Guerin, V | 1 |
| Bene, MC | 1 |
| Amiel, C | 1 |
| Hartemann, P | 1 |
| Leclere, J | 1 |
| Faure, G | 1 |
| Kohno, T | 1 |
| Mitsukawa, T | 1 |
| Matsukura, S | 1 |
| Tsunetoshi, Y | 1 |
| Ishikawa, E | 1 |
| Jap, TS | 1 |
| Ho, LT | 1 |
| Won, JG | 1 |
| Harada, T | 1 |
| Katagiri, M | 1 |
| Shimaoka, K | 1 |
| Ishihara, M | 2 |
| Zeigler, ZR | 1 |
| Iannuzzi, D | 1 |
| Trzepacz, PT | 1 |
| Klein, I | 1 |
| Roberts, M | 1 |
| Greenhouse, J | 1 |
| Levey, GS | 1 |
| Ohmori, T | 1 |
| Hosoya, T | 2 |
| Hody, B | 1 |
| Condé, D | 1 |
| Leclech, G | 1 |
| Edan, G | 1 |
| Nicol, M | 1 |
| Ogasawara, H | 1 |
| Desai, RK | 1 |
| Norman, RJ | 1 |
| Jialal, I | 1 |
| Joubert, SM | 1 |
| Eshøj, O | 1 |
| Kvetny, J | 1 |
| Mogensen, EF | 1 |
| Pearson, DW | 1 |
| Cuthbert, GF | 1 |
| Vermiglio, F | 1 |
| Saller, B | 2 |
| Müller, R | 1 |
| Wadman, B | 1 |
| Connors, MH | 1 |
| Styne, DM | 1 |
| Katakura, M | 2 |
| Yukimura, Y | 2 |
| Szabó, T | 1 |
| Mossetti, G | 1 |
| Salomone Megna, A | 1 |
| Lanzano, C | 1 |
| Maddaloni, D | 1 |
| Leonello, D | 1 |
| Gravina, E | 1 |
| Kakezono, F | 1 |
| Kiriyama, T | 1 |
| Morita, S | 2 |
| Ohtakara, S | 1 |
| Morimoto, I | 1 |
| Okamoto, S | 1 |
| Attali, JR | 1 |
| Valensi, P | 1 |
| Darnis, D | 1 |
| Weisselberg, C | 1 |
| Sebaoun, J | 1 |
| van Ouwerkerk, BM | 1 |
| Bos, G | 1 |
| van Oudenaren, A | 1 |
| Benner, R | 1 |
| Beniko, M | 1 |
| Ikota, A | 1 |
| Mizumoto, H | 1 |
| Kunita, H | 1 |
| Steel, NR | 1 |
| Taylor, JJ | 1 |
| Stephenson, AM | 1 |
| Stratton, A | 1 |
| Holcombe, M | 1 |
| Bizzarro, A | 1 |
| Fontana, A | 1 |
| Daponte, A | 1 |
| Iacono, G | 1 |
| Peluso, G | 1 |
| Eisenstein, Z | 1 |
| Engelsman, E | 1 |
| Kalechman, Y | 1 |
| Sredni, B | 1 |
| Yamaji, T | 1 |
| Takaku, F | 1 |
| Sato, F | 1 |
| Grönhagen-Riska, C | 1 |
| Fyhrquist, F | 1 |
| Välimäki, M | 1 |
| Czernobilsky, H | 1 |
| Fiehn, W | 1 |
| Brandi, ML | 1 |
| Zonefrati, R | 1 |
| Rotella, CM | 1 |
| Toccafondi, R | 1 |
| Gómez Huelgas, R | 1 |
| Porras Vivas, JJ | 1 |
| San Román Terán, CM | 1 |
| García Calvo, MI | 1 |
| García Royan, A | 1 |
| Petrov, IM | 1 |
| Péter, F | 1 |
| Breyer, H | 1 |
| Kovács, L | 1 |
| Luo, GC | 1 |
| Adachi, T | 1 |
| Malarkey, WB | 1 |
| Jackson, R | 1 |
| Wortsman, J | 1 |
| Robuschi, G | 3 |
| Montermini, M | 3 |
| Manfredi, A | 3 |
| Gnudi, A | 3 |
| Busnardo, B | 2 |
| Girelli, ME | 1 |
| Rubello, D | 1 |
| Eccher, C | 1 |
| Betterle, C | 1 |
| Wu, RH | 1 |
| Kumar, M | 1 |
| Parente, JT | 1 |
| Pearson, C | 1 |
| Burnett, AK | 1 |
| Creutzig, H | 1 |
| McCruden, D | 1 |
| Naito, N | 1 |
| Hoffman, WH | 1 |
| Miceli, JN | 1 |
| Kågedal, B | 2 |
| Manabe, Y | 1 |
| Barge, A | 1 |
| Chowns, J | 1 |
| Broadbent, M | 1 |
| Temple, RC | 1 |
| Houghton, BJ | 1 |
| Kirner, J | 1 |
| Papic, M | 2 |
| Stein-Streilein, J | 2 |
| Guffee, J | 1 |
| Fletcher, MA | 1 |
| Hiramatsu, K | 1 |
| Maruyama, K | 1 |
| Kameko, M | 1 |
| Kanai, M | 1 |
| Miki, K | 3 |
| Fujii, S | 1 |
| Wada, M | 1 |
| d'Amato, L | 2 |
| Borciani, E | 1 |
| Negrotti, L | 1 |
| Heyma, P | 1 |
| Harrison, LC | 1 |
| Sundram, FX | 1 |
| Takahashi, T | 1 |
| Furuhashi, N | 1 |
| Petrick, PA | 1 |
| Nissim, M | 1 |
| Menezes-Ferreira, MM | 1 |
| Blank, MS | 1 |
| Tucci, JR | 1 |
| Shima, H | 1 |
| Doi, K | 1 |
| Hansen, PE | 1 |
| Iversen, E | 2 |
| Jensen, SE | 1 |
| Majima, M | 1 |
| Kitazawa, A | 1 |
| Nakao, S | 1 |
| Yamashita, S | 1 |
| Matsuzawa, Y | 1 |
| Harada, M | 1 |
| Matsuda, T | 1 |
| Aiba, M | 1 |
| Hirayama, A | 1 |
| Yamashita, T | 1 |
| Nasser, H | 1 |
| Buchholtz Hansen, PE | 1 |
| Eskjaer Jensen, S | 1 |
| Shirakami, A | 1 |
| Hirai, Y | 1 |
| Takeichi, T | 1 |
| Nishino, H | 1 |
| Inomoto, T | 1 |
| Shigekiyo, T | 1 |
| Kawauchi, S | 1 |
| Herman, GE | 1 |
| Kanluen, S | 1 |
| Monforte, J | 1 |
| Husain, M | 1 |
| Spitz, WU | 1 |
| Järnerot, G | 1 |
| Karpman, BA | 1 |
| Filetti, S | 1 |
| Young, RA | 1 |
| Stoffer, SS | 1 |
| Tan, SH | 1 |
| Wong, HB | 1 |
| Uma, R | 1 |
| Reggio, R | 1 |
| Tørring, J | 1 |
| Barlli, AL | 1 |
| Claunch, BC | 1 |
| Gärtner, R | 1 |
| Bechtner, G | 1 |
| Greil, W | 1 |
| Horn, K | 1 |
| Pickardt, CR | 1 |
| Neĭmark, II | 1 |
| Katsevman, AE | 1 |
| Dudarev, VA | 1 |
| Slukhaĭ, IuF | 1 |
| Lithell, H | 1 |
| Vessby, B | 1 |
| Selinus, I | 1 |
| Hatakeyama, T | 1 |
| Yagi, H | 1 |
| Bayer, MF | 1 |
| Kriss, JP | 1 |
| Hegele, RA | 1 |
| Frueh, BR | 1 |
| Benger, RS | 1 |
| Palmer, BN | 1 |
| Holdaway, IM | 1 |
| Frengley, PA | 1 |
| Evans, MC | 1 |
| Jurney, TH | 1 |
| Bian, TY | 1 |
| Jeng, CY | 1 |
| Kugai, N | 1 |
| Akisada, M | 1 |
| Hayek, A | 1 |
| Chapman, EM | 2 |
| Crawford, JD | 1 |
| Van Herle, AJ | 2 |
| Lawton, NF | 1 |
| Ekins, RP | 2 |
| Nabarro, JD | 1 |
| Furth, ED | 2 |
| Dentinger, M | 1 |
| De Costre, P | 1 |
| Buhler, U | 1 |
| Beall, GN | 2 |
| Hollingsworth, DR | 2 |
| Austin, E | 1 |
| Low, JC | 1 |
| Dussault, JH | 3 |
| Wong, ET | 1 |
| Doe, RP | 1 |
| Liberti, P | 2 |
| Stanbury, JB | 1 |
| Loeb, PB | 1 |
| Drash, AL | 1 |
| Kenny, FM | 1 |
| Pittman, JG | 1 |
| Jacobs, HS | 1 |
| Mackie, DB | 1 |
| Eastman, CJ | 1 |
| Ellis, SM | 1 |
| McHardy-Young, S | 1 |
| Reinfrank, RF | 1 |
| Schulz, U | 1 |
| Breuel, HP | 1 |
| Nowrousian, MR | 1 |
| Kattermann, R | 1 |
| Luig, H | 1 |
| Vanhaerlst, L | 1 |
| Golstein, J | 1 |
| Cauchie, C | 1 |
| Ermans, AM | 1 |
| Bastenie, PA | 1 |
| Mills, LC | 1 |
| Irie, M | 1 |
| Enomoto, K | 1 |
| Enomoto, H | 1 |
| Nukii, T | 1 |
| Schneider, PB | 1 |
| Liewendahl, K | 3 |
| Gordin, A | 1 |
| Richards, AR | 1 |
| Addison, GM | 1 |
| Owen, GM | 1 |
| Letonturier, P | 2 |
| Tourneur, R | 2 |
| Sénécal, P | 2 |
| Vurbanov, V | 1 |
| Stancheva, M | 1 |
| Strashimirov, D | 1 |
| Purves, HD | 1 |
| Matsuzaki, F | 1 |
| Rives, K | 1 |
| Becker, DV | 2 |
| Heimann, P | 1 |
| Foster, AE | 1 |
| Dowling, JT | 2 |
| Hamburger, JI | 2 |
| Paul, S | 1 |
| Sahadevan, V | 1 |
| Field, EO | 1 |
| Laroche, C | 1 |
| Grégoire, J | 1 |
| Schneck, O | 1 |
| Eber, O | 2 |
| Wascher, H | 1 |
| Wils, JA | 1 |
| Kloppenborg, PW | 1 |
| Mahaux, JE | 2 |
| Nagel, M | 2 |
| Rovis, L | 1 |
| Fenzi, GF | 1 |
| Baschieri, L | 1 |
| Wallack, MS | 1 |
| Adelberg, HM | 1 |
| Heinonen, OP | 1 |
| Viherkoski, M | 1 |
| Aro, A | 1 |
| Kvist, G | 1 |
| Laitinen, O | 1 |
| Knekt, P | 1 |
| Valenta, L | 2 |
| Coulombe, P | 2 |
| Silverstein, GE | 1 |
| Zoppetti, G | 1 |
| Cottino, F | 1 |
| Costa, A | 1 |
| Rothenbuchner, G | 1 |
| Birk, J | 1 |
| Ishihara, A | 1 |
| Pfeiffer, EF | 1 |
| McKean, HE | 1 |
| Roeckel, I | 1 |
| Reboul, J | 1 |
| Caille, JM | 1 |
| Bellet, M | 1 |
| Tessier, JP | 1 |
| Ambrosi, B | 1 |
| Travaglini, P | 1 |
| Trotto, G | 1 |
| Brenner, MA | 1 |
| Newman, ES | 1 |
| Odell, WD | 2 |
| Bellabarba, D | 1 |
| Mantel, O | 1 |
| Decourt, J | 1 |
| Tsukui, T | 1 |
| Furihata, R | 1 |
| Grossman, W | 1 |
| Robin, NI | 1 |
| Johnson, LW | 1 |
| Brooks, H | 1 |
| Selenkow, HA | 1 |
| Dexter, L | 1 |
| Gillquist, J | 1 |
| Karlberg, B | 1 |
| Sjödahl, R | 1 |
| Kennedy, TH | 1 |
| Stewart, RD | 1 |
| Munro, R | 1 |
| Skvortsova, RI | 1 |
| Shuvalova, IE | 1 |
| Raymond, JP | 1 |
| Delorme, ML | 1 |
| Fraisse, R | 1 |
| Mashimo, K | 1 |
| Kishino, F | 1 |
| Nishiooeda, Y | 1 |
| Van Welsum, M | 1 |
| Feltkamp, TE | 1 |
| De Vries, MJ | 1 |
| Ho, RS | 1 |
| Shenkman, L | 4 |
| Mitsuma, T | 3 |
| Blum, M | 1 |
| Hollander, CS | 4 |
| Patel, YC | 1 |
| Burger, HG | 1 |
| Hamilton, CR | 1 |
| Johnston, MV | 1 |
| Beckers, C | 1 |
| Cornette, C | 1 |
| Thalasso, M | 1 |
| Lande, G | 1 |
| Kjolseth, I | 1 |
| Lindström, H | 1 |
| Hjern, B | 1 |
| Gyertyánfy, G | 1 |
| Gesztesi, E | 1 |
| Cavlieri, RR | 1 |
| Becker, CE | 1 |
| Uller, RP | 1 |
| Shah, DH | 1 |
| Thakare, UR | 1 |
| Shownkeen, RC | 1 |
| Pahuja, DN | 1 |
| Mandlik, MY | 1 |
| Algvere, P | 1 |
| Almqvist, S | 1 |
| Backlund, EO | 1 |
| DeSanto, LW | 1 |
| MacCarty, CS | 1 |
| Riley, FC | 1 |
| Cevallos, JL | 1 |
| Anderson, DR | 1 |
| Guido, R | 1 |
| Vianello, A | 1 |
| Casson, F | 1 |
| Varotto, L | 1 |
| Vagenakis, AG | 1 |
| Adams, L | 1 |
| Webster, BR | 1 |
| Britton, A | 1 |
| Ezrin, C | 2 |
| Kumar, RS | 1 |
| Musa, BU | 1 |
| Appleton, WG | 1 |
| López Ruiz, F | 1 |
| Wahner, HW | 2 |
| Tötterman, J | 1 |
| Bauer, A | 1 |
| Abraham, GE | 1 |
| Sugar, HS | 1 |
| Küchle, HJ | 1 |
| Menking, M | 1 |
| Wiebel, J | 1 |
| Schmid, WU | 1 |
| Schmidt, WT | 1 |
| Ebel, KD | 1 |
| Ritter, R | 1 |
| Rolland, M | 1 |
| Montfort, MF | 1 |
| Lissitzky, S | 1 |
| Asper, SP | 1 |
| Singh, SP | 1 |
| Mayberry, WE | 1 |
| Bilstad, JM | 1 |
| Sizemore, GW | 1 |
| Uthgenannt, H | 1 |
| Adlung, J | 1 |
| Brinkhoff, H | 1 |
| Fellinger, K | 1 |
| Bergmann, H | 1 |
| Erd, W | 1 |
| Höfer, R | 1 |
| Kolarz, G | 1 |
| Perelman, R | 1 |
| Devaux, JP | 1 |
| Pouliot, P | 1 |
| Marie, J | 1 |
| Tuohimaa, E | 1 |
| Fukuchi, M | 1 |
| Williams, AD | 1 |
| Schönbaum, E | 2 |
| Berman, M | 1 |
| Hoff, E | 1 |
| Barandes, M | 1 |
| Becker, DB | 1 |
| Sonenberg, M | 1 |
| Benua, R | 1 |
| Gautier, E | 1 |
| Juillard, E | 1 |
| Samuelsson, SM | 1 |
| Werner, I | 1 |
| Dean, GW | 1 |
| Stelzer, M | 1 |
| Desbarats-Schonbaum, ML | 1 |
| Morton, WM | 1 |
| Runyan, JW | 1 |
| Bansi, HW | 1 |
| Wittig, G | 1 |
| Tengroth, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease[NCT05643365] | 300 participants (Anticipated) | Observational [Patient Registry] | 2013-01-01 | Recruiting | |||
| Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine[NCT06083636] | 500 participants (Anticipated) | Observational | 2022-07-26 | Recruiting | |||
| he Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial[NCT06068179] | Phase 2/Phase 3 | 205 participants (Anticipated) | Interventional | 2023-10-08 | Not yet recruiting | ||
| B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease[NCT02316691] | 2 participants (Actual) | Observational | 2016-01-31 | Terminated | |||
| The Influence of Continuous Block-replacement Therapy on the Effect of Radioiodine in Patients With Hyperthyroidism[NCT00150124] | Phase 4 | 100 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Comparison of Exercise Capacity and Physical Activity Levels in Patients With Hyperthyroid and Healthy Controls[NCT04825964] | 30 participants (Actual) | Observational | 2021-03-19 | Completed | |||
| A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease[NCT02685514] | 22 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| Efficacy Of Non Invasive Diagnostic Procedures In Evaluating The Influence Of Maternal Autoimmune Thyroid Gland Disease On Fetus[NCT02017080] | 300 participants (Anticipated) | Observational | 2014-01-31 | Recruiting | |||
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients[NCT02993302] | Phase 2 | 25 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
| Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism: A Clinical Trial With Historical Control[NCT01039818] | Phase 3 | 30 participants (Actual) | Interventional | 1997-02-28 | Completed | ||
| Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study[NCT00341198] | 700 participants | Observational | 2002-04-02 | Completed | |||
| Comparison of Efficacy and Safety of Intravenous Pulsed Methylprednisolone and Oral Methotrexate Versus Intravenous Pulsed Methylprednisolone and Oral Placebo in the Treatment of Active Moderate and Severe Thyroid Eye Disease - a Prospective, Randomized, [NCT00348413] | 80 participants (Anticipated) | Interventional | 2003-06-30 | Completed | |||
| Implantation of Thyroid Gland After Total Thyroidectomy in Quadriceps Femoris Muscle[NCT04684953] | 40 participants (Anticipated) | Interventional | 2022-01-31 | Not yet recruiting | |||
| Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter[NCT04856488] | Phase 3 | 182 participants (Anticipated) | Interventional | 2021-11-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Dendritic cells maturation levels were measured by the CD206 (NCT02993302)
Timeframe: 1 year
| Intervention | nM (Mean) |
|---|---|
| PTU + Oral 1α-D3 | 54.08 |
| PTU + Placebos | 53.42 |
Dendritic cells maturation levels were measured by the CD80 (cluster of differentiation 80) (NCT02993302)
Timeframe: 1 year
| Intervention | nM (Median) |
|---|---|
| PTU + Oral 1α-D3 | 45.60 |
| PTU + Placebos | 54.51 |
fT4 (free thyroxine) (NCT02993302)
Timeframe: 1 year
| Intervention | ng/dL (Mean) |
|---|---|
| PTU + Oral 1α-D3 | 2.65 |
| PTU + Placebos | 2.09 |
Dendritic cells maturation levels were measured by the IL-12 (interleukin-12)/IL-10 ratio (NCT02993302)
Timeframe: 1 year
| Intervention | ratio (Median) |
|---|---|
| PTU + Oral 1α-D3 | 0.49 |
| PTU + Placebos | 0.21 |
80 reviews available for thyroxine and Basedow Disease
| Article | Year |
|---|---|
Role of Dietary Supplements in Thyroid Diseases.
Topics: Dietary Supplements; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Diseases; Thyr | 2022 |
Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Iodine; Iodine Radioisotopes; Male; Middle Ag | 2022 |
Hyperthyroidism: A Review.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Iodine Radioisot | 2023 |
Best practices in mitigating the risk of biotin interference with laboratory testing.
Topics: Adult; Aged; Aged, 80 and over; Awareness; Biotin; Child; Child, Preschool; Diagnostic Errors; Dieta | 2019 |
Myopathy after rapid correction of hyperthyroidism: A case report and review of literature.
Topics: Adult; Antithyroid Agents; Creatine Kinase; Female; Graves Disease; Humans; Methimazole; Myalgia; Re | 2020 |
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Graves Disease; Humans; Hypothyroidism; Mortality; Progno | 2021 |
Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review.
Topics: Animals; Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Graves Ophthalmopathy; Human | 2020 |
Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Methimazole; Thyroid Hormones; Thyroxine; | 2021 |
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.
Topics: Antithyroid Agents; Child, Preschool; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; | 2021 |
Graves' Disease: Can It Be Cured?
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypot | 2019 |
[Neonatal hyperthyroidism: a case report and literature review].
Topics: Antithyroid Agents; Apnea; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, | 2013 |
Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
Topics: Adult; Antithyroid Agents; Carbimazole; Diplopia; Graves Disease; Graves Ophthalmopathy; Humans; Hyp | 2015 |
Influence of cigarette smoking on thyroid gland--an update.
Topics: Female; Graves Disease; Hashimoto Disease; Humans; Hyperthyroidism; Hypothyroidism; Pregnancy; Pregn | 2014 |
Fetal thyroïdology.
Topics: Adolescent; Adult; Amnion; Antithyroid Agents; Female; Fetal Diseases; Graves Disease; Humans; Hyper | 2014 |
Surgical Intervention for Medically Refractory Hyperthyroidism.
Topics: Adrenergic beta-1 Receptor Antagonists; Antithyroid Agents; Atenolol; Child; Female; Graves Disease; | 2016 |
Endocrinology Update: Thyroid Disorders.
Topics: Antithyroid Agents; Biopsy, Fine-Needle; Family Practice; Graves Disease; Humans; Hyperthyroidism; H | 2016 |
[Autoimmune diseases of the thyroid gland].
Topics: Combined Modality Therapy; Evidence-Based Medicine; Graves Disease; Hormone Replacement Therapy; Hum | 2017 |
Clinical practice. Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Arrhythmias, Cardiac; Female; Graves Disease | 2008 |
Autoimmune thyroid disease in pregnancy: a review.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Pregnanc | 2009 |
Antithyroid drug regimen for treating Graves' hyperthyroidism.
Topics: Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; Humans; Hyperthyroidism; M | 2010 |
Diagnosis and management of thyroid disease in pregnancy.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioiso | 2010 |
Urticaria and thyroid autoimmunity.
Topics: Adolescent; Adult; Autoimmunity; Child; Graves Disease; Hashimoto Disease; Helicobacter Infections; | 2011 |
[Current questions of thyroid diseases in childhood].
Topics: Adolescent; Biopsy, Fine-Needle; Child; Child, Preschool; Congenital Hypothyroidism; Diagnosis, Diff | 2011 |
Thyroid disorders during pregnancy: impact on the fetus.
Topics: Adult; Antithyroid Agents; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hyperthyroidism; | 2011 |
Thyroid disorders.
Topics: Animals; Bile Acids and Salts; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male | 2012 |
Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy.
Topics: Antithyroid Agents; Autoantibodies; Chronic Disease; Graves Disease; Humans; Remission, Spontaneous; | 2002 |
Surgical management in Graves' disease.
Topics: Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Incidence; Iodine Rad | 2002 |
Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
Topics: Antithyroid Agents; Combined Modality Therapy; Graves Disease; Humans; Iodine Radioisotopes; Lithium | 2003 |
[ENDOCRINOLOGY].
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Androgens; Angiotensins; Cartilage; | 1964 |
GRAVES' DISEASE.
Topics: Antithyroid Agents; Blood; Goiter; Graves Disease; Humans; Iodine; Iodine Isotopes; Physiology; Thyr | 1964 |
Antithyroid drug regimen for treating Graves' hyperthyroidism.
Topics: Antithyroid Agents; Graves Disease; Humans; Randomized Controlled Trials as Topic; Thyroxine | 2003 |
Antithyroid drug regimen for treating Graves' hyperthyroidism.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Randomized Controlled Trials as Topic; | 2004 |
[Hypothyroidism--diagnosis].
Topics: Age Factors; Aged; Autoantibodies; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Grave | 2004 |
[Problems and new developments in the management of Graves' disease: medical therapy].
Topics: Clinical Trials as Topic; Goiter; Graves Disease; Humans; Thyroxine | 2004 |
Antithyroid drugs.
Topics: Agranulocytosis; Algorithms; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Me | 2005 |
Antithyroid drug regimen for treating Graves' hyperthyroidism.
Topics: Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; Humans; Hyperthyroidism; M | 2005 |
[Autoimmune thyroid disease].
Topics: Animals; Antithyroid Agents; Apoptosis; Fas Ligand Protein; Graves Disease; Humans; Immunoglobulin G | 2005 |
A systematic review of drug therapy for Graves' hyperthyroidism.
Topics: Antithyroid Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graves Disease; Hum | 2005 |
[Subclinical hypothyroidism].
Topics: Arteriosclerosis; Chronic Disease; Diagnosis, Differential; Female; Graves Disease; Humans; Hypothyr | 2006 |
[Postoperative hypothyroidism].
Topics: Diagnosis, Differential; Graves Disease; Humans; Hypothyroidism; Postoperative Complications; Progno | 2006 |
[Postpartum autoimmune thyroid syndrome].
Topics: Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; Hypothy | 2006 |
[Current thyroid diagnostics and therapy in disorders of fertility and in pregnancy].
Topics: Abortion, Spontaneous; Adult; Antithyroid Agents; Autoantibodies; Diabetes Mellitus, Type 1; Diabete | 2006 |
Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Arteries; Elasticity; Female; Graves Disease; Humans; Hyperthyroidism; Male | 2007 |
Obstetric management of thyroid disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Infant; Pregnancy; Pregnancy | 2007 |
Significance of low thyroid-stimulating hormone in pregnancy.
Topics: Autoantibodies; Child; Diagnosis, Differential; Female; Fetal Diseases; Graves Disease; Humans; Hype | 2007 |
Thyroid nodular disease: an emerging problem.
Topics: Algorithms; Biopsy, Fine-Needle; Comorbidity; Diagnostic Imaging; Disease Management; Goiter, Nodula | 2008 |
Treatment of hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Diet; Female; Goiter, Nodular; Graves Disease; Huma | 1980 |
Thyroid disease in the elderly.
Topics: Age Factors; Aged; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; | 1983 |
Radioimmunoassay of human thyrotropin: analytical and clinical developments.
Topics: Adolescent; Adult; Aged; Aging; Child; Child, Preschool; Circadian Rhythm; Female; Goiter; Graves Di | 1984 |
[Progress in studies on the physiopathology, diagnosis and treatment of Graves-Basedow disease (selected problems)].
Topics: Autoimmune Diseases; Graves Disease; Humans; Thyrotropin; Thyroxine; Triiodothyronine | 1984 |
Childhood thyromegaly: recent developments.
Topics: Adolescent; Child; Graves Disease; Humans; Iodine Radioisotopes; Neoplasms, Radiation-Induced; Propy | 1981 |
The management of thyroid nodules.
Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Female; Graves Disease; Humans; Italy; | 1995 |
Detection and treatment of hypothyroidism and Graves' disease.
Topics: Aged; Aged, 80 and over; Female; Graves Disease; Humans; Hypothyroidism; Male; Thyrotropin; Thyroxin | 1995 |
[T4 autoantibody].
Topics: Autoantibodies; Female; Graves Disease; Humans; Male; Thyroiditis, Autoimmune; Thyroxine | 1993 |
Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
Topics: Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; Hypothyroidism; Immunoglobu | 1993 |
Thyroxine suppression therapy in Graves' disease.
Topics: Antithyroid Agents; Asian People; Graves Disease; Humans; Thyroxine; White People | 1997 |
[Administration of levothyroxine in the treatment of Basedow disease].
Topics: Animals; Clinical Trials as Topic; Graves Disease; Humans; Multicenter Studies as Topic; Prospective | 1999 |
Practice guidelines for the detection and management of thyroid dysfunction. A comparative review of the recommendations.
Topics: Adult; Aged; Antithyroid Agents; Contraindications; Female; Graves Disease; Humans; Hyperthyroidism; | 1999 |
Controversial aspects of thyroid disease.
Topics: Cardiovascular Diseases; Graves Disease; Humans; Iodine Radioisotopes; Patient Compliance; Smoking; | 1999 |
[Neonatal hypothyroidism].
Topics: Antithyroid Agents; Autoantibodies; Carrier Proteins; Diagnosis, Differential; Female; Graves Diseas | 2000 |
[Hyperthyreosis in Basedow's disease].
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; T | 1998 |
The assessment of thyroid function and structure.
Topics: Biopsy, Needle; Carrier Proteins; Goiter; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; P | 1978 |
[Current diagnosis and differential diagnosis of thyroid diseases].
Topics: Adenoma; Diagnosis, Differential; Edema; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotope | 1979 |
[Thyrotropic hormone and the thyroid gland (present status)].
Topics: Blood Proteins; Circadian Rhythm; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; P | 1977 |
[Interpretation of TRH test].
Topics: Acromegaly; Adult; Brain Neoplasms; Drug Interactions; Estradiol Congeners; Female; Graves Disease; | 1976 |
[Progress in endocrinological therapy of basedow's and Hashimoto's diseases].
Topics: Antithyroid Agents; Graves Disease; Humans; Thyroiditis, Autoimmune; Thyroxine | 1991 |
Endocrinology.
Topics: Adult; Diphosphonates; Endocrine System Diseases; Graves Disease; Growth Hormone; Humans; Hypercalce | 1991 |
Thyroid disease in pregnancy and the postpartum period.
Topics: Antithyroid Agents; Breast Feeding; Female; Fertility; Fetus; Graves Disease; Humans; Hyperthyroidis | 1985 |
[Bronchial asthma and hyperthyroidism. Considerations apropos of 2 cases].
Topics: Aged; Asthma; Female; Graves Disease; Humans; Hypothyroidism; Middle Aged; Thyrotoxicosis; Thyroxine | 1988 |
[Postoperative hypothyroidism].
Topics: Adult; Antigens; Autoantibodies; Autoimmune Diseases; Graves Disease; Hormones; Humans; Hypothyroidi | 1986 |
[Factors interfering with and influencing the measurement of direct and indirect parameters of free thyroxine].
Topics: Autoantibodies; Blood Protein Disorders; Contraceptives, Oral; Female; Furosemide; Graves Disease; H | 1986 |
Hyperthyroidism.
Topics: Adenoma; Carbimazole; Child; Eye Manifestations; Female; gamma-Globulins; Graves Disease; Hot Temper | 1972 |
The pharmacology of substances affecting the thyroid gland.
Topics: Acetylcholine; Antithyroid Agents; Bacterial Proteins; Cyclic AMP; Epinephrine; Graves Disease; Huma | 1971 |
Thyroid diseases.
Topics: Adrenergic beta-Antagonists; Carbimazole; Drug Therapy, Combination; Female; Goiter; Graves Disease; | 1974 |
[Toxic adenoma of the thyroid gland].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Ra | 1966 |
Current concepts in management of thyroid disease.
Topics: Eye Diseases; Graves Disease; Humans; Iodine Isotopes; Long-Acting Thyroid Stimulator; Methimazole; | 1970 |
Interaction of drugs with thyroid hormone binding sites.
Topics: Binding Sites; Blood Proteins; Cell Nucleus; Drug Interactions; Endoplasmic Reticulum; Graves Diseas | 1973 |
Thyroid physiology in health and disease.
Topics: Adult; Animals; Cattle; Chemical Phenomena; Chemistry; Chorionic Gonadotropin; Female; Graves Diseas | 1974 |
Mechanisms of Graves' disease and endocrine exophthalmos.
Topics: Animals; Binding Sites; Biological Assay; Exophthalmos; Fishes; Graves Disease; Humans; Hyperthyroid | 1969 |
Symposium on hyperthyroidism.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxine; Triiodothyronine | 1970 |
108 trials available for thyroxine and Basedow Disease
| Article | Year |
|---|---|
A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Topics: Adult; Autoimmunity; Cholecalciferol; Dietary Supplements; Female; Graves Disease; Hashimoto Disease | 2023 |
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Potas | 2020 |
Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
Topics: Administration, Intravenous; Adult; Antithyroid Agents; Diplopia; Exophthalmos; Eye Pain; Female; Gl | 2021 |
Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.
Topics: Adult; Antithyroid Agents; Carnitine; Combined Modality Therapy; Fatty Acids; Fatty Acids, Volatile; | 2017 |
Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial.
Topics: Adolescent; Antithyroid Agents; Child; Drug Therapy, Combination; Graves Disease; Humans; Immunoglob | 2019 |
Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women.
Topics: Adiponectin; Female; Graves Disease; Humans; Insulin Resistance; Middle Aged; Sex Hormone-Binding Gl | 2013 |
A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Child; China; Drug Administration Schedule; Drug Therapy, Com | 2014 |
Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Drug Administration Schedule; Drug Therapy, Comb | 2015 |
Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study.
Topics: Adult; Chemoprevention; Drug Administration Schedule; Early Medical Intervention; Female; Follow-Up | 2016 |
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Topics: Adult; Antioxidants; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Meth | 2017 |
Rituximab in relapsing Graves' disease, a phase II study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Autoant | 2008 |
[Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
Topics: Antibodies; Combined Modality Therapy; Disease Progression; Graves Disease; Humans; Iodine Radioisot | 2009 |
A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
Topics: Adult; Aged; Antithyroid Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Go | 2011 |
Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study.
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypot | 2011 |
Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
Topics: Adolescent; Antithyroid Agents; Child; Drug Eruptions; Female; Graves Disease; Humans; Liver; Male; | 2011 |
Short-term effect of radioactive iodine therapy on CXCL-10 production in Graves' disease.
Topics: Adult; Chemokine CXCL10; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Th | 2011 |
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Topics: Antithyroid Agents; Graves Disease; Humans; Iodine Radioisotopes; Lithium; Methimazole; Prospective | 2002 |
Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Hormone Replacement Therapy; Humans; Hypot | 2002 |
Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease.
Topics: Antibodies; Antithyroid Agents; Drug Combinations; Graves Disease; Humans; Prognosis; Prospective St | 2002 |
Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid- | 2002 |
Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Th | 2003 |
[Clinical observation on xiehuo yangyin powder in treating 30 initial stage of toxic and diffuse goiter patients].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Femal | 2003 |
T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantigens; Carbimazole; Female; Graves Disease; Horm | 2003 |
Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium.
Topics: Adult; Antioxidants; Antithyroid Agents; Drug Therapy, Combination; Female; Glutathione Peroxidase; | 2004 |
Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Catalase; Ceruloplasmin; Female; Glutathione Peroxid | 2004 |
Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
Topics: Adolescent; Adult; Analysis of Variance; Antibodies, Monoclonal; Antithyroid Agents; Drug Administra | 2004 |
Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Female; Graves Disease; Humans; Iodi | 2004 |
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Cholestyramine R | 2005 |
A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Female; Graves Disease; Hormone Replacement Therapy; Humans; Hyperth | 2005 |
Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; | 2005 |
Thyroid hormone increases mannan-binding lectin levels.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Ma | 2005 |
Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake.
Topics: Adult; Antithyroid Agents; Diet; Female; Graves Disease; Humans; Iodine; Male; Methimazole; Middle A | 2006 |
Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease.
Topics: Aged; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Health Status; Humans; Iodide Perox | 2007 |
Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
Topics: Adolescent; Adult; Antithyroid Agents; Child; Drug Therapy, Combination; Female; Goiter, Nodular; Gr | 2007 |
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Methimazole; Propy | 2007 |
Clinical and endocrine features and long-term outcome of Graves' disease in early childhood.
Topics: Age of Onset; Antithyroid Agents; Attention Deficit Disorder with Hyperactivity; Carbimazole; Child; | 2007 |
Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy.
Topics: Adult; Aged; Antimutagenic Agents; Chromosome Breakage; Dietary Supplements; Dose-Response Relations | 2007 |
TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Topics: Adult; Antithyroid Agents; Autoantibodies; Autoimmunity; Graves Disease; Humans; Immunoglobulins, Th | 2008 |
The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Hyperthyroidis | 2007 |
Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Autoantibodies; Dose-Response Relationship, | 1983 |
Carbimazole and the autoimmune response in Graves' disease.
Topics: Antibody Formation; Autoantibodies; Carbimazole; Cells, Cultured; Graves Disease; Humans; Lymphocyte | 1980 |
Immune recognition of hormonogenic sites of human thyroglobulin: studies of Graves' sera and a murine monoclonal antibody with thyroid hormone antibody activity.
Topics: Animals; Antibodies, Monoclonal; Autoantibodies; Binding, Competitive; Epitopes; Graves Disease; Hum | 1993 |
Response to methimazole in Graves' disease. The European Multicenter Study Group.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Iodides; Male; | 1995 |
Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Topics: Adolescent; Adult; Antibodies; Child; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1995 |
Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study.
Topics: Adult; Age Factors; Autoantibodies; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Midd | 1995 |
The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism.
Topics: Adult; Dose-Response Relationship, Radiation; Drug Therapy, Combination; Female; Graves Disease; Hum | 1995 |
Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
Topics: Adult; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Interleukin-6; Male; Middle | 1995 |
[Recurrence of Graves-Basedow disease: the influence of treatment schedule].
Topics: Adult; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Prognosis; Recu | 1995 |
Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
Topics: Adult; Carbimazole; Female; Graves Disease; HLA-DQ Antigens; HLA-DR Antigens; Humans; Male; Middle A | 1994 |
The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole.
Topics: Adult; Aged; Autoantibodies; Eye Diseases; Female; Graves Disease; Humans; Hypothyroidism; Immunoglo | 1994 |
Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.
Topics: Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Graves Disease; Hum | 1994 |
Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose.
Topics: Adult; Antibodies; Carbimazole; Dose-Response Relationship, Drug; Eye Diseases; Female; Graves Disea | 1994 |
A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Male; Methimazole; Middle A | 1993 |
Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
Topics: Adult; Antibodies; Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Female; Graves Diseas | 1996 |
Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Administration Schedule; Drug Therapy, Combination | 1996 |
Remission with carbimazole therapy & assessment of T4 suppression test as an index of relapse in patients with Graves' disease in India.
Topics: Adult; Carbimazole; Female; Graves Disease; Humans; Male; Recurrence; Remission Induction; Thyroid F | 1996 |
Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Child; Female; Graves Disease; Humans; | 1996 |
Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hormones; Humans; Injections, Subcutaneous; Intercell | 1996 |
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Carbimazole; Female; Graves Disease; Humans; Hypert | 1997 |
Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?
Topics: Adolescent; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Child; Female; Graves Disease; H | 1997 |
Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Antithyroid Agents; Autoantibodies; Female; Graves Di | 1997 |
Soluble intercellular adhesion molecule-1 and Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Graves | 1997 |
Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Topics: Adolescent; Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobuli | 1997 |
Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Topics: Adult; Aged; Antibodies; Antithyroid Agents; Arteries; Female; Graves Disease; Hormones; Humans; Iod | 1997 |
Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease.
Topics: Adult; Antibodies; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Ma | 1998 |
Induction of oral tolerance in human autoimmune thyroid disease.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Autoantibodies; Autoantigens; Autoimmune Disease | 1998 |
A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
Topics: Adult; Antithyroid Agents; Carbimazole; Drug Administration Schedule; Drug Therapy, Combination; Fem | 1998 |
[Therapeutic effect and its mechanism exploration on mainly using traditional Chinese medicine of replenishing qi and nourishing yin in treating Graves disease].
Topics: Adolescent; Adult; Antithyroid Agents; Biological Transport, Active; Child; Drug Therapy, Combinatio | 1997 |
Role of colestipol in the treatment of hyperthyroidism.
Topics: Adult; Antithyroid Agents; Colestipol; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroid | 1998 |
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatment.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Carbimazole; Drug Administration Schedule; | 1999 |
Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunochemistry; Immunoglobulins, Thyroid-S | 1999 |
Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Topics: Adult; Antibodies, Blocking; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulins, Th | 1999 |
Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 1999 |
Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Drug Combinations; Female; Goiter; Graves D | 2000 |
Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Evaluation Studies as Topic; Female; Graves Disease; Hu | 1996 |
[Clinical epidemiology of Basedow's disease in Belgium].
Topics: Adult; Antibodies; Antithyroid Agents; Belgium; Double-Blind Method; Drug Therapy, Combination; Grav | 2000 |
Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Topics: Adult; Antithyroid Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Graves Dis | 2001 |
Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Topics: Adult; Antithyroid Agents; Double-Blind Method; Female; Graves Disease; Humans; Middle Aged; Propylt | 2001 |
The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 2001 |
The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Topics: Adult; Antithyroid Agents; Combined Modality Therapy; Female; Follow-Up Studies; Graves Disease; Hum | 2001 |
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Topics: Administration, Oral; Bone Density; Combined Modality Therapy; Diplopia; Exophthalmos; Eyelids; Fema | 2001 |
[Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Huma | 2001 |
The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
Topics: Adult; Animals; Antithyroid Agents; CHO Cells; Combined Modality Therapy; Cricetinae; Female; Graves | 2002 |
Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue.
Topics: Adipose Tissue; Adult; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; Fibroma; Graves | 2002 |
The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidi | 1975 |
Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
Topics: Adult; Drug Evaluation; Female; Follow-Up Studies; Graves Disease; Hormones; Humans; Hypothyroidism; | 1979 |
[Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
Topics: Age Factors; Clinical Trials as Topic; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroi | 1976 |
Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Topics: Adult; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male | 1992 |
Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Autoantibodies; Female; Graves Disease; Humans; Immun | 1991 |
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Topics: Adult; Combined Modality Therapy; Eye; Eye Diseases; Female; Glucocorticoids; Graves Disease; Humans | 1991 |
Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Hyperthyroidism; Ipodate; M | 1991 |
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Topics: Adolescent; Adult; Autoantibodies; Drug Therapy, Combination; Female; Graves Disease; Humans; Hypert | 1991 |
Antithyroid drug treatment of von Basedow's disease: results from a multicenter study.
Topics: Adult; Aged; Graves Disease; Humans; Methimazole; Middle Aged; Thyroxine; Triiodothyronine | 1991 |
Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.
Topics: Aged; Aged, 80 and over; Autoantibodies; Betamethasone; Female; Graves Disease; Humans; Iodine Radio | 1991 |
Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study.
Topics: Bone Density; Bone Diseases, Metabolic; Bone Resorption; Clinical Trials as Topic; Follow-Up Studies | 1990 |
The effect of amiodarone on the control of hyperthyroidism by propylthiouracil.
Topics: Adult; Amiodarone; Drug Therapy, Combination; Female; Graves Disease; Hemodynamics; Humans; Middle A | 1990 |
Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine.
Topics: Adult; Antithyroid Agents; Child; Clinical Trials as Topic; Graves Disease; Humans; Iodine; Postoper | 1988 |
Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease.
Topics: Follow-Up Studies; Graves Disease; HLA-DR Antigens; HLA-DR3 Antigen; Humans; Immunoglobulin G; Immun | 1989 |
Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease.
Topics: Adult; Aged; Autoantibodies; Betamethasone; Female; Graves Disease; Humans; Immunoglobulin G; Immuno | 1986 |
Treatment of hyperthyroidism with a small single daily dose of methimazole.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobu | 1988 |
Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
Topics: Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Graves Disease; Heart Rat | 1988 |
Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosis.
Topics: Adult; Aged; Clinical Trials as Topic; Follow-Up Studies; Graves Disease; Humans; Methimazole; Middl | 1987 |
Serum free thyroid hormones are decreased by betamethasone treatment in Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Female; Graves Disease; Humans; Male; Middle Aged; Ra | 1988 |
Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
Topics: Adult; Clinical Trials as Topic; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Potassi | 1986 |
Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid and hyperthyroid man.
Topics: Antithyroid Agents; Clinical Trials as Topic; Graves Disease; Humans; Hyperthyroidism; Hypothyroidis | 1966 |
Effects of beta blockade on the peripheral manifestations of thyrotoxicosis.
Topics: Achilles Tendon; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anxiety; Female; Graves Disea | 1971 |
Effects of oestrogens on thyroxine turnover in hyperthyroidism.
Topics: Adult; Estrogens; Female; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenous; Iodine I | 1972 |
Optic neuropathy of graves's disease. Treatment by transantral or transfrontal orbital decompression.
Topics: Craniotomy; Diplopia; Frontal Bone; Graves Disease; Humans; Iodine Radioisotopes; Length of Stay; Ma | 1974 |
1174 other studies available for thyroxine and Basedow Disease
| Article | Year |
|---|---|
Myopathy Associated with Treatment of Graves' Disease.
Topics: Antithyroid Agents; Child; Female; Graves Disease; Humans; Methimazole; Myalgia; Thyroxine; Triiodot | 2021 |
The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.
Topics: Adult; Animals; Autoantibodies; China; CHO Cells; Cricetulus; Female; Graves Disease; Humans; Immuno | 2021 |
Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease.
Topics: Adult; Aged; Biomarkers; Cross-Sectional Studies; Diagnosis, Differential; Diiodotyrosine; Female; G | 2022 |
Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
Topics: Autoantibodies; Bacterial Translocation; Biomarkers; China; Dysbiosis; Fatty Acid-Binding Proteins; | 2021 |
Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Echocardiography; Female; Forced Expiratory | 2021 |
Autoimmune Thyroid Disorders in Autoimmune Addison Disease.
Topics: Addison Disease; Graves Disease; Hashimoto Disease; Humans; Hypothyroidism; Thyroid Hormones; Thyroi | 2022 |
Postradioiodine Graves' management: The PRAGMA study.
Topics: Adult; Antithyroid Agents; Graves Disease; Graves Ophthalmopathy; Humans; Hyperthyroidism; Hypothyro | 2022 |
A hypothyroid mother after subtotal thyroidectomy delivered a newborn with hyperthyroidism from fetal stage: a case report.
Topics: Antithyroid Agents; Female; Fetal Diseases; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; | 2022 |
The Study of Biological Activity of a New Thieno[2,3-D]-Pyrimidine-Based Neutral Antagonist of Thyrotropin Receptor.
Topics: Animals; Graves Disease; Pyrimidines; Rats; Receptors, G-Protein-Coupled; Receptors, Thyrotropin; Th | 2022 |
Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
Topics: Female; Fetal Diseases; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; | 2022 |
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Topics: Antithyroid Agents; Graves Disease; Humans; Iodine Radioisotopes; Thyroid Neoplasms; Thyroxine | 2022 |
A Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination.
Topics: Adult; COVID-19; COVID-19 Vaccines; Diabetes Mellitus, Type 1; Female; Graves Disease; Hashimoto Dis | 2023 |
Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves' Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method.
Topics: Antithyroid Agents; Computers; Graves Disease; Humans; Methimazole; Models, Theoretical; Thyroid Hor | 2022 |
A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Methimazole; Pregn | 2022 |
["Block and replace" of sodium levothyroxine therapy].
Topics: Aged; Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Methimazole; Sodium; Thyroxine | 2022 |
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
Topics: Autoantibodies; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; | 2022 |
Murine Thyroid IL-4 Expression Worsens Hypothyroidism on Iodine Restriction and Mitigates Graves Disease Development.
Topics: Animals; Graves Disease; Hyperthyroidism; Hypothyroidism; Interleukin-4; Iodides; Iodine; Mice; Sulf | 2022 |
Time to Normalization and Sustainable Normal Serum Thyrotropin Concentrations in Patients with Hyperthyroidism: Comparison of Methimazole and Radioactive Iodine Treatments.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Methimazole; Thyr | 2022 |
Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease.
Topics: Autoantibodies; C-Reactive Protein; Cytokines; Graves Disease; Humans; Interleukins; Iodide Peroxida | 2022 |
Clinical significance of hepatic function in Graves disease with type 2 diabetic mellitus: A single-center retrospective cross-sectional study in Taiwan.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Cross-Sectional Studies; Diabetes Mel | 2022 |
High levels of thyroid hormones promote recurrence of Graves' disease via overexpression of B-cell-activating factor.
Topics: Graves Disease; Humans; Hyperthyroidism; Immunoglobulin G; Interleukin-4; Thyroxine; Triiodothyronin | 2022 |
Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia.
Topics: Adult; C-Reactive Protein; Glycosaminoglycans; Graves Disease; Humans; Hypothyroidism; Male; Pericar | 2022 |
Thyroid function in infants born to women with hypothyroidism: An observational study at an Australian tertiary perinatal centre.
Topics: Australia; Congenital Hypothyroidism; Female; Graves Disease; Humans; Infant; Infant, Newborn; Infan | 2023 |
Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
Topics: Autoantibodies; Clinical Relevance; Cross-Sectional Studies; Graves Disease; Graves Ophthalmopathy; | 2023 |
Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
Topics: Biotin; Graves Disease; Humans; Male; Middle Aged; Streptavidin; Thyroid Hormones; Thyroxine; Triiod | 2023 |
Thyroid function test variability and cardiovascular morbidity in hyperthyroidism.
Topics: Antithyroid Agents; Cardiovascular Diseases; Graves Disease; Humans; Hyperthyroidism; Male; Retrospe | 2023 |
Familial dysalbuminemic hyperthyroxinemia combined with Graves' disease: a rare case report.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroxinemia, Familial Dysalbuminemic; Iodine Radioisoto | 2023 |
Different doses of methimazole treatment of children and adolescents with graves' disease: a clinical study based on 161 cases of outpatients.
Topics: Adolescent; Antithyroid Agents; Child; Graves Disease; Humans; Methimazole; Outpatients; Thyroxine | 2023 |
Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Topics: Adult; Aged; Atrophy; Case-Control Studies; Female; Graves Disease; Humans; Hypothyroidism; Iodine R | 2019 |
Graves' disease complicated by fetal goitrous hypothyroidism treated with intra-amniotic administration of levothyroxine.
Topics: Drug Administration Routes; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hypothyroidism; | 2019 |
Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisot | 2020 |
Follow-up of infants born to mothers with autoinmune thyroid disease. What should not be screened?
Topics: Adult; Autoimmune Diseases; Female; Follow-Up Studies; Graves Disease; Humans; Infant, Newborn; Male | 2020 |
"Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Co | 2020 |
Case 4: Chronic and Progressive Muscle Weakness in a 9-year-old Girl.
Topics: Child; Creatine Kinase; Diagnosis, Differential; Female; Graves Disease; Humans; Muscle Weakness; Ph | 2019 |
The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study.
Topics: Adult; Diet; Female; Follow-Up Studies; Goiter; Graves Disease; Humans; Iodine; Iodine Radioisotopes | 2020 |
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
An unusual skin rash in a person with type 1 diabetes.
Topics: Aged; Diabetes Mellitus, Type 1; Graves Disease; Hormone Replacement Therapy; Humans; Iodine Radiois | 2020 |
Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
Topics: Adult; B-Cell Activating Factor; Cytokines; Female; Graves Disease; Hashimoto Disease; Humans; Inter | 2020 |
Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study.
Topics: Adult; Atrial Fibrillation; Body Mass Index; Coronary Artery Disease; Datasets as Topic; Female; Gra | 2020 |
Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; | 2020 |
New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone.
Topics: Animals; Cell Membrane; Chorionic Gonadotropin; Drug Design; Graves Disease; Humans; Iodide Peroxida | 2020 |
Predictors of euthyreosis in hyperthyroid patients treated with radioiodine
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Goiter, Nodular; Graves Disease; Humans; Hypert | 2020 |
Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Pregnancy; | 2020 |
TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunoglobulins, Thyroid-Sti | 2020 |
Hemodynamic changes in neonates born to mothers with Graves' disease.
Topics: Female; Graves Disease; Hemodynamics; Humans; Infant, Newborn; Mothers; Thyroxine; Triiodothyronine | 2021 |
A recurrent mass on the big toe.
Topics: Combined Modality Therapy; Foot Diseases; Graves Disease; Humans; Male; Middle Aged; Myxedema; Progn | 2020 |
Hyperthyroidism and vascular cell adhesion molecule-1 are associated with a low ankle-brachial index.
Topics: Adult; Ankle Brachial Index; Antithyroid Agents; Case-Control Studies; Cross-Sectional Studies; Fema | 2020 |
Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antithyroid Agents; Case-Control Studies; Child; Chin | 2020 |
Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism
Topics: Adolescent; Age Distribution; Antithyroid Agents; Autoantibodies; Biomarkers; Child; Female; Graves | 2021 |
Serum thyroglobulin is associated with orbitopathy in Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Female; Graves Disease; Graves Ophthalmopathy; Humans; | 2021 |
Graves' disease in a five-month-old boy with an unusual treatment course.
Topics: ATPases Associated with Diverse Cellular Activities; Graves Disease; Humans; Infant; Male; Membrane | 2021 |
Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Maternal-F | 2021 |
Calm Before the Storm: Marine-Lenhart Syndrome After Hashimoto Thyroiditis.
Topics: Adenoma; Adrenergic beta-Antagonists; Aged; Antithyroid Agents; Carbimazole; Female; Goiter, Nodular | 2021 |
Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
Topics: Aged; Biomarkers, Tumor; Goiter, Nodular; Graves Disease; Humans; Iodide Peroxidase; Iodothyronine D | 2021 |
Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
Topics: 3T3 Cells; Animals; Autoantibodies; Disease Models, Animal; Electroporation; Enzyme-Linked Immunosor | 2017 |
Neonatal Graves' Eye Disease.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Infant; Methimazole; Thyrotropin; Thyroxine; Tri | 2017 |
Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Circulating MicroRNA; Female; Graves Disease; Humans; | 2017 |
An Unusual Manifestation of Celiac Disease in an Adolescent With Down Syndrome and Graves Disease.
Topics: Adolescent; Celiac Disease; Child; Contraceptives, Oral, Hormonal; Diet, Gluten-Free; Down Syndrome; | 2017 |
[Once weekly L-thyroxine treatment in non-compliance: A case report].
Topics: Administration, Oral; Adult; Drug Administration Schedule; Graves Disease; Humans; Hypothyroidism; M | 2017 |
Fetal goitrous hypothyroidism treated by intra-amniotic levothyroxine administration: case report and review of the literature.
Topics: Adult; Antithyroid Agents; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hypothyroidism; P | 2017 |
Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease: A Multicenter Study.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Graves Disease; Humans; Male; Middle Aged; Progn | 2018 |
Unnoticed maternal Graves' disease revealed by the baby's low free thyroxine in newborn screening: an underestimated condition supporting thyroid disease screening among pregnant women.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Male; Maternal-Fetal Exchang | 2018 |
[Hyperthyroidism in children at the University Hospital in Dakar (Senegal)].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Exophthalmos; Female; Goiter; Graves Disease; Hosp | 2017 |
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged | 2017 |
Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
Topics: Adolescent; Antithyroid Agents; Carbimazole; Child; Child, Preschool; Counseling; Drug Administratio | 2018 |
A patient-specific treatment model for Graves' hyperthyroidism.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Methimazole; Models, Biological; Thyroi | 2018 |
Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
Topics: Adult; B-Lymphocytes; Cross-Sectional Studies; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylatio | 2018 |
Pancytopenia: a rare complication of Graves' disease.
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Methi | 2018 |
A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Retr | 2018 |
Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases.
Topics: Adult; Aged; Antibodies, Antinuclear; Antithyroid Agents; Autoantibodies; Enzyme-Linked Immunosorben | 2018 |
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Models, Theoretical; R | 2018 |
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
Topics: Adrenal Cortex Hormones; Autoantibodies; Autoantigens; Female; Graves Disease; Graves Ophthalmopathy | 2018 |
MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Postpartum Period; Pregnancy; Pregnancy Complica | 2019 |
Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy".
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Thyroxine | 2019 |
Response to Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy".
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Thyroxine | 2019 |
Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hashimoto Disease; Humans; Hypothyroidism; Immunoglob | 2018 |
[Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].
Topics: Antithyroid Agents; Biotin; Diagnostic Errors; Female; Graves Disease; Humans; Hyperthyroidism; Hypo | 2018 |
A case report of 131I therapy for Graves' disease patient with hemiagenesis.
Topics: Adult; China; Female; Graves Disease; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Radi | 2019 |
Serum autotaxin levels are associated with Graves' disease.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Antithyroid Agents; Graves Disease; Humans; Mice; Phosphoric Dies | 2019 |
Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study.
Topics: Adult; Body Mass Index; Female; Graves Disease; Humans; Hyperthyroidism; Insulin-Like Growth Factor | 2019 |
Factitious thyrotoxicosis: how to find it.
Topics: Female; Graves Disease; Humans; Iodine Radioisotopes; Thyroid Neoplasms; Thyrotoxicosis; Thyroxine | 2020 |
Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles - a case series.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Female; Graves Disease; Hashimoto Disease; Humans; | 2019 |
Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease.
Topics: Adult; Autoantibodies; B-Cell Activating Factor; Case-Control Studies; Female; Graves Disease; Hashi | 2019 |
Possible participation of colloid antigen 2 and abhormone (IgG with hormone activity) for the etiology of Graves' disease.
Topics: Acetylcholine; Animals; Antibodies; Antigens; Autoantibodies; Carcinoembryonic Antigen; Graves Disea | 2019 |
[Hyperthyroidism and hypopituitarism: two incompatible diagnoses?]
Topics: Aged; Cortisone; Graves Disease; Humans; Hyperthyroidism; Hypopituitarism; Immunoglobulins, Thyroid- | 2019 |
Evaluation of neutrophil-to-lymphocyte ratio and hematologic parameters in patients with Graves' disease.
Topics: Case-Control Studies; Graves Disease; Humans; Inflammation; Lymphocyte Count; Lymphocytes; Neutrophi | 2019 |
Higher dose of methimazole causes frequent adverse effects in the management of Graves' disease in children and adolescents.
Topics: Adolescent; Antithyroid Agents; Child; Female; Graves Disease; Humans; Male; Methimazole; Retrospect | 2012 |
Expression of osteopontin in patients with thyroid dysfunction.
Topics: Adolescent; Adult; Biomarkers; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male | 2013 |
Remission of autoimmune hyperthyroidism after chemotherapy for cancer.
Topics: Adult; Antithyroid Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Comorbidity; Female; Graves | 2014 |
Lymphocyte-platelet crosstalk in Graves' disease.
Topics: Adolescent; Adult; Blood Platelets; Female; Goiter, Nodular; Graves Disease; Humans; Lymphocyte Acti | 2014 |
Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Retrospective Studies; Thyroto | 2013 |
Increased serum interleukin-33 levels in patients with Graves' disease.
Topics: Adult; Aged; Autoimmunity; Biomarkers; Female; Graves Disease; Hashimoto Disease; Humans; Interferon | 2013 |
[Graves' dermopathy on the big toe].
Topics: Adult; Biopsy; Carbimazole; Decompression, Surgical; Fibroblasts; Foot Dermatoses; Glycosaminoglycan | 2013 |
Pregnancy outcomes in women with severe hypothyroidism.
Topics: Abortion, Spontaneous; Adult; Female; Graves Disease; Hashimoto Disease; Hormone Replacement Therapy | 2013 |
[Plasmapheresis before thyroidectomy in a patient with thyrotoxicosis and hepatotoxicity by propylthiouracil: case report].
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Liver; Male; Plasmapheresis; Preoperative Care; P | 2013 |
A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Interferon-gamma; Int | 2013 |
Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aging; Autoantibodies; Female; Goiter, Nodular; Graves Dise | 2013 |
Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy.
Topics: Ablation Techniques; Adult; Antithyroid Agents; Combined Modality Therapy; Dietary Supplements; Fema | 2013 |
Hyperthyroid monkeys: a nonhuman primate model of experimental Graves' disease.
Topics: Animals; Antigens; Autoantibodies; Biomarkers; Disease Models, Animal; Female; Gene Transfer Techniq | 2013 |
Thyroid "vise" in an infant with neonatal Graves' disease.
Topics: Female; Graves Disease; Humans; Infant; Pregnancy; Pregnancy Complications; Thyroid Gland; Thyroxine | 2013 |
Elevated serum immunoglobulin G4 levels in patients with Graves' disease and their clinical implications.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immun | 2014 |
Unexpected conversion from hypothyroidism to an euthyroid state due to Graves' disease in a patient with an ectopic thyroid.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hypothyroidism; Thyroid Dysgenesis; Thyro | 2014 |
Interleukin-21 is associated with disease activity in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Female; Graves Disease; Humans; Immunoglobulins, Thyr | 2014 |
Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Kaplan-Meier Estimate; Male; Midd | 2014 |
Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Topics: Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Postpartum Period; Receptors, Thy | 2014 |
Follow-up of newborns of mothers with Graves' disease.
Topics: Adult; Birth Weight; Female; Follow-Up Studies; Graves Disease; Humans; Infant, Newborn; Male; Mothe | 2014 |
Images in clinical medicine. Neonatal thyrotoxicosis.
Topics: Adult; Apgar Score; Eyelids; Female; Fetal Growth Retardation; Graves Disease; Heart Rate, Fetal; Hu | 2014 |
Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient.
Topics: Adult; Diagnosis, Differential; Graves Disease; Hispanic or Latino; Humans; Hypokalemia; Hypokalemic | 2014 |
Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Topics: Abortion, Spontaneous; Adult; Antithyroid Agents; Congenital Hypothyroidism; Female; Fetal Growth Re | 2014 |
Abrupt onset of muscle dysfunction after treatment for Grave's disease: a case report.
Topics: Diagnosis, Differential; Edema; Electromyography; Emergencies; Female; Graves Disease; Hormone Repla | 2014 |
Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; H | 2015 |
[Relationship between depression and thyroid hormone levels in patients with Graves disease].
Topics: Depression; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Radiopharmaceuticals; Risk | 2014 |
Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging | 2014 |
[Autoimmune thyroiditis in childhood].
Topics: Child; Cross-Sectional Studies; Female; Graves Disease; Hashimoto Disease; Humans; Male; Methimazole | 2014 |
Graves' disease and coeliac disease: screening and treatment dilemmas.
Topics: Adult; Celiac Disease; Diet, Gluten-Free; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyr | 2014 |
Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Male; Middle Aged; Receptors, Thyrotropin; Th | 2015 |
Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Topics: Adult; Aged; Antithyroid Agents; Chemical and Drug Induced Liver Injury; China; Female; Graves Disea | 2015 |
A case of fetal hyperthyroidism treated with maternal administration of methimazole.
Topics: Antithyroid Agents; Cordocentesis; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hyperthyr | 2014 |
[Levothyroxine malabsortion].
Topics: Administration, Oral; Dose-Response Relationship, Drug; Female; Gastritis, Atrophic; Graves Disease; | 2015 |
Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.
Topics: Adenoviridae; Animals; Autoantibodies; Cardiomegaly; Disease Models, Animal; Female; Graves Disease; | 2015 |
A 2013 European survey of clinical practice patterns in the management of Graves' disease.
Topics: Antithyroid Agents; Autoantibodies; Europe; Female; Graves Disease; Humans; Methimazole; North Ameri | 2016 |
Foetal thyroid dysfunction: treat the mother first!
Topics: Autoantibodies; Congenital Hypothyroidism; Female; Fetal Diseases; Graves Disease; Humans; Pregnancy | 2015 |
Immunologic and hormonal effects of prophylthiouracil treatment using maintenance dose in Graves' disease patients.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Interleukin-4; Male; Propylthiouracil; Th | 2014 |
Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
Topics: Adolescent; Age Factors; Antithyroid Agents; Child; Child, Preschool; Female; Follow-Up Studies; Gra | 2015 |
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Topics: Algorithms; Chorionic Gonadotropin; Diagnosis, Differential; Female; Graves Disease; Hashimoto Disea | 2015 |
Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Topics: Adult; Autoantibodies; Case-Control Studies; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lym | 2015 |
Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
Topics: Adult; Agouti-Related Protein; Appetite; Basal Metabolism; Calcium-Binding Proteins; Case-Control St | 2015 |
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.
Topics: Adenoma; Adult; Age Factors; Aged; Atrial Fibrillation; Chi-Square Distribution; Female; France; Goi | 2016 |
Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation.
Topics: Autoantibodies; Chimera; Graves Disease; Humans; Receptors, Thyrotropin; Sensitivity and Specificity | 2015 |
Decreased serum level of IL-7 in patients with active Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Enzyme-Linked Immunosorbent Assay; Femal | 2015 |
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Topics: Abnormalities, Drug-Induced; Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; H | 2015 |
INTERACTIVE MEDICAL CASE. A Man with Bizarre Behavior.
Topics: Diagnosis, Differential; Graves Disease; Humans; Hypocalcemia; Hypoparathyroidism; Male; Postoperati | 2015 |
Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Graves Ophthalmopathy; Hormone Replacement Therap | 2015 |
Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2015 |
β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Antigens; Atrial Fibrillation; Autoantibodies; Coronar | 2016 |
[T3-predominant Graves' disease in paediatric patients].
Topics: Child; Graves Disease; Humans; Thyroxine | 2016 |
[Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study].
Topics: Actins; Animals; Capsules; Disease Models, Animal; Drugs, Chinese Herbal; Female; Graves Disease; Me | 2015 |
Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Cohort Studies; Dexamethasone; | 2016 |
Symptomatic Graves' Disease After Autoimmune Hypothyroidism.
Topics: Adult; Disease Progression; Fatigue; Graves Disease; Hashimoto Disease; Heart Rate; Humans; Immunogl | 2016 |
Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Male; Me | 2016 |
Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.
Topics: Adult; Disease Progression; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Ma | 2016 |
Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.
Topics: Age of Onset; Alleles; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Genetic Assoc | 2017 |
Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Topics: Aged; Antithyroid Agents; Fatigue; Female; Goiter; Graves Disease; Humans; Mediastinal Diseases; Met | 2016 |
Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.
Topics: Biotin; Diagnostic Errors; Dietary Supplements; Graves Disease; Humans; Hyperthyroidism; Male; Middl | 2016 |
The preliminary clinical observation and analysis of childbearingage women with a history of iodine-131 treatment for Graves' disease.
Topics: Abortion, Spontaneous; Adult; Female; Fetal Development; Graves Disease; Humans; Iodine Radioisotope | 2016 |
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Topics: Adult; Age Factors; Antithyroid Agents; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; | 2016 |
The management of Graves' disease in New Zealand 2014.
Topics: Antithyroid Agents; Disease Management; Endocrinologists; Graves Disease; Humans; Internal Medicine; | 2016 |
Analysis of iodine-131-induced early thyroid hormone variations in Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulatin | 2016 |
Management of Graves' disease during pregnancy in the Poitou-Charentes Region.
Topics: Adolescent; Adult; Antithyroid Agents; Female; France; Graves Disease; Humans; Hyperthyroidism; Preg | 2016 |
Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis.
Topics: Adult; Autoantibodies; Biomarkers; Cross-Sectional Studies; Female; Graves Disease; Hashimoto Diseas | 2016 |
Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Japan; Male; Methimazole; Middle Aged; Or | 2016 |
Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease.
Topics: Antithyroid Agents; Biomarkers; Case-Control Studies; Cell Line; Down-Regulation; Enzyme-Linked Immu | 2016 |
Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Case-Control Studies; Cells, Cultured; Chromatograp | 2017 |
Serum immunoglobulin G4 levels and Graves' disease phenotype.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulin G; Male; Middle Aged; Phenotyp | 2017 |
Clinical Evaluation of the First Automated Assay for the Detection of Stimulating TSH Receptor Autoantibodies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Automation; Female; Follow-Up Studies; G | 2016 |
A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
Topics: Adult; Africa, Northern; Aged; Antithyroid Agents; Endocrinologists; Female; Graves Disease; Health | 2017 |
Irisin and Myostatin Levels in Patients with Graves' Disease.
Topics: Adult; Case-Control Studies; Energy Metabolism; Female; Fibronectins; Graves Disease; Humans; Male; | 2016 |
The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Logistic Models; Male; | 2017 |
Limited cutaneous systemic sclerosis arising in a patient with Graves' disease.
Topics: Adult; Antithyroid Agents; Facial Dermatoses; Female; Graves Disease; Hormone Replacement Therapy; H | 2017 |
Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Topics: Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Ma | 2017 |
An improved method for the establishment of a model of Graves' disease in BALB/c mice.
Topics: Animals; Disease Models, Animal; Female; Graves Disease; Humans; Immunization; Mice, Inbred BALB C; | 2017 |
The relationship between neonatal developmental dysplasia of the hip and maternal hyperthyroidism.
Topics: Biomarkers; Female; Follow-Up Studies; Graves Disease; Hip Dislocation, Congenital; Humans; Incidenc | 2008 |
Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Topics: Adolescent; Adult; Antithyroid Agents; Apoptosis; Blotting, Western; Child; Female; Goiter, Nodular; | 2008 |
Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
Topics: Adult; Antibodies; Disease Progression; Family; Female; Graves Disease; Hashimoto Disease; Humans; H | 2008 |
Association of CT60 polymorphism of the CTLA4 gene with Graves' disease in Taiwanese children.
Topics: Adolescent; Adult; Age of Onset; Alleles; Antigens, CD; Child; Child, Preschool; CTLA-4 Antigen; DNA | 2008 |
[Prognostic factors in the relapse of Graves disease].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Immu | 2008 |
Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Topics: Adult; Antithyroid Agents; Blood Glucose; C-Reactive Protein; Carbimazole; Cytokines; Female; Graves | 2008 |
Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
Topics: Adolescent; Adult; Aged; Aging; Cross-Sectional Studies; Female; Graves Disease; Humans; Male; Middl | 2009 |
[Especially important in childhood--early intervention for thyroid disease].
Topics: Antithyroid Agents; Child; Child, Preschool; Female; Goiter, Endemic; Graves Disease; Hashimoto Dise | 2008 |
Nodular pretibial myxedema.
Topics: Adult; Biopsy; Combined Modality Therapy; Graves Disease; Humans; Iodine Radioisotopes; Leg Dermatos | 2008 |
Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Tromsø study.
Topics: Adenoma; Adult; Aged; Cohort Studies; Female; Goiter, Nodular; Graves Disease; Health Surveys; Human | 2008 |
IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report.
Topics: Antiviral Agents; Drug Therapy, Combination; Graves Disease; Hepatitis C; Humans; Interferon-alpha; | 2008 |
Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects.
Topics: Aged; Blood Glucose; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Ad | 2009 |
The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.
Topics: Adult; Aged; Case-Control Studies; Chi-Square Distribution; Female; Graves Disease; Hashimoto Diseas | 2009 |
Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Midd | 2009 |
The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism.
Topics: Adult; Female; Graves Disease; Hormone Replacement Therapy; Humans; Hypothyroidism; Pregnancy; Pregn | 2009 |
First case study of periodic hypokalemic thyreotoxic paresis with partial respiratory insufficiency and concomitant sinus bradycardia.
Topics: Adult; Arrhythmia, Sinus; Bradycardia; Combined Modality Therapy; Diagnosis, Differential; Graves Di | 2009 |
Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immun | 2009 |
Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; | 2009 |
Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; CD4 Lymphocyte Count; Cells, Cultured; Female; Flow | 2009 |
Predictors of time to remission and treatment failure in patients with Graves' disease treated with propylthiouracil.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Male; Propylthiouracil; Sex Factors; Smoking; Th | 2009 |
Immunization with thyroglobulin induces Graves'-like disease in mice.
Topics: Animals; Autoantibodies; Cattle; Disease Models, Animal; Female; Graves Disease; Immunization; Immun | 2009 |
Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease: an effect of maternally derived thyrotrophin receptor antibodies?
Topics: Adult; Antithyroid Agents; Autoantibodies; Congenital Hypothyroidism; Female; Graves Disease; Humans | 2009 |
Elevated free thyroxine levels detected by a neonatal screening system.
Topics: Adult; Base Sequence; Congenital Hypothyroidism; DNA Mutational Analysis; Female; Graves Disease; Hu | 2009 |
[Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
Topics: Adult; Aged; Autoantibodies; Disease Progression; Female; Goiter; Graves Disease; Humans; Hypothyroi | 2009 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
Severe hyperthyroidism: aetiology, clinical features and treatment outcome.
Topics: Acute Disease; Adult; Female; Goiter; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, Thyr | 2010 |
Thyroid disorders of neonates born to mothers with Graves' disease.
Topics: Adult; Congenital Hypothyroidism; Female; Graves Disease; Humans; Infant; Infant, Newborn; Male; Mat | 2009 |
Assisting the diagnosis of Graves' hyperthyroidism with Bayesian-type and SOM-type neural networks by making use of a set of three routine tests and their correlation with free T4.
Topics: Alkaline Phosphatase; Bayes Theorem; Cholesterol; Diagnosis, Computer-Assisted; Female; Graves Disea | 2010 |
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Enzyme-Linked Immunosorbent Assay; Female; Fluoc | 2010 |
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Cohort Studies; Female; Graves Disease; Humans; Hyperth | 2010 |
Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome?
Topics: Creatine Kinase; Female; Graves Disease; Humans; Myositis; Syndrome; Thyroid Hormones; Thyroidectomy | 2009 |
[Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009].
Topics: Administration, Oral; Adult; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Grav | 2009 |
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
Topics: Adult; Aged; Chi-Square Distribution; Female; Glucocorticoids; Graves Disease; Graves Ophthalmopathy | 2010 |
Human multidrug resistance-1 gene expression levels in graves-basedow disease.
Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance; Female | 2010 |
The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Antithyroid Agents; Biomarkers; Bone Density; Ca | 2010 |
Resistance to thyroid hormone in a patient with coexisting Graves' disease.
Topics: Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; Thyroid Hormone Receptors beta; Thyroid H | 2010 |
Hashimoto's thyroiditis following Graves' disease.
Topics: Adult; Female; Graves Disease; Hashimoto Disease; Humans; Male; Middle Aged; Thyroxine | 2010 |
The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Czech Republic; Female; Genotype; Graves Disease | 2010 |
Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease.
Topics: Adolescent; Autoantibodies; Child; Disease Progression; Female; Graves Disease; Hashimoto Disease; H | 2010 |
A patient with Graves' disease and three types of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Fatal Outcome; Female; Graves Disease; Humans; Neoplasm | 2010 |
[A rare case of Graves' disease in a patient on regular haemodialysis].
Topics: Adult; Biomarkers; Graves Disease; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimulating; Iod | 2010 |
Endoscopic thyroidectomy via breast approach for patients with Graves' disease.
Topics: Adult; Blood Loss, Surgical; Breast; Endoscopy; Female; Graves Disease; Humans; Male; Middle Aged; T | 2010 |
Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Hashimoto Disease; Humans; Immunoglobulins, Thyro | 2010 |
Treatment of fetal goitrous hypothyroidism: value of direct intramuscular L-thyroxine therapy.
Topics: Adult; Antithyroid Agents; Cordocentesis; Female; Fetal Diseases; Goiter; Graves Disease; Hormone Re | 2010 |
Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
Topics: Adolescent; Blood Glucose; Child; Female; Ghrelin; Goiter; Graves Disease; Hashimoto Disease; Humans | 2010 |
Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Exophthalmos; Female; Goiter; Graves Disease; Humans; Hyp | 2010 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Bl | 2010 |
Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
Topics: Antiparkinson Agents; Antithyroid Agents; Benserazide; Carbimazole; Drug Combinations; Female; Grave | 2010 |
Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Topics: Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Fibrosis; Graves | 2010 |
Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
Topics: Adult; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Pleural Effusion; Thyroto | 2010 |
Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Female; Graves Disease; Humans; Iodide Peroxidase; Iodo | 2011 |
A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
Topics: Antigen-Antibody Reactions; Cells, Cultured; Graves Disease; Humans; Immunochemistry; Immunoglobulin | 2011 |
Takotsubo cardiomyopathy and severe hypothyroidism.
Topics: Coronary Angiography; Echocardiography; Electrocardiography; Female; Graves Disease; Humans; Hypothy | 2011 |
Experience with lentivirus-mediated CD40 gene silencing in a mouse model of Graves' disease.
Topics: Adenoviridae; Animals; B7-1 Antigen; B7-2 Antigen; CD40 Antigens; Disease Models, Animal; Female; Fo | 2011 |
Assisting the diagnosis of Graves' hyperthyroidism with pattern recognition methods and a set of three routine tests parameters, and their correlations with free T4 levels: Extension to male patients.
Topics: Alkaline Phosphatase; Cholesterol; Creatinine; Diagnosis, Computer-Assisted; Female; Graves Disease; | 2011 |
Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine.
Topics: Adult; Antithyroid Agents; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hypothyroidism; I | 2011 |
Graves' disease. When thyroid hormones run wild.
Topics: Graves Disease; Humans; Patient Education as Topic; Thyroxine; Triiodothyronine | 2011 |
Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission.
Topics: Adolescent; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimu | 2011 |
B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; B-Lymphocytes; Cell Count; Disease Models, Animal; | 2011 |
Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Topics: Antithyroid Agents; Carbimazole; Ectodermal Dysplasia; Face; Female; Graves Disease; Humans; Infant; | 2012 |
Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit.
Topics: Adenoviridae; Animals; Antibodies; Antigens, CD; Female; Gene Expression Regulation; Genetic Vectors | 2011 |
Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Endot | 2011 |
Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Topics: Adult; Apoptosis; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Forkhe | 2011 |
Stable isotope-dilution liquid chromatography/tandem mass spectrometry method for determination of thyroxine in saliva.
Topics: Adult; Drug Stability; Female; Graves Disease; Humans; Isotope Labeling; Linear Models; Male; Reprod | 2011 |
Small molecule TSHR agonists and antagonists.
Topics: Animals; Cells, Cultured; Drug Discovery; Drug Evaluation, Preclinical; Graves Disease; Humans; Iodi | 2011 |
Evaluation of oxidative status in patients with hyperthyroidism.
Topics: Adult; Algorithms; Antioxidants; Cross-Sectional Studies; Female; Goiter, Nodular; Graves Disease; H | 2011 |
Radioiodine therapy for hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyroxine; T | 2011 |
Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Topics: Autoantibodies; Education, Medical, Continuing; Education, Nursing, Continuing; Female; Graves Disea | 2011 |
Discovery of a fetal goiter on prenatal ultrasound in women treated for Graves' disease: first, do no harm.
Topics: Antithyroid Agents; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hypothyroidism; Male; Pr | 2011 |
Hyperthyroidism presenting with hyperglycemia in an adolescent female.
Topics: Adolescent; Adrenergic beta-Antagonists; Antithyroid Agents; Blood Glucose; Female; Graves Disease; | 2011 |
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Topics: Adult; Antithyroid Agents; Biomarkers; Denmark; Drug Administration Schedule; Feasibility Studies; F | 2011 |
The significance of immune-related molecule expression profiles in an animal model of Graves' disease.
Topics: Adenoviridae; Animals; B7-2 Antigen; CD40 Antigens; Disease Models, Animal; Female; Gene Expression | 2012 |
Graves' disease following subacute thyroiditis.
Topics: Adult; Age of Onset; Aged; Blood Sedimentation; Female; Graves Disease; Humans; Immunoglobulins, Thy | 2011 |
Rapidly vanishing hyperthyroidism.
Topics: Adult; Anti-Infective Agents, Local; Appendectomy; Female; Graves Disease; Humans; Iodine; Povidone- | 2013 |
Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
Topics: Adult; Diagnosis, Differential; Exons; Female; Genes, Dominant; Genes, erbA; Goiter, Nodular; Graves | 2012 |
Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease.
Topics: Adult; Body Mass Index; Calcifediol; Calcium; Female; Graves Disease; Humans; Immunoenzyme Technique | 2012 |
Seizures and postictal stupor in a patient with uncontrolled Graves' hyperthyroidism.
Topics: Adolescent; Anticonvulsants; Antithyroid Agents; Diagnosis, Differential; Drug Therapy, Combination; | 2012 |
[Determination of serum neopterin levels in patients with autoimmune thyroid diseases].
Topics: Adult; Aged; Autoantibodies; Biomarkers; Female; Graves Disease; Hashimoto Disease; Humans; Iodide P | 2012 |
Takotsubo cardiomyopathy complicating thyroidectomy for Graves' disease.
Topics: Adult; Antihypertensive Agents; Electrocardiography; Female; Graves Disease; Humans; Metoprolol; Tak | 2012 |
Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
Topics: Aged; Aged, 80 and over; Animals; Antibodies, Blocking; CHO Cells; Cricetinae; Cricetulus; Female; G | 2012 |
Genetic linkages for thyroxine released in response to thyrotropin stimulation in three sets of recombinant inbred mice provide evidence for shared and novel genes controlling thyroid function.
Topics: Animals; Cattle; Crosses, Genetic; Disease Models, Animal; Female; Genetic Linkage; Graves Disease; | 2013 |
Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years.
Topics: Adult; Arrhythmias, Cardiac; Autoantibodies; Diagnosis, Differential; Female; Flushing; Graves Disea | 2013 |
Genes that characterize T3-predominant Graves' thyroid tissues.
Topics: Adult; Bone Morphogenetic Proteins; Cadherins; Creatine Kinase; Creatine Kinase, Mitochondrial Form; | 2013 |
Elephantiasis legs.
Topics: Adult; Antithyroid Agents; Elephantiasis; Graves Disease; Humans; Iodine Radioisotopes; Leg; Male; M | 2014 |
Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
Topics: Adult; Alcohol Drinking; Anti-Infective Agents, Local; Case-Control Studies; Denmark; Disease Progre | 2013 |
Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Topics: Adolescent; CD4 Antigens; Child; Female; Forkhead Transcription Factors; Graves Disease; Hashimoto D | 2013 |
Rising serum thyroxine levels and chorea in graves' disease.
Topics: Adolescent; Anemia, Sickle Cell; Antithyroid Agents; Bone Marrow Transplantation; Chorea; Comorbidit | 2013 |
Pseudohypoparathyroidism and Graves'disease: a rare combination of two endocrinological diseases.
Topics: Adult; Calcitriol; Calcium; Calcium Carbonate; Female; Graves Disease; Humans; Methimazole; Parathyr | 2002 |
Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.
Topics: Animals; Antibodies, Monoclonal; Antithyroid Agents; Area Under Curve; Autoantibodies; Case-Control | 2002 |
Prevalence of diaphragmatic muscle weakness and dyspnoea in Graves' disease and their reversibility with carbimazole therapy.
Topics: Adult; Antithyroid Agents; Carbimazole; Diaphragm; Dyspnea; Exercise; Female; Forced Expiratory Volu | 2002 |
Does Graves' disease during puberty influence adult bone mineral density?
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Female; Femur Neck; Graves Disease; Humans; | 2002 |
Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Pregnancy; Prenatal Ca | 2002 |
The aftermath of orbital radiotherapy for graves' ophthalmopathy.
Topics: Adult; Aged; Decompression, Surgical; Dose Fractionation, Radiation; Female; Follow-Up Studies; Grav | 2002 |
[Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report].
Topics: Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; Radion | 2002 |
Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?
Topics: Adult; Follow-Up Studies; Graves Disease; Half-Life; Humans; Iodine Radioisotopes; Middle Aged; Radi | 2002 |
Reversible increase of serum activin A levels in women with Graves' disease.
Topics: Activins; Adult; Aged; Autoantibodies; Female; Follicle Stimulating Hormone; Graves Disease; Humans; | 2002 |
Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Topics: Animals; Antibodies; Disease Models, Animal; Eye Proteins; Female; Graves Disease; Humans; Membrane | 2002 |
Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Topics: Adolescent; Antigens, CD19; B-Lymphocytes; Case-Control Studies; CD3 Complex; CD4-Positive T-Lymphoc | 2003 |
IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy.
Topics: Adolescent; Adult; Aged; Calcium; Celiac Disease; Dose-Response Relationship, Drug; Female; Gliadin; | 2003 |
Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Immunoglobulins, | 2003 |
[Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radioiodine treatment in Graves' disease].
Topics: Follow-Up Studies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioisotope | 2003 |
The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid- | 2003 |
A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism.
Topics: Adenoviridae; Animals; Antibodies; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Escher | 2003 |
Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.
Topics: Antiviral Agents; Female; Graves Disease; Hepatitis C; Humans; Hypothyroidism; Interferon alpha-2; I | 2003 |
Lack of effect of long-term octreotide therapy in severe thyroid-associated dermopathy.
Topics: Adult; Anthropometry; Body Mass Index; Clinical Trials as Topic; Drug Administration Schedule; Femal | 2003 |
Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Topics: Amniotic Fluid; Antithyroid Agents; Autoantibodies; Blood Specimen Collection; Female; Fetal Blood; | 2003 |
Don't forget the thyroid in the etiology of psychoses.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hypothyroidism; Methimazole; Middle Aged; Psycho | 2003 |
[Drug treatment of immune hyperthyroidism (Basedow disease). Patient selection, long-term follow-up and prevention of recurrence].
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Long-Term Care; Randomized Co | 2003 |
The metabolism of radiothyroxine in exophthalmic goiter.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroxine | 1952 |
[Disturbance of activity of the thyroid gland and regulation possibilities with theory of hyperthyroidism and Basedow's disease].
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Gland; Thyroxine; Viscera | 1953 |
[Clinical trials with thyroxin antagonists in Basedow's disease].
Topics: Antithyroid Agents; Benzoates; Graves Disease; Humans; Hyperthyroidism; Thyroxine | 1954 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
A qualitative difference in the plasma protein thyroid hormone complex in diffuse toxic goiter as compared to nodular toxic goiter and the euthyroid state.
Topics: Blood Proteins; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones; Thyroxin | 1956 |
Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroxine | 1958 |
[ISOTOPE TESTS OF RADIO-THYROXIN HALF-LIFE AND IN VITRO ERYTHROCYTE FIXATION OF LABELLED TRIIODOTHYRONINE].
Topics: Anorexia Nervosa; Erythrocytes; Goiter; Graves Disease; Half-Life; Hypercholesterolemia; Hyperthyroi | 1963 |
[PROBLEMS IN HYPERTHYROIDISM].
Topics: Blood Chemical Analysis; Goiter; Graves Disease; Hyperthyroidism; Immune Sera; Iodine Isotopes; Mice | 1963 |
GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE.
Topics: Blood; Drug Therapy; Glucocorticoids; Goiter; Graves Disease; Humans; Long-Acting Thyroid Stimulator | 1964 |
EFFECT OF THROXINE ON EXOPHTHALMOS IN THYROTOXICOSIS.
Topics: Exophthalmos; Goiter; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Statistics as Topic; | 1965 |
PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE.
Topics: Autoantibodies; Biological Assay; gamma-Globulins; Goiter; Graves Disease; Humans; Hyperthyroidism; | 1965 |
[THYROTOXICOSIS WITHOUT HYPERSECRETION OF THYROXINE. A PRE-BASEDOW FORM].
Topics: Exophthalmos; Goiter; Graves Disease; Humans; Hyperthyroidism; Thyrotoxicosis; Thyroxine | 1964 |
Euthyroid patients with early eye signs of Graves' disease; their responses to L-triiodothyronine and thyrotropin.
Topics: Eye; Graves Disease; Hormones; Humans; Hyperthyroidism; Pituitary Gland; Pituitary Gland, Anterior; | 1955 |
[A case of Hypothyroid Graves' disease with extremely high titers of TSAb].
Topics: Graves Disease; Hormone Replacement Therapy; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimul | 2003 |
Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues.
Topics: Adult; Female; Gonadotropin-Releasing Hormone; Graves Disease; Humans; Immunoglobulins, Thyroid-Stim | 2003 |
Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment.
Topics: Adult; Antithyroid Agents; Enzyme Activation; Female; Graves Disease; Humans; Iodide Peroxidase; Iso | 2003 |
Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
Topics: Animals; Female; Graves Disease; HLA Antigens; HLA-DQ Antigens; HLA-DR3 Antigen; Humans; Male; Mice; | 2003 |
Thyroid hormone autoantibodies in Hashimoto's thyroiditis: often transient but also increasingly frequent.
Topics: Autoantibodies; Epstein-Barr Virus Infections; Graves Disease; Humans; Thyroid Hormones; Thyroiditis | 2003 |
Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
Topics: Adenoviridae; Animals; Autoantibodies; B-Lymphocytes; Female; Genetic Vectors; Graves Disease; Immun | 2003 |
[Thyroid dysfunction in pregnant women and correlation with clinical and metabolical status of their newborns].
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Infant, Newborn, Diseases; P | 2003 |
Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed.
Topics: Antithyroid Agents; Female; Fetal Blood; Graves Disease; Humans; Hyperthyroidism; Infant; Infant, Ne | 2003 |
Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report.
Topics: Adolescent; Anesthesia; Anti-Inflammatory Agents; Dexamethasone; Graves Disease; Humans; Iopanoic Ac | 2004 |
Pediatric Graves' disease: outcome and treatment.
Topics: Adolescent; Antithyroid Agents; Body Height; Child; Child, Preschool; Decision Making; Exophthalmos; | 2003 |
[Radioiodine labelled human thyroglobulin in the normal state and in Basedow's disease].
Topics: Graves Disease; Humans; Iodine Radioisotopes; Thyroglobulin; Thyroxine | 1952 |
Images in thyroidology. Graves' disease unmasking ectopic thyroid tissue.
Topics: Choristoma; Graves Disease; Humans; Male; Middle Aged; Thyroid Gland; Thyroidectomy; Thyroxine; Trea | 2004 |
Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Topics: Adult; Antithyroid Agents; Case-Control Studies; Female; Graves Disease; Humans; Hypothyroidism; Int | 2004 |
Intraoperative thyroid storm: a case report.
Topics: Adolescent; Antithyroid Agents; Diagnosis, Differential; Female; Graves Disease; Humans; Intraoperat | 2004 |
Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.
Topics: Animals; Autoimmunity; DNA-Binding Proteins; Female; Graves Disease; Immunoglobulin G; Interferon-ga | 2004 |
Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders.
Topics: Autoantibodies; Biomarkers; Female; Graves Disease; Humans; Male; Receptors, Thyrotropin; Reference | 2004 |
The presence of the antigliadin antibodies in autoimmune thyroid diseases.
Topics: Antibodies; Gliadin; Graves Disease; Humans; Polyendocrinopathies, Autoimmune; Thyroiditis, Autoimmu | 2003 |
Patient entry of information: evaluation of user interfaces.
Topics: Drug Administration Schedule; Drug Prescriptions; Graves Disease; Humans; Internet; Medical Records; | 2004 |
Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Autoantibodies; Binding Sites, Antibody; Cycli | 2004 |
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Topics: Adoptive Transfer; Animals; CHO Cells; Cricetinae; Disease Models, Animal; Environment; Female; Grav | 2005 |
TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antiviral Agents; Autoantibodies; Female; Graves Disea | 2004 |
Cardiovascular effects of thyroxine in combination with methimazole in premenopausal female Graves' disease patients: case-control study.
Topics: Adult; Antithyroid Agents; Cardiovascular System; Case-Control Studies; Drug Therapy, Combination; E | 2004 |
Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
Topics: Antithyroid Agents; Carboxylic Acids; Female; Graves Disease; Humans; Hydrogen Peroxide; Male; Methi | 2005 |
Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Antigens; Graves Disease; HIV Infections; Humans; Imm | 2004 |
Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity.
Topics: Adult; Alkaline Phosphatase; Female; Graves Disease; Humans; Likelihood Functions; Male; Middle Aged | 2005 |
Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.
Topics: Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Peptidyl | 1986 |
Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroxinemia; Hypothyroidism; I | 2005 |
Central hypothyroidism in infants who were born to mothers with thyrotoxicosis before 32 weeks' gestation: 3 cases.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Infant, Premature; Infant, Prematur | 2005 |
Autoimmune thyroid disease with fluctuating thyroid function.
Topics: Adult; Female; Graves Disease; Hashimoto Disease; Humans; Iodine Radioisotopes; Thyroxine; Time Fact | 2005 |
Antithyroid drugs.
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Hyperthyroidism; Methimazole; | 2005 |
Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoantibodies; Female; Graves Disease; Hepacivirus; Hepatitis C, Chronic; Humans; | 2005 |
Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; G | 2005 |
Observations concerning the natural history of subclinical hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Goiter, Nodular; Gra | 2005 |
Thyrotoxic, hypokalaemic periodic paralysis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Graves Disease; Humans; Hypokal | 2005 |
Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Fetus; Graves Disease; Humans; Immunoglobulins, T | 2005 |
[Basedow's disease. Individual therapy of is great significance].
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Iodine Radioisotopes; Methima | 2005 |
Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Topics: Adolescent; Antigens, CD; Antigens, Differentiation; Autoantibodies; CD28 Antigens; Child; CTLA-4 An | 2005 |
Oxidative stress in Graves' disease patients and antioxidant protection against lymphocytes DNA damage in vitro.
Topics: Acetylcysteine; Adult; Antioxidants; Ascorbic Acid; Comet Assay; DNA Damage; Female; Graves Disease; | 2005 |
Thyroid function during pregnancy in women with past Graves' disease.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Pregnancy C | 2005 |
Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease.
Topics: Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Pro | 2005 |
Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Male; Sensitivity and Specificity; T | 2005 |
Video-assisted subtotal or near-total thyroidectomy for Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Follow-Up Studies; Graves D | 2006 |
The possible contribution of anti-Gal to Graves' disease.
Topics: Enzyme-Linked Immunosorbent Assay; Epitopes; Extracellular Matrix Proteins; Graves Disease; Humans; | 2005 |
Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels.
Topics: Adult; Ascites; CA-125 Antigen; Female; Graves Disease; Humans; Hyperthyroidism; Methimazole; Ovaria | 2005 |
Hypothyroid symptoms following radioiodine therapy for Graves' disease.
Topics: Antithyroid Agents; Drug Therapy, Combination; Fatigue; Graves Disease; Humans; Hypothyroidism; Iodi | 2005 |
Successful use of iodine and levothyroxine to treat Graves' disease in a pregnant patient with allergy to antithyroid drugs and high thyrotropin-binding inhibitor immunoglobulin after radioiodine therapy.
Topics: Adult; Antithyroid Agents; Autoantibodies; Drug Hypersensitivity; Female; Graves Disease; Humans; Im | 2005 |
PTU-associated vasculitis in a girl with Turner Syndrome and Graves' disease.
Topics: Antithyroid Agents; Child; Female; Graves Disease; Humans; Propylthiouracil; Thyroxine; Turner Syndr | 2006 |
Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
Topics: Anemia, Aplastic; Antithyroid Agents; Blood Cell Count; Bone Marrow; Child; Female; Graves Disease; | 2007 |
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Femal | 2006 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Female; | 2006 |
Movement disorders associated with hyperthyroidism: expanding the phenotype.
Topics: Autoantibodies; Dystonic Disorders; Graves Disease; Humans; Male; Middle Aged; Phenotype; Thyrotropi | 2006 |
Treatment of post-partum thyrotoxicosis.
Topics: Antithyroid Agents; Breast Feeding; Female; Graves Disease; Humans; Infant, Newborn; Iodine Radioiso | 2006 |
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism.
Topics: Adult; Female; Graves Disease; Hashimoto Disease; Humans; Methimazole; Pregnancy; Pregnancy Complica | 2006 |
Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
Topics: Adult; Antithyroid Agents; Autonomic Nervous System; Case-Control Studies; Electrocardiography, Ambu | 2006 |
Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Topics: Adult; Antithyroid Agents; Case-Control Studies; Endothelin-1; Female; Graves Disease; Humans; Insul | 2006 |
The role of selenium in thyroid autoimmunity and cancer.
Topics: Animals; Antioxidants; Autoimmune Diseases; Glutathione Peroxidase; Graves Disease; Humans; Models, | 2006 |
Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
Topics: Adult; Antithyroid Agents; Chi-Square Distribution; Female; Graves Disease; Humans; Hypothyroidism; | 2005 |
TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2006 |
Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene.
Topics: Autoantibodies; DNA; Electrophoresis, Agar Gel; Genotype; Graves Disease; Hashimoto Disease; Humans; | 2006 |
Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
Topics: Adenoviridae; Animals; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Genetic | 2006 |
Triiodothyronine production in Graves' hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Neoplasms | 2006 |
Two-day thionamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease.
Topics: Adult; Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; Humans; Hyperthyroi | 2006 |
A hyperthyroid patient with measurable thyroid-stimulating hormone concentration - a trap for the unwary.
Topics: Adenoma; Adult; Antibodies, Heterophile; Diagnostic Errors; Female; Graves Disease; Humans; Immunoas | 2006 |
Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease.
Topics: Adult; Elephantiasis; Female; Graves Disease; Humans; Leg Dermatoses; Myxedema; Skin Diseases; Thyro | 2006 |
Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Calsequestrin; Cell Cycle Proteins; Collagen; Enzyme | 2006 |
Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer.
Topics: Adult; Carcinoma; Female; Goiter, Nodular; Graves Disease; Hormone Replacement Therapy; Humans; Hype | 2007 |
Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.
Topics: Animals; Autoantibodies; Cell Line; Complementarity Determining Regions; Disease Progression; Genes, | 2007 |
[Central congenital hypothyroidism due to Graves' disease in the mother].
Topics: Adult; Congenital Hypothyroidism; Diseases in Twins; Female; Graves Disease; Humans; Infant, Newborn | 2006 |
Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Biomarkers; Female; Follow-Up Studies; | 2006 |
HLA class II distribution in Congolese with hyperthyroidism: preliminary results.
Topics: Child; Democratic Republic of the Congo; Exophthalmos; Graves Disease; HLA-D Antigens; Humans; Hyper | 2006 |
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2006 |
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
Topics: Chemokine CXCL10; Chemokines, CXC; Female; Goiter, Nodular; Graves Disease; Humans; Interferon-gamma | 2007 |
An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Topics: Animals; Autoantibodies; Cell Line; CHO Cells; Chronic Disease; Cricetinae; Cricetulus; Disease Mode | 2007 |
[Central congenital hypothyroidism due to Graves' disease in the mother].
Topics: Biomarkers; Congenital Hypothyroidism; Diseases in Twins; Female; Graves Disease; Humans; Pregnancy; | 2007 |
[Graves' disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases].
Topics: Adult; Autoantibodies; Cross Reactions; Female; Graves Disease; Humans; Platelet Count; Purpura, Thr | 2007 |
Predicting outcome of treatment with radiotherapy in endocrine ophthalmopathy.
Topics: Adult; Aged; Autoantibodies; C-Reactive Protein; Confidence Intervals; Data Interpretation, Statisti | 2007 |
Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Blood Flow Velocity; Female; Graves Disease; Humans; Im | 2007 |
The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.
Topics: Adaptation, Physiological; Adult; Biomarkers; Bone and Bones; Calcium; Case-Control Studies; Collage | 2007 |
Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease.
Topics: Adult; Child; Child, Preschool; Congenital Hypothyroidism; Female; Graves Disease; Humans; Infant; I | 2007 |
Premature twins of a mother with Graves' disease with discordant thyroid function: a case report.
Topics: Adult; Antithyroid Agents; Congenital Hypothyroidism; Diagnosis, Differential; Drug Administration S | 2007 |
Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice.
Topics: Animals; Antibodies, Monoclonal; Autoimmunity; Drug Administration Schedule; Female; Genetic Predisp | 2007 |
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Goiter, Nodular; Graves D | 2007 |
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; | 2007 |
Thigh muscle stiffness assessed with magnetic resonance elastography in hyperthyroid patients before and after medical treatment.
Topics: Adult; Case-Control Studies; Echo-Planar Imaging; Elasticity; Female; Graves Disease; Humans; Hypert | 2007 |
Hashimoto's thyroiditis presenting as Graves-Basedow disease.
Topics: Diagnosis, Differential; Female; Graves Disease; Hashimoto Disease; Humans; Iodide Peroxidase; Middl | 2007 |
Congenital goiter in premature twins due to propylthiouracil treatment.
Topics: Congenital Hypothyroidism; Diseases in Twins; Female; Graves Disease; Humans; Infant, Newborn; Male; | 2007 |
[Postpartum thyroiditis with unusual evolution].
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Met | 2007 |
Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation.
Topics: Adult; Amniotic Fluid; Antithyroid Agents; Congenital Hypothyroidism; Female; Fetal Diseases; Fetal | 2007 |
An unusual cause of jaundice.
Topics: Adult; Antithyroid Agents; Carbimazole; Graves Disease; Humans; Jaundice; Male; Thyrotoxicosis; Thyr | 2007 |
Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
Topics: Adult; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged; Pred | 2007 |
Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Hashimoto Disease; Humans; Immunoglobulin G; Immunogl | 2007 |
Fetal goiter and bilateral ovarian cysts.
Topics: Amniocentesis; Amniotic Fluid; Antithyroid Agents; Cesarean Section; Female; Fetal Blood; Follicle S | 2008 |
Reversible chorea in association with Graves' disease and moyamoya syndrome.
Topics: Adult; Brain; Carotid Arteries; Cerebral Angiography; Chorea; Female; Graves Disease; Humans; Hypert | 2008 |
The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Immuno | 2008 |
[Rhabdomyolysis in a patient with postoperative hypothyroidism and hypoparathyroidism].
Topics: Acute Kidney Injury; Aged, 80 and over; Female; Fluid Therapy; Graves Disease; Humans; Hydroxycholec | 2008 |
Thyroid function disorders--Guidelines of the Netherlands Association of Internal Medicine.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Male; | 2008 |
An alternative therapy for graves' disease: clinical effects and mechanisms of an herbal remedy.
Topics: Animals; Cell Line; Cell Proliferation; Cyclic AMP; DNA; Drugs, Chinese Herbal; Graves Disease; Huma | 2008 |
A case of severe cholestatic jaundice associated with Graves' disease.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Cholangiopancreatography, Magnetic Resonance; Chole | 2008 |
Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function.
Topics: Adiponectin; Adult; Antithyroid Agents; Body Mass Index; Case-Control Studies; Female; Graves Diseas | 2008 |
Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
Topics: Adult; Aged, 80 and over; Antigens, CD; Autoantibodies; Brazil; Case-Control Studies; Child; Child, | 2008 |
Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Topics: Adult; Aged; Eye; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Long-Acting Thyr | 1967 |
Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1980 |
Lack of effect of somatostatin on thyroid gland function in Graves' disease.
Topics: Adult; Female; Graves Disease; Growth Hormone; Humans; Insulin; Middle Aged; Somatostatin; Thyroid G | 1980 |
[Surgical indications, preoperative care, surgery and postoperative care in Basedow's disease and other forms of hyperthyroidism].
Topics: Adenoma; Adrenergic beta-Antagonists; Adult; Aged; Carbimazole; Graves Disease; Heart Failure; Human | 1980 |
Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
Topics: Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulat | 1980 |
Conditions which affect interpretation of thyroid function tests.
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Function Tests; T | 1981 |
The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies.
Topics: Animals; Antibodies; Biological Assay; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; | 1981 |
The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.
Topics: Adult; Aged; Animals; Antibodies; Biological Assay; Female; Goiter; Goiter, Nodular; Graves Disease; | 1982 |
[Euthyroid exophthalmos: evaluation of 6 patients].
Topics: Antibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Thyrotropin; Thyrotr | 1983 |
The assay of Graves' immunoglobulins: a comparison of different methods.
Topics: Adult; Aged; Antibodies; Biological Assay; Female; Graves Disease; Humans; Immunoglobulin G; Immunog | 1983 |
Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease.
Topics: Adult; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; Middle Aged; | 1983 |
[Determination of serum thyroid-stimulating immunoglobulin and its clinical significance in patients with Graves' disease].
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
Topics: Adult; Aged; Antithyroid Agents; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; M | 1980 |
The assessment and management of hyperthyroidism.
Topics: Adenoma; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Sympatholytics; | 1980 |
[Stimulation of endogenous TSH secretion and endocrine orbitopathy].
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Male; Methimazole; Middle Ag | 1980 |
Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Gl | 1981 |
[Endocrine disorders in toxic goiter in the postoperative period].
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex; Adult; Circadian Rhythm; Epinephrine; Estroge | 1981 |
Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Topics: Adult; Alpha-Globulins; Calcitonin; Female; Graves Disease; Humans; Hyperthyroidism; Postpartum Peri | 1981 |
[Hyperthyroidism caused by triiodothyronine (T3-toxicosis)].
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Thyroid Function Te | 1981 |
Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
Topics: Alpha-Globulins; Graves Disease; Humans; Thyroiditis; Thyroxine; Thyroxine-Binding Proteins; Triiodo | 1982 |
[TBG abnormality and free thyroxine (author's transl)].
Topics: Adult; Alpha-Globulins; Female; Graves Disease; Humans; Male; Middle Aged; Thyroxine; Thyroxine-Bind | 1982 |
Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin Fc Fragments; | 1982 |
Laboratory tests for evaluating thyroid therapy.
Topics: Antithyroid Agents; Drug Evaluation; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Methim | 1982 |
Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
Topics: Adult; Aged; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Long-Term Care; Male; Middl | 1983 |
T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.
Topics: Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglo | 1983 |
[Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; Male; Methimazole; Mid | 1983 |
Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1984 |
[Hormonal activity and morphological changes in the thyroid gland in toxic goiter].
Topics: Graves Disease; Humans; Iodine; Protein Binding; Thyroid Function Tests; Thyroid Gland; Thyroxine | 1983 |
[Serum free thyroxine in thyroid diseases, with special reference to Graves' disease during the treatment].
Topics: Antithyroid Agents; Graves Disease; Humans; Radioimmunoassay; Thyroxine | 1983 |
Thyroid T4 5'-deiodinase activity in normal and abnormal human thyroid glands.
Topics: Adenoma; Antithyroid Agents; Graves Disease; Humans; In Vitro Techniques; Iodide Peroxidase; Peroxid | 1984 |
Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Autoimmune Diseases; Female; Goiter; Graves Disease | 1983 |
Properties of human thyroidal and extrathyroidal TSH receptors.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Chorionic Gonadotropin; Female; Graves Disease; Humans; | 1981 |
Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay.
Topics: Adult; Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Kinetics; Male; Perchlorates; P | 1982 |
Thyroid disease with monoclonal (immunoglobulin G lambda) antibody to triiodothyronine and thyroxine.
Topics: Adult; Antibodies, Monoclonal; Antibody Affinity; Graves Disease; Humans; Hypothyroidism; Immunoglob | 1983 |
Na-K-dependent ATPase in red cells and thyroid status.
Topics: Adolescent; Child; Child, Preschool; Congenital Hypothyroidism; Dwarfism; Dwarfism, Pituitary; Eryth | 1982 |
Decreased beta-adrenergic receptor density in mononuclear leukocytes from thyroidectomized patients.
Topics: Adenoma; Adult; Cholecystectomy; Dihydroalprenolol; Goiter; Graves Disease; Humans; Middle Aged; Mon | 1983 |
Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin.
Topics: Bucladesine; Culture Techniques; Dactinomycin; Enzyme Induction; Graves Disease; Humans; Iodide Pero | 1983 |
[The role of circulating immune complexes in the pathogenesis of Graves' disease].
Topics: Antibodies; Antigen-Antibody Complex; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Lympho | 1983 |
Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease.
Topics: Adult; Carbimazole; Drug Administration Schedule; Drug Therapy, Combination; Female; Graves Disease; | 1983 |
A pregnant women with 'large' eyes.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Pregnancy; Pregnancy Complications; | 1984 |
Primary hypothyroidism followed by hyperthyroidism. Five case reports.
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; Thyroxi | 1984 |
Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Autoantibodies; Child; Evaluation Studies as Topic; Female; Graves Disease; | 1984 |
Urine TRH immunoreactivity in hypothyroid and hyperthyroid patients.
Topics: Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Graves Dise | 1984 |
Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Methimazole; Prognosis; Propylthiouracil; R | 1984 |
Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies.
Topics: Adult; Aged; Antibody Affinity; Autoantibodies; Female; Goiter; Graves Disease; Humans; Male; Middle | 1984 |
The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Thyroxine; Time F | 1984 |
Thirty-five cases of transient hyperthyroidism.
Topics: Adult; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Iod | 1984 |
[Dynamics of the serum lipid indices in thyrotoxicosis].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Lipids; Male; Middle Aged; | 1984 |
Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
Topics: Adult; Female; Goiter; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Male; Maternal-Fetal | 1984 |
Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland.
Topics: Graves Disease; Humans; Iodine; Iodine Radioisotopes; Thyroid Gland; Thyrotropin; Thyroxine; Time Fa | 1984 |
Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement.
Topics: Administration, Oral; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1984 |
T4 suppression test involving 24-hour thyroidal 131I uptake in patients with Graves' disease compared to the T3 suppression test.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Middle Aged; Propylt | 1984 |
Graves' ophthalmopathy. An unusual course.
Topics: Female; Graves Disease; Humans; Middle Aged; Prednisone; Recurrence; Thyroxine; Tomography, X-Ray Co | 1984 |
Overview of thyroidology--1984.
Topics: Goiter; Graves Disease; Humans; Hypothyroidism; Therapeutic Equivalency; Thyroid Diseases; Thyroid F | 1984 |
[Measurement of anti-thyroxine antibody in the serum using a labeled-thyroxine-analog].
Topics: Autoantibodies; Evaluation Studies as Topic; Graves Disease; Humans; Radioimmunoassay; Thyroiditis, | 1984 |
Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
Topics: Adult; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid Function Tests; Thyr | 1983 |
[The effects of plasma exchange upon patients with malignant exophthalmos due to Graves' disease].
Topics: Adult; Female; Graves Disease; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulator; Male; Middl | 1983 |
[Serum ratios of triiodothyronine to thyroxine and reverse-triiodothyronine in Graves' disease and destruction-induced thyrotoxicosis].
Topics: Adult; Aged; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle | 1983 |
Serum free thyroid hormones in T3-toxicosis: a study of 35 patients.
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroid Function Tests; Thyroid Hormones; Thyrotropin; Thyr | 1983 |
Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotop | 1983 |
[In vitro diagnosis of T3 thyrotoxicosis].
Topics: Adult; Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Middle Age | 1983 |
Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man.
Topics: Blood Glucose; Female; Gluconeogenesis; Glycerol; Graves Disease; Humans; Hypothyroidism; Male; Meta | 1983 |
Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders.
Topics: Adult; Aged; Autoantibodies; Autoradiography; Chromatography, Gel; Female; Graves Disease; Humans; I | 1983 |
Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves' disease.
Topics: Adolescent; Adult; Dexamethasone; Drug Therapy, Combination; Female; Graves Disease; Humans; Ipodate | 1983 |
[Thyroid hormone autoantibodies in Hashimoto's disease and Graves' disease].
Topics: Adult; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Hormones; T | 1983 |
Attention disturbance in Graves' disease.
Topics: Adult; Attention; Female; Graves Disease; Humans; Male; Thyroxine; Triiodothyronine | 1983 |
[A new thyrotoxicosis index (bases for calculation and applications)].
Topics: Graves Disease; Humans; Hyperthyroidism; Thyroxine | 1982 |
Changes in thyroid functions in patients with euthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Antibodies; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypothy | 1980 |
[Clinicopathological study on the chronic thyroiditis and Graves' disease --relationship between histological classification and function (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Female; Graves Disease; Humans; M | 1980 |
Graves' disease associated with elevated serum thyroxine-binding globulin concentrations.
Topics: Adult; Child; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Pedigree; Thyrotropin; | 1980 |
Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Thyr | 1980 |
Thyroid storm with normal serum triiodothyronine level during diabetic ketoacidosis.
Topics: Adolescent; Diabetic Ketoacidosis; Female; Graves Disease; Humans; Ketone Bodies; Thyroid Crisis; Th | 1981 |
Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Topics: Antibodies; Female; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyrotropin; Thyrotropin | 1981 |
Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
Topics: Feedback; Graves Disease; Humans; Methimazole; Pituitary Gland; Thyroid Gland; Thyrotropin; Thyrotro | 1982 |
Tests of thyroid function important to the ophthalmologist.
Topics: Antibody Formation; Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Thyroid Functi | 1982 |
Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease.
Topics: Adolescent; Adult; Autoantibodies; Female; Graves Disease; Hemagglutination Tests; Humans; Male; Mid | 1982 |
Interrelationship between TSH- and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis.
Topics: Adult; Antibodies; Autoimmune Diseases; Female; Graves Disease; Humans; Pituitary Neoplasms; Prolact | 1982 |
[Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy].
Topics: Adult; Aged; Diagnosis, Differential; Exophthalmos; Female; Graves Disease; Humans; Male; Middle Age | 1982 |
[Indications and pharmacokinetic study of lithium carbonate in the treatment of the acute phase of Basedow's disease].
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Kinetics; Lithium; Lithium Carbonate; Male | 1982 |
Functional relationships of the hypothalamic-pituitary-testicular system in Graves' disease.
Topics: Adult; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Graves Disease; Huma | 1982 |
Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
Topics: Adult; Antibodies; Carbimazole; Female; Graves Disease; Humans; Male; Propylthiouracil; Thyrotropin; | 1980 |
Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Potassium Iodide; Preoperative Car | 1980 |
Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methimazole; Prop | 1980 |
Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease.
Topics: Adolescent; Adult; Aging; Autoantibodies; Child; Female; Follow-Up Studies; Graves Disease; Humans; | 1980 |
Modified subtotal thyroidectomy in the management of Graves' disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Graves Disease; Humans; Hypothyroidism; Male; Po | 1980 |
Triiodothyronine-binding immunoglobulin in a patient with Grave's disease and its effect on metabolism and radioimmunoassay of triiodothyronine.
Topics: Autoantibodies; Chromatography, Gel; Female; Graves Disease; Humans; Immunoglobulin Fab Fragments; I | 1980 |
[Compensation of the hormonal and metabolic disorders as a general principle in treating endocrine system diseases].
Topics: Adaptation, Physiological; Adult; Child; Endocrine System Diseases; Graves Disease; Humans; Hyperthy | 1980 |
[Clinical evaluation of the thyroid gland function based on T3, T4 and TSH activity and histopathological changes in various types of goiter].
Topics: Adult; Goiter, Nodular; Graves Disease; Humans; Middle Aged; Thyroid Gland; Thyrotropin; Thyroxine; | 1980 |
[Basic and clinical evaluation of the measurement of serum thyroxine with Phadebes T4 radioimmunoassay kit (author's transl)].
Topics: Graves Disease; Humans; Hypothyroidism; Radioimmunoassay; Reagent Kits, Diagnostic; Thyroxine | 1980 |
Assessment of cardiac reserve in patients with hyperthyroidism.
Topics: Adult; Blood Pressure; Cardiac Output; Graves Disease; Heart; Heart Rate; Hemodynamics; Humans; Hype | 1980 |
[Primary hypothyroidism as a possible cause of hypertension from long-term follow-up studies of patients with Graves' disease (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Graves Disease; Humans; Hypertension; Hyp | 1980 |
Studies on the pathophysiological role of thyroidal prostaglandin E (PGE) in Graves' disease.
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperparathyroidism; Indomethacin; Male; Middle Aged; P | 1980 |
Serum myoglobin in thyroid disease.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle A | 1980 |
[Facility of aqueous humor outflow and the serum level of thyroid hormones (author's transl)].
Topics: Adolescent; Adult; Aged; Aqueous Humor; Female; Graves Disease; Humans; Male; Middle Aged; Thyroidec | 1980 |
Clinical and pathological significance of sibling Graves' disease.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Male; Thyroglobulin; Thyroid Gland; Thyroidectomy | 1980 |
[Pathogenesis, clinical aspects and internal therapy of Basedow's disease and other forms of hyperthyroidism].
Topics: Adult; Aged; Autoimmune Diseases; Carbimazole; Goiter, Nodular; Graves Disease; Humans; Hyperthyroid | 1980 |
[Nuclear medicine aspects of Basedow's disease and other forms of hyperthyroidism].
Topics: Adenoma; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Iodine Radioisotopes; Pituitary N | 1980 |
[Elastotonometric curves and blood triiodothyronine and thyroxine levels (author's transl)].
Topics: Adult; Aged; Female; Goiter, Nodular; Graves Disease; Humans; Intraocular Pressure; Male; Middle Age | 1980 |
Thyroid physiology and functional tests.
Topics: Calcitonin; Goiter, Nodular; Graves Disease; Humans; Iodine Radioisotopes; Long-Acting Thyroid Stimu | 1980 |
The deceptively tender goiter.
Topics: Adult; Aspirin; Blood Sedimentation; Diagnosis, Differential; Female; Graves Disease; Humans; Hypert | 1981 |
Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.
Topics: Adolescent; Adult; Dopamine beta-Hydroxylase; Female; Graves Disease; Humans; Male; Propranolol; Thy | 1980 |
Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos.
Topics: Adult; Aged; Antibodies; Autoantibodies; Exophthalmos; Female; Graves Disease; Humans; Male; Middle | 1981 |
Acquired refractoriness to thyroid hormone action in treated toxic nodular goiter.
Topics: Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyrotropin; Thyroxine; Triiodothyronine | 1981 |
Long-term results of radioiodine (131I) therapy in 331 patients with Graves' disease.
Topics: Autoantibodies; Cholesterol; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radio | 1980 |
Pancytopenia complicating Graves' disease and drug-induced hypothyroidism.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Middle Aged; Pancytopenia; Thyroxine | 1981 |
Dissolution of gallstones following thyroxine administration. A case report.
Topics: Administration, Oral; Adult; Carbimazole; Cholelithiasis; Female; Graves Disease; Hormones; Humans; | 1981 |
Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
Topics: Adenoma; Carcinoma; Dithiothreitol; Graves Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Th | 1981 |
Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.
Topics: Adult; Autoimmune Diseases; Graves Disease; Humans; Hypothyroidism; Male; Thyroxine | 1981 |
Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol.
Topics: Female; Graves Disease; Humans; Ipodate; Kinetics; Male; Propranolol; Propylthiouracil; Thyroxine; T | 1981 |
Thyroid function tests during carbimazole therapy.
Topics: Adolescent; Adult; Carbimazole; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Fu | 1980 |
Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged | 1981 |
Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism.
Topics: Adult; Blood Pressure; Body Weight; Female; Graves Disease; Humans; Ipodate; Kinetics; Male; Middle | 1982 |
Thyroid hormone formation catalyzed by human thyroid peroxidase: a new and physiological measurement of thyroid peroxidase.
Topics: Diiodotyrosine; Graves Disease; Humans; In Vitro Techniques; Iodide Peroxidase; Methimazole; Methods | 1982 |
Effect on exophthalmos of various methods of treatment of Graves' disease.
Topics: Exophthalmos; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Propylt | 1982 |
Effect of anti-thyroxin autoantibodies on radioimmunoassay of free thyroxin in serum.
Topics: Autoantibodies; Cross Reactions; False Positive Reactions; Graves Disease; Humans; Male; Middle Aged | 1982 |
[Clinical evaluation of serum free T4 in patients with low Ts syndrome and pregnant patients with thyroid diseases (author's transl)].
Topics: Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Pregnancy; Pregnancy Complications; | 1982 |
Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Postpartum Period; Pregnancy; Pregnancy Comp | 1982 |
[Serum free thyroxine after 131I therapy for Graves' disease (author's transl)].
Topics: Graves Disease; Humans; Iodine Radioisotopes; Prognosis; Thyrotropin; Thyroxine; Triiodothyronine | 1981 |
Brief clinical report: Graves disease in a patient with the del(18p) syndrome.
Topics: Adolescent; Autoimmune Diseases; Chromosome Aberrations; Chromosome Deletion; Chromosome Disorders; | 1982 |
Anterior mediastinal mass in a patient with Graves' disease.
Topics: Adolescent; Female; Graves Disease; Humans; Propylthiouracil; Thymus Gland; Thyroxine; Triiodothyron | 1982 |
[Relation between hypoxia and thyroid function].
Topics: Altitude; Animals; Graves Disease; Humans; Hypoxia; Oxygen Consumption; Rats; Space Flight; Thyroid | 1982 |
Serum levels of calcium and parathyroid hormone after subtotal thyroid resection for Graves' disease.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Proteins; Calcium; Female; Graves Disease; Humans; Ma | 1982 |
[The changes in the serum thyroid hormone concentrations in Graves patients with congestive heart failure the onset of T4 toxicosis (author's transl)].
Topics: Adult; Aged; Female; Graves Disease; Heart Failure; Humans; Male; Middle Aged; Thyroid Hormones; Thy | 1982 |
Early remission in thyrotoxicosis produced by short courses of treatment.
Topics: Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Male; Thyroxine; Ti | 1982 |
Sequential deiodination of thyroxine in human thyroid gland.
Topics: Diiodothyronines; Graves Disease; Humans; Hydrogen-Ion Concentration; Iodide Peroxidase; Iodine; Kin | 1982 |
[Clinical study of Basedow's disease with T4 toxicosis].
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Thyroid Function Te | 1982 |
Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
Topics: Female; Graves Disease; Humans; Male; Oculomotor Muscles; Orbit; Plasmapheresis; Prednisolone; Thyro | 1982 |
[A long term follow-up study of patients with Graves' disease: the correlation between thyroid functions and histological findings].
Topics: Follow-Up Studies; Graves Disease; Humans; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; | 1982 |
Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease.
Topics: Adolescent; Adult; Autoimmune Diseases; Cell Count; Female; Graves Disease; Hemolytic Plaque Techniq | 1982 |
[Measurement of thyroxine-binding index by enzyme-linked immunosorbent assay (author's transl)].
Topics: Enzyme-Linked Immunosorbent Assay; Graves Disease; Humans; Hypothyroidism; Immunoenzyme Techniques; | 1982 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
Productivity of thyroglobulin and thyroid hormone on human thyroid cell in collagen gel culture.
Topics: Adenoma; Adult; Carcinoma, Papillary; Child; Collagen; Culture Techniques; Female; Gels; Graves Dise | 1995 |
[Hyperthyroidism].
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Radionuclide Imaging; Thyroid Function | 1994 |
Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
Topics: Adult; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimula | 1993 |
[Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 1994 |
Soluble endothelium-associated adhesion molecules in patients with Graves' disease.
Topics: Autoantibodies; Cell Adhesion Molecules; E-Selectin; Endothelium, Vascular; Female; Goiter; Graves D | 1994 |
[Autoimmune diseases of the thyroid in the mother; consequences for fetus and newborn infant].
Topics: Adult; Antithyroid Agents; Autoimmune Diseases; Female; Graves Disease; Humans; Hyperthyroidism; Inf | 1995 |
Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Topics: Adult; Cell Adhesion Molecules; Cohort Studies; E-Selectin; Enzyme-Linked Immunosorbent Assay; Femal | 1995 |
Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Prognos | 1995 |
Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Blotting, Western; Female; Graves Disease; HSP70 Heat-Sh | 1995 |
Hypothyroidism preceding hyperthyroidism in a patient with continuously positive thyroid stimulating antibody.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimulating; Middle Aged; T | 1995 |
Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Methimazole; M | 1995 |
Immunogenic and non-immunogenic hyperthyroidism. Recent trends in prealpine Switzerland and in coastal Poland.
Topics: Adenoma; Adult; Age Factors; Aged; Graves Disease; Humans; Hyperthyroidism; Incidence; Middle Aged; | 1995 |
Thionamides alter the efficacy of radioiodine treatment in patients with Graves' disease.
Topics: Adult; Chi-Square Distribution; Contraindications; Discriminant Analysis; Female; Graves Disease; Hu | 1995 |
Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Blood Glucose; Female; Glucose Clamp Technique; Graves Disease; Humans; Inf | 1995 |
Transient hypothyroidism after iodine-131 therapy for Grave's disease.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Life Tables; Male; Middle Aged | 1995 |
Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
Topics: Adult; Aged; Exophthalmos; Eye Diseases; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-St | 1995 |
CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease.
Topics: Adult; Aged; Antigens, CD; Autoantibodies; Autoimmune Diseases; B-Lymphocytes; CD4-Positive T-Lympho | 1993 |
Reducing effect of nadolol on serum levels of free thyroid hormones in hyperthyroidism.
Topics: Adolescent; Adult; Blood Pressure; Female; Graves Disease; Humans; Male; Middle Aged; Nadolol; Thyro | 1994 |
Does thyroxine therapy prevent recurrence of Graves' hyperthyroidism?
Topics: Graves Disease; Humans; Methimazole; Recurrence; Thyroxine | 1995 |
Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody.
Topics: Adult; Animals; Antibody Specificity; Autoimmune Diseases; CHO Cells; Congenital Hypothyroidism; Cri | 1994 |
Auditory brainstem responses in thyroid diseases before and after therapy.
Topics: Adult; Evoked Potentials, Auditory, Brain Stem; Female; Graves Disease; Humans; Hyperthyroidism; Hyp | 1995 |
Evidence for the effect of antibodies to TSH receptors on the thyroid ultrasonographic volume in patients with Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Graves Disease; Humans; Male; Middle Aged; P | 1994 |
Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Immunoradiometric Assay; Puerperal D | 1994 |
Urticaria due to blue dye in synthroid tablets.
Topics: Adult; Coloring Agents; Female; Graves Disease; Humans; Indigo Carmine; Indoles; Tablets; Thyroxine; | 1994 |
Hyperthyroidism.
Topics: Graves Disease; Humans; Iodine Radioisotopes; Methimazole; Practice Patterns, Physicians'; Thyroxine | 1995 |
Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
Topics: Animals; Disease Models, Animal; Female; Graves Disease; Immunoglobulin G; Iodine; Mice; Mice, Inbre | 1995 |
Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
Topics: Adult; Cell Count; Cytotoxicity, Immunologic; Female; Graves Disease; Humans; Interleukin-2; Killer | 1995 |
[Clinical significance of the measurement of the urinary concentration of iodine in differentiating silent thyroiditis from Graves' disease].
Topics: Creatinine; Diagnosis, Differential; Graves Disease; Humans; Iodine; Thyroiditis; Thyroxine; Triiodo | 1994 |
Hyperuricemia in patients with hyperthyroidism due to Graves' disease.
Topics: Adolescent; Adult; Aged; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Kid | 1995 |
[Association of generalized sarcoidosis and diffuse toxic goiter].
Topics: Female; Graves Disease; Humans; Middle Aged; Prednisolone; Sarcoidosis; Thyroid Diseases; Thyroid Gl | 1994 |
Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Topics: Adenylyl Cyclases; Animals; Cattle; Graves Disease; Hyperthyroidism; Hypophysectomy; Hypothyroidism; | 1995 |
Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
Topics: Animals; Asialoglycoproteins; Autoantibodies; Chorionic Gonadotropin; Graves Disease; HLA-DR Antigen | 1993 |
The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.
Topics: Adolescent; Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyr | 1994 |
Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
Topics: Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Immunoglobulins, Thyroid-Stimulating | 1994 |
Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease.
Topics: Adult; Amidohydrolases; Autoantibodies; Binding, Competitive; Biotin; Biotinidase; Carrier Proteins; | 1994 |
Thyroid hormone autoantibodies in patients with untreated Graves' disease: with special reference to age.
Topics: Adolescent; Adult; Aged; Aging; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle | 1993 |
[Neonatal hyperthyroidism in non-diagnosed Basedow's disease of the mother. Problems of diagnosis and therapy illustrated by a case history].
Topics: Adult; Bilirubin; C-Reactive Protein; Drug Therapy, Combination; Female; Graves Disease; Hepatomegal | 1994 |
Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Iodide Peroxidase; Male; Methimazole; Propylt | 1994 |
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?
Topics: Eye; Eye Diseases; Graves Disease; Humans; Indium Radioisotopes; Methimazole; Octreotide; Pentetic A | 1994 |
Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese.
Topics: Adolescent; Adult; Disease Susceptibility; Female; Genetic Predisposition to Disease; Graves Disease | 1994 |
Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
Topics: Adult; Biomarkers; CD4 Antigens; CD8 Antigens; Female; Graves Disease; Humans; Immunity, Cellular; L | 1994 |
Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy.
Topics: Adolescent; Adult; Antibodies; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Meth | 1994 |
Conjugal Graves' disease.
Topics: Adult; Autoimmune Diseases; Child; Family Health; Female; Graves Disease; Humans; Hyperthyroidism; M | 1993 |
Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice.
Topics: Animals; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioi | 1993 |
Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Graves Disease; Humans; Iodine Ra | 1993 |
The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Perchlorates; Thyroi | 1994 |
Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.
Topics: Animals; Female; Graves Disease; Humans; Iodine Radioisotopes; Methimazole; Mice; Middle Aged; Radio | 1993 |
Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?
Topics: Confidence Intervals; Drug Administration Schedule; Exophthalmos; Female; Graves Disease; Humans; Hy | 1994 |
Anti-cardiolipin antibodies in autoimmune thyroid diseases.
Topics: Adult; Antibodies, Anticardiolipin; Autoimmune Diseases; Female; Graves Disease; Humans; Immunoglobu | 1994 |
[Basedow-Graves disease development in 2 patients with primary hypothyroidism: exceptional development of the autoimmune thyroid disease].
Topics: Adult; Autoimmune Diseases; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; M | 1993 |
[The association of Graves' disease with serum soluble interleukin 2 receptor].
Topics: Adolescent; Adult; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Ma | 1993 |
Modification of a nonincinerative method for determination of iodine in iodoproteins.
Topics: Chromatography, Gel; Enzyme-Linked Immunosorbent Assay; Graves Disease; Humans; Iodine; Kinetics; Sp | 1993 |
A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Family; Female; Follow-Up Studies; | 1993 |
Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease.
Topics: Autoantibodies; Cell Line; Chorionic Gonadotropin; Cyclic AMP; Female; Graves Disease; Humans; Postp | 1993 |
Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studie | 1993 |
Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease.
Topics: Adolescent; Adult; Antibodies; Eosinophils; Female; Graves Disease; Humans; Leukocyte Count; Male; M | 1993 |
Evaluation of thyroid function in patients with thyroid hormone autoantibodies.
Topics: Adolescent; Adult; Autoantibodies; Child; Dialysis; Female; Graves Disease; Humans; Male; Middle Age | 1993 |
Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterization.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Graves Disease; Humans; Mice; Mice, SCID; Organoid | 1993 |
Surgical management of toxic goitre in Khartoum.
Topics: Adolescent; Adult; Carbimazole; Combined Modality Therapy; Drug Therapy, Combination; Female; Graves | 1993 |
Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Goiter, Nodular; Graves Disease; Humans; Hypert | 1993 |
Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit.
Topics: Combined Modality Therapy; Drug Therapy, Combination; Female; Graves Disease; Humans; Infusions, Int | 1993 |
Chemiluminescent third-generation assay (Amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed.
Topics: Bias; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunoassay; Immunoglobulin M; Lumine | 1993 |
Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Immunoassay; Luminescent Measurements; Male; | 1993 |
Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease.
Topics: Adult; Autoantibodies; Body Weight; Female; Graves Disease; Heart Rate; Humans; Ipodate; Male; Methi | 1993 |
N-glycans modulate in vivo and in vitro thyroid hormone synthesis. Study at the N-terminal domain of thyroglobulin.
Topics: Chromatography, Affinity; Chromatography, Gel; Endocytosis; Glycoconjugates; Glycopeptides; Graves D | 1995 |
Immunosuppression of Graves' hyperthyroidism--still an elusive goal.
Topics: Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Immunosuppressio | 1996 |
[Treatment of Basedow-Graves disease in pregnancy].
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Materna | 1995 |
In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil.
Topics: Adult; Dose-Response Relationship, Drug; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hyp | 1995 |
In utero treatment of fetal goitrous hypothyroidism caused by maternal Graves' disease.
Topics: Adult; Female; Fetal Diseases; Graves Disease; Humans; Hypothyroidism; Pregnancy; Pregnancy Complica | 1995 |
Separation of autonomous function from cell density in non-immunogenic hyperthyroidism. I. Quantification by double-isotope parametric scintigraphy.
Topics: Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Radioimmunoa | 1995 |
Failure of thyroxine therapy for Graves disease.
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Methimazole; Thyroxine; Treat | 1996 |
Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Topics: Animals; Antithyroid Agents; Cell Line; CHO Cells; Cricetinae; Epitopes; Goiter; Graves Disease; Hum | 1996 |
Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Maternal-Fetal | 1996 |
Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.
Topics: Adult; Autoantibodies; Carbon Dioxide; Carbon Radioisotopes; Cells, Cultured; Citrate (si)-Synthase; | 1996 |
[Basedow disease--thyrostatic drugs combined with thyroxine?].
Topics: Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Thyroid Function | 1996 |
The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Half-Life; Humans; Iodine; Iodine Radioisotopes; Male; Methimazole; M | 1996 |
Parameters of respiratory burst and arachidonic acid metabolism in polymorphonuclear granulocytes from patients with various thyroid diseases.
Topics: Adenoma; Adult; Arachidonic Acids; Calcimycin; Candida albicans; Dinoprostone; Female; Graves Diseas | 1996 |
Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism--implications for localization of thyroid hormone absorption in the gut.
Topics: Antiprotozoal Agents; Female; Giardiasis; Graves Disease; Humans; Hypothyroidism; Intestinal Absorpt | 1996 |
Decreased secretion of gonadotropins in a patient with Graves' disease.
Topics: Antithyroid Agents; Body Weight; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotrop | 1996 |
Relationships between plasma thyrotropin receptor antibodies and lipid or lipoprotein parameters in Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Female; Graves Disease; Humans; Lipids; Lipoproteins; Mi | 1996 |
Is there one successful antithyroid regimen for Graves' disease?
Topics: Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Immune Tolerance | 1996 |
Elevated plasma adrenomedullin level in hyperthyroidism.
Topics: Adrenomedullin; Adult; Blood Pressure; Female; Graves Disease; Heart Rate; Humans; Male; Middle Aged | 1996 |
Thyroid morphology and function after surgical treatment of thyroid diseases.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Goiter, Nodular; Gra | 1996 |
Graves' disease and autoimmune factor VIII deficiency.
Topics: Autoimmune Diseases; Cyclophosphamide; Female; Graves Disease; Hemophilia A; Humans; Immunoglobulins | 1996 |
Comment: therapeutic failure with levothyroxine brand interchange.
Topics: Drugs, Generic; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Therapeutic Equivalenc | 1995 |
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.
Topics: Animals; Antigen-Antibody Reactions; Cattle; Cyclic AMP; Female; Graves Disease; Histocompatibility | 1996 |
Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Topics: Adult; Antibody-Dependent Cell Cytotoxicity; Blotting, Western; Electrophoresis, Polyacrylamide Gel; | 1996 |
Exophthalmos in Cushing's syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cushing Syndrome; Exophthalmos; Female; Graves Disease; | 1996 |
The many causes of subclinical hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Mal | 1996 |
The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging.
Topics: Autoantibodies; Female; Graves Disease; HLA Antigens; Humans; Middle Aged; Radionuclide Imaging; Rec | 1996 |
Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
Topics: Acute Disease; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Immunologic Techniques; Male; | 1997 |
Transient hypothyroidism.
Topics: Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Thyroxine; Time Factors | 1997 |
Plasma selectin levels in patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; E-Selectin; Female; Graves Disease; Humans; L-Selectin; M | 1996 |
Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Collagen; Collagen Type I; | 1996 |
Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Receptors, Thyrotropin; Thyroid Gland; Thyroi | 1996 |
Management of multiple-antibody-mediated hyperthyroidism in children with Down's syndrome.
Topics: Adolescent; Antithyroid Agents; Autoantibodies; Child; Down Syndrome; Female; Graves Disease; Humans | 1997 |
[Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease].
Topics: Adult; Age Factors; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Male; M | 1997 |
Cholesterol 7 alpha-hydroxylase activity in hypothyroidism and hyperthyroidism in humans.
Topics: Adenoma; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, HDL; Cholesterol, | 1997 |
[Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Developmental Disabilities; | 1997 |
Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
Topics: Adult; Aged; Female; Goiter; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Mid | 1997 |
Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
Topics: Animals; Asialoglycoproteins; Cattle; Cells, Cultured; Chorionic Gonadotropin; Dose-Response Relatio | 1997 |
Total thyroidectomy for Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Re | 1997 |
Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Blood Loss, Surgical; Female; Graves Disease | 1997 |
The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Topics: Bone Development; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Infant, Newborn | 1997 |
Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Female; Goiter; Graves Disease; Humans; Iodide Peroxidas | 1997 |
Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
Topics: Adult; CD4-Positive T-Lymphocytes; Cells, Cultured; Female; Graves Disease; Humans; Integrin beta1; | 1997 |
Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Topics: Adenoma; Adult; Aged; Biomarkers; Collagen; Collagen Type I; Diagnosis, Differential; Female; Goiter | 1997 |
Alteration of platelet aggregation in patients with thyroid disorders.
Topics: Adenosine Diphosphate; Adult; Female; Graves Disease; Humans; Hypothyroidism; In Vitro Techniques; M | 1997 |
Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Topics: Female; Fetal Blood; Fetal Diseases; Graves Disease; Humans; Hypothyroidism; Maternal-Fetal Exchange | 1997 |
Necrobiosis lipoidica diabeticorum and thyroid disease.
Topics: Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Middle Aged; Necrobiosis Lipo | 1997 |
Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism.
Topics: Adult; Antithyroid Agents; Apolipoprotein A-I; Apolipoproteins B; Carrier Proteins; Cholesterol; Cho | 1998 |
Late and transient increases in free T4 after radioiodine treatment for Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; Iodine Radioisotopes; | 1997 |
Serum androgen levels in hyperthyroid women.
Topics: Adult; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Dihydrotestosterone; Female; | 1997 |
Recent trends in the management of Graves' hyperthyroidism in Japan: opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone.
Topics: Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Humans; Japan; Societies, Medical; Su | 1997 |
A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy.
Topics: Antibodies, Blocking; Autoantibodies; Cells, Cultured; Female; Graves Disease; Humans; Immunoglobuli | 1998 |
[TSH-receptor blocking antibodies in juvenile thyrotoxicosis].
Topics: Age Factors; Antibodies, Blocking; Antithyroid Agents; Child; Female; Graves Disease; Humans; Hypoth | 1998 |
[How I study Basedow's disease: from classic clinical examination to radioimmunologic diagnosis].
Topics: Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Physical Examination; Radioimmunodetec | 1997 |
Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients.
Topics: Adolescent; Adult; Aged; Autoantibodies; Biomarkers; Female; Follow-Up Studies; Graves Disease; Huma | 1997 |
Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, | 1998 |
[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Topics: Administration, Oral; Antithyroid Agents; Female; Graves Disease; Half-Life; Humans; Iodine Radioiso | 1998 |
[Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Child; Female; Graves Disease; Human | 1998 |
[Hematological changes in hyperthyroidism. A case report].
Topics: Anemia; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iatrogenic Disease; Iodin | 1998 |
Spuriously high free thyroxine with the Access free T4 assay.
Topics: Artifacts; Dandy-Walker Syndrome; Graves Disease; Humans; Immunoenzyme Techniques; Luminescent Measu | 1998 |
Platelet epidermal growth factor in thyroid disorders.
Topics: Adult; Blood Platelets; Epidermal Growth Factor; Female; Graves Disease; Humans; Hypothyroidism; Mal | 1998 |
Prevalence and significance of steatorrhea in patients with active Graves' disease.
Topics: Absorption; Adult; Antithyroid Agents; Body Mass Index; Carbimazole; Case-Control Studies; Celiac Di | 1998 |
Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
Topics: Adult; Apolipoprotein A-I; Body Mass Index; Carrier Proteins; Centrifugation, Density Gradient; Chol | 1998 |
Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease.
Topics: Adolescent; Adult; Antigens, CD; Autoantibodies; B-Lymphocytes; Female; Graves Disease; Humans; Immu | 1998 |
[Simultaneous occurrence of Graves' ophthalmopathy and autonomous thyroid nodules].
Topics: Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide I | 1998 |
Impaired Na+,K+ATPase activity in red blood cells in euthyroid women treated with levothyroxine after total thyroidectomy for Graves' disease.
Topics: Adult; Binding Sites; Erythrocytes; Female; Graves Disease; Hormone Replacement Therapy; Humans; Oua | 1998 |
[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; Child; Female; Graves Disease; Humans; Iodine Radio | 1998 |
Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Topics: Adolescent; Adult; Eye Diseases; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, T | 1998 |
Soluble CD27 in thyroid disorders.
Topics: Acute Disease; Adult; Aged; Antithyroid Agents; Biomarkers; Chronic Disease; Female; Graves Disease; | 1998 |
Normal serum concentrations of sex hormone binding-globulin in patients with hyperthyroidism due to subacute thyroiditis.
Topics: Adenoma; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Reference Values | 1998 |
Graves' hyperthyroidism after postpartum thyroiditis.
Topics: Abortion, Therapeutic; Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Middle Aged; Pre | 1998 |
Serum cytokines in thyrotoxicosis.
Topics: Adult; Antithyroid Agents; Carbimazole; Cytokines; Female; Goiter, Nodular; Graves Disease; Humans; | 1999 |
Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
Topics: Adult; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Interleukin-12; | 1999 |
Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Immunoglo | 1999 |
Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.
Topics: Adult; Autoantibodies; Biopsy, Needle; Female; Graves Disease; Humans; Hypothyroidism; Immunoglobuli | 1999 |
A sneak peek: a case of early thyroid eye disease.
Topics: Diagnostic Techniques, Ophthalmological; Female; Graves Disease; Humans; Middle Aged; Ocular Motilit | 1999 |
Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Topics: Adenoma; Aged; Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid- | 1999 |
Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.
Topics: Adult; Antithyroid Agents; Autoantibodies; Biopsy, Needle; Female; Goiter; Graves Disease; Humans; I | 1999 |
Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Topics: Adult; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypothyro | 1999 |
Apparent cure of Graves-Basedow disease after sibling allogeneic bone marrow transplantation.
Topics: Adult; Anemia, Aplastic; Autoantibodies; Bone Marrow Transplantation; Female; Follow-Up Studies; Gra | 1999 |
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
Topics: Abatacept; Alanine; Alleles; Antigens, CD; Antigens, Differentiation; Case-Control Studies; Chromoso | 1999 |
[Attempted suicide with 400 thyroxine pills: what happened to the physician-patient relationship?].
Topics: Antithyroid Agents; Brachytherapy; Female; Graves Disease; Humans; Hypothyroidism; Middle Aged; Phys | 1999 |
A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease.
Topics: Alanine Transaminase; Antibodies, Antinuclear; Autoantibodies; Female; Goiter; Graves Disease; Hepat | 1999 |
Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; Humans; Immunoglobulin A; Immunogl | 1999 |
Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.
Topics: Adult; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antithyroid Agents; Diagnosis, Differential; F | 1999 |
Fetal pituitary negative feedback at early gestational age.
Topics: Adult; Amniotic Fluid; Feedback; Female; Fetal Blood; Fetal Diseases; Gestational Age; Graves Diseas | 1999 |
Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor.
Topics: Amino Acid Sequence; Animals; Antibodies; Disease Models, Animal; Glycoproteins; Graves Disease; Hum | 1999 |
Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Topics: Adolescent; Adult; Antithyroid Agents; Child; Combined Modality Therapy; Drug Evaluation; Female; Gr | 1999 |
Graves' disease presenting with cholestatic jaundice.
Topics: Adult; Cholestasis; Female; Graves Disease; Humans; Liver Function Tests; Thyrotropin; Thyroxine | 1999 |
Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism.
Topics: Adult; Female; Gestational Age; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Parathyroid | 1999 |
Postpartum thyroiditis in women with hypothyroidism antedating pregnancy?
Topics: Autoimmune Diseases; Female; Graves Disease; Humans; Hypothyroidism; Logistic Models; Pregnancy; Pre | 1999 |
Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production.
Topics: Adult; Aged; Autoantibodies; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Graves Disease; H | 1999 |
Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients.
Topics: Adult; Antithyroid Agents; Case-Control Studies; Female; Graves Disease; Growth Hormone; Growth Horm | 1999 |
Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Topics: Adenoma; Adult; Antithyroid Agents; Carcinoma, Papillary; Female; Graves Disease; Humans; Iodine Rad | 1999 |
Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Human Growth Hormone; Humans; Insulin-Like Growth | 1999 |
Color Doppler ultrasonography in patients with subacute thyroiditis.
Topics: Adult; Aged; Blood Vessels; Female; Graves Disease; Humans; Middle Aged; Recovery of Function; Refer | 1999 |
Familial dysalbuminemic hypertriiodothyroninemia in a Japanese kindred.
Topics: Female; Graves Disease; Humans; Middle Aged; Pedigree; Serum Albumin; Thyrotropin; Thyroxine; Triiod | 2000 |
[T3-thyrotoxicosis: incidence, significance and correlation with iodine intake].
Topics: Graves Disease; Humans; Hungary; Iodine; Thyrotoxicosis; Thyroxine; Triiodothyronine | 2000 |
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report.
Topics: Autoantibodies; Biomarkers; Graves Disease; Humans; Male; Middle Aged; Oculomotor Muscles; Thyroidit | 2000 |
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
Topics: Animals; Autoantibodies; Autoimmune Diseases; CHO Cells; Cricetinae; Cricetulus; Disease Models, Ani | 2000 |
Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Body Weight; Female; Follow-Up Studies; Grave | 1999 |
Thyroid suppression test with L-thyroxine and [99mTc] pertechnetate.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Depression, Chemical; Female; Goiter; Graves D | 2000 |
Seasonal changes in calcium homeostasis affect the incidence of postoperative tetany in patients with Graves' disease.
Topics: Adult; Alkaline Phosphatase; Calcifediol; Calcitriol; Calcium; Female; Graves Disease; Homeostasis; | 2000 |
A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.
Topics: Adult; Antithyroid Agents; Carcinoma, Papillary; Granuloma; Graves Disease; Humans; Lymphatic Metast | 2000 |
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Case-Control Studies; Female; Glucocorticoids; Graves D | 2000 |
Congenital neonatal thyrotoxicosis and previous maternal radioiodine therapy.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Infant, Newborn; Infant, Premature; Infant, P | 2000 |
Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years.
Topics: Antithyroid Agents; Autoantibodies; Biomarkers; Endocrinology; Graves Disease; Humans; Iodide Peroxi | 2000 |
Circulating endothelium-related adhesion molecules in black South African patients with Graves' disease.
Topics: Adolescent; Adult; Black People; E-Selectin; Female; Graves Disease; Humans; Intercellular Adhesion | 2000 |
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Interferon beta-1a; Interferon beta-1b; Inter | 2000 |
Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.
Topics: Adult; Dose-Response Relationship, Drug; Graves Disease; Humans; Hyperpituitarism; Male; Nephrotic S | 2000 |
Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
Topics: Antithyroid Agents; Autoantibodies; Cholesterol, HDL; Cholesterol, LDL; Female; Graves Disease; Huma | 2000 |
Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Topics: Adult; Antithyroid Agents; Autoantibodies; Breast Feeding; Drug Administration Schedule; Evaluation | 2000 |
Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
Topics: Antithyroid Agents; Autoantibodies; Child; Exophthalmos; Female; Graves Disease; Humans; Immunoglobu | 2000 |
An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Biomarkers; Female; Goiter; Goiter, | 2000 |
Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Goiter, Nodular; Graves Disease; Humans; Int | 2000 |
[Indications for surgical treatment of diffuse toxic goiter].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; | 2000 |
Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Graves Disease; Humans; Leptin; Middle Aged; Thyro | 2000 |
Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; | 2000 |
Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Topics: Adipose Tissue; Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobul | 2000 |
Tachycardia-induced cardiomyopathy secondary to thyrotoxicosis: a young man with previously unrecognized Graves' disease.
Topics: Adult; Atrial Fibrillation; Cardiomyopathy, Dilated; Echocardiography; Electrocardiography; Graves D | 2000 |
[Hypothyroidism and endocrine orbitopathy].
Topics: Adult; Autoantibodies; Binding Sites, Antibody; Female; Graves Disease; Humans; Hypothyroidism; Rece | 2000 |
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antithyroid Agents; Autoantibodies; Biomarkers; Bone and B | 2000 |
Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Autoantibodies; CD4 Lymphocyte Count | 2000 |
Spuriously high serum concentrations of TSH due to the use of an automatic pipetting device.
Topics: Artifacts; Automation; Female; Goiter; Graves Disease; Humans; Hypothyroidism; Radioimmunoassay; Thy | 2000 |
[Hyperthyroidism: a cause of serum ferritin elevation].
Topics: Autoantibodies; Erythrocytes; Ferritins; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; | 2000 |
Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglob | 2000 |
Thyroid-associated ophthalmopathy in black South Africans with Graves' disease: relationship to serum antibodies reactive against eye muscle and orbital connective tissue autoantigens.
Topics: Adolescent; Adult; Autoantibodies; Autoantigens; Black People; Connective Tissue; Eye; Female; Grave | 2000 |
Graves' disease after 131I therapy for toxic nodule.
Topics: Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Thyroid Nodule; Thyrotropin; Thyroxine | 2001 |
Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
Topics: Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Thyrotoxico | 1998 |
Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients.
Topics: Adult; Antithyroid Agents; Erythrocytes; Female; Glutathione; Graves Disease; Humans; Male; Nitric O | 2001 |
Congenital thyrotoxicosis in premature infants.
Topics: Antithyroid Agents; Autoantibodies; Carbimazole; Female; Fetal Blood; Fetal Growth Retardation; Grav | 2001 |
Graves' disease presenting as hemiparkinsonism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Diagnosis, Diff | 2001 |
Triiodothyronine predominant Graves' disease in a South-East Asian population: prevalence and clinical significance.
Topics: Asia, Southeastern; Graves Disease; Humans; Thyroxine; Triiodothyronine | 2001 |
Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
Topics: Adult; Female; Gestational Age; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunoglobu | 2001 |
[Graves' disease. Clinical features and treatment results].
Topics: Antithyroid Agents; Disease-Free Survival; Female; Graves Disease; Humans; Iodine Radioisotopes; Mal | 2001 |
[Thyroid function tests].
Topics: Graves Disease; Humans; Isoantibodies; Receptors, Thyrotropin; Thyroid Diseases; Thyroid Function Te | 2001 |
[An index based on the age and free thyroxine rate predicts the likelihood of Graves' disease in hyperthyroidism].
Topics: Adult; Age Factors; Animals; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Mod | 2001 |
Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter.
Topics: Adolescent; Antithyroid Agents; Autoantibodies; Child; Female; Goiter, Nodular; Graves Disease; Huma | 2001 |
Hyperthyroidism is associated with lengthening of ventricular repolarization.
Topics: Adrenergic beta-Antagonists; Adult; Electrocardiography, Ambulatory; Electrolytes; Female; Follow-Up | 2001 |
A case of pulmonary metastatic thyroid cancer complicated with Graves' disease.
Topics: Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimula | 2001 |
Detection of antipituitary antibodies in patients with autoimmune thyroid disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Autoantigens; Blotting, Western; Enzyme | 2001 |
Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Topics: Acidosis, Respiratory; Adult; Anesthetics; Antithyroid Agents; Carbon Dioxide; Creatine Kinase; Dant | 2001 |
Serum cytokines levels in Graves' disease.
Topics: Adult; Case-Control Studies; Cytokines; Female; Graves Disease; Humans; Male; Thyrotoxicosis; Thyrox | 2000 |
Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Disease-Free Survival; Family; Female; | 2001 |
Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Cohort Studies; Female; Goiter, Nodular; Graves Disease | 2001 |
Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Topics: Adult; Analysis of Variance; Antithyroid Agents; Epitopes; Female; Graves Disease; Humans; Immunoglo | 2001 |
Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Female; Goiter; Graves Disease; Hemodynamics; Humans; Hyperthyroidis | 2001 |
Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
Topics: Aged; Antithyroid Agents; Carbimazole; Female; Goiter, Nodular; Graves Disease; Humans; Iodine Radio | 2001 |
Association between lithium use and thyrotoxicosis caused by silent thyroiditis.
Topics: Adult; Antimanic Agents; Female; Graves Disease; Humans; Iodine Radioisotopes; Lithium Carbonate; Ma | 2001 |
Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Cross-Sectional Studies; Graves Disease; Hormone Replac | 2001 |
[Increased serum PIVKA-II levels in hyperthyroidism].
Topics: Adolescent; Adult; Aged; Biomarkers; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle A | 2001 |
Severe myocardial ischemia following hormone replacement in two cases of hypothyroidism with normal coronary arteriogram.
Topics: Acute Disease; Coronary Angiography; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Ag | 2001 |
Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease.
Topics: Adult; Antibodies; Cryopreservation; Graves Disease; Humans; Hypothyroidism; Iodide Peroxidase; Male | 2002 |
Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
Topics: Adult; Aged; Animals; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglob | 2002 |
Production of 8-OHdG and cytochrome c by cultured human mononuclear cells in patients with autoimmune thyroid disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antigens, Nuclear; Cytochrome c Group; Deoxyguanosine; Female; G | 2001 |
Blocking type anti-tSH receptor antibodies detected by radioreceptor assay in Graves' disease.
Topics: Adolescent; Adult; Animals; Antibodies, Blocking; Cells, Cultured; Female; Graves Disease; Humans; I | 2001 |
Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass.
Topics: Adult; Biopsy, Needle; Carcinoma, Papillary; Female; Graves Disease; Humans; Iodine Radioisotopes; L | 2002 |
Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism.
Topics: Adipose Tissue; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Interleukin-6; Leptin; Pl | 2002 |
Pitfalls to avoid while interpreting thyroid function tests: five illustrative cases.
Topics: Adult; Aged; Contraceptives, Oral; Coronary Artery Bypass; Diagnosis, Differential; Diagnostic Error | 2002 |
Prevalence of hypergastrinemia in patients with hyper- and hypothyroidism: impact for calcitonin?
Topics: Aged; Calcitonin; Female; Gastrins; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; M | 2002 |
Accelerated production of nucleosome in cultured human mononuclear cells in untreated Graves' disease.
Topics: Adult; Apoptosis; Caspase 3; Caspases; Cytochrome c Group; DNA; Fas Ligand Protein; fas Receptor; Fe | 2002 |
[Acute posterior multifocal placoid pigment epitheliopathy associated with Graves-Basedow's disease].
Topics: Acute Disease; Adult; Antithyroid Agents; Choroid; Combined Modality Therapy; Female; Fluorescein An | 2002 |
Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Diagnosis, Differential; Eo | 2002 |
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Hyperplasia; Immunoglobulin G; Immunoglobulins, T | 1978 |
Stimulation with thyrotrophin-releasing hormone (TRH) during antithyroid treatment.
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Goiter, Nodular; Graves Disease; Humans; Male; Middl | 1975 |
Hormonal pattern of relapse in hyperthyroidism.
Topics: Carbimazole; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Radioimmunoassay; Recurrenc | 1975 |
Serum triiodothyronine 7-15 years after fractionated low dose radioiodine therapy of thyrotoxicosis.
Topics: Adult; Aged; Cholesterol; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; M | 1975 |
Value of routine serum-triiodothyronine estimation in diagnosis of thyrotoxicosis.
Topics: Evaluation Studies as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Male; Radioimmunoassay | 1975 |
Intentional radioiodine ablation in Graves' disease.
Topics: Administration, Oral; Adult; Aged; Evaluation Studies as Topic; Follow-Up Studies; Graves Disease; H | 1975 |
Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Iodine; Thyroid Gland; Thyrox | 1975 |
Endocrine and metabolic diseases. Treatment of thyroid disease: I.
Topics: Adult; Aged; Antithyroid Agents; Child; Child, Preschool; Eye Manifestations; Female; Graves Disease | 1976 |
Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Methimazole; Middle Age | 1976 |
[Basedow's disease in the pregnant woman. Should thyroxine be added to synthetic antithyroid drugs?].
Topics: Antithyroid Agents; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Maternal-Fetal Exchange; | 1976 |
Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
Topics: Adolescent; Adult; Antithyroid Agents; Female; Graves Disease; Humans; In Vitro Techniques; Iodine R | 1977 |
Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents.
Topics: Adolescent; Antithyroid Agents; Carbimazole; Child; Child, Preschool; Drug Administration Schedule; | 1977 |
Diagnosis of hyperthyroidism when serum-thyroxine alone is raised.
Topics: Adult; Aged; Delirium; False Negative Reactions; Female; Follow-Up Studies; Gastroenteritis; Graves | 1977 |
Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
Topics: Administration, Oral; Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; | 1977 |
[Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
Topics: Adult; Chronic Disease; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Function Tests; T | 1977 |
[Evolution of thyroximemia in the course of Basedow's disease treated with thyroid antagonists].
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Male; Thyroxine | 1977 |
[Management of patients with thyrotoxicosis of childbearing age (author's transl)].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antithyroid Agents; Female; Graves Diseas | 1977 |
Thyroid function.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Pregnancy; Radio | 1978 |
Closer correlation between serum triiodothyronine and basal metabolic rate during antithyroid drug treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Antithyroid Agents; Basal Metabolism; Female; Graves Disease; Humans; Male; Methi | 1978 |
Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
Topics: Adult; Autoimmune Diseases; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism | 1978 |
Long term antithyroid drug therapy for intractable cases of Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Recurrence; Thyroxine; | 1978 |
T3/T4 ratio in thyroid disease.
Topics: Diagnosis, Differential; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1978 |
[Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Male; Thyroid Hormones; Thyrotr | 1979 |
T3/T4 ratio in thyroid disease.
Topics: Diagnosis, Differential; False Negative Reactions; Female; Graves Disease; Humans; Hyperthyroidism; | 1979 |
[Practical experiences with the TRH rapid test in the diagnosis of thyroid function].
Topics: Graves Disease; Hyperthyroidism; Hypothyroidism; In Vitro Techniques; Radionuclide Imaging; Thyroid | 1979 |
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
Topics: Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; | 1979 |
An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
Topics: Animals; Catecholamines; Cyclic AMP; gamma-Globulins; Graves Disease; Humans; Hyperthyroidism; Long- | 1978 |
[Early histological changes of the thyroid gland sway the prognosis of juvenile thyrotoxicosis treated with antithyroid therapy (author's transl)].
Topics: Adolescent; Antithyroid Agents; Child; Child, Preschool; Female; Graves Disease; Humans; Male; Progn | 1979 |
[Hyperthyroidism: diagnosis (author's transl)].
Topics: Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Radionuclide Imaging; Thyroid Function Tes | 1978 |
Spectrum of pituitary alterations with mild and severe thyroid impairment.
Topics: Adult; Aged; Cholesterol; Female; Graves Disease; Growth Hormone; Humans; Hydrocortisone; Hypoglycem | 1978 |
Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.
Topics: Adolescent; Adult; Child; Female; Graves Disease; Humans; Iodides; Iodine Radioisotopes; Male; Middl | 1978 |
[Pathophysiology of the thyroid gland. Some newer aspects (author's transl)].
Topics: Binding, Competitive; Exophthalmos; Graves Disease; Humans; Immunoglobulin G; Receptors, Cell Surfac | 1977 |
The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism.
Topics: Adolescent; Adult; Body Weight; Drug Evaluation; Female; Graves Disease; Humans; Ipodate; Male; Midd | 1978 |
Clinicopathological conference. Twenty-six year old postpartum female with thyrotoxicosis.
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Thy | 1979 |
Thyrotoxicosis: relations between clinical state and biochemical changes during carbimazole treatment.
Topics: Adult; Carbimazole; Female; Graves Disease; Humans; Male; Middle Aged; Sex Hormone-Binding Globulin; | 1977 |
Graves' disease associated with familial deficiency of thyroxine-binding globulin.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Pedigree; Serum Globulins; Thyroxine; Thyr | 1977 |
The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; Pro | 1977 |
Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.
Topics: Adolescent; Adult; Female; Graves Disease; Haploidy; Histocompatibility Antigens; HLA Antigens; Huma | 1977 |
[Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)].
Topics: Dose-Response Relationship, Radiation; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroid | 1977 |
[Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)].
Topics: Adolescent; Adult; Autoantibodies; Child; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid | 1978 |
[Study of the thyroid function by the I-M TRH test (2 mg) (author's transl)].
Topics: Adult; Evaluation Studies as Topic; Female; Graves Disease; Humans; Hyperthyroidism; Male; Thyroid D | 1978 |
[Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease].
Topics: Graves Disease; Humans; Pituitary Gland, Anterior; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing | 1978 |
Transient recurrence of hyperthyroidism after delivery in Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Microsomes; | 1977 |
Ophthalmic Graves's disease: natural history and detailed thyroid function studies.
Topics: Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Syndrome; Thyroid Function Tests; Th | 1977 |
Lack of indomethacin effect on thyroid function in man.
Topics: Adult; Graves Disease; Humans; Indomethacin; Iodine Radioisotopes; Male; Middle Aged; Prostaglandins | 1977 |
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Male; Middle Aged; Propranolol; Thyroxine; | 1977 |
Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
Topics: Graves Disease; Humans; Infant; Methimazole; Propylthiouracil; Thyroid Hormones; Thyrotropin; Thyrox | 1977 |
Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Topics: Drug Therapy, Combination; Graves Disease; Humans; Iodides; Iodine; Methimazole; Propranolol; Propyl | 1977 |
Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
Topics: Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Male; Middle Aged; Thyroxine; | 1977 |
Reduction of plasma triiodothyronine (T3) induced by propranolol.
Topics: Adult; Female; Graves Disease; Humans; Male; Propranolol; Thyroxine; Time Factors; Triiodothyronine | 1977 |
T3 toxicosis in children.
Topics: Child; Female; Graves Disease; Humans; Hyperthyroidism; Propylthiouracil; Thyroid Function Tests; Th | 1977 |
Compensated low-dose 131I therapy of Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Radi | 1977 |
Combination drug therapy for treatment of hyperthyroid Grave's disease.
Topics: Adult; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1977 |
[Retrobulbular tissue changes following TSH administration and influence of various drugs in rats].
Topics: Animals; Graves Disease; Hydrocortisone; Male; Methionine; Rats; Thyroid Gland; Thyrotropin; Thyroxi | 1977 |
[Therapy of hyperthyroidism, compiled according to the recommendations of the section on thyroid gland of the German Endocrinological Society. 2. Control of therapy, therapy of endocrine ophthalmopathies, therapy during pregnancy and in childhood].
Topics: Adrenal Cortex Hormones; Child; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Prognosi | 1977 |
Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Middle Aged; Thy | 1977 |
[Diagnostic value and indication of the suppression test within the scope of thyroid-function diagnostics].
Topics: Adenoma; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Thyroid Function Tests; Thyr | 1977 |
[Long term follow-up after thyroidectomy].
Topics: Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Recurrence; Thyroid Neoplasms; Thyroidec | 1978 |
Complete heart block with hyperthyroidism.
Topics: Adult; Atrial Fibrillation; Electrocardiography; Female; Graves Disease; Heart Block; Humans; Hypoth | 1978 |
Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
Topics: Child, Preschool; Female; Graves Disease; Humans; Potassium Iodide; Propylthiouracil; Thyroglobulin; | 1978 |
Chemical determination of iodinated compounds in human thyroid.
Topics: Adult; Aged; Animals; Diiodotyrosine; Female; Graves Disease; Humans; Iodine; Male; Methods; Middle | 1978 |
Graves' hyperthyroidism. Spontaneous occurrence after autoimmune hypothyroidism with persistent infiltrative ophthalmopathy.
Topics: Adult; Autoimmune Diseases; Eye Manifestations; Female; Graves Disease; Humans; Hypothyroidism; Iodi | 1978 |
T4-thyrotoxicosis.
Topics: Adult; Graves Disease; Humans; Male; Thyroxine; Triiodothyronine | 1978 |
[Differential diagnosis and treatment of the goitre (author's transl)].
Topics: Diagnosis, Differential; Goiter; Graves Disease; Humans; Potassium Iodide; Thyroiditis, Autoimmune; | 1978 |
[Value of the assay of plasma triiodothyronine level for the diagnosis of hyperthyroidism and hypothyroidism].
Topics: Adult; Aged; Contraceptives, Oral; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; | 1978 |
Thyroid function tests simulating Graves' disease in alcoholic hepatitis.
Topics: Adult; Diagnosis, Differential; Graves Disease; Hepatitis, Alcoholic; Humans; Liver; Male; Thyroid F | 1978 |
T4 toxicosis in Graves' disease.
Topics: Aged; Graves Disease; Humans; Male; Thyroxine | 1978 |
[Hyperthyroidism in older patients].
Topics: Aged; Cardiovascular Diseases; Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hyp | 1978 |
Prevention and management of hyperthyroid storm.
Topics: Adrenal Glands; Graves Disease; Humans; Hyperthyroidism; Propylthiouracil; Sympatholytics; Thyroid C | 1978 |
On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.
Topics: Animals; Graves Disease; Guinea Pigs; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulator; Pitu | 1978 |
[Three cases of multinodular toxic goiter (author's transl)].
Topics: Adolescent; Adult; Female; Goiter, Nodular; Graves Disease; Humans; Radionuclide Imaging; Thyroid Gl | 1978 |
Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulin G; Long-Acting Thyroid Stimulator; Male; | 1979 |
[Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
Topics: Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes | 1979 |
Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy.
Topics: Adult; Aged; Drug Evaluation; Female; Graves Disease; Humans; Male; Middle Aged; Premedication; Prop | 1979 |
Alkaline phosphatase isoenzyme patterns in hyperthyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Female; Graves Disease; Humans; Hyperthyroidism; Isoe | 1979 |
Plasma dopamine-beta-hydroxylase activity and thyroid suppressibility in Graves' disease.
Topics: Dopamine beta-Hydroxylase; Graves Disease; Humans; Iodine; Thyroid Gland; Thyroxine; Triiodothyronin | 1979 |
Serum thyroglobulin in patients with toxic and non-toxic goitres compared to sex- and age-matched control subjects.
Topics: Adenoma; Adult; Age Factors; Aged; Female; Goiter; Goiter, Nodular; Graves Disease; Humans; Male; Mi | 1979 |
A radioimmunoassay for measurement of 3,5-diiodothyronine.
Topics: Amniotic Fluid; Diiodothyronines; Female; Fetal Blood; Graves Disease; Humans; Hyperthyroidism; Hypo | 1979 |
Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.
Topics: Graves Disease; Humans; Hyperthyroidism; Ipodate; Kinetics; Male; Reference Values; Thyroiditis, Aut | 1978 |
Inhibition of thyroidal iodine release by estrogens in patients with hyperthyroidism.
Topics: Adult; Dienestrol; Female; Graves Disease; Humans; Iodides; Male; Middle Aged; Phenols; Thyroid Glan | 1979 |
Metabolic clearance and production rates of prolactin in man.
Topics: Adenoma; Adult; Aged; Dopamine; Female; Graves Disease; Humans; Hypothyroidism; Male; Metabolic Clea | 1979 |
The regulation of thyrotrophin secretion by exogenous thyroxine and triiodothyronine.
Topics: Carbimazole; Graves Disease; Humans; Male; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronin | 1979 |
Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.
Topics: Adenoma; Adenylyl Cyclases; Adult; Aged; Enzyme Activation; Female; Graves Disease; Humans; Hyperthy | 1979 |
[Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part. I. Solid-state radioimmunoassy for human serum TSH and its clinical application (author's transl)].
Topics: Animals; Cushing Syndrome; Goiter, Nodular; Graves Disease; Humans; Hypothyroidism; Rabbits; Radioim | 1975 |
[Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part II. Development of rapid radioimmunoassay for triiodothyronine (author's transl)].
Topics: Adult; Animals; Female; Graves Disease; Humans; Hypothyroidism; Male; Rabbits; Radioimmunoassay; Thy | 1975 |
[Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treate
Topics: Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Thyroiditis, Autoimmune; Thyrotropi | 1975 |
Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations.
Topics: Acromegaly; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Thyrotr | 1976 |
Insufficient TSH stimulation after successful treatment for hyperthyroidism.
Topics: Follow-Up Studies; Graves Disease; Humans; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Tr | 1976 |
Graves thyrotoxicosis following primary thyroid failure.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Thyroid (USP); Thyrotropin; | 1976 |
Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
Topics: Adult; Antibodies; Female; Graves Disease; Humans; Iodine Radioisotopes; Lithium; Male; Thyroglobuli | 1976 |
[Serum T4 and T3 levels during administration of Lugol's solution in Basedow's disease].
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; Solutions; Thyroxine; Triiod | 1976 |
Blood coagulation and fibrinolysis in thyroid disease.
Topics: Autoantibodies; Blood Coagulation; Factor VIII; Fibrinolysis; Graves Disease; HLA Antigens; Humans; | 1976 |
Circulating immune complexes in Graves' disease.
Topics: Adolescent; Adult; Antigen-Antibody Complex; Autoimmune Diseases; Female; Graves Disease; Humans; Hy | 1976 |
Hyperthyroidism.
Topics: Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Methimazole; Propylthiouracil; Thyroi | 1976 |
Hemiagenesis of the thyroid gland.
Topics: Adult; Congenital Abnormalities; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotop | 1975 |
Serum triiodothyronine concentration in the diagnosis of hyperthyroidism.
Topics: Adenoma; Carbimazole; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Radioimmunoassa | 1975 |
Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Topics: Adult; Aged; Animals; Biological Assay; Carbimazole; Female; Graves Disease; Humans; Iodine Radioiso | 1975 |
[Determination of serum triiodothyronine by radioimmunoassay].
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Diseases; Thyroxi | 1975 |
Acute effects of corticosteroids on thyroid activity in Graves' disease.
Topics: Adolescent; Adult; Dexamethasone; Female; Graves Disease; Humans; Male; Middle Aged; Thyroglobulin; | 1975 |
Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Topics: Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyrotropin; Thyroxine; Triiodothyronine | 1975 |
Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
Topics: Adult; Dexamethasone; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; Thyroxine; | 1975 |
Iodide-induced (SSKI) hypothyroidism in infancy.
Topics: Adult; Asthma; Female; Graves Disease; Humans; Hypothyroidism; Infant; Male; Potassium Iodide; Propy | 1975 |
[Clinical studies on autoimmune mechanisms of the thyroid. Part 2. Studies on measurements of serum thyroblobulin concentrations in patients with various thyroid diseases (author's transl)].
Topics: Antibodies; Chromatography, Affinity; Cross Reactions; Graves Disease; Humans; Thyroglobulin; Thyroi | 1975 |
Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Carbimazole; Drug Therapy, Combinati | 1992 |
Thyroxine-binding globulin variant (TBG-Kumamoto): identification of a point mutation and genotype analysis of its family.
Topics: Adult; Base Sequence; Codon; Electrophoresis, Agar Gel; Exons; Female; Genotype; Graves Disease; Hum | 1992 |
Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Immunor | 1992 |
Spin echo nuclear magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy.
Topics: Adult; Autoantibodies; Carbimazole; Erythrocytes; Female; Glutathione; Graves Disease; Humans; Immun | 1992 |
Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report.
Topics: Aged; Autoantibodies; Blotting, Western; Eye Diseases; Graves Disease; Humans; Hypothyroidism; Immun | 1992 |
Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment.
Topics: Adult; Atrial Fibrillation; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Iodine; | 1992 |
Refractoriness at peripheral and pituitary receptors in general and pituitary types of thyroid hormone resistance.
Topics: Child; Cholesterol; Female; Graves Disease; Humans; Male; Pituitary Diseases; Pituitary Gland; Recep | 1992 |
Thyroid ultrasonography related to clinical and laboratory findings in patients with silent thyroiditis.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Thyroglobulin; Thyroid Gland; Thyroiditis, | 1992 |
Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy.
Topics: Adult; Antibodies; Dose-Response Relationship, Drug; Female; Fetus; Graves Disease; Humans; Iodine; | 1992 |
The possible etiological role of psychological disturbances in Graves' disease.
Topics: Adult; Anxiety; Autoantibodies; CD4-CD8 Ratio; Depression; Female; Graves Disease; Humans; Leukocyte | 1992 |
Radioimmunoassay of thyrotropin-releasing hormone in euthyroid subjects and in patients with thyroid diseases.
Topics: Circadian Rhythm; Graves Disease; Humans; Hypothyroidism; Male; Radioimmunoassay; Reference Values; | 1992 |
Identification of thyroxine-sulfate (T4S) in human serum and amniotic fluid by a novel T4S radioimmunoassay.
Topics: Amniotic Fluid; Analysis of Variance; Female; Graves Disease; Humans; Ipodate; Pregnancy; Propylthio | 1992 |
Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease?
Topics: Adult; Antibodies; Autoimmune Diseases; CD4-CD8 Ratio; Female; Graves Disease; Humans; Lymphocytes; | 1992 |
Alteration of renal function in hyperthyroidism: increased tubular secretion of creatinine and decreased distal tubule delivery of chloride.
Topics: Adult; Blood Urea Nitrogen; Chlorides; Creatinine; Female; Graves Disease; Humans; Kidney; Kidney Fu | 1992 |
[Disorders of iodine resorption and iodination due to thyrostatic medication].
Topics: Adult; Female; Graves Disease; Humans; Iodine; Methimazole; Thyroxine | 1992 |
Serum levels of free and bound testosterone in hyperthyroidism.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Luteinizing Hormone; Male; | 1992 |
Increased serum concentration of type IV collagen peptide and type III collagen peptide in hyperthyroidism.
Topics: Collagen; Graves Disease; Humans; Hyperthyroidism; Thyroxine; Triiodothyronine | 1992 |
Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?
Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Goiter, Nodular; Graves Disease; Humans; | 1992 |
Hyperthyroidism accelerates growth in Turner's syndrome.
Topics: Child; Female; Graves Disease; Growth Disorders; Humans; Methimazole; Propranolol; Puberty; Thyroid | 1992 |
Class IV lupus nephritis associated with Graves' disease.
Topics: Carbimazole; Child; Chlorambucil; Graves Disease; Humans; Lupus Nephritis; Male; Prednisolone; Propy | 1992 |
Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.
Topics: Adult; Eye Diseases; Female; Graves Disease; Humans; Male; Middle Aged; Predictive Value of Tests; P | 1992 |
Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Topics: Adolescent; Child; Child, Preschool; Female; Graves Disease; Humans; Hyperthyroidism; Hypothalamo-Hy | 1992 |
Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Antibodies; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Pregnancy | 1992 |
[Neonatal hyperthyroidism secondary to Basedow's disease in the mother].
Topics: Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins, Thyro | 1991 |
Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Immunogl | 1991 |
Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease.
Topics: Adult; Aged; Autoantibodies; Enzyme-Linked Immunosorbent Assay; Female; Goiter, Nodular; Graves Dise | 1991 |
Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
Topics: Autoantibodies; Biopsy, Needle; Blood Sedimentation; C-Reactive Protein; Female; Graves Disease; Hum | 1991 |
Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cholesterol; Europe; Female; Graves Disease; H | 1991 |
A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.
Topics: Adult; Antibodies, Monoclonal; Autoantibodies; Dose-Response Relationship, Drug; Female; Graves Dise | 1991 |
Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes.
Topics: Adenylyl Cyclases; Autoantibodies; Autoimmunity; Cross Reactions; Dose-Response Relationship, Immuno | 1991 |
Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
Topics: Adult; Antithyroid Agents; Female; Goiter, Nodular; Graves Disease; Humans; Incidence; Iodine Radioi | 1991 |
Administration of thyroxine in treated Graves' disease.
Topics: Antithyroid Agents; Graves Disease; Humans; Thyroid Gland; Thyroxine | 1991 |
Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism.
Topics: Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methimazol | 1991 |
Thyroid stimulating antibodies in patients with Graves' ophthalmopathy.
Topics: Adolescent; Adult; Antibodies; Cyclic AMP; Eye Diseases; Female; Graves Disease; Humans; In Vitro Te | 1991 |
Identification of a 27-kilodalton protein with the properties of type I iodothyronine 5'-deiodinase in human thyroid gland.
Topics: Adenocarcinoma, Papillary; Adenoma; Affinity Labels; Autoradiography; Electrophoresis, Polyacrylamid | 1992 |
[Mitral valve prolapse associated with Basedow's disease and active hyperthyroidism. Preliminary report].
Topics: Adult; Body Weight; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Mitral Valve | 1990 |
Evaluation of a new chemiluminescence technique for human thyrotropin (BeriLux hTSH): diagnostic value of five immunometric assay methods.
Topics: Adult; Evaluation Studies as Topic; Female; Graves Disease; Humans; Immunoassay; Immunoenzyme Techni | 1991 |
The effect of xenotransplantation of human thyroid tissue following radioactive iodine-induced thyroid ablation on thyroid function in the nude mouse.
Topics: Animals; Feedback; Goiter, Nodular; Graves Disease; Humans; Iodine Radioisotopes; Mice; Mice, Nude; | 1991 |
A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays.
Topics: Adult; Follow-Up Studies; Graves Disease; Humans; Methimazole; Middle Aged; Recurrence; Remission In | 1991 |
Changes in serum thyroid hormone autoantibody concentrations during pregnancy: a case report.
Topics: Adult; Autoantibodies; Female; Fetal Blood; Graves Disease; Humans; Immunoglobulin G; Immunoglobulin | 1991 |
Propylthiouracil hypersensitivity with circumstantial evidence for drug-induced reversible sensorineural deafness: a case report.
Topics: Adult; Arthritis; Carbimazole; Drug Hypersensitivity; Female; Graves Disease; Hearing Loss, Sensorin | 1991 |
Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Topics: Adult; Autoantibodies; Cell Membrane; Cytosol; Enzyme-Linked Immunosorbent Assay; Female; Graves Dis | 1991 |
Inter-relationships between selenium and thyroid hormone metabolism in the rat and man.
Topics: Animals; Electrophoresis, Polyacrylamide Gel; Glutathione Peroxidase; Graves Disease; Humans; Hypert | 1991 |
Blood lymphocyte population following 131I treatment for hyperthyroidism.
Topics: Adult; Autoimmunity; B-Lymphocytes; Concanavalin A; Female; Graves Disease; Humans; Immunoglobulin M | 1991 |
[Diffuse hyperthyroid goiter treated with I131, papillary carcinoma occurring after iodine radioisotope treatment, and thyroxine malabsorption. A clinical case].
Topics: Carcinoma, Papillary; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid Neopl | 1991 |
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Female; Femur; Femur Neck; Follow-Up Studies; Graves D | 1991 |
Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
Topics: Autoantibodies; Carbimazole; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Thyroxine | 1991 |
Hyperthyroidism in the geriatric population.
Topics: Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Goiter, Nodular; Graves Disease; | 1991 |
Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months.
Topics: Adolescent; Adult; Aged; Carbonic Anhydrases; Erythrocytes; Graves Disease; Humans; Middle Aged; Pre | 1991 |
Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
Topics: Animals; Epithelium; Graves Disease; HLA-DR Antigens; Interferon-gamma; Interleukin-2; Male; Mice; M | 1991 |
High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Antigens, Differentiation, T-Lymphocyte; CD8 Antigens; Enzyme-Link | 1991 |
Treatment of hyperthyroidism with potassium iodide.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Potassium Iodide; Thyrotropin; Thyroxi | 1991 |
Sera but not immunoglobulins of ophthalmic Graves' patients stimulate human embryonal fibroblasts' biosynthetic activity in culture.
Topics: Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Eye Diseases; Fibroblasts; Glycosaminoglycans; G | 1991 |
Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
Topics: Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; I | 1990 |
Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.
Topics: Adult; Autoantibodies; Combined Modality Therapy; Dexamethasone; Female; Graves Disease; Humans; Imm | 1990 |
The effect of pre-operative potassium iodide therapy on antibody production.
Topics: Antibody Formation; Autoantibodies; B-Lymphocytes; Carbimazole; Enzyme-Linked Immunosorbent Assay; F | 1990 |
The prognostic value of thyrotropin receptor antibody (TRAb) levels in Graves' disease.
Topics: Antibodies; Autoantibodies; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Prognosis; | 1990 |
Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
Topics: Adult; Autoantibodies; Eye Diseases; Female; Graves Disease; Humans; Hyaluronic Acid; Immunoglobulin | 1990 |
Follow-up study of thyroid stimulating-blocking antibodies in hypothyroid patients.
Topics: Adolescent; Adult; Aged; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyr | 1990 |
Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
Topics: Adolescent; Adult; Antibodies; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyr | 1990 |
Successful in utero treatment of fetal goiter and hypothyroidism.
Topics: Adult; Amnion; Female; Fetal Diseases; Goiter; Graves Disease; Humans; Hypothyroidism; Injections; P | 1991 |
Islet cell antibodies in patients with autoimmune thyroid disease.
Topics: Adolescent; Adult; Autoantibodies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Graves Dise | 1991 |
Treatments for Graves' disease--letting the thyroid rest.
Topics: Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Methimazole; Receptors, Thyrotropin; Thyrox | 1991 |
Sudden appearance and subsequent disappearance of interference in immunometric assays of thyrotropin neutralizable with purified mouse IgG.
Topics: Adolescent; Animals; Female; Graves Disease; Humans; Immunoglobulin G; Mice; Radioimmunoassay; Refer | 1991 |
Thyroxine replacement in post-radioiodine hypothyroidism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Drug Administration Schedule; Femal | 1991 |
[Studies on thyroid hormone autoantibody (THAA) in 2 cases of Graves' disease with spuriously high free thyroxine values].
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Immunoglobulin G; Methimazole; Thyroxine | 1991 |
The use of low voltage electric therapy in the treatment of 'Graves ophthalmopathy'.
Topics: Adult; Aged; Carbimazole; Electric Stimulation Therapy; Exophthalmos; Female; Graves Disease; Humans | 1991 |
The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion.
Topics: Animals; Autoantibodies; Bone Marrow Transplantation; Disease Models, Animal; Enzyme-Linked Immunoso | 1991 |
Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
Topics: Eye Diseases; Graves Disease; Humans; Iodine Radioisotopes; Retrospective Studies; Thyroxine | 1991 |
Two cases of Graves' disease with antithyroid hormone antibodies: implication on the role of thyroglobulin as an antigen.
Topics: Adenoma; Antibodies, Monoclonal; Autoantibodies; Autoantigens; Female; Graves Disease; Humans; Middl | 1990 |
Defective response of natural killer activity to thyroxine in Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Killer Cells, Natural; Male; Middle Aged; Thyroxine | 1990 |
[Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Male; Methimazole; Middle A | 1990 |
[Posttreatment hypothyroidism in diffuse toxic goiter. A complication or evolution?].
Topics: Combined Modality Therapy; Graves Disease; Humans; Hypothyroidism; Thyroid Function Tests; Thyrotrop | 1990 |
Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Graves Disease; Humans; Middle Aged; Thyroid Gland; Thyroidectomy; Thyrotro | 1990 |
Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice.
Topics: Animals; Autoimmunity; Epithelium; Graves Disease; HLA-DR Antigens; Humans; Interferon-gamma; Mice; | 1990 |
Plasma atrial natriuretic peptide in patients with Graves' disease.
Topics: Age Factors; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Female; Graves Disease; Heart Ra | 1990 |
The mechanism for the discrepancy between serum total and free thyroxine values induced by autoantibodies: report on two patients with Graves' disease.
Topics: Adult; Autoantibodies; Autoradiography; False Positive Reactions; Female; Graves Disease; Humans; Im | 1990 |
Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring.
Topics: Birth Weight; Carbimazole; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Disea | 1990 |
Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Graves Disease; Humans; Lipopr | 1990 |
The measurement of the serum sex-hormone binding globulin in various thyroid diseases.
Topics: Biomarkers; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Methimazole; R | 1990 |
Iodine deficiency disorder (IDD) presenting as hypothyroidism with a large pericardial effusion.
Topics: Adolescent; Deficiency Diseases; Diagnosis, Differential; Graves Disease; Humans; Iodine; Male; Peri | 1990 |
[The significance of serum fructosamine measurement in patients with thyroid diseases].
Topics: Creatine Kinase; Female; Fructosamine; Glycated Hemoglobin; Graves Disease; Hexosamines; Humans; Hyp | 1990 |
Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism.
Topics: Adult; Aged; Female; Graves Disease; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinet | 1990 |
[Radioimmunologic research in the complex assessment of thyroid status in primary hypothyroidism].
Topics: Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hypothyroidism; Male; Middle Aged; R | 1990 |
Comparison of RA 131I treatment protocols for Graves' disease.
Topics: Combined Modality Therapy; Eye Diseases; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radi | 1990 |
Normalization of thyroid blood flow in Graves' hyperthyroidism following radioactive iodine therapy.
Topics: Aged; Aged, 80 and over; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Re | 1990 |
Factors influencing the outcome of thyrostatic drug therapy in Graves' disease.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Goiter; Graves Disease; HLA Antigens; H | 1990 |
Trial of thyroid autotransplantation in patients with Graves' disease whose remnant thyroid has unintentionally been made too small at subtotal thyroidectomy.
Topics: Adult; Autoantibodies; Female; Follow-Up Studies; Graves Disease; Humans; Iodine Radioisotopes; Male | 1990 |
Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Function | 1985 |
Clinical management of patients with hyperthyroidism.
Topics: Adenoma; Adolescent; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Child; Female; Goiter, | 1985 |
Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
Topics: Amides; Antibodies; Antithyroid Agents; Follow-Up Studies; Graves Disease; Humans; Physical Examinat | 1986 |
Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases.
Topics: Adenocarcinoma; Goiter; Graves Disease; Humans; Immunoenzyme Techniques; Staining and Labeling; Thyr | 1986 |
Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Female; Graves Disease; Humans; Iodine Radioisot | 1986 |
Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
Topics: Antibodies; Antithyroid Agents; Female; Fetal Blood; Fetal Diseases; Fetus; Graves Disease; Humans; | 1986 |
Studies on suppressor T lymphocyte function in Graves' disease by 3H-thymidine interpolation.
Topics: Adolescent; Adult; Antithyroid Agents; Graves Disease; Humans; Middle Aged; T-Lymphocytes, Regulator | 1987 |
Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Female; Goiter, Nodular; Graves Dise | 1987 |
[Treatment of T3-predominant Graves' disease].
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Prognosis; Thyroxine; Triiodothyron | 1988 |
Hypothyroidism with spontaneous progression to hyperthyroidism.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Thyroidectomy; Thyroiditis, | 1989 |
Hyperpigmentation in Graves' disease.
Topics: Adult; Black People; Female; Graves Disease; Humans; Male; Pigmentation Disorders; Thyroxine | 1989 |
Thyroxine may decrease serum thyroxine-binding globulin levels.
Topics: Animals; Cattle; Graves Disease; Humans; Hypothyroidism; Thyroiditis, Autoimmune; Thyroxine; Thyroxi | 1989 |
Studies on peripheral T lymphocyte subsets in patients with autoimmune thyroid diseases.
Topics: Adult; Antibodies, Monoclonal; Female; Graves Disease; Humans; Male; Middle Aged; T-Lymphocytes; T-L | 1989 |
Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
Topics: Adult; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Immunoglobulin G; Immunog | 1989 |
Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
Topics: Antibodies; Eye Diseases; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid | 1989 |
Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Cell Line; Cyclic AMP; Enzyme-Linked Immunosorbent A | 1989 |
Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Topics: Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; | 1989 |
Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.
Topics: Autoantibodies; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Middle Aged; M | 1989 |
Free radicals and Graves' disease: the effects of therapy.
Topics: Adult; Carbimazole; Ceruloplasmin; Female; Free Radicals; Graves Disease; Humans; Iodine Radioisotop | 1989 |
Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomy.
Topics: Adult; Body Weight; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Preanesthetic Medica | 1989 |
Immunological aspects of Graves' disease patients in different clinical stages.
Topics: Adult; Antibodies, Monoclonal; Antibody Formation; Antigen-Antibody Complex; Female; Graves Disease; | 1989 |
Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy.
Topics: Female; Graves Disease; Humans; Middle Aged; Radioimmunoassay; Thyroid Function Tests; Thyroid Hormo | 1989 |
A case of Graves' disease associated with polymyositis.
Topics: Adult; Female; Graves Disease; Humans; Muscles; Myositis; Radioimmunoassay; Thyroid Function Tests; | 1989 |
Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil.
Topics: Adult; Breast Feeding; Female; Fetal Diseases; Graves Disease; Humans; Hypothyroidism; Infant, Newbo | 1989 |
Does thyroid function influence serum beta 2-microglobulin?
Topics: Adult; beta 2-Microglobulin; Carbimazole; Female; Goiter, Nodular; Graves Disease; Humans; Hypothyro | 1989 |
Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease.
Topics: Adult; Antigens, Differentiation; Female; Fluorescent Antibody Technique; Graves Disease; Humans; Ly | 1989 |
Measurement of anti-thyroglobulin IgG in serum by novel and sensitive immune complex transfer enzyme immunoassay.
Topics: Adult; Aged; Chromatography, Affinity; Cross Reactions; Dinitrophenols; Female; Graves Disease; Huma | 1989 |
Insulin secretion and sensitivity in hyperthyroidism.
Topics: Administration, Oral; C-Peptide; Female; Glucose; Graves Disease; Humans; Hyperthyroidism; Insulin; | 1989 |
Effect of 8-anilino-1-naphthalene sulfonic acid (ANS) on the interaction between thyroid hormone and anti-thyroid hormone antibodies.
Topics: Anilino Naphthalenesulfonates; Antibodies; Antigen-Antibody Reactions; Dose-Response Relationship, D | 1989 |
A comparative evaluation of the surgical and radioiodine treatments for Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid | 1989 |
Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Graves Disease; Humans; | 1989 |
Modulation of mild bleeding disorder during remissions and exacerbations of Graves' disease.
Topics: Adult; Blood Platelets; Epistaxis; Female; Graves Disease; Humans; Hyperthyroidism; Platelet Aggrega | 1989 |
Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Prospective Studies; Thyr | 1989 |
Improved assay method for activity of thyroid peroxidase-catalysed coupling of iodotyrosine residues of thyroglobulin utilizing h.p.l.c. for analysis of iodothyronines.
Topics: Chromatography, High Pressure Liquid; Graves Disease; Humans; Iodide Peroxidase; Methods; Microsomes | 1989 |
Functional properties of human thyroid follicles cultured within collagen gel.
Topics: Cells, Cultured; Collagen; Cyclic AMP; Graves Disease; Humans; Kinetics; Methimazole; Propylthiourac | 1988 |
[Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
Topics: Adult; Aged; Erythrocyte Membrane; Female; Graves Disease; Humans; Hypothyroidism; Kidney Failure, C | 1988 |
Spectrum of thyroid function abnormalities in gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications; | 1988 |
Prediction of the course of Graves' disease after medical antithyroid treatment.
Topics: Adolescent; Adult; Aged; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobuli | 1985 |
Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
Topics: Adolescent; Adult; Carbimazole; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, T | 1985 |
Gamma-glutamyltranspeptidase and alkaline phosphatase serum activities: their relation to the outcome of Graves' disease.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Child, Preschool; Female; gamma-Glutamyltransferase; | 1985 |
Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graves Disease; Humans; Im | 1985 |
Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
Topics: Adult; Antibodies; Congenital Hypothyroidism; Female; Graves Disease; Humans; Hypothyroidism; Immuno | 1986 |
Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimul | 1986 |
Clinical and immunological follow-up of pregnant women with Graves disease.
Topics: Adult; Female; Follow-Up Studies; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid | 1986 |
Detection of TSH-binding inhibiting immunoglobulins in patients with Graves' disease and non toxic goiter.
Topics: Adult; Female; Goiter; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulatin | 1986 |
[A correlation between the concentrations of serum T4 and the values for TSH binding inhibiting antibody (TBIAb) during the clinical course of a patient with hashitoxicosis].
Topics: Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobulins, Thyroid-Stimulating; Middle Aged; | 1987 |
Detection of thyroid-stimulating antibodies in thyroid diseases, employing rat thyroid fragment perifusion.
Topics: Adult; Aged; Aged, 80 and over; Animals; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglo | 1987 |
Changes in thyroid-stimulating and TSH-binding inhibitory activities in a patient who developed hyperthyroidism due to Graves' disease following primary hypothyroidism.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunoglobulin G; Immunoglob | 1986 |
Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunity, Cellular; Immunoglobulin G; Immun | 1987 |
Prediction of remission after antithyroid drug treatment in Graves' disease.
Topics: Adolescent; Adult; Antibodies; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; HLA A | 1988 |
T-lymphocyte subsets in pregnant women with Graves' disease.
Topics: Adolescent; Adult; Antibodies; Female; Graves Disease; Humans; Leukocyte Count; Microsomes; Pregnanc | 1987 |
Production of and response to interleukin-2 in Graves' disease.
Topics: Adult; Antibody Formation; Cell Line; Cell Line, Transformed; Female; Graves Disease; Humans; Interl | 1988 |
Plasma atrial natriuretic peptide in states of altered thyroid function.
Topics: Adolescent; Adult; Aged; Atrial Natriuretic Factor; Female; Graves Disease; Humans; Hyperthyroidism; | 1988 |
Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance.
Topics: Adolescent; Adult; Drug Resistance; Female; Graves Disease; Humans; Hyperthyroidism; Iodides; Male; | 1985 |
Thyroid hormones affect serum angiotensin I converting enzyme levels.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; | 1985 |
Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.
Topics: Adolescent; Adult; Aged; Female; Goiter, Endemic; Goiter, Nodular; Graves Disease; Humans; Hyperthyr | 1985 |
Catecholamine, vasoactive intestinal peptide and thyrotrophin-dependent cAMP levels display a different sensitivity to iodothyronines in both normal and pathological human thyroid cells in culture.
Topics: Adult; Catecholamines; Cells, Cultured; Cyclic AMP; Female; Graves Disease; Humans; Male; Middle Age | 1985 |
[Changes in the hormone profile, central hemodynamics and tissue blood flow in patients with thyrotoxic goiter during treatment with lithium carbonate].
Topics: Adult; Female; Graves Disease; Hemodynamics; Humans; Lithium; Lithium Carbonate; Male; Microcirculat | 1986 |
[TSH and prolactin studies with TRH-loading in juvenile Basedow's disease].
Topics: Adolescent; Adult; Child; Female; Graves Disease; Humans; Male; Prolactin; Thyrotropin; Thyrotropin- | 1986 |
A case of total thyroxine-binding globulin deficiency with Graves' disease: fluctuations of plasma triiodothyronine/thyroxine ratio.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Methimazole; Thyroid Hormones; | 1986 |
[Value of the triiodothyronine suppression test with serum T4 and thyroid 131I uptake as indexes in judging the prognosis of Graves' disease].
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Pr | 1986 |
Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Middle Aged; Thyroid Function Tests; Thyroiditis; | 1987 |
Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Topics: Adult; Autoantibodies; DNA; Female; Graves Disease; HLA-DR Antigens; Humans; Lymphocytes; Male; Meth | 1988 |
Long-term assessment of patients with macroprolactinemia.
Topics: Adult; Autoimmune Diseases; Dopamine; Female; Graves Disease; HLA-DR Antigens; Humans; Hyperprolacti | 1988 |
Long term thyroid function after subtotal thyroidectomy for Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Gland; Thyroidec | 1988 |
Amelioration of Graves' disease during pregnancy.
Topics: Adolescent; Female; Graves Disease; Humans; Pregnancy; Pregnancy Complications; Radioimmunoassay; Th | 1988 |
Differential immunosuppressive action of carbimazole and propylthiouracil.
Topics: Adult; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; Immunosuppressive Agents; Male; | 1988 |
Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Autoantibodies; Female; Graves Disease; Humans; Iodide Peroxidase; Iodine; Iodine | 1988 |
Pharmacokinetics of propylthiouracil in children and adolescents with Graves' disease in the hyperthyroid and euthyroid states.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Kinetics; Male; Propylthiouracil; Thyroid Functio | 1988 |
Adenomatous goiter with hyperthyroidism.
Topics: Adenoma; Adolescent; Adult; Child; Female; Follow-Up Studies; Goiter; Graves Disease; Humans; Hypert | 1988 |
Changes in sex steroid and gonadotrophin concentrations during treatment of Graves' thyrotoxicosis in males.
Topics: Adult; Gonadal Steroid Hormones; Gonadotropins; Graves Disease; Humans; Luteinizing Hormone; Male; M | 1988 |
Stimulation of Graves' thyroids in vitro.
Topics: Graves Disease; Humans; Hyperthyroidism; In Vitro Techniques; Propranolol; Receptors, Thyrotropin; T | 1987 |
Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.
Topics: Cell Line; Cytotoxicity, Immunologic; Flow Cytometry; Graves Disease; Humans; Hyperthyroxinemia; Imm | 1987 |
Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease.
Topics: Antibodies, Antinuclear; Autoimmune Diseases; Female; Goiter; Graves Disease; Humans; Lupus Erythema | 1987 |
Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
Topics: Animals; Cytotoxicity Tests, Immunologic; Disease Models, Animal; Female; Graves Disease; Hypothyroi | 1987 |
[Determination of thyroid volume using computerized ultrasonography and its clinical application].
Topics: Adolescent; Adult; Aged; Animals; Anthropometry; Body Height; Female; Graves Disease; Humans; Male; | 1986 |
Factors predicting the course of diabetes mellitus in hyperthyroid patients.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Disease Susceptibility; Female; Glucose Toleran | 1986 |
Autoantibodies to thyroid hormones: association with falsely low hormone levels measured by 'Amerlex' assay.
Topics: Adult; Autoantibodies; False Negative Reactions; Female; Graves Disease; Humans; Immunosorbent Techn | 1986 |
Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Female; Graves Disease; Humans; Hypothyroidism; Iodine; Mal | 1987 |
Radioiodine (I-131) uptakes and hormonal (T4) levels in hyperthyroid patients receiving radioiodine therapy while on anti-thyroid drugs and relation to incidence of hypothyroidism at one year.
Topics: Adult; Aged; Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypoth | 1986 |
Measurement of thyroid hormone concentrations in human placenta.
Topics: Abortion, Spontaneous; Female; Fetal Blood; Graves Disease; Humans; Obstetric Labor, Premature; Plac | 1987 |
Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain.
Topics: Animals; Biological Assay; Cell Line; Dose-Response Relationship, Drug; Graves Disease; Humans; Rats | 1987 |
A case of thyroxine thyrotoxicosis.
Topics: Autoantibodies; Female; Graves Disease; Humans; Middle Aged; Protein Binding; Thyroxine; Triiodothyr | 1987 |
Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy.
Topics: Autoantibodies; Child; Female; Graves Disease; Humans; Methimazole; Middle Aged; Prednisolone; Propy | 1986 |
A new type of albumin with predominantly increased binding affinity for 3,3',5-triiodothyronine in a patient with Graves' disease.
Topics: Adult; Binding Sites; Female; Graves Disease; Humans; Protein Binding; Radioimmunoassay; Serum Album | 1987 |
[Goiter size and prognosis of thyrotoxicosis treated medically].
Topics: Adult; Aged; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans; Male; Middle Aged; | 1987 |
[Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease].
Topics: Graves Disease; Humans; Thyroid Gland; Thyroxine; Triiodothyronine | 1987 |
[A case of familial hypercholesterolemia associated with Basedow's disease].
Topics: Adult; Graves Disease; Humans; Hyperlipoproteinemia Type II; Male; Probucol; Thyroxine; Triiodothyro | 1987 |
Follicle structure-dependency of thyroglobulin and thyroxin staining in the thyroid glands of Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Thyroglobulin; Thyroxine | 1987 |
[Thyroid biological evaluation: critical study].
Topics: Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Radioimmunoassay; Thyroid Function Tests; T | 1987 |
Highly sensitive immunoradiometric assay for TSH and thyroid radioiodine uptake as predictors of thyroid suppression test.
Topics: Adult; Aged; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thioamides; Th | 1987 |
Goitre size and outcome of medical treatment of Graves' disease.
Topics: Adult; Aged; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans; Male; Methimazole; | 1986 |
Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Prognosis; Thyroxine; Triiodothyronine | 1986 |
Changes in plasma fibronectin levels in thyroid diseases.
Topics: Adolescent; Adult; Aged; Female; Fibronectins; Goiter; Graves Disease; Humans; Hypothyroidism; Male; | 1986 |
Fatal thyrotoxic crisis.
Topics: Adult; Death, Sudden; Female; Graves Disease; Humans; Myocardium; Thyroid Crisis; Thyroid Gland; Thy | 1986 |
Effects of betamethasone on serum iodothyronines and thyroid hormone-binding proteins in Graves' disease.
Topics: Adult; Aged; Betamethasone; Carrier Proteins; Female; Graves Disease; Humans; Male; Middle Aged; Thy | 1986 |
Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
Topics: Antibodies; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Ipodate; Thyroid Gland | 1987 |
Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Euthyroid Sick Syndromes; Female; Goiter; G | 1987 |
Euthyroid pretibial myxedema.
Topics: Diagnosis, Differential; Female; Graves Disease; Humans; Leg Dermatoses; Middle Aged; Myxedema; Thyr | 1987 |
Relapse markers in childhood thyrotoxicosis.
Topics: Adolescent; Carbimazole; Child; Child, Preschool; Female; Graves Disease; Humans; Male; Recurrence; | 1987 |
Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
Topics: Animals; Graves Disease; Humans; Iodide Peroxidase; Kidney; Kinetics; Liver; Long-Acting Thyroid Sti | 1987 |
A comparison of the effects of propylthiouracil and methimazol on circulating thyroid hormones and various measures of peripheral thyroid hormone effects in thyrotoxic patients.
Topics: Achilles Tendon; Adult; Basal Metabolism; Female; Graves Disease; Humans; Male; Methimazole; Middle | 1985 |
Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Male; Potassium Iodide; Thyroid Hormones; Thyroxine; | 1985 |
Effect of hyperthyroidism and its treatment on bone mineral content.
Topics: Adult; Bone and Bones; Calcium; Graves Disease; Humans; Iodine Radioisotopes; Longitudinal Studies; | 1985 |
Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
Topics: Catalysis; Chemical Phenomena; Chemistry; Chromatography, Gel; Graves Disease; Humans; Hydrogen-Ion | 1985 |
Characterization of microheterogeneity of human thyroglobulin from different thyroid disorders.
Topics: Adenoma; Densitometry; Electrophoresis, Polyacrylamide Gel; Goiter; Graves Disease; Humans; Iodine; | 1985 |
Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter.
Topics: Adult; Boston; Dose-Response Relationship, Drug; Environment; Female; Graves Disease; Humans; Hypoth | 1985 |
[Use of plasmapheresis for the preoperative preparation of toxic goiter patients].
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Plasmapheresis; Preoperat | 1985 |
High muscle lipoprotein lipase activity in thyrotoxic patients.
Topics: Adipose Tissue; Adult; Apolipoproteins; Carbimazole; Female; Graves Disease; Humans; Lipoprotein Lip | 1985 |
Computer simulation for hormones related to primary thyropathy.
Topics: Computers; Graves Disease; Humans; Hyperthyroidism; Hypothalamo-Hypophyseal System; Hypothyroidism; | 1985 |
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Radioimmunoassay; Thyroid Dis | 1985 |
Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Topics: Adult; Antibody Formation; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypothyroidis | 1985 |
Spontaneous reversal of vertical diplopia in Graves' eye disease.
Topics: Diplopia; Female; Graves Disease; Humans; Male; Middle Aged; Prednisone; Thyroxine; Time Factors; Vi | 1985 |
Clinical and laboratory assessment of thyroid abnormalities.
Topics: Autoantibodies; Blood Proteins; Graves Disease; Humans; Iodine Radioisotopes; Palpation; Radionuclid | 1985 |
Detection of familial dysalbuminaemic hyperthyroxinaemia.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Serum A | 1985 |
[Value of studying blood levels of thyroid hormones for the diagnosis and surgical treatment of toxic goiter].
Topics: Adolescent; Adult; Aged; Blood Proteins; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; | 1985 |
Thyrotropin-releasing hormone tests in an outpatient clinic.
Topics: Adolescent; Adult; Aged; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypothalamic Diseas | 1985 |
Long term treatment of Graves' hyperthyroidism with sodium ipodate.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Long-Term Care; Male; Middle Aged; Thyroxine; Triiod | 1985 |
Alterations in circulating thyroid hormones and thyrotropin in euthyroid patients with Graves' disease after total thyroidectomy: comparison between responders and nonresponders to TSH-releasing hormone.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Thyroid Hormones; Thyroidectomy; Thyrotrop | 1985 |
Relationship between serum free thyroxine, total thyroxine and thyroxine-binding globulin concentrations in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Male; Middle Aged; Radioimmunoassay; Thyrox | 1985 |
Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine.
Topics: Adolescent; Age Factors; Child; Chronic Disease; Congenital Abnormalities; Female; Follow-Up Studies | 1970 |
Thymic hyperplasia in Graves' disease.
Topics: Adult; Antithyroid Agents; Autoradiography; Culture Techniques; Female; Graves Disease; Humans; Long | 1971 |
Failure of pituitary response to thyrotrophin-releasing hormone in euthyroid Graves' disease.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidis | 1971 |
Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
Topics: Animals; Antibodies; Fluorescent Antibody Technique; Graves Disease; Haplorhini; Hemagglutination Te | 1971 |
Diurnal rhythm in total serum thyroxine levels.
Topics: Adrenal Glands; Blood Proteins; Body Fluids; Circadian Rhythm; Dexamethasone; Fasting; Feeding Behav | 1971 |
Radioimmunoassay for measurement of triiodothyronine in human serum.
Topics: Animals; Antithyroid Agents; Binding Sites; Cross Reactions; Graves Disease; Humans; Hyperthyroidism | 1971 |
Thyroxine derivatives in amniotic fluid. Fetal outcome in three patients with thyroid problems.
Topics: Adult; Amniocentesis; Amniotic Fluid; Female; Fetal Diseases; Graves Disease; Humans; Hypothyroidism | 1971 |
Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
Topics: Adult; Aged; Body Height; Body Weight; Chromatography, Ion Exchange; Graves Disease; Half-Life; Huma | 1972 |
Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Topics: Chromatography, Ion Exchange; Female; Graves Disease; Humans; Immune Sera; Immunoelectrophoresis; Im | 1972 |
Prevalence of low-titer and "negative" antithyroglobulin antibodies in biopsy-proved juvenile Hashimoto's thyroiditis.
Topics: Autoantibodies; Biopsy; Child; Graves Disease; Humans; Thyroglobulin; Thyroid Function Tests; Thyroi | 1973 |
Advances in the laboratory diagnosis of thyroid disease. II.
Topics: Child; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Metabolism, Inborn Errors; Radioimmu | 1973 |
Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Long-Acting Thyroid Sti | 1972 |
Total and free triiodothyronine and thyroxine levels in thyroid storm and recurrent hyperthydroidism.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Postoperative Complicati | 1973 |
Hyperthyroidism and pregnancy.
Topics: Antithyroid Agents; Female; Fetal Diseases; Fetus; Graves Disease; Humans; Hyperthyroidism; Infant, | 1972 |
[Significance and reliability of various tests of thyroid function in medical practice (author's transl)].
Topics: Adenoma; Estrogens; Evaluation Studies as Topic; Goiter; Graves Disease; Humans; Hyperthyroidism; Hy | 1973 |
Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antibodies; Child; Child, Preschool; Female; Graves Disease; Humans; Hypert | 1973 |
Drug treatment in thyroid disease.
Topics: Antithyroid Agents; Female; Goiter; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypoth | 1974 |
[Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
Topics: Antithyroid Agents; Graves Disease; Humans; Radioimmunoassay; Thyrotropin-Releasing Hormone; Thyroxi | 1974 |
Laboratory examination of the thyroid. 1. In vitro tests.
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; Pregnancy; Protein Binding; R | 1974 |
Iodine-induced toxic diffuse goitre.
Topics: Adult; Female; Graves Disease; Humans; Iodine; Seaweed; Thyroid Function Tests; Thyrotropin; Thyroxi | 1974 |
Thyroid physiology and functional tests.
Topics: Achilles Tendon; Basal Metabolism; Calcitonin; Goiter; Graves Disease; Humans; Hyperthyroidism; Iodi | 1974 |
Treatment of thyrotoxicosis with lithium carbonate.
Topics: Adult; Antithyroid Agents; Carbimazole; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyr | 1974 |
[L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Topics: Adenoma; Adult; Animals; Antibodies; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radi | 1974 |
[Total and free thyroxine in certain thyroid diseases (preliminary report)].
Topics: Goiter; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Diseases; Thyroid F | 1974 |
Purves symposium: 2. Pituitary morphology in relationship to function. General principles.
Topics: Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Cytoplasmic Granules; Estrogens; Follicle St | 1974 |
[Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
Topics: Antithyroid Agents; Graves Disease; Humans; Iodine; Thyroxine | 1974 |
Action of potassium iodide on thyroxine metabolism.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Potassium Iodide; Thyr | 1966 |
Ultrastructure of human thyroid. A study of normal thyroid, untreated and treated diffuse toxic goiter.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Male; Microscopy | 1966 |
Occurrence of hyperthyroidism in patients receiving thyroid hormone.
Topics: Adolescent; Adult; Alopecia; Antithyroid Agents; Fatigue; Female; Goiter; Graves Disease; Humans; Hy | 1967 |
Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment.
Topics: Adult; Aged; Biological Transport, Active; Blood Proteins; Electrophoresis; Female; Graves Disease; | 1968 |
Studies of peripheral thyroxine distribution in thyrotoxicosis and hypothyroidism.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Io | 1968 |
When and how to use higher 131-I doses for hyperthyroidism.
Topics: Adult; Age Factors; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Heart Disea | 1968 |
Thyroid stimulating substances in human saliva.
Topics: Animals; Goiter; Graves Disease; Humans; Hyperthyroidism; Hypophysectomy; Iodine Radioisotopes; Long | 1968 |
[Therapy of acute thyrotoxic attacks].
Topics: Adrenal Glands; Antithyroid Agents; Catecholamines; Cortisone; Drug Synergism; Graves Disease; Guane | 1968 |
Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Topics: Antithyroid Agents; Depression, Chemical; Graves Disease; Humans; Imidazoles; Iodine; Iodine Radiois | 1970 |
[Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
Topics: Antithyroid Agents; Betamethasone; Dextrothyroxine; Eye Diseases; Graves Disease; Humans; Hyperthyro | 1967 |
Radioimmunological studies on the long-acting thyroid stimulator.
Topics: Animals; Antithyroid Agents; Chromatography; Culture Techniques; Graves Disease; Humans; Immunochemi | 1970 |
A thyroid suppression test using a single dose of L-thyroxine.
Topics: Administration, Oral; Cholesterol; Graves Disease; Humans; Iodine Radioisotopes; Pulse; Reflex; Slee | 1970 |
Diagnosis of hyperthyroidism. Statistical evaluation of laboratory and clinical criteria.
Topics: Adenoma; Cholesterol; Diagnosis, Computer-Assisted; Diagnosis, Differential; Glucosephosphate Dehydr | 1970 |
Thyroglobulin and thyroid acid protease activity in thyroid disease.
Topics: Adenoma; Fluorometry; Graves Disease; Humans; Hydrogen-Ion Concentration; Iodine; Peptide Hydrolases | 1970 |
Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Topics: Adult; Aged; Dexamethasone; Female; Graves Disease; Humans; Hypothalamus; Iodine Radioisotopes; Long | 1973 |
[TRH stimulation test. II. Evaluation of thyroid response].
Topics: Chemical Phenomena; Chemistry; Diagnosis, Differential; Graves Disease; Humans; Hypopituitarism; Hyp | 1973 |
[TRH stimulation test. II. Evaluation of thyroid response].
Topics: Diagnosis, Differential; Graves Disease; Humans; Hypopituitarism; Hypothyroidism; Radioimmunoassay; | 1973 |
Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
Topics: Adult; Aged; Chromatography, Gel; Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle | 1974 |
Normal serum triiodothyronine concentration and the lack of TSH response to TRH in patients with euthyroid Graves' disease.
Topics: Adult; Antibodies; Female; Graves Disease; Hemagglutination Tests; Humans; Immunoglobulin G; Iodine | 1973 |
[Interglandular relations in so-called extinctive thyroid nodules].
Topics: 17-Ketosteroids; Female; Follicle Stimulating Hormone; Goiter, Nodular; Graves Disease; Growth Hormo | 1973 |
[Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Topics: Animals; Biological Assay; Fluorescent Antibody Technique; Graves Disease; Humans; Hyperthyroidism; | 1974 |
[Endocrine opthalmopathy-- new physiopathological viewpoints through the determination of T3, T4 and TSH following TRH stimulation].
Topics: Graves Disease; Humans; Stimulation, Chemical; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1974 |
Goiter, immunological observations, and thyroid function tests in Down syndrome.
Topics: Adolescent; Adult; Autoantibodies; Child; Down Syndrome; Erythrocytes; Female; Goiter; Graves Diseas | 1974 |
[Treatment of Basedow hyperthyroidism by protracted doses of radioactive iodine].
Topics: Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Long-Term Care; Middle Aged; Myxed | 1969 |
[Hypothalamo-pituitary-adrenal function in hyperthyroidism and hypothyroidism].
Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Dexamethasone; Female; Graves | 1970 |
The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism.
Topics: Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Perchlorates; Radioimmu | 1971 |
[Repercussions of thyroid diseases on adrenocortical function].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone | 1973 |
Inhibitory action of thyroid hormone of the activation of adenyl cyclase-cyclic AMP system by thyroid-stimulating hormone in human thyroid tissues from euthyroid subjects and thyrotoxic patients.
Topics: Adenylyl Cyclases; Adipose Tissue; Cyclic AMP; Enzyme Activation; Epididymis; Graves Disease; Humans | 1974 |
Preoperative treatment of hyperthyroidism. Effect on primary postoperative complications.
Topics: Adult; Aged; Carbimazole; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; L | 1974 |
Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Topics: Animals; Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Iodine; Iodine Ra | 1974 |
The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Topics: Carbimazole; Graves Disease; Humans; Immune Adherence Reaction; Iodine; Iodine Radioisotopes; Propyl | 1974 |
[Inorganic iodine treatment of Basedow's disease].
Topics: Adult; Female; Graves Disease; Humans; Iodine; Male; Middle Aged; Thyroxine | 1974 |
[Effect of neomycin on certain indicators of carbohydrate and cortisol metabolism and level of thyroid hormones in toxic goiter].
Topics: 17-Hydroxycorticosteroids; Adult; Carbohydrate Metabolism; Citrates; Female; Graves Disease; Humans; | 1974 |
[Disorders of calcium metabolism after radical treatments of hyperthyroidism].
Topics: Calcitonin; Calcium Metabolism Disorders; Graves Disease; Humans; Hydroxyproline; Hyperthyroidism; H | 1974 |
[Letter: Endocrine ophthalmopathy].
Topics: Exophthalmos; Eyeglasses; Graves Disease; Humans; Iodine; Male; Middle Aged; Prednisone; Thyroid Fun | 1974 |
[Proceedings: Blood T3-T4 ratio in various states of thyroid function].
Topics: Graves Disease; Humans; Thyroiditis, Autoimmune; Thyroxine; Triiodothyronine | 1974 |
[Proceedings: Thyroid stimulating substances in man. (1). New findings concerning autoregulation of the thyroid gland of man: increases of adenyl cyclase caused by TSH administration and their inhibition by T3 and T4 in the thyroid of normal individuals a
Topics: Adenylyl Cyclases; Graves Disease; Humans; In Vitro Techniques; Thyroid Gland; Thyrotropin; Thyroxin | 1974 |
Hypothyroidism after thyroidectomy for Graves's disease: a search for an explanation.
Topics: Autoantibodies; Complement Fixation Tests; Female; Fluorescent Antibody Technique; Graves Disease; H | 1974 |
Competitive ligand-binding assay for measurement of thyronine-binding globulin (TBG).
Topics: Animals; Binding Sites; Cattle; Chromosome Aberrations; Chromosome Disorders; Dogs; Female; Graves D | 1972 |
Recurrent hyperthyroidism presenting as triiodothyronine toxicosis.
Topics: Adenoma; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Radioimmun | 1972 |
Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
Topics: Administration, Oral; Adult; Female; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenou | 1973 |
Effect of synthetic thyrotrophin releasing hormone (TRH) in man.
Topics: 11-Hydroxycorticosteroids; Adult; Aged; Brain Neoplasms; Female; Follicle Stimulating Hormone; Grave | 1972 |
Acromegaly and toxic goiter. Cure of the hyperthyroidism and acromegaly by proton-beam partial hypophysectomy.
Topics: Acromegaly; Animals; Female; Graves Disease; Growth Hormone; Humans; Immune Sera; Middle Aged; Proto | 1972 |
Unilateral proptosis due to orbital pseudotumor in a patient with Hashimoto's thyroiditis.
Topics: Adult; Blepharoptosis; Dexamethasone; Diagnosis, Differential; Eye Diseases; Female; Functional Late | 1972 |
Serum thyroxine radioimmunoassay.
Topics: Aniline Compounds; Animals; Female; Graves Disease; Humans; Hypothyroidism; Methods; Naphthalenes; P | 1972 |
[Triiodothyronine-thyrotoxicosis].
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Protein Binding; Recurrence; Thyroglobulin | 1972 |
Thyroxine and triiodothyronine in the human thyroid.
Topics: Adenocarcinoma; Autopsy; Binding, Competitive; Chromatography, Thin Layer; Goiter; Graves Disease; H | 1973 |
The concentration of peroxidase in normal and adenomatous human thyroid tissue with special reference to patients with Pendred's syndrome.
Topics: Aged; Deafness; Female; Goiter; Goiter, Nodular; Graves Disease; Humans; Iodine; Iodine Isotopes; Ma | 1973 |
Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
Topics: Autoantibodies; Chronic Disease; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Long-Acting T | 1973 |
Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease.
Topics: Feces; Female; Graves Disease; Humans; Iodine Isotopes; Kinetics; Liver; Male; Phenobarbital; Radioi | 1973 |
Comparison of alterations in circulating thyroglobulin, triiodothyronine and thyroxine in response to exogenous (bovine) and endogenous (human) thyrotropin.
Topics: Adenoma; Adolescent; Adult; Animals; Cattle; Female; Graves Disease; Humans; Hypothyroidism; Male; T | 1973 |
Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results.
Topics: Adult; Diet; Female; Graves Disease; Humans; Iodine; Male; Methimazole; Middle Aged; Propylthiouraci | 1973 |
Iodinated thyrolipids: their possible role in homonogenesis.
Topics: Animals; Carcinoma; Cystadenoma; Goiter, Nodular; Graves Disease; Humans; In Vitro Techniques; Iodin | 1973 |
Pterional orbital decompression in progressive ophthalmopathy of Graves' disease II. A follow-up study.
Topics: Adult; Aged; Diplopia; Exophthalmos; Eye Diseases; Female; Follow-Up Studies; Graves Disease; Humans | 1973 |
Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
Topics: Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Potassium Iodide; R | 1974 |
[The "acute" disappearance of radiothyroxine from the blood of normal, hyperthyroid and hypothyroid subjects].
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Male; | 1968 |
Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Female; Fluorescent Antibody Technique; Graves Disease; | 1971 |
Further studies on the rate of disappearance of labelled thyroxine from the intravascular compartment of man, with reference to the role of thyroxine binding proteins.
Topics: Adolescent; Adult; Aged; Computers; Diethylstilbestrol; Female; Goiter; Graves Disease; Humans; Hype | 1967 |
Effect of prednisone on thyroxine distribution.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Liver; Metabolic Clearance Rate; Middle Aged; Myxede | 1968 |
[Diagnosis of goiter].
Topics: Graves Disease; Humans; Thyroxine; Thyroxine-Binding Proteins | 1967 |
Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter.
Topics: Cholesterol; Female; Graves Disease; Humans; Hypothyroidism; Iodides; Iodine Isotopes; Male; Myxedem | 1969 |
Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
Topics: Administration, Oral; Chromatography, Paper; Electrophoresis; Female; Graves Disease; Humans; Hypert | 1971 |
Determination of total and free serum thyroxine in thyroid diseases.
Topics: Chromatography, Paper; Goiter; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; Hypothyroid | 1971 |
[Long-term treatment of hyperthyroidism using antithyroid substances in combination with synthetic thyroid hormones].
Topics: Drug Synergism; Goiter; Graves Disease; Humans; Hyperthyroidism; Imidazoles; Long-Term Care; Sulfhyd | 1971 |
[Results of long-term therapy in euthyroid endocrinal ophthalmopathy].
Topics: Graves Disease; Humans; Long-Term Care; Prednisone; Thyroxine | 1971 |
Alterations in circulating estradiol-17-beta in male patients with Graves's disease.
Topics: Adolescent; Adult; Aged; Child; Estradiol; Follicle Stimulating Hormone; Graves Disease; Gynecomasti | 1972 |
What the internist should know about the ophthalmopathy of Graves' disease.
Topics: Adult; Diplopia; Eye; Eye Diseases; Eye Injuries; Eye Manifestations; Eyelid Diseases; Female; Glauc | 1972 |
[Therapy of endocrine ophthalmopathies].
Topics: Graves Disease; Humans; Iodine Isotopes; Thyroid Function Tests; Thyroxine | 1972 |
Premature craniosynostosis associated with hyperthyroidism in 4 children with reference to 5 further cases in the literature.
Topics: Bone Development; Child; Child, Preschool; Craniosynostoses; Female; Graves Disease; Growth; Humans; | 1972 |
Clinical experience with assays for triiodothyronine.
Topics: Animals; Antibodies; Chromatography, Paper; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism | 1972 |
Iodoamino acid composition of the thyroglobulin of normal and diseased thyroid glands. Comparison with in vitro iodinated thyroglobulin.
Topics: Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Diiodotyrosine; Goiter; Graves Disease; | 1972 |
Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
Topics: Adult; Graves Disease; Humans; Hyperthyroidism; Methimazole; Methylthiouracil; Propylthiouracil; Rad | 1972 |
The physiological role of triiodothyronine.
Topics: Goiter, Endemic; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine Isotopes; Radioimmu | 1972 |
35-S-sulfate uptake by mouse harderian gland: effect of serum from patients with Graves' disease.
Topics: Animals; Chromatography; Eye Diseases; Graves Disease; Hyperthyroidism; Hypothyroidism; Immunoglobul | 1971 |
Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function.
Topics: Adolescent; Adult; Age Factors; Aged; Basal Metabolism; Blood Proteins; Carcinoma; Child; Child, Pre | 1971 |
[Diagnosis and treatment of the so-called toxic adenoma of the thyroid gland].
Topics: Adenoma; Diagnosis, Differential; Graves Disease; Humans; Iodine Isotopes; Iodine Radioisotopes; Thy | 1971 |
[Thyroid gland inhibition test in patients with endocrine ophthalmic diseases].
Topics: Adult; Aged; Diagnosis, Differential; Eye Diseases; Eye Manifestations; Graves Disease; Humans; Hype | 1971 |
[Basedow's disease with acute thyrotoxic crisis in a 25-month-old girl].
Topics: Arrhythmias, Cardiac; Carbimazole; Child, Preschool; Dehydration; Diarrhea; Female; Graves Disease; | 1971 |
The role of gammacinematography in thyroid surgery.
Topics: Carbimazole; Depression, Chemical; Goiter; Graves Disease; Humans; Iodine Isotopes; Methods; Radionu | 1969 |
[Endocrine ophthalmopathy].
Topics: Exophthalmos; Eye Diseases; Graves Disease; Humans; Hyperthyroidism; Myxedema; Thyroid Gland; Thyrox | 1969 |
[LATS production by lymphocyte culture].
Topics: Amino Acids; Animals; Antibody Formation; Antigens; Carbon Isotopes; Chromatography, DEAE-Cellulose; | 1969 |
Thyroid gland in Graves' disease: victim or culprit?
Topics: Adolescent; Adult; Aged; Analysis of Variance; Graves Disease; Humans; Immunoglobulin G; Iodine Radi | 1970 |
On the mechanism of the McKenzie bioassay.
Topics: Animals; Biological Assay; Blood Proteins; Chromatography, Ion Exchange; Female; Graves Disease; Inj | 1970 |
Abnormalities in thyroid hormone production and metabolism in hyperthyroidism.
Topics: Diiodotyrosine; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Monoiodotyrosine; Thyroi | 1970 |
[Diseases of the thyroid gland].
Topics: Daunorubicin; Goiter; Graves Disease; Hematologic Diseases; Hodgkin Disease; Humans; Hyperthyroidism | 1967 |
[Basedowian ophthalmopathies. Pathogenic role of 1-triiodothyronine and LATS. Therapeutic role of 1-thyroxine, d-thyrosine and corticoids].
Topics: Adrenal Cortex Hormones; Graves Disease; Humans; Long-Acting Thyroid Stimulator; Thyroxine; Triiodot | 1967 |
Iodine kinetics in man--a model.
Topics: Computers; Graves Disease; Humans; Hyperthyroidism; Hypophysectomy; Hypothyroidism; Iodides; Iodine; | 1968 |
["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, Newborn, Diseases; | 1968 |
Long acting thyroid stimulator (LATS) and iodo-amino acids in localized pretibial myxeodema.
Topics: Adult; Blood Proteins; Diiodotyrosine; Female; Graves Disease; Humans; Iodine; Long-Acting Thyroid S | 1968 |
Ophthalmopathy with hypothyroidism.
Topics: Adult; Female; Goiter; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Prednisone; Thyroxin | 1968 |
[On the pathogenetic significance of hypophyseal factors in endocrine ophthalmopathy].
Topics: Adult; Exophthalmos; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Male; Middle | 1969 |
The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Topics: Adult; Autoantibodies; Exophthalmos; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotope | 1969 |
The hyperfunctioning thyroid nodule.
Topics: Adenoma; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; | 1969 |
[On the problems of pathogenesis of Basedow's disease and thyrotoxicosis as well as endocrine ophthalmopathy].
Topics: Graves Disease; Humans; Hyperthyroidism; Lymphocytes; Pituitary Hormones, Anterior; Thymus Gland; Th | 1965 |
[On the goiter-deafness syndrome (Pendred)].
Topics: Adolescent; Cell Division; Deafness; Female; Graves Disease; Humans; Peroxidases; Thyroxine | 1965 |
D-thyroxine in the treatment of patients with endocrine exophthalmos.
Topics: Graves Disease; Humans; Thyroxine | 1964 |
The radiothyroxine turnover study in the diagnosis of thyroid disease.
Topics: Adult; Congenital Hypothyroidism; Female; Graves Disease; Humans; Hyperthyroidism; In Vitro Techniqu | 1966 |